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Summary 
Aspergillus fumigatus is an opportunistic pathogen which can cause severe 
disease in immunocompromised patients. A. fumigatus produces metabolites, 
through a non-ribosomal peptide synthesis mechanism, including iron-chelating 
molecules known as siderophores and other unusual compounds such as gliotoxin. 
These provide the fungus with a unique strategy for survival in the host, and 
contribute to pathogenicity. The aim of this project was to identify interactions 
between non-ribosomal peptide synthetase genes (termed pes1 and sidD) and to 
identify metabolites produced by these genes, which contribute to the virulence of A. 
fumigatus in immunocompromised patients.  
A. fumigatus pes1 mutants (pes1) were generated in three genetic backgrounds 
(akuB, ATCC46645 and sidD46645), confirmed by Southern blot and qRT-PCR 
analysis. A. fumigatus ∆akuB:∆pes1 was significantly more sensitive to oxidative 
stress than wild-type (P < 0.01). It was found that, in vitro, either pes1 or sidD 
significantly improved fungal tolerance to anti-fungal drugs (amphotericin B and 
voriconazole, respectively) which strongly suggests that either gene may play a role 
in mediating drug resistance/tolerance in patients. It was found that under oxidative 
stress conditions that this double mutant was significantly less sensitive to iron-
limiting conditions than A. fumigatus ∆sidD, indicating that the peptide encoded via 
pes1 is involved in the response of siderophore-deficient A. fumigatus to low iron 
availability, such as during infection. Compared to wild-type A. fumigatus, 
∆sidD:∆pes1 was significantly less virulent than either single mutant in the Galleria 
mellonella virulence model system. Significantly, pes1 was found to be involved in 
the biosynthesis of the conidial metabolite, fumigaclavine C, as this metabolite was 
absent in both A. fumigatus ∆akuB:∆pes1 and ∆pes146645.  
In parallel studies, we identified a gene (gliK) responsible for gliotoxin 
biosynthesis and showed that gliK is involved in protecting A. fumigatus against 
oxidative stress, gliotoxin presence and secretion of gliotoxin from A. fumigatus. 
Overall, our findings may lead to improvements in therapy for patients suffering 
from invasive aspergillosis in the medium-to long-term. 
  
 
 
 
 
 
 
CHAPTER 1 
 
 
 
Introduction 
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1. Introduction 
1.1 General Characteristics of Aspergillus fumigatus 
Aspergillus fumigatus is a member of the Ascomycetes class of fungi. It is an 
ubiquitous soil dwelling fungus that is found mainly in decaying vegetation. 
Environmentally, A. fumigatus plays an important role in nitrogen and carbon 
recycling (Dagenais and Keller, 2009). A. fumigatus is thermostable and can survive 
in temperatures of up to 70 oC and still maintain growth at 55 oC (Latge, 1999). It 
forms septate mycelia which reproduce asexually by the production of conidial 
spores (Figure 1.1). The conidia are arranged in conidiophores where millions of 
conidia are attached in chains of eight spores (Figure 1.1) (Latge, 1999). Conidia (2 – 
3 µm in diameter) are released from the conidophore and easily become airborne 
(Denning et al., 2002). The released conidia undergo germination to form septate 
hyphae. A. fumigatus colonies are distinguishable from other fungi due to their grey-
green colour as a result of the conidia pigmentation (Figure 1.1). Although generally 
considered to reproduce by asexual means, genes involved in the sexual cycle are 
present in the A. fumigatus genome (Dyer and Paoletti, 2005). Recently, 
identification of the sexual cycle in A. fumigatus was discovered, confirming sexual 
reproduction in the fungus (O'Gorman et al., 2009). The genus Aspergillus contains 
over 250 species (Geiser et al., 2007). However, only a small number of the species 
are pathogenic including Aspergillus fumigatus, Aspergillus niger, Aspergillus 
terreus, Aspergillus nidulans and Aspergillus flavus (Mabey et al., 2004). Of these 
few pathogenic species, A. fumigatus is the most pathogenic, and is responsible for 
approximately 90 % of all invasive aspergillosis infections (Dagenais and Keller, 
2009).  
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Figure 1.1: Lifecycle of A. fumigatus (A) The conidia released from the 
conidiophores germinate to form septate mycelia which produce conidiophores that 
release the conidia (Latge, 1999), (B) Scanning electron microscopy (SEM) of 
conidiophores (Taken from Latge, 2002) and (C) The grey-green colour of A. 
fumigatus due to the pigmentation of the conidia. 
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1.2 Pathogenesis of Aspergillus fumigatus 
A. fumigatus is an opportunistic pathogen, due to the inhalation of up to 100 
spores by any individual in a day. Any unchallenged conidia can lodge in the alveoli 
of the lungs and germinate; establishing an Aspergillus infection, particularly in 
immunocompromised individuals. The germinating conidia form a mycelial mass, 
begin to fill the lungs, and can potentially disseminate throughout the body. 
Normally, a healthy individual will clear any conidia by the innate immune response, 
usually by phagocytotic killing (Segal, 2007). Immunocompromised individuals are 
susceptible to Aspergillus infection as their immune system can be defective and will 
not clear conidia efficiently (Dagenais and Keller, 2009). The burden of this 
additional infection can easily result in death, thus A. fumigatus is one of the most 
virulent pathogenic fungi.  
An infection by an Aspergillus spp. is called aspergillosis and this type of 
infection can be divided into degrees of severity, where invasive aspergillosis (IA) is 
the most fatal type of infection (Latge, 1999). Other infections include chronic cavity 
pulmonary aspergillosis (CCPA), and allergic bronchopulmonary aspergillosis 
(ABPA) and saprophytic aspergilloma (Buckingham and Hansell, 2003). 
Aspergilloma or “fungal ball” is a term used to describe the growth of Aspergillus 
spp. in the cavities of the lung that were created by pre-existing lung diseases or 
disorders such as tuberculosis or sarcodosis. Individuals with aspergilloma are 
usually asymptomatic and are only diagnosed by chance due to chest X-rays taken 
for a different pulmonary symptom (Latge, 1999). Individuals diagnosed with 
aspergillomas in the cavities of the chest are diagnosed with CCPA. 
ABPA is a long-term hypersensitivity disorder which is a common complication 
in individuals with cystic fibrosis and asthma (Denning, 2001). ABPA results from 
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increased mucus levels within the lungs of these individuals which enables the 
germination of conidia. This is a persistent disease which can be distinguished from 
other Aspergillus infections due to hallmark elevation of IgE (Moss, 2002).  
IA is characterised by the expansion of the aspergilloma from lung cavities into 
the surrounding tissue and then disseminating throughout the body. The incidence of 
IA has increased dramatically due to the increase in transplant and chemotherapy 
patients who are immunosuppressed (Baddley et al., 2001; Marr et al., 2002; 
Cordonnier et al., 2006). The mortality rate associated with IA ranges from 60 – 90 
% depending on the primary condition causing the immunosuppression (Latge, 
1999).  
 
1.2.1 Toxins and virulence factors associated with A. fumigatus 
A. fumigatus can release a variety of toxins into the surrounding environment to 
kill other competing microorganisms (Calvo et al., 2002), which the fungus uses to 
enhance its survival in the environment (Losada et al., 2009).  
The pathogenesis of A. fumigatus is enhanced by virulence factors. One of the 
best studied fungal toxins is gliotoxin, which is produced by many fungal species 
(Figure 1.2). It is acutely toxic with immunosuppressive properties (Sutton et al., 
1994). It is a member of the epipolythiodioxopiperazine (ETP) family and is 
characterised by a disulphide bridge across a diketopiperazine ring. Gliotoxin will be 
discussed further in Chapter 5.  
Another important toxin found in A. fumigatus is fumagillin, which is an anti-
tumour antibiotic which inhibits angiogenesis (Figure 1.2) (Rementeria et al., 2005). 
It exhibits a toxic affect by inhibiting the proliferation of endothelial cells and 
restricts the cillary functions of the human respiratory epithelium. It works by 
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targeting the enzyme methionine aminopeptidase 2, and forms an irreversible bond 
(Bunger et al., 2004). It has been recently demonstrated that fumagillin can alter 
neutrophil activity and therefore reduce the localised immune response (Fallon et al., 
2010).  
Helvolic acid, otherwise known as fumigacin, is a member of a family of natural 
steroid antibiotics known as fusidanes, which is also produced by A. fumgiatus 
(Figure 1.2) (Rementeria et al., 2005). It can have an effect on the oxidative burst of 
macrophages and can rupture epithelial cells (Amitani et al., 1995).  
Verruculogen is a member of the indole alkaloid group called tremorgens (Figure 
1.2). This toxin has neurotoxic properties and is secreted from the mycelia during 
growth.  
Fumigaclavines are metabolites produced by Aspergillus spp. and other fungi 
(Figure 1.2). There are seven members of this ergot alkaloid group, which are 
characterised by the four-member ergoline ring (Coyle and Panaccione, 2005), 
named: Agroclavine, Festuclavine, Elymoclavine, Chanaclavine, Fumigaclavine A, 
B and C (Frisvad et al., 2009). Ergot alkaloids are associated with conidia, and 
represent 1 % of the conidial content (Panaccione and Coyle, 2005). There are four 
alkaloids identified in order of abundance in A. fumigatus:  Fumigaclavine C, 
festuclavine, fumigaclavine A and fumigaclavine B. Fumigaclavine C accounts for 
1.2 – 12 mg/g conidia, depending on the media used to grow the fungus. 
Fumigaclavine C has been shown to effect T lymphocytes by inhibiting their 
activation and proliferation, as well as reducing production of TNFα (Rementeria et 
al., 2005). Fumigaclavine C will be discussed further in Chapter 4. 
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Figure 1.2: Chemical structures of toxins secreted from Aspergillus fumigatus. 
 
A. fumigatus produces such a wide range of metabolites that can be classified into 
24 different families (Frisvad et al., 2009). Many metabolites that help the survival 
of A. fumigatus in a human host are considered to be important virulence factors. 
Due to the hosts immune response and sub-optimal conditions, the fungus has 
evolved a battery of extracellular products to acquire essential nutrients, such as iron 
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to survive (Losada et al., 2009). Siderophores are responsible for recruiting iron in 
iron-depleted conditions (Howard, 1999). As iron is crucial for all living organisms, 
the ability of the fungus to ensure a constant supply of this essential metal is 
extremely important for fungal survival in a human host (Hissen et al., 2004). The 
role of siderophores in fungal pathogenicity will be discussed in more detail later in 
this chapter.  
A. fumigatus produces small basic ribosome-inactivating proteins (17 kDa), 
called ribotoxins, such as restrictocin, α-sarcin and mitogillin (Tomee and Kauffman, 
2000). These inhibit protein synthesis and function by catalytically inactivating the 
large ribosomal subunits. Restrictocin is one of the best studied ribotoxins, and has 
been shown to be highly toxic to eukaryotic cell lines in the nanomolar range (Nayak 
et al., 2001).  
The metabolites involved in virulence contribute to fungal survival in the human 
host. Thus, identifying genes encoding metabolite biosynthesis, which contribute to 
the virulence of the fungus, may pinpoint possible targets for future anti-fungal 
therapies. 
 
1.2.2 Current methods for detection and treatment of A. fumigatus infection 
The current methods for detecting and treating A. fumigatus are invasive, 
expensive and can be ineffective. Therefore it is a necessity to continue searching for 
possible anti-fungal targets in A. fumigatus (Krishnan-Natesan and Chandrasekar, 
2008). The current methods for detecting A. fumigatus infection are by X-ray or CT 
scan of the lungs, in which the mycelia mass has become so well established that the 
fungal mass is visible (Maschmeyer et al., 2007). These methods also establish if 
cavities have been formed as a result of an infection. A bronchoscopy may be 
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performed, where tubing is sent down into the lungs, and airways, facilitating the 
retrieval of biopsies and fluid samples for examination (Cockrill and Hales, 1999).  
Non-invasive tests include (i) Galactomannan detection, (ii) (1-3)β-glucan 
detection and (iii) PCR amplification of specific regions of the fungal genome. 
Galactomannan is a heat-stable heteropolysaccharide present in the cell wall of most 
Aspergillus and Penicillium species (Verdaguer et al., 2007). The galactomannan 
assay uses EB-A2, a monoclonal antibody derived from rats, which detects the 
β(1,5)-linked galactofuranoside side-chain residues of the galactomannan molecule 
(Hope et al., 2005). Using the ELISA sandwich method, detection is confirmed due 
to the multiple immunoreactive epitopes on an individual molecule of 
galactomannan. The sensitivity of the assay can be compromised due to the fact that 
the binding of EB-A2 requires for a positive result four or more galactofuranoside 
epitopes, and therefore, a sub-optimal amount of binding may not be enough for 
valid detection (Hope et al., 2005).  The galactomannan detection assay is 
commercially available as PlateliaTM Aspergillus (Bio-Rad Laboratories, Marnes-La-
Coquette, France and Bio-Rad Laboratories, Hercules, CA, USA).  
(1-3)β-glucan is present in the cell wall of most fungi (Maertens et al., 2007), 
hindering the use of this molecule as a specific A. fumigatus analyte. The (1-3)β-
glucan molecule is able to activate the coagulation cascade, via a serine protease 
zymogen, within amoebocytes derived from the haemolymph of horseshoe crabs 
(Maertens et al., 2007). The activated clotting enzyme can be detected via cleavage 
of synthetic chromogenic substrate, which is the basis of the assay. As the (1-3)β-
glucan assay is carried out using serum specimens, consideration needs to be given to 
the presence of serine protease inhibitors found in human plasma, which need to be 
inactivated before use in the assay (Hope et al., 2005). The β-glucan assay is 
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available in three commercial forms: FungitellTM (Associates of Cape Cod Inc., East 
Falmout, MA, USA), Fungi-Tec GTM (Seikagaku Kogyo Corporation, Tokyo, Japan) 
and Wako-WB003 (Wako Pure Chemical Industries, Osaka, Japan). 
PCR detection can be carried out by the use of pan-fungal primers that are used 
to amplify conserved regions in the DNA of fungal species. Ribosomal DNA (rDNA) 
is the most common target, specifically targeting the 18S (Halliday et al., 2006), 28S 
(White et al., 2006) and 5.8S genes as well as the internal transcribed spacer (ITS) 
regions, ITS1 and ITS2 (Lau et al., 2007). PCR amplification has been used in 
conjunction with other diagnostic tools to enable a more sensitive and specific 
evaluation of Aspergillus infection. This includes the combination of mitochondrial 
PCR amplification with the galactomannan ELISA assay, named PCR-ELISA 
(Florent et al., 2006). More specific PCR targets are being identified that can be used 
as a detection method for A. fumigatus infection but there is a lack of standardisation 
with these PCR assays (Thornton, 2010). 
A new avenue for the detection of A. fumigatus infection being explored is the 
lateral flow device (Thornton, 2008). The basis for this type of detection is based on 
the murine monoclonal antibody, MAb JF5, which is raised against a protein epitope 
on an N-linked glycoprotein antigen present in the hyphal cell wall of A. fumigatus. 
This analyte is present in Aspergillus species, as well as closely related species. 
Unfortunately, there was weak cross-reactivity with some Penicillium species, but 
there was no cross-reactivity with antigens that are the cause of false positives in the 
galactomannan test (Thornton, 2008). Comparing the commercially available assays, 
it was found that the lateral flow device was more sensitive than the galactomannan 
test and the (1-3)β-D-glucan test (Wiederhold et al., 2009). Therefore, the use of the 
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MAb JF5 may be a more selective antibody to use compared to the EB-A2 antibody 
in the future.   
 
Treatment of A. fumigatus infection is mainly based on the principle that 
ergosterol is the main sterol found in fungal cell membranes, whereas cholesterol is 
the mammalian counterpart (Beauvais and Latge, 2001). Treatments either target 
ergosterol of the fungal membrane directly or inhibit ergosterol biosynthesis, leaving 
production of the mammalian sterol, cholesterol, intact and uninhibited. In 2001, the 
only drugs available for the treatment of A. fumigatus infections were either 
amphotericin B - a polyene agent, or itraconazole - an azole agent  (Figure 1.3) 
(Beauvais and Latge, 2001). Since 2001, “second generation” azoles have been 
developed, namely, fluconazole, voriconazole and posaconazole (Figure 1.3).  
Amphotericin B works by binding to the membrane sterols which results in the 
formation of pores. Beyond this, it is unclear what the precise mode of action is 
which causes irreversible cell damage to the fungus. Even though amphotericin B has 
been used for decades, there is a major drawback due to the toxic effects of its use in 
the mammalian host (Del Bono et al., 2008). Hence, the discovery of azole 
alternatives was a huge advancement in the treatment of A. fumigatus infections 
(Maretens, 2004). Azole inhibition targets P450 demethylase, which is involved in 
the conversion of lanosterol to ergosterol (White et al., 1998). This inhibition leads 
to the accumulation of methylated sterols and depletion of ergosterol, resulting in 
leakage through the cell membrane (Beauvais and Latge, 2001).  
Itraconazole is a broad spectrum triazole which is less toxic than amphotericin B. 
It has good activity against Candida spp., Aspergillus spp., and other fungal 
pathogens (Maretens, 2004). Fluconazole can be used in mucocutaneous candidiosis 
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but does not have a useful activity against filamentous fungi (Maretens, 2004). 
Voriconazole has a wide spectrum in vitro activity against fungi from all clinically 
important pathogenic groups. Additionally, it is several-fold more active than 
fluconazole and itraconazole against Candida spp. However, resistant strains of 
Candida spp. to fluconazole and itraconazole have also shown resistance to 
voriconazole (Maretens, 2004). Posaconazole is a hydroxylated analogue of 
itraconazole. It also has a broad spectrum activity against opportunistic pathogens, 
including zygomycetes. It has the same activity as voriconazole and is more effective 
than amphotericin B, fluconazole and itraconazole (Maretens, 2004). 
Caspofungin is a member of the family of echinocandins, which disrupt the cell 
wall synthesis of fungi by inhibiting the synthesis of (1-3)β-glucan (Heinz and 
Einsele, 2008). This is a different target than the other anti-fungal drugs as it does not 
interact with cytochrome P450, ensuring that drug-drug interactions are not a 
limitation for dual drug therapy.  Caspofungin has showed promise in use against 
Aspergillus infections in organ transplantation patients (Groetzner et al., 2008), as 
well as in combination therapy with voriconazole (Thomas et al., 2010).  
The emergence of anti-fungal drug resistance by A. fumigatus is of great concern, 
as there has been a significant rise in the frequency of azole resistant A. fumigatus 
strains since 2004 (Howard et al., 2009), with many isolates displaying cross-
resistance between all the current azole drugs. Even more disconcerting, is the 
emergence of zygomycosis, an infection by Zygomycetes, in patients treated with 
voriconazole (Kontoyiannis et al., 2005). It is thought that the increase in this 
opportunistic mycosis is due to its resistance to voriconazole and this selective 
preference for zygomycosis is increasing the virulence potential of the organism 
(Lamaris et al., 2009).  Hence there is a requirement for the identification of new 
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anti-fungal drug targets that can be used to alleviate the reliance on voriconazole, and 
also to introduce new drugs with fewer side-effects and higher efficacy. 
 
 
Figure 1.3: Structures of anti-fungal drugs used in the treatment of infections caused 
by Aspergillus spp. and other fungal pathogens. 
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1.3 Genome sequencing and identification of gene clusters 
Sequencing of the genome of A. fumigatus (strain AF293) in 2005 has led to 
many important advances in the study of this pathogenic fungus, resulting in a better 
understanding of the fungus (Nierman et al., 2005). The in silico annotated genome 
of A. fumigatus and other Aspergillus genome sequences are available at the Central 
Aspergillus Data Respository (CADRE) (http://www.cadre-genomes.org.uk) (Mabey 
et al., 2004) where the genome can be analysed using ContigView, Geneview and 
Protview providing in silico information on the transcript queried by the user, such as 
genomic DNA (gDNA) and cDNA sequences, protein sequences, chromosome 
location, neighbouring genes, size of transcript, and number of introns. 
 The entire 29.4 Mb genome was sequenced and showed that A. fumigatus 
contains 9926 predicted genes, of which 3288 were genes with an unknown function 
(Nierman et al., 2005). Concurrently, the genomic sequencing of A. oryzae was 
carried out (Machida et al., 2005) as well as sequencing of A. nidulans (Galagan et 
al., 2005). Comparative genomics was used to analyse the genome of A. nidulans 
with reference to A. fumigatus and A. oryzae (Galagan et al., 2005). Two more A. 
fumigatus strains were sequenced in 2008, A. fumigatus A1163 and A. clavatus 
NRRL1, along with the closely related Neosartorya fischeri strain NRRL181 
(Fedorova et al., 2008). Here, it was noticed in phylogenomic analysis, that four of 
the virulence associated genes, a para-aminobenzoic acid synthetase, pabaA, a 
histidine kinase, fos-1, a polyketide synthase gene, pksP, involved in conidial 
pigment biosynthesis and a non-ribosomal peptide synthetase, pes1, showed 
accelerated evolution in the branch leading to the two A. fumigatus strains, indicating 
a positive selection for these genes as an evolutionary selection advantage.  
14 
 
Genes used for a common purpose are generally found in clusters in the 
genome (Figure 1.4), and are generally species-specific (Nierman et al., 2005). 
There are 26 gene clusters involved in the production of secondary metabolites 
divided into polyketide synthetase, non-ribosomal peptide synthetase and/or 
dimethylallyl tryptophan synthetase genes (Nierman et al., 2005; Stack et al., 
2007). The identification of these metabolites as ‘secondary’ does not signify the 
importance of the respective molecules, just that they are not involved in primary 
growth and development of the fungus (Keller et al., 2005). Secondary 
metabolites are dispensable by the fungus on an individual basis, but are 
produced during specific times in the life cycle (Calvo et al., 2002). Most 
secondary metabolite clusters contain a transcriptional regulator, indicating that 
the cluster regulates the expression of the genes contained within the cluster. 
Only 13 of these clusters have orthologues identifiable in A. oryzae or A. 
nidulans and even in the clusters identified, ten clusters are missing many of the 
genes identified in A. fumigatus (Nierman et al., 2005). Secondary metabolite 
gene clusters are usually located near telomeres (Keller et al., 2005). However, a 
major challenge still exists for the association of a particular gene cluster with 
production of a specific secondary metabolite. 
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Figure 1.4: Gene clusters which encode metabolite production in A. fumigatus. 
Although gene cluster organisation is known, the functions of individual genes 
within clusters, or trans-acting events between clusters, remain unclear. *Cluster 
identified to date (Unsold and Li, 2005; Steffan et al., 2009). 
 
1.4 Non-ribosomal peptide synthetases 
Non-ribosomal peptide synthetases (NRP synthetases) are multifunctional 
enzymes that catalyse the biosynthesis of a variety of peptides in bacteria and fungi 
(Figure 1.5). The products include the medically-important penicillin, from A. 
nidulans (Bok and Keller, 2004), toxins such as HC-toxin from Cochliobolus 
carbonum (Pitkin et al., 1996) and gliotoxin from A. fumigatus (Sugui et al., 2007), 
surfactin from Bacillus subtilis (Steller et al., 2004) and siderophores from A. 
fumigatus (Hissen et al., 2004). The wide variety of products of NRPS and the 
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importance of such products have stimulated much interest in the biosynthesis of 
these products (Bok et al., 2006b).  
In brief, the synthesis of non-ribosomal peptides consists of NRP synthetase gene 
activation, either involved in a cluster of genes or individually. The NRP synthetase 
enzyme generates the NRP peptide by incorporating substrates into a chain by mono- 
or multi-modular NRP synthetases, where each module is responsible for the 
generation of individual components of the final peptide. The NRP synthetase is 
activated by the transfer of a phosphopantetheine group (Ppant) from Coenzyme A to 
a specific residue in the NRP synthetase. The transfer of Ppant is facilitated by the 
activity of 4’-phosphopantetheinyl transferase (4’PPtase). The peptide chain 
generated by the NRP synthetase can then undergo modification and release from the 
NRP synthetase as the final NRP peptide product (Figure 1.5).  
 
 
Figure 1.5: Schematic overview of the process of, and enzyme functions, involved in 
NRP synthesis (Stack et al., 2007). 
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Amino acid selection and activation in ribosomal protein synthesis is carried out 
by the action of tRNA synthases, whereby amino acyladenylate is converted to 
amino acyl-tRNA (Stachelhaus and Marahiel, 1995). The mechanism by which NRP 
synthetases produce peptides is similar as amino acid selection and activation is 
carried out by the adenylation domains in NRP synthetases, but there are two major 
differences in this process. Firstly, ribosomal peptide synthesis only uses the 20 
proteinogenic amino acids resulting in this type of synthesis only capable of making 
linear chains (Stachelhaus et al., 1996), whereas, NRP synthetases are capable of 
using a wide variety of substrates such as fatty acids and α-hydroxy acids, as well as 
other non-proteinogenic and proteingoenic amino acids (Caboche et al., 2008). 
Secondly, ribosomal protein synthesis involves strict proof-reading to ensure the 
correct substrate specific for the reaction, whereas non-ribosomal synthesis shows 
less strict substrate selection and incorporation (Stachelhaus et al., 1999).   
 
1.4.1 Structure arrangement and domains 
 NRP synthetases are composed of discrete domains, namely, adenylation (A), 
thiolation (T) (also known as peptidyl carrier protein (PCP)) and condensation (C). 
These domains group together as a distinct module of the NRP synthetase. Some 
NRP synthetase genes have additional domains present, such as epimerase (E) 
domains which are responsible for the L- to D- amino acid conversion and 
thioesterase (TE) domains which are involved in the release of the synthesised 
peptide from the NRP synthetase. Each module is responsible for the activation of a 
specific amino acid for protein synthesis, selected from a wide range of substrates 
which include more than just the 20 proteinogenic amino acids, as previously 
mentioned, which add to the diverse range of functions of non-ribosomally 
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synthesised peptides (Stachelhaus et al., 1996). Furthermore, these peptides can also 
be modified through N-methylation, acylation, glycosylation and hererocyclic ring 
formation (Stachelhaus et al., 1996). An NRP synthetase gene can be multi-modular 
where more than one module is involved in creating the entire peptide in which each 
individual module is responsible for incorporating one amino acid into the final 
peptide (Kleinkauf and Von Dohren, 1996). The order of the modules determines the 
sequence of the peptide product (Stachelhaus et al., 1996). The general NRP 
synthetase domain arrangement is at its basic level composed of an initiation module, 
followed by elongation modules which build the “growing” peptide, and finishes 
with a termination module (Lautru and Challis, 2004). A diagram of the Pes1 domain 
architecture (Reeves et al., 2006) is detailed in Figure 1.6.  
 
 
Figure 1.6: Diagram representing the Pes1 domain architecture consisting of 4 
adenylation domains (A1 – A4), five thiolation domains (T1 – T5), five condensation 
domains (C1 – C5) and two eperimisation domains (E1 & E2). 
 
NRP synthetases are classified into three classes: (A) linear, (B) iterative and (C) 
nonlinear (Figure 1.7) (Mootz et al., 2002).  
Linear NRP synthetase types have the classic architecture of C-A-T and the each 
module is only used once in the production of the peptide, as each module 
incorporates an individual amino acid and adds to the growing chain of the peptide. 
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Examples of linear NRP synthetases proteins include surfactin, cyclosporin and 
ACV, the penicillin precursor (Mootz et al., 2002).  
Iterative NRP synthetase types use the modules more than once to produce 
repeats of small peptides that are combined to make the final single peptide. Hence, 
this NRP synthetase type consists of a smaller number of modules, where each 
module produces the same number of peptides as the other modules within the NRP 
synthetase. Examples of iterative NRP synthetases proteins include enterobactin and 
gramicidin S (Mootz et al., 2002).  
Non-linear NRP synthetase types deviate from the standard linear architecture, 
notably by the presence of at least one unusual arrangement of the standard C-A-T 
domain arrangement. This deviation usually results in internal cyclizations or branch-
point synthesis. Examples of non-linear NRPS synthesised peptides include 
syringomycin and bleomycin (Mootz et al., 2002). 
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Figure 1.7: Classification of NRPS classes where the NRPS are divided into linear, 
iterative and nonlinear types (Mootz et al., 2002). The arrangement of the domains 
due to the specific architecture results in the variety of NRP synthetase products. 
 
NRP synthetases are produced in an inactive apo-form and require post-
translational modification to become the active halo-form (Lambalot et al., 1996). 
The post-translational modification is carried out by transfer of a 4’-
phosphopantetheine group from Coenzyme A, to a specific conserved serine residue 
within the thiolation domain(s) of the NRP synthetase and this reaction is catalysed 
by 4’-PPtase (Figure 1.8). The addition of the –SH of the Ppant group acts as a 
nucleophile for acylation by the adenylation domain specific substrate (Lambalot et 
al., 1996). The 4’-PPtase was only identified recently in A. fumigatus (Keszenman-
Pereyra et al., 2003; Oberegger et al., 2003; Neville et al., 2005; Stack et al., 2009). 
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Using the A. fumigatus 4’-PPtase, a homologue was identified in A. nidulans (NpgA) 
(Keszenman-Pereyra et al., 2003). The 4’-PPTase found in A. nidulans (NpgA) was 
found to be used in a diverse range of enzymes used in primary and secondary 
metabolism, including the production of penicillin (Keszenman-Pereyra et al., 2003; 
Oberegger et al., 2003).  
 
 
Figure 1.8: Conversion of apoprotein (apo – acyl carrier protein) to holoprotein by 
transfer of Ppant from Coenzyme A catalysed by 4’pptase (Lambalot et al., 1996) 
 
1.4.2 Mechanisms 
The mechanism by which NRP synthetase enzymes facilitate the generation of a 
peptide by a specific substrate has been widely studied (Meier and Burkart, 2009). 
The adenylation domain chooses a specific amino acid substrate via binding to a non-
linear selective pocket of around 8 – 10 amino acids in the domain (Schwarzer et al., 
2003). These amino acids consisting of these non-linear motifs are called core 
motifs, found throughout the adenylation domains and are highly conserved (Table 
1.1) (Schwarzer et al., 2003).  
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Table 1.1: Core MOTIFS of NRP synthetase adenylation domains according to 
Schwarzer et al., 2003, where the core motifs are recognised by the pattern of amino 
acids. 
NRP synthetase adenylation domain core motifs* 
A1 L(TS)YxEL 
A2 LKAGxAYL(VL)P(LI)D 
A3 LAYxxYTSG(ST)TGxPKG 
A4 FDxS 
A5 NxYGPTE 
A6 GELxJGX(VL)ARGYL 
A7 Y(RK)TGDL 
A8 GRxPxQVKIRGxRIELGEIE 
A9 LPxYM(IV)P 
A10 NGK(VL)DR 
* amino acids in brackets are alternative choice of amino acids that can be 
used to create the same core motif. 
 
Some of the bacterial adenylation domain-specific substrates have been 
identified, leading to the identification of specific substrates of some bacterial NRP 
synthetases including gramicidin S synthetase 1, GrsA, involved in the production of 
gramicidin S, which has shown substrate specificity for L-phenylalanine in the 
adenylation domain (Conti et al., 1997). The fungal adenylation domain specific 
substrates also remain elusive with only a handful identified, some of which are 
detailed in Table 1.2 (Doyle, 2009).  
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Table 1.2: Adenylation domain substrate specificity of fungal NRP or PK/ NRP 
synthetases (Taken from Doyle, 2009). 
Enzyme 
type 
Final product Adenylation domains Species Reference 
NRP synthetases 
SidD TAFC A1( N5-cis-
anhydromevalonyl-N5-
hydroxy-L-ornithine 
A. fumigatus Schrettl et al. (2007) 
SidC FCa N5-acetly-N5-
hydroxy-L-ornitine, 
Ser, Glyb 
A. fumigatus Schrettl et al. (2007) 
GliP Gliotoxin A1 (L-Phe) and  
A2 (L-Ser) 
A. fumigatus Baliber et al. (2006) 
Hybrid polyketide/NRP synthetases 
FUSS Fusarin C A1 (homoserine) Fusarium 
moniliforme 
Rees et al. (2007) 
TENS 2-pyridone 
tenellin 
L-Tyrc Beauveria 
bassiana 
Eley et al. (2007) 
PsoA pseurotin A L-Phe A. fumigatus Maiya et al. (2007) 
TdiA terrequinone A Arylic acidc A. nidulans Bok et al. (2006b) 
CheA cytochalasan L-Trp Penicillium 
expansum 
Schümann et al. (2007) 
a
 Ferricrocin (FC) can be converted to hydroxyferricrocin (HFC) by ferricrocin 
hydroxylase. 
b
 Precise coding potential of each domain remains to be demonstrated. 
c
 Proposed substrate. 
 
Once the adenylation domain binds the specific substrate, the activated substrate 
is transferred to the thiolation domain (or PCP domain) (Weber and Marahiel, 2001). 
Here, the Ppant group from Coenzyme A is tethered to the thiolation domain, and 
this group accepts the activated substrate. The thiolation domain is similar to the 
Acyl Carrier Proteins (ACP) of fatty acid and polyketide biosynthesis. The co-factor-
bound substrate is then transferred to the condensation domain. The substrate is then 
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attached as a thioester to the condensation domain of the following module to join 
the amino acid bound by that module, making the condensation domain the point 
where the individual peptides formed by each neighbouring module are linked 
together to form the final peptide (Figure 1.9) (Kleinkauf and Von Dohren, 1996).  
 
 
Figure 1.9: Diagram of amino acid attachment and peptide bond formation in a 
discrete NRP synthetase module where the reaction is carried out by (1) substrate 
adenylation by A-domain, (2) Thioester formation – loading of PCP (T-domain), (3) 
peptide bond formation by upstream C-domain and (4) Peptide bond formation by 
downstream C-domain. (Weber and Marahiel, 2001). 
 
Until recently, NRP synthetase domain structure could only be determined by 
crystal or NMR structural investigations, which did not reveal the mechanisms by 
which the domains interact with each other (Koglin et al., 2008). Further NMR and 
X-ray crystallographic structure investigations revealed the interaction between 
adenylation domains and the thiolation domains.  It was found that the thiolation 
domain exists in three different conformations depending on the activity taking 
place; non-modified apo-PCP (A and A/H) state, A/H state and the 4’-Ppant 
modified holo-PCP (A/H and H) state (Koglin et al., 2008). Ppant interacts with the 
thiolation domain in the apo-state, once the substrate is bound to the adenylation 
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domain; the binding of the Ppant arm to the thiolation domain changes the 
conformation of the thiolation domain through A/H to holo state. This 
conformational change allows the binding of the substrate to the Ppant arm, releasing 
it from the adenylation domain and transporting it by the Ppant swinging arm, via the 
thiolation domain to the condensation domain (Figure 1.10).  
 
Adenylation domain specificity is the key to discovering the substrates and the 
final peptide products of NRP synthetase. Each adenylation domain contains a large 
N-terminal core domain (~450 aa) and a small C-terminal subdomain (~100 aa) The 
two sub-domains are connected by a hinge consisting of 5 – 10 residues (Gulick, 
2009). It is thought that the adenylation domain has an open structure where the 
incoming amino acid substrate is able to bind, and once binding occurs, the domains 
rearrange into a closed formation to keep the amino acid locked to the adenylation 
domain where it undergoes activation (Figure 1.10). The activated amino acid is 
transferred to the 4’-Ppant arm tethered to the thiolation domain and this release 
returns the adenylation to the open conformation (Yonus et al., 2008).  
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Figure 1.10: Thiolation (PCP domain) and adenylation domain cycle where the 
thiolation domain changes from non-modified apo-form to 4’-Ppant modified holo-
form. The adenylation domain changes from an open conformation, ready to accept 
incoming amino acids, to a closed conformation to bind the incoming specific amino 
acids (Strieker et al., 2010). 
 
In 2007, the thiolation and condensation domain interaction was determined in 
the NRP synthetase, tyrocidine synthetase, TycC (Samel et al., 2007). As the 
condensation domain is the point where the amino acids/peptides of neighbouring 
modules link to add to the growing peptide chain, it is important for the condensation 
domains to be able to interact directly with each other to elongate the peptide. The 
condensation domain was found to consist of two equally sized sub-domains in a V-
shaped conformation which are connected by a small hinge region at the bottom of 
the V (Samel et al., 2007). The V-shape allows room for the amino acid, incoming 
from the thiolation domain at the donor site, as well as the amino acid from the 
neighbouring condensation domain at the acceptor site (Figure 1.11). 
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Figure 1.11: X-ray structure of the PCP and condensation di-domain of TycC, where 
the thiolation domain transfers the bound amino acid to the acceptor site of the 
condensation domain (Strieker et al., 2010). 
 
1.4.3 Functions and products 
Non-ribosomal peptides have been identified in a wide range of bacteria and 
fungi (Doyle, 2009). With more genomes being sequenced, the identification of more 
NRP synthetase genes have been revealed, identifying non-ribosomally synthesised 
metabolites such as TAFC, ferricrocin, and bassianolide (Jirakkakul et al., 2008).  
Cramer et al. (2006b) have carried out a phylogenomic analysis of the NRP 
synthetase genes putatively identified in Aspergillus spp., in an attempt to link NRP 
synthetase module alignment with production specific non-ribosomal peptide 
products. It was shown that A. fumigatus contained 14 NRPS genes, of which only 
three had a previously assigned function (Table 1.3), namely ferrichrome (Eisendle et 
al., 2003), gliotoxin (Cramer et al., 2006a) and fumitremorgin B (Maiya et al., 2006) 
biosynthesis. However, a gene involved in the biosynthesis of the siderophore, 
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triacetlyfusarinine C (TAFC), named sidD was predicted based on the phylogenomic 
analysis in the study.  
 
Table 1.3: NRP synthetase genes identified in A. fumigatus, with predicted domain 
architecture based on in silico analysis (Cramer et al., 2006b; Stack et al., 2007). 
Gene Domain Architecture CADRE ID NRPS peptide 
product 
pes1  (pesB)    ATECACATCATECTCT AFUA_1G10380               
sidC ATCATCATCTCTC AFUA_1G17200 Ferrichrome  
sidE ATCATC AFUA_3G03350  
sidD  (Nps6) ATCATC  AFUA_3G03420 TAFC 
pesF ATCATCT AFUA_3G12920  
pesG ATC AFUA_3G13730  
pesH ACATC AFUA_3G15270  
pesI  (pes3) ATCATECATCETCATCATCATEC AFUA_5G12730  
pesJ C*ATC  AFUA_6G09610  
pesK  (gliP) ATCATCT AFUA_6G09660 Gliotoxin 
pesL ATC AFUA_6G12050  
pesM  ATCATCEATC(TE) AFUA_6G12080  
pesN  (ftmA) ACATC AFUA_8G00170 Fumitromorgen B 
pesO PKSNNCAT(DH4) AFUA_8G00540  
 
 
The deletion of a NRP synthetase (gliP) from the A. fumigatus genome resulted 
in the loss of gliotoxin production (Cramer et al., 2006a). It was determined that 
GliP, the NRP synthetase responsible for gliotoxin production used L-phenylalanine 
and L-serine as substrates in the first step of gliotoxin biosynthesis (Balibar and 
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Walsh, 2006). A. fumigatus employs siderophores for the recruitment and storage of 
iron, namely triacetylfusarinine C (TAFC) and ferricrocin (FC), respectively.  
Deletion of the NRP synthetase involved in the individual siderophore biosynthesis, 
sidD and sidC, respectively, resulted in the lack of production of these essential 
metabolites (Schrettl et al., 2007). Fumitremorgin B biosynthesis begins with the 
NRP synthetase-mediated condensation of L-tryptophan and L-proline by FtmA 
(pesN) resulting in brevanimide F production which is the first intermediate in the 
biosynthesis of fumitremorgin B (Maiya et al., 2006). 
 
1.4.3.1 Siderophore biosynthesis and production for the utilisation of Iron 
Iron is a metal that represents a paradox in biological organisms as it is 
absolutely essential for growth, yet the presence of free iron can cause the catalytic 
formation of reactive oxygen species (ROS) which are detrimental to the organisms 
that require iron to survive (Howard, 1999). Plants, animals and bacteria store iron as 
ferritin, phytoferritin or bacterioferritin, respectively, to counteract the toxic effects 
of iron (Johnson, 2008).  These types of iron storage systems have not been detected 
in fungi, with the exception of zygomycetes (Matzanke et al., 1987). Iron is most 
abundant in ferric (Fe3+) form (Neilands, 1995), which reacts with oxygen to form 
insoluble ferric hydroxides, which are then unavailable for utilization by 
microorganisms. The acquisition of iron is considered to be a key step in the 
infectious process of pathogens, as iron in a host is tightly bound to proteins (Schrettl 
et al., 2004). Pathogens must be able to obtain iron from the host which is used for 
metabolism and growth. In the case of A. fumigatus, the fungus has an ability to 
survive in human serum even though free iron concentrations are deemed too low to 
support its’ growth (Gifford et al., 2002). A. fumigatus does not have specific uptake 
systems for taking host iron from sources such as heme, ferritin or transferrin 
30 
 
(Schrettl et al., 2004), it instead uses two high-affinity iron uptake systems, namely, 
(i) the reductive iron assimilation (RIA) system and (ii) siderophore-assisted iron 
uptake (Haas, 2003). These two systems are activated in iron starvation 
environments. The RIA system reduces ferric iron (Fe3+) to ferrous iron (Fe2+) and 
subsequently sequesters the reduced iron, whereas siderophores are low molecular 
mass, ferric iron-specific chelators.  
Siderophores are usually hydroxamates, characterised by the presence of N-δ-
acyl-N-δ-hydroxy-L-ornithine. There are four major hydroxamate families identified: 
(i) rhodotorulic acid, (ii) coprogens, (iii) ferrichromes and (iv) fusarinines (Figure 
1.12) (Haas, 2003).  
Rhodotorulic acid is mainly found in basidiomyceteous yeasts and is the weakest 
of the four hydroxamate siderophores for binding iron, as 1 mol of the siderophore 
binds with 2 mol of iron (Haas, 2003). Coprogens are produced by a number of plant 
pathogens. They are composed of N-δ-acyl-N-δ-hydroxy-L-ornithine, 
anhydromevalonic acid and acetic acid, where 1 mol of the compound binds with 1 
mol of iron (Renshaw et al., 2002).  
The important siderophores for Aspergillus spp. are the other two siderophores, 
ferrichromes and fusarinines (Figure 1.12). Ferrichromes are cyclic peptides 
containing a tripeptide of N-δ-acyl-N-δ-hydroxyornithine and a combination of 
glycine, serine or alanine (Reiber et al., 2005). Fusarinines are either linear or cyclic 
hydroxamates where N-hydroxyornithine is N-acylated by anhydromevalonic acid 
(Haas, 2003). 
Fe3+ is classed as a hard acid due to its high charge-radius ratio, resulting in a 
high affinity for hard base donor atoms such as oxygen (O) (Renshaw et al., 2002). 
As the ligands of siderophores are hard donors, Fe3+ has a high affinity for the 
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molecule, making siderophores a specific binder of iron. Once the iron binds to the 
siderophore, a thermodynamically stable complex is formed as the Fe3+ centre is 
spherically symmetric, having no directional preference for individual metal – O 
bonds (Renshaw et al., 2002). The interaction between the iron atom and the donor 
atoms is largely electrostatic where the siderophore O atoms form a distorted 
octahedron of O atoms around the central iron atom, optimising the interaction of the 
positively charged metal and the negatively charged oxygen (Renshaw et al., 2002). 
 
 
Figure 1.12: Chemical structures of hydroxamate siderophores found in fungi 
(Howard, 1999). 
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A. fumigatus produces three hydroxamate-type siderophores: extracellular 
fusarinine C (FSC) and TAFC, and an intracellular ferricrocin (FC) (Schrettl et al., 
2007). The combined iron recruitment of the RIA and siderophore systems ensures 
that there is a steady supply of iron for A. fumigatus to be a successful pathogen. 
Fungi such as A. nidulans and A. fumigatus produce siderophores during iron 
starvation conditions.  
In Aspergillus, siderophores were first identified in A. nidulans where the 
genome was found to contain a GATA factor, SreA, that negatively regulates the 
biosynthesis of siderophores and relative iron uptake (Figure 1.13) (Haas et al., 
1999). As SreA showed similar homology to the siderophore repressor transcription 
factor SRE from Neurospora crassa and URBS1 in Ustilago maydis, its 
identification led to the discovery of siderophores in A. nidulans (Haas et al., 1999).  
 
 
Figure 1.13: SreA binding to GATA repressing the expression of the L-ornitine N5-
oxygenase (sidA) which is the first step of the siderophore biosynthetic pathway. The 
presence of iron signals for the binding of SreA to GATA, whereas reduction in iron 
presence signals for the release of SreA from GATA, allowing transcription of sidA. 
 
In A. nidulans ∆sreA a decrease in extracellular siderophore production and an 
increased accumulation of the intracellular siderophore (FC) was observed 
(Oberegger et al., 2001). This change in siderophore production caused deregulation 
of siderophore-bound iron uptake as well as ornithine esterase expression. 
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Interestingly, the lack of negative regulation from SreA did not completely 
deregulate extracellular siderophore production, as there was still negative regulation 
by the iron availability. This gave the first indication that there are additional iron 
regulation mechanisms besides SreA in control of siderophore production 
(Oberegger et al., 2001). 
 
Following the discovery that SreA was involved in regulating siderophore 
biosynthesis, A. nidulans ∆sreA was used to identify individual genes involved in 
siderophore biosynthesis, using the de-repression of the genes during iron-replete 
conditions (Oberegger et al., 2002b). Here, sidA was identified, which displayed 
significant similarity to sid1 of U. maydi. sidB and sidC were identified with 
fragments showing similarity to sid2 of U. maydis as well as other NRPS genes 
(Oberegger et al., 2002b). The genes, mirA, mirB and mirC were identified in 
Saccharomyces cerevisiae to be upregulated during iron starvation, indicating they 
play a role in iron acquisition for the non-siderophore producing organism 
(Oberegger et al., 2002a).   
 
It was established that genes involved in siderophore biosynthesis could be 
characterised by transcriptional induction under iron-limited conditions which were 
de-repressed in ∆sreA under iron-replete conditions (Eisendle et al., 2003). As sidA 
and sidC completely fulfilled the terms of this characterisation, they were 
investigated for their role in siderophore biosynthesis in A. nidulans (Oberegger et 
al., 2002b). Characterisation of A. nidulans ∆sidA and ∆sidC strains identified that 
∆sidA did not produce either extracellular or intracellular siderophores, and therefore 
was unable to grow unless the media was supplemented with 1.5 mM FeSO4. 
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Interestingly, media supplementation with FeCl3 or ferric citrate was not able to 
restore ∆sidA growth. The ∆sidC strain was able to produce normal amounts of 
TAFC but completely lacked FC production, indicating involvement in the 
production of the intracellular siderophore (Eisendle et al., 2003).  
The ability of ∆sidA and ∆sidC to produce conidia was also investigated by 
Eisendle et al. (2003). ∆sidA was not able to produce conidia unless the media was 
supplemented with siderophores. Supplementation with 10 µM TAFC partially 
restored conidial production, whereas the presence of 10 µM FC completely restored 
conidial production. The ∆sidC strain showed a reduced level of conidiation unless 
the media was supplemented with FC (10 µM), which completely restored conidia 
production, indicating that the intracellular siderophore, FC, is essential for efficient 
conidiation. Furthermore, it was discovered that the ∆sidA and ∆sidC strains had an 
increase in intracellular iron, due to the lack FC production in both strains. This 
intracellular iron build up was also noted in ∆sreA, where the amount of iron found 
intracellularly was directly correlated with the extracellular iron supply. This 
deregulation of iron uptake causes oxidative stress in the cell and was also observed 
in the ∆sidA and ∆sidC strains, where the sensitivity was more notable in the ∆sidA 
strain.      
 
Schrettl et al. (2004) identified an ortholog of A. nidulans sidA in A. fumigatus, 
also named sidA. In contrast to the growth deficiencies of the A. nidulans ∆sidA, the 
A. fumigatus ∆sidA strain was able to grow to a moderate level in iron depleted 
conditions. This indicates that A. fumigatus must possess additional iron assimilation 
systems that A. nidulans does not. A. fumigatus ∆sidA showed sensitivity towards an 
inhibitor of the reductive iron assimilation pathway, batho-phenanthroline-disulfonic 
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acid disodium salt (BPS), the genes involved in a potential RIA pathway were 
investigated. Screening of the A. fumigatus genome identified several putative 
metalloreductase-encoding genes, one putative ferroxidase (fetC) and one potential 
high affinity iron permease-encoding gene (ftrA) (Schrettl et al., 2004).  Deletion of 
ftrA resulted in an 8-fold increase in TAFC production, most likely due to 
compensation by the siderophore system where the RIA system is absent. A double 
mutant, ∆sidA:∆ftrA was created, and this strain was unable to sustain any growth, 
even in iron-replete conditions, unless culture media was supplemented with FC, 
indicating that mechanisms for the uptake of available iron are essential and that ftrA 
encodes an essential component of an iron uptake system independent of the 
siderophore system (Schrettl et al., 2004). Furthermore, in their study, the double 
mutant was unable to sustain growth on media containing human iron-containing 
sources such as haemoglobin, hemin, holotransferrin and ferritin, indicating that A. 
fumigatus double mutant does not have any specific system for the removal of iron 
from the host. However, previously it has been shown that A. fumigatus is capable of 
chelating iron from holotransferrin (Hissen et al., 2004). This is one of the main 
reasons why A. fumigatus is classed as an opportunistic pathogen. 
 
To investigate the role of iron acquisition in the virulence of A. fumigatus, both 
∆sidA and ∆ftrA were tested in murine models of aspergillosis (Schrettl et al., 2004). 
Here, the ∆ftrA strain was as virulent as the wild-type strain and leading to the 
conclusion that the reductive iron assimilation system plays no role in virulence of A. 
fumigatus. However, virulence of the ∆sidA strain was completely attenuated, 
indicating that the siderophore system is essential for virulence. A closer look at A. 
fumigatus ∆sidA in the lungs of mice showed that the conidia did not germinate. 
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Concurrently, Hissen et al. (2005) identified A. fumigatus sidA as a siderophore 
related virulence factor, as the wild-type strain was able to remove iron from human 
transferrin, compared to the ∆sidA strain which was unable to remove the iron from 
transferrin.  
 
In 2005, sidD was found to be regulated by iron availability (Reiber et al., 2005). 
The discovery of sidD was through a BLAST search using sidC as the search 
parameter. sidD was also highly similar to sid2 of A. oryzae. Like the other 
siderophore related genes, sidD expression was found to be repressed in iron-replete 
conditions, with expression observed under iron-limiting conditions. 
 
Ferricrocin C (FC) is a major iron storage compound in hyphae during excessive 
iron conditions (Eisendle et al., 2006). It was found that oxidative stress caused the 
accumulation of intracellular iron during both iron-depleted and -replete conditions. 
It was noted that the increase of iron-containing FC was mediated by transcriptional 
upregulation of sidC expression, because treatments with hydrogen peroxide and 
paraquat under iron-replete conditions upregulated the transcription of sidC. Using A. 
nidulans ∆sidC in iron-replete conditions, it was found that there was an increase in 
TAFC production as well as intracellular iron content, indicating that the iron 
utilization within the cell was inefficient as there was nowhere for the excess iron to 
be stored. Importantly, it was found that the ∆sidC conidia were more sensitive to 
oxidative stress than the mycelia, which exhibited wild-type resistance. Furthermore, 
the ∆sidC conidia showed delayed germination indicating that FC plays an important 
role in germination. The importance of conidial siderophore storage in germination 
was highlighted by Charlang et al. (1981). Recently, it was demonstrated the FC is 
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involved in the intra- and trans-cellular iron distribution, where FC is used to 
transport iron from the hyphae to the conidia (Wallner et al., 2009). The absence of 
FC results in iron starvation in the conidia.  
 
The iron contained in TAFC needs to be released from the siderophore for use in 
the fungal cell. For this to occur, the ester bonds of TAFC are hydrolyzed, decreasing 
the affinity of TAFC for iron followed by the release of cleavage products, leaving 
the iron free within the cell to be transferred into metabolic pathways where it is 
utilized or to FC for storage. The hydrolysis is thought to be carried out by the TAFC 
esterase, EstB (Kragl et al., 2007). An A. fumigatus ∆estB strain showed reduced 
transfer rate of iron from TAFC to FC, which in turn delayed iron-sensing and 
resulted in impaired growth. The ∆estB strain was still able to hydrolyze TAFC 
indicating that there are other mechanisms for the hydrolysis of TAFC, but 
hydrolysis is optimised by active EstB.  
 
The siderophore biosynthetic pathway was first postulated by Plattner and 
Diekmann (1994) and has been significantly updated by Schrettl et al. (2007). The L-
ornithine N5-oxygenase gene, sidA, is involved in the first committed step of the 
biosynthesis of both intracellular and extracellular siderophores in A. fumigatus 
(Figure 1.14). Firstly, L-ornithine is converted to N5-hydroxy-L-ornithine by L-
ornithine-N5-oxygenase encoded by sidA (Eisendle et al., 2003). After N5-hydroxy-
L-ornithine is synthesised, the pathway splits to enable either extracellular or 
intracellular siderophore biosynthesis.  
For the extracellular siderophore, TAFC, the N5-hydroxy-L-ornithine is 
converted to N5-cis-anhydromevalonyl-N5-hydroxy-L-ornithine by the N5-
38 
 
transacylase, encoded by sidF using cis-anhydro-mevalonyl-CoA as the substrate. 
The N5-cis-anhydromevalonyl-N5-hydroxy-L-ornithine is converted to fusarinine C 
by the NRP synthetase, encoded by sidD. Fusarinine C is then converted into the 
extracellular siderophore, TAFC, by a N2-transacetylase, encoded by sidG, using 
acetyl-CoA as the substrate.  
For the intracellular siderophore, N5-hydroxy-L-ornithine is converted to N5-
acetyl- N5-hydroxy-L-ornithine, by an unidentified N5-transacylase using acetyl-
CoA as the substrate. The N5-acetyl- N5-hydroxy-L-ornithine is converted into FC by 
the NRP synthetase, encoded by sidC, using serine and glycine as substrates. FC is 
converted to hydroxyferricrocin (HFC) by an unknown ferricrocin hydroxylase 
(Schrettl et al., 2007). The enzyme SidD and the FC synthetase, SidC were identified 
by Reiber et al. (2005), and SidF and SidG were identified by Schrettl et al. (2007).  
 
 
Figure 1.14: Biosynthesis of siderophores in A. fumigatus (Schrettl et al., 2007). 
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Some fungi have the ability to utilise siderophores produced by other organisms 
even though they do not possess the machinery to produce the siderophores 
themselves, such as S. cerevisiae (Oberegger et al., 2002b). This species employs 
two distinct high-affinity uptake systems which are regulated by the transcriptional 
activators Aft1p and Aft2p. The uptake of iron requires surface metalloreductases 
(Fre1p and Fre4p) which reduce Fe3+ to Fe2+ (Kosman, 2003). The reduced iron is 
transported to the cell by a permease-oxidase complex (Ftr1p/Fet3p) allowing the 
uptake of both siderophore-bound iron and unbound reduced iron.  
 
In A. nidulans, a gene encoding FreA was identified which is similar to 
metalloreductase, which was not regulated by SreA indicating that there are genes 
involved in iron availability responses other than those controlled by SreA 
(Oberegger et al., 2002a). Many siderophore producing fungi have been identified, 
some of which are detailed in Table 1.4. Fungi use a wide array of siderophore types. 
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Table 1.4: Species of fungi which have been shown to produce either intracellular or extracellular siderophores 
Siderophore producing fungi Extracellular siderophore Intracellular siderophore Reference 
Aspergillus fumigatus TAFC/ fusarinine C Ferricrocin  Nilius et al. (1990)  
Aspergillus nidulans TAFC/ fusarinine C Ferricrocin Charlang et al. (1981)  
Aspergillus oryzae Ferrichrysin Ferricrocin Yamada et al. (2003) 
Cochliobolus heterostrophus Coprogen/ fusarinine Ferricrocin Lee et al. (2005)  
Magnaporthe grisea Coprogen Ferricrocin Antelo et al. (2006)  
Fusarinium graminearum Coprogen/ fusarinine Ferricrocina Oide et al. (2006)  
Penicillium chrysogenum Fusarinine C Ferrichrome Charlang et al. (1981) 
Neurospora crassa Coprongen Ferricrocin Matzanke et al. (1987)  
Ustilago maydis Ferrichrome Ferrichrome Bolker et al. (2008)  
Schizosaccharomyces pombe Ferrichrome Ferrichrome Schwecke et al. (2006)  
Rhodotorula pilimanae  Rhodotorulic acid Rhodotorulic acid Muller et al. (1985) 
a
 predicted siderophore 
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Intracellular siderophores are found exclusively in fungi, giving an advantage 
over bacteria, plants and animals which all lack a ferritin-mediated iron storage 
system (Haas et al., 2008). The ability to scavenge for iron, mediated by 
siderophores, has given fungal species an advantage over other non-siderophore 
utilizing organisms, as they are able to recruit iron in iron-depleted conditions which 
facilitates growth and development that would otherwise be impossible (Hissen et 
al., 2004). The ability of fungal strains such as A. fumigatus to recruit iron 
contributes to the virulence of the fungus. As a pathogenic organism, the siderophore 
system enables A. fumigatus to counteract oxidative stress, encountered either in the 
environment or by a host immune system (Eisendle et al., 2006).  
 
Oxidative stress of fungi in a host is due to the reactive oxygen species (ROS) 
produced by the macrophages that eliminate conidia and the hydrogen peroxide 
produced by neutrophil activity that kill fungal hyphae (Schaffner et al., 1982). The 
main protective factor against oxidative killing employed by A. fumigatus is the 
presence of catalases in the conidia and mycelia (Paris et al., 2003b). Catalase is an 
antioxidant metalloenzyme, used by all aerobic organisms in the protection against 
oxidative damage (Rementeria et al., 2005).  
A. fumigatus contains three catalases, Cat1 and Cat2 in the hyphae, and CatA in 
the conidia. It was demonstrated that mycelia deficient in both Cat1 and Cat2 were 
slightly more susceptible to hydrogen peroxide whereas the lack of CatA exhibited 
high sensitivity to hydrogen peroxide (Paris et al., 2003b).  
Iron-depleted A. fumigatus is more sensitive to hydrogen peroxide and 
inappropriate iron storage can catalyze the formation of ROS which is the reason 
why A. fumigatus ∆sidA and ∆sidC strains exhibit hypersensitivity to hydrogen 
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peroxide during iron-depleted growth (Schrettl et al., 2007). The ability of hydrogen 
peroxide to kill conidia and hyphae of ∆sidA and ∆sidC was significantly higher than 
that of the wild-type, indicating that the siderophore conidial iron storage and the 
intracellular siderophore are extremely important in the protection of the fungus 
against oxidative stress. Human macrophages exposed to either A. fumigatus wild-
type or ∆sidA conidia showed that the wild-type conidia activated a higher 
production of TNF-α than ∆sidA conidia, indicating that the siderophore system may 
compromise parts of the innate immune response (Seifert et al., 2008). A. fumigatus 
∆sidD hyphae, deficient in the extracellular siderophore, also exhibited sensitivity to 
hydrogen peroxide.  
The catalase activity was investigated in siderophore deficient strains, and it was 
shown that the expression of the hyphal catalases, Cat1 and Cat2, were no different 
between the varying siderophore deficient strains (∆sidA, ∆sidC, ∆sidD, ∆sidF and 
∆sidG) and were comparable to the wild-type indicating that the oxidative stress 
exhibited by these strains was not due to catalase deficiency. Furthermore, the ∆sreA 
strain induced an increase in expression of Cat1 compared to the wild-type, 
indicating that the oxidative stress response is activated during a disruption of iron 
homeostasis in the fungus (Schrettl et al., 2008).  
The conidial catalase, CatA, showed decreased expression in the ∆sidA and 
∆sidC strains but could be restored when the media was supplemented with the 
intracellular siderophore, FC, indicating that the decrease in catalase expression is 
due to the lack of FC. In transcriptional profiling, it was found that the siderophore 
system genes were upregulated in vivo during iron-depleted conditions (McDonagh 
et al., 2008), but differential expression was not observed during exposure to 
hydrogen peroxide alone. The RIA system would be in use during the iron replete 
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conditions and the siderophore system would not need to be expressed during this 
time. Therefore the up-regulation of the siderophore genes during murine infection 
would be a better representation of the fungus in a low-iron environment coupled 
with oxidative stress, especially as the catalase, Cat2, was also highly upregulated 
during the in vivo profiling.   
 
1.4.3.2 Fumigaclavine C biosynthesis and production 
Many different fungi produce ergot alkaloids which result in a wide variety of 
clavines and lysergyl-derived ergot alkaloids being generated. The ergot alkaloid 
production in fungi generally results in the accumulation of ergopeptines, which are 
derived from non-ribosomally synthesised peptides containing lysergic acid and 
three amino acids. Simple amides of lysergic acid, such as ergine and ergovine can 
also be generated (Coyle and Panaccione, 2005).  
In A. fumigatus, there are seven members of the ergot alkaloids produced, 
named: agroclavine, festuclavine, elymoclavine, chanaclavine, fumigaclavine A, B 
and C (Frisvad et al., 2009). Ergot alkaloids are associated with conidia, and 
represent 1 % of the conidial content in which four alkaloids are identified, in order 
of abundance: fumigaclavine C, festuclavine, fumigaclavine A and fumigaclavine B 
(Panaccione and Coyle, 2005). Fumigaclavine C accounts for 1.2 – 12 mg/g conidia, 
depending on the media used to grow the fungus. Fumigaclavine C has been 
identified as having a mass of 366, consisting of C23H30N2O2 (Larsen et al., 2007).  
The final ergot alkaloid metabolites produced by the different fungi contain the 
same four member ergoline ring system, but differ in the number, type and position 
of the side chains (Figure 1.15). The ergot alkaloid produced by Claviceps purpurea 
is ergoamine. This was the first ergot alkaloid identified in a fungus and so is used as 
the metabolite that ergot alkaloids produced in other fungi are compared to. The 
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ergot alkaloid produced in A. fumigatus is Fumigaclavine C and in Neotyphodium 
lolii is ergovaline. 
 
 
Figure 1.15: Final ergot alkaloid metabolites produced in fungal species, where 
ergoamine is produced by C. purpurea, fumigaclavine C is produced by A. fumigatus 
and ergovaline is produced by N. lolii. 
 
In A. fumigatus, the biosynthesis of fumigaclavine C involves a complex 
pathway that begins with the prenylation of L-tryptophan by dimethylallyl 
pyrophosphate (DMAPP). This first step in the pathway was discovered due to the 
comparison of A. fumigatus production of fumigaclavine with the ergot alkaloid 
production in the fungus C. purpurea of ergoamine (Coyle and Panaccione, 2005). 
The biosynthesis of ergoamine in also begins with the prenylation of L-tryptophan 
by DMAPP. Interestingly, the final steps in the production of ergoamine involve two 
NRP synthetases, LspB and LspA (Ortel and Keller, 2009). The divergence between 
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these ergot alkaloid products only occurs after the production of the intermediate, 
chanoclavine (Coyle et al., 2010). In another fungus, N. lolii, the production of the 
ergot alkaloid, ergovaline, also begins with the prenylation of L-tryptophan with 
DMAPP. The final product is also the result of NRP synthetase involvement. The 
similarities and divergence between the ergot alkaloid production in A. fumigatus, C. 
purpurea and N. Lolii is detailed in Figure 1.16 and will be discussed in more detail 
in Chapter 4. 
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Figure 1.16: Ergot alkaloid biosynthesis in fungal species has a complex pathway 
with common steps initialising the pathway and diverges after the production of the 
intermediate chanoclavine. The function of the genes detailed is provided in the key 
below, where the genes involved in the production of fumigaclavine C in A. 
fumigatus are in purple, genes involved in the production of ergotamine in C. 
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purpurea are in red and the genes involved in the production of ergovaline in N. lolii 
are in blue. 
Gene function  A. fumigatus  C. purpurea  N. lolli  
DMAT synthase  fgaPT2 cpd1  dmaW  
N-methyltransferase  fgaMT  easF  easF  
Unknown fgaOX1  cpox1  cpox1  
Dehydrogenase  fgaDH  cpox2  Unknown 
Unknown fgaOX3  cpox3 easA  
Unknown fgaFS  easG  easG  
monooxygenase   cloA  cloA 
NRPS   lpsB  lpsB  
NRPS   lpsA  lpsA*  
O’-acetyltransferase  fgaAT    
Reverse prenyltransferase  fgaPT1    
 
 
1.4.3.3 Fumitremorgin biosynthesis and production 
Tremorgenic mycotoxins, such as fumitremorgin B or verruculogen, result in 
intermittent or sustained tremors in vertebrate animals (Khoufache et al., 2007). 
Fumitremorgins are members of a group of prenylated indole alkaloids derived from 
L-tryptophan and L-proline. This group includes other compounds detected in A. 
fumigatus extracts, such as tryprostatins, cyclotryprostatins and spirotryprostatins 
and it is thought that these compounds are derived from the diketopiperazine cyclo-
L-Trp-L-Pro, known as brevianamide F (Grundmann et al., 2008). The NRP 
synthetase encoding gene, ftmA, found within the cluster identified as the 
fumitremorgin biosynthesis cluster, was confirmed to catalyze the first step in the 
biosynthetic pathway of fumitremorgin B (Figure 1.17) (Maiya et al., 2006). 
Overexpression of ftmA caused an accumulation of brevianamide F in A. nidulans. 
Interestingly, the A. fumigatus strain AF293, a clinical isolate, is not capable of 
producing the typical end-products such as TR-2, fumitremorgin A and B and 
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verrulculogen, but instead produces the intermediate fumitremorgin C (Larsen et al., 
2007). There is evidence that fumitremorgin B can be derived from TR-2, indicating 
an intermediate role for TR-2 in the biosynthesis of verruculogen (Willingale et al., 
1983). The production of verruculogen is variable between A. fumigatus isolates 
(Tepsic et al., 1997; Kosalec et al., 2005a) and although initially not found in 
conidial extracts (Fischer et al., 2000), verruculogen is definitely a conidial 
metabolite (Khoufache et al., 2007). It has also been established that the 
fumitremorgin biosynthetic cluster was down-regulated in A. fumigatus ∆stuA, a 
strain deficient in the full adaptive response to hypoxia (Sheppard et al., 2005).  
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Figure 1.17: Proposed biosynthetic pathway for the fumitremorgin family of non-ribosomal peptides. 
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1.4.3.4 A. fumigatus NRP synthetase, Pes1 
The phylogenomic study carried out by Cramer et al. (2006b) (Table 1.3) 
identified genes in A. fumigatus which had orthologs in other Aspergillus species but 
these genes also had no identified product or function. These genes, known to be 
NRP synthetases, had no identifiable product and it was unclear as to the function of 
the putative NRP synthetase genes. The expression analysis of the NRP synthetase 
genes in A. fumigatus AF293 was carried out to characterise the genes. In this 
analysis, pes1 (AFUA_1G10380) was shown to be minimally expressed in 
Sabouraud media and not expressed in all other conditions tested (Cramer et al., 
2006b). Concurrent investigation of the pes1 gene established it was expressed at all 
time points in minimal essential media (MEM) in the A. fumigatus strains 
ATCC26933, ATCC16424 and ATCC13073 (Reeves et al., 2006).  
This study also confirmed that pes1 plays a role in conidial morphology and 
hydrophobicity whereby a pes1 disrupted mutant exhibited reduced virulence, as well 
as increased sensitivity to oxidative stress. The Pes1 protein was purified from 
mycelial lysates of A. fumigatus ATCC26933 and eluted at a mass of 500 kDa. In 
SDS-PAGE analysis, a dominant protein band was detected using immunoaffinity-
purified antibodies (IgG-Pes1) (Reeves et al., 2006). The protein was approximately 
33 % of the predicted mass of Pes1 and the authors indicated that this may represent 
the C-terminal proteolytic fragment of the protein.  
The identification of the NRP peptide product encoded by pes1 is still elusive, 
but pes1 expression profiles have been generated through many transcriptional 
profiling studies. Large scale profile studies have been possible due to the 
availability of the full genomic sequencing of A. fumigatus and other related strains 
and species (Fedorova et al., 2008). Genome-wide microarrays can be used to 
identify the effect a deleted gene has on other genes, without screening each 
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individual gene. Schrettl et al. (2008) used this method to investigate the genes 
regulated by the SreA transcription factor. Here, microarray analysis was conducted 
with RNA isolated from wild-type and ∆sreA strains which were grown in iron-
limiting conditions for a defined period of time (12 hr) and then transferred to iron-
replete conditions. As previously mentioned, SreA is a repressor of siderophore 
production in iron-replete conditions. This profiling identified 1147 genes that were 
differentially expressed in ∆sreA, which interestingly included pes1 (upregulated in 
∆sreA after 30 min). As pes1 expression is upregulated in the absence of this 
regulator, this may indicate that pes1 plays a role in the protection against oxidative 
stress during this sudden change in Fe3+ levels, potentially by signalling or 
interacting with siderophores or related biosynthesis genes.   
Similarly, the transcriptional profiling of A. fumigatus ∆laeA strain, compared to 
the wild-type, revealed that this global regulator, LaeA, controlled the expression of 
many secondary metabolite gene clusters which included pes1 as well as the ergot 
alkaloid family of fumigaclavines, gliotoxin and the fumitremorgin family (Perrin et 
al., 2007). Interestingly, the expression of pes1 as well as the neighbouring ABC 
multi-drug transporter were down-regulated in ∆stuA, a gene involved in the hypoxic 
adaptation of the fungus (Sheppard et al., 2005). Also similarly to ∆pes1, the ∆stuA 
strain was sensitive to hydrogen peroxide, indicating that this sensitivity exhibited by 
∆stuA may be due, in part, to the down-regulation of pes1 expression. 
 
1.4.3.5 Global regulation of NRPS genes 
The nuclear protein, LaeA, was found to regulate the transcription of secondary 
metabolites in A. fumigatus, A. nidulans and A. terreus (Bok and Keller, 2004).  The 
∆laeA strain was found to exhibit wild-type growth and development, but lacked the 
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same level of virulence (Bok et al., 2005).  The decrease in virulence was associated 
with altered conidial morphology and lack of gliotoxin production.  
Further investigation into the decreased virulence revealed that LaeA controlled 
the production of lovastatin in A. terreus, sterigmatocystin and penicillin in A. 
nidulans and gliotoxin in A. fumigatus, conversely the overexpression of LaeA 
resulted in an increase of both lovastatin and penicillin gene cluster transcription and 
production. LaeA production was found to be negatively regulated by two signal 
transduction proteins, PkaA and RasA (Figure 1.18).  
As previously mentioned, transcriptional profiling of the ∆laeA strain compared 
to the wild-type showed that 13 of the 22 secondary metabolite gene clusters 
identified in A. fumigatus were down-regulated due to the absence of the regulator 
(Perrin et al., 2007). The LaeA regulation of metabolite biosynthesis in A. fumigatus 
will be discussed further in Chapter 4. 
 
 
Figure 1.18: Proposed model of secondary metabolite regulation by LaeA and some 
of the metabolites produced under this regulation. (Taken from Bok et al., (2004)). 
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1.5 Gliotoxin 
Aspergillus species produce a wide range of metabolites, including siderophores, 
antibiotics and toxins (Foster and Karow, 1945; Haas, 2003; Gardiner et al., 2005c). 
One such toxin is gliotoxin, which is also produced by several other fungi, and is 
acutely toxic with a broad range of immunosuppressive properties (Sutton et al., 
1994). Gliotoxin is a member of the family of epipolythiodioxopiperazine (ETP) 
compounds, and is uniquely characterised by a disulphide bridge across a 
diketopiperazine ring (Figure 1.19). ETPs function by generating Reactive Oxygen 
Species (ROS) via redox cycling between the oxidized (disulphide) and reduced 
(dithiol) forms (Figure 1.19) (Eichner et al., 1988; Gardiner et al., 2005c). The 
disulphide bridge is thus responsible for the toxicity of the compound (Rodriguez 
and Carrasco, 1992). Disulphide bridge formation can be inhibited by the addition of 
a cellular reductant such as glutathione (GSH) or dithiothreitol (DTT), which in turn 
inhibit the production of the oxygen radicals, hindering the formation of the 
disulphide bond (Gardiner et al., 2005c).  
 
 
Figure 1.19: Redox cycling between the reduced (dithiol) and oxidized (disulphide) 
forms of gliotoxin generating reactive oxygen species (Gardiner et al., 2005c).  
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Gliotoxin was first isolated as a product of Gliocladium fimbriatum by Weindling 
and Emerson (1936) and then in Aspergillus spp. (Kidd, 1947). The natural function 
of gliotoxin is hypothesised to be a defence mechanism against other competing 
organisms, such as bacteria and fungi that cannot protect themselves against 
gliotoxin, within the same environment (Tekaia and Latge, 2005).  
 
Gliotoxin is regarded as one of the major immunosuppressive factors associated 
with Aspergillus spp. infections, as it causes a spectrum of effects on the host 
immune response such as inhibition of (i) macrophage phagocytosis (Eichner et al., 
1986), (ii) NADPH oxidase (Yoshida et al., 2000) (iii) mitogen-activated T-cell 
proliferation (Mullbacher and Eichner, 1984), (iv) mast cell activation (Niide et al., 
2006) and (v) cytotoxic T-cell responses (Yamada et al., 2000). The presence of 
gliotoxin also induces epithelial cell damage (Amitani et al., 1995) as well as both 
apoptotic (Piva, 1994; Suen et al., 2001) and necrotic (Hurne et al., 2002) cell death 
in mammalian cells. Previously, it has been shown that gliotoxin can be detected in 
the lungs of mice experiencing aspergillosis and also in serum of patients diagnosed 
with invasive aspergillosis (Lewis et al., 2005). Gliotoxin has also been shown to 
inhibit the activity of NF-κB which results in reducing neutrophil survival (Walmsley 
et al., 2005) and its toxicity is of great interest, especially as it has been shown to 
induce apoptosis of cancer cells (Pan and Harday, 2007). Recently, gliotoxin has 
been shown to inhibit angiogenesis occurring at infection sites, in a dose dependent 
manner (Ben-Ami et al., 2009). Furthermore, in a murine infection model, an A. 
fumigatus strain deficient in gliotoxin production due to deletion of gliP (which 
encodes a non-ribosomal peptide synthetase, one of the essential enzymes for 
gliotoxin biosynthesis), did not inhibit angiogenesis to the same extent as the wild-
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type strain (Ben-Ami et al., 2009). Therefore, it is important to understand and 
analyse the biosynthesis of this toxin, and determine its role in the virulence arsenal 
of gliotoxin-producing fungi.  
 
The biosynthesis of gliotoxin is hypothesised to occur as described in Figure 
1.20, where phenylalanine and serine are substrates for the non-ribosomal peptide 
synthetase, GliP, to produce cyclo-(L-phenylalanyl-L-seryl) (Balibar and Walsh, 
2006). The next steps have been proposed to generate intermediates which have not 
been isolated or characterised but are thought to involve a series of sulphurisations, 
oxidations, chaisan rearrangement reactions, and methylation (Gardiner et al., 
2005c). 
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Figure 1.20: Proposed pathway for gliotoxin biosynthesis (Gardiner and 
Howlett, 2005a). The only known intermediate is cyclo L-phenylalanyl-L-serine. 
All other compounds are predicted (bracketed) and the order of reactions may not 
be correct. 
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Bioinformatic analysis has shown that the genes within the A. fumigatus ETP 
cluster are extremely similar to the sirodesmin biosynthesis gene cluster of 
Leptosphaeria maculans (Figure 1.21) (Gardiner and Howlett, 2005a). Sirodesmin 
PL is a toxin produced by the plant pathogen L. maculans which causes lesions on 
plant leaves and is a member of the ETP producing family (Gardiner et al., 2004). 
Putative ETP clusters have also been identified in a range of fungi including A. 
fumigatus, Penicillium lilacinaechinulatum, A. clavatus, Trichoderma virens, A. 
terrus, A. flavus, A. oryzae, L. maculans, T. reesei, and A. zeae (Patron et al., 2007).  
 
 
Figure 1.21: Comparison of the putative gliotoxin and sirodesmin biosynthetic 
gene clusters from Aspergillus fumigatus and Leptosphaeria maculans, 
respectively. The ‘‘other’’ category contains genes encoding cytochrome P450 
monooxygenases (gliF, sirB, sirE), a prenyl transferase (sirD), an acetyl 
transferase (sirH), epimerases (sirQ, sirR, sirS), an oxidoreductase (sirO) and a 
gene encoding a hypothetical protein (gliK), as indicated by * (Gardiner et al., 
2005c). 
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1.6 Double mutations 
The advantage of the double mutations can be clearly seen in the situations where 
separate single mutants confer no phenotypical difference from the wild-type, but the 
double mutation results in fatal (Kafer and Mayor, 1986) or extreme detrimental 
outcomes (Novak et al., 1995; Fujiwara et al., 2000; Belaish et al., 2008; Etxebeste 
et al., 2009; Zhang et al., 2009). Double mutant strains can also show that genes 
involved in the same function or protein production can compensate for the absence 
of each other, as the double mutation results in the decrease or absence of such 
production (Fujiwara et al., 2000; Ichinomiya et al., 2002a; Ichinomiya et al., 2002b; 
Flipphi et al., 2003; Ichinomiya et al., 2005). Furthermore, the double mutation of 
genes can reveal interactions between the separate functions or pathways showing 
contributing interactions that would not normally be observed. This is seen in A. 
nidulans calcium homeostasis signalling transcription factor CrzA, which is 
important in the adaption to osmotic stress. Here, the double mutant (∆crzA:∆hogA) 
was rendered hypersensitive to osmotic stress in plate cultivations, whereas the 
individual single mutants were not (Hagiwara et al., 2008).  
Double mutants created in A. fumigatus have involved putative virulence factors, 
including the mutant lacking restrictocin, a major antigen found in the urine of 
patients with invasive aspergillosis (IA) along with the removal of the alp gene 
encoding an alkaline protease which is subject to nitrogen, sulphur, and carbon 
catabolite repression and also pH regulation (Smith et al., 1994). This double mutant 
was slightly less virulent than the wild-type strain.  
A. fumigatus double mutants have also involved nutrient uptake, such as zinc 
acquisition from the surrounding environment. In A. fumigatus, the genes zrfA and 
zrfB were postulated to be involved in zinc transportation. The expression of zrfA and 
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zrfB was differentially down-regulated in the presence of zinc. Transcription of zrfB 
was absent at a concentration of zinc 50-fold higher that that required to halt 
transcription of zrfA. Also, the growth level of ∆zrfA was identical to the wild-type 
but the ∆zrfB strain had a reduction in growth (Vicentefranqueira et al., 2005). In 
acidic conditions which omitted zinc from the media, the ∆zrfA strain showed the 
same growth potential as the wild-type but the ∆zrfB strain showed a reduced 
capability to grow. More importantly, the double mutant showed a complete growth 
deficiency in the acidic non-zinc media (Vicentefranqueira et al., 2005). In the 
present study, it is proposed to dissect interaction between A. fumigatus sidD and 
pes1 NRP synthetase by creating an A. fumigatus ∆sidD:∆pes1 double mutant. 
 
1.7 Insect virulence models 
Animal models such as mice and rats are routinely used to study the virulence of 
microorganisms due to the susceptibility of these animals to infection, including 
infection with Aspergillus spp. (Krappmann, 2006). Infection studies can vary from 
identification of gene production, metabolite screening and anti-fungal properties. To 
generate reliable, reproducible and significant results, studies using animal models 
can easily become costly and time-consuming. An alternative method was required 
to avoid high cost and other unfavourable factors associated with use of vertebrate 
animal models (Kavanagh and Reeves, 2004). The use of insects such as Galleria 
mellonella and Drosophila melanogaster as virulence models has shown good 
correlation with the murine virulence models (Lionakis and Kontoyiannis, 2005; 
Renwick et al., 2006; Mylonakis, 2008; Spikes et al., 2008; Jackson et al., 2009; 
Chamilos et al., 2010). 
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The greater wax moth, G. mellonella, in its larvae state has been used to test the 
virulence of a range of bacteria and fungi, as this model has shown strong correlation 
to virulence seen in murine models (Jander et al., 2000; Brennan et al., 2002). G. 
mellonella possesses an immune system, similar to that of the mammalian innate 
immune system (Kavanagh and Reeves, 2004). The immune cells of G. mellonella 
are composed of granulocytes and plasmatocytes which enable phagocytosis in a 
lectin-mediated manner (Tojo et al., 2000). Also, similar to the mammalian immune 
system, is the presence of reactive oxygen species, defensins, transferrin and 
lyzozyme. This immune response can be used to investigate the relative 
pathogenicity of microorganisms, such as A. fumigatus. Larvae are injected with an 
inoculum of conidia through the cuticle of the last left proleg. The infection process 
can be visualised as the larvae undergo melanisation which changes the colour of the 
larvae from white to dark brown. The G. mellonella model system has previously 
been used to show that A. fumigatus strains had different relative pathogenicities, 
where ATCC26933 was found to be more virulent than ATCC14109, which in turn 
was more virulent than ATCC16424, and ATCC13073 which was the least virulent 
(Reeves et al., 2004a). Here the virulence was attributed to the production levels of 
gliotoxin, which was found to vary between strains within the tissue of the larvae. 
The G. mellonella model can be used to determine virulence involvement of certain 
genes by comparing larval survival following infection with wild-type and mutant 
strains. Using the G. mellonella model, the pes1 gene was shown contribute to the 
virulence of A. fumigatus in a ∆pes1 strain, as the mutant strain exhibited a reduced 
virulence (Reeves et al., 2006).  
The fruit fly D. melanogaster uses cellular and humoral mechanisms in 
antimicrobial defence (Simon et al., 2008). It releases antimicrobial peptides, one of 
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which, drosomycin, has high activity against filamentous fungi such as A. fumigatus 
(Chamilos et al., 2008). The release of drosomycin is under the control of signals 
mediated by Toll, a transmembrane receptor (Simon et al., 2008). The mammalian 
interleukin-1 receptor type I (IL-1RI), shows high similarity to the D. melanogaster 
Toll (Rock et al., 1998). Toll-like receptors (TLRs) are responsible for the 
recognition of microorganisms and activation of the innate immune response 
(Birchler et al., 2001). D. melanogaster deficient in the toll signalling pathway can 
be used as an infection model. The flies are fed, or injected via the dorsal thorax, 
with A. fumigatus conidia resulting in infection of the hemolymph (Lionakis and 
Kontoyiannis, 2005).  As the flies can be used as a model of invasive aspergillosis, 
they can be used to assess the effect of anti-fungal drugs and also the effect of pre-
incubation of one anti-fungal on the efficiency of another (Lamaris et al., 2008). 
Here, it was concluded that pre-exposure of A. fumigatus AF293 conidia to 
voriconazole did not hinder the efficacy of posaconazole, and vice-versa. 
Furthermore, pre-incubation of the conidia with the anti-fungal drugs did not change 
the minimum inhibitory concentration (MIC) of the drug during subsequent 
infection. Recently, Chamilos et al. (2010) have shown that A. fumigatus strains 
deficient in sidA and sidD, respectively, show an attenuated virulence in the D. 
melanogaster Toll deficient model. This result was confirmed in the murine model, 
confirming that the D. melanogaster as a virulence model is a useful, cost effective 
and easy method of obtaining preliminary results that can be further verified in other 
virulence models. On the other hand, dosing and ease of use are the main drawbacks 
with using D. melanogaster as a virulence model.  
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1.8 Oxidative stress response 
The main defence response of the host towards invading Aspergillus spp. is 
mediated by macrophage killing of the incoming conidia. The macrophage defence 
mechanism is mediated by the release of ROS (Segal, 2007). A. fumigatus and other 
pathogenic fungi can protect themselves from this defensive attack by mediating an 
oxidative stress response (Lessing et al., 2007).  
Activating protein (AP-1) is a family of transcription factors. The AP-1 
homologue YAP1 is known as a central regulator of the oxidative stress response in 
S. cerevisiae (Qiao et al., 2010). Previous work has demonstrated that A. fumigatus 
YAP1 homologue, AfYap1, contributes to oxidative stress response in vitro in the 
fungus (Qiao et al., 2008). In the presence of oxidative stress, AfYap1 translocates 
from the cytoplasm to the nucleus in A. fumigatus. Proteomic analysis of A. 
fumigatus exposed to hydrogen peroxide showed that expression of 27 proteins 
increased and 17 exhibited decreased expression levels (Lessing et al., 2007). Of the 
proteins that increased, the majority were associated with antioxidant defence, 
composed of: heat shock proteins, protein translocation apparatus, central metabolic 
pathways, amino acid and trehalose metabolism and proteins of the cytoskeleton. 
This protein profile resembles that of the protection mechanisms in S. cerevisiae, 
Schizosaccharomyces pombe and C. albicans (Lessing et al., 2007). 
All aerobic organisms are exposed to ROS and have developed enzymatic and 
non-enzymatic defences against them. Enzymatic defences include superoxide 
dismutase (SOD) and catalases, and non-enzymatic defences include the production 
of melanin, mannitol and trehalose (Rementeria et al., 2005). SOD converts one 
harmful ROS, such as superoxide, to another form of ROS, namely hydrogen 
peroxide (Missall et al., 2004). Catalases, as mentioned previously, are antioxidant 
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metalloenzymes which promote the conversion of hydrogen peroxide to water and 
molecular oxygen (Missall et al., 2004). As previously mentioned, there are three 
catalases encoded in A. fumigatus which are produced during invasive aspergillosis, 
one conidial catalase, catA and two mycelial catalases, cat1 and cat2 (Paris et al., 
2003b). Cat1 and Cat2 protect A. fumigatus from peroxidase killing but not 
macrophage killing. Disruption of both genes results in a less virulent strain, whereas 
disruption of either catalase singularly does not change the virulence of the strain 
from the wild-type state (Paris et al., 2003b).  
Melanins are multifunctional polymers that are capable of reducing oxidants. 
There are two types of melanin identified in fungal pathogenesis: (i) 1,8-
dihydroxynaphthalene (DHN) and (ii) 3,4-dihydroxyphenylalanine (DOPA). DHN is 
produced in the conidial pigment and protects from ROS and oxidative killing by 
macrophages (Brakhage et al., 1999). DOPA is a strong antioxidant which protects 
against oxidative stress from macrophages (Hamilton and Gomez, 2002).  
Mannitol is a polyol that scavenges for ROS in vitro. It has also been shown that 
mannitol is required for stress tolerance in A. niger conidiospores (Ruijter et al., 
2003).  
Trehalose (α-D-glucopyranosyl-α-D-glucopyranoside) is a non-reducing 
disaccharide which accumulates during heat and oxidative stress (Fillinger et al., 
2001). It stabilises membranes and native proteins and prevents the aggregation of 
denatured proteins. 
It has been shown that exposure of fungal spores or mycelia to hydrogen 
peroxide promotes oxidative stress (Angelova et al., 2005). Oxidative stress in 
microorganisms cause diverse responses depending on the oxidative stress applied, 
due to the different oxidative stress pathways and reactions (Aguirre et al., 2005). 
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There has also been evidence indicating a change in fungal cell morphology is due to 
reaction by the fungus to oxidative stress (Missall et al., 2004). 
In particular, it has been well documented that the NRP synthetases, sidD and 
pes1 are involved in protection against oxidative stress (Eisendle et al., 2006; Reeves 
et al., 2006; Schrettl et al., 2007). 
 
1.9 Thesis Rationale and Objectives. 
Invasive aspergillosis is a significant disease risk for immunocompromised 
individuals, with mortality rates as high as 90 % (Denning, 1998). Many studies are 
now focused on identifying novel drug targets in the organism, and the pace of 
functional genomic studies in A. fumigatus is gathering as a consequence of the 
availability of the entire genome sequence of A. fumigatus AF293 (Nierman et al., 
2005). The pathogenicity of A. fumigatus can be, in part, attributed to metabolites 
secreted during infection (e.g., siderophores or gliotoxin) (Willger et al., 2009). 
Moreover, secondary metabolite, or natural product, biosynthesis represents a 
distinct aspect of the biochemistry of A. fumigatus, with respect to animals, and thus 
represents the focus of significant work directed towards drug target identification 
(Keller et al., 2005).  
At least 14 NRPS gene clusters have been identified in A. fumigatus, yet the 
products and functions of the majority of them still remain elusive (Cramer et al., 
2006b). Of the characterised NRPS products, siderophores and gliotoxin have been 
shown to contribute to the virulence of A. fumigatus (Sugui et al., 2007; Haas et al., 
2008). However, little is known about the interaction between NRP peptides, 
although new studies have identified the possibility of cross-talk between NRPS 
clusters (Lazos et al., 2010). Indeed, it is not unusual for distant genes to work 
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together, as in the case of the siderophore system where sidA, the gene involved in 
the first committed step of siderophore biosynthesis does not cluster with the other 
genes required for the biosynthesis of the siderophores, such as the NRP synthetases 
sidD and sidC (Schrettl et al., 2004). 
Previously it was established that A. fumigatus ∆pes1 exhibited increased 
sensitivity to oxidative stress and also displayed an altered conidial morphology and 
hydrophobicity (Reeves et al., 2006), however the NRP peptide product encoded by 
the NRP synthetase, Pes1, was not identified. More recent work has suggested that 
the increased rate of evolution of pes1 may be associated with its pathogenicity 
potential (Fedorova et al., 2008). Additionally, disruption of sidD, a siderophore 
synthetase which is required for TAFC biosynthesis, in A. fumigatus was also shown 
to result in increased sensitivity to oxidative stress and also play a role in virulence 
(Schrettl et al., 2007). Thus, it was hypothesised that interplay between pes1- and 
sidD-encoded NRP peptides may synergistically contribute to resistance to oxidative 
stress in A. fumigatus. 
The function of genes in many NRPS gene clusters remains elusive as they share 
neither overall, nor domain, homology with known proteins. This represents a major 
challenge in expanding our understanding of fungal biochemistry. An example of 
one such gene is gliK in the gliotoxin biosynthetic cluster.  Consequently, deletion of 
this gene followed by functional analysis of the deficient fungal strain should both 
illuminate its function and allow assessment of any potential as a drug target. 
 
Thus, the objectives of the work presented in this thesis are as follows: 
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1. Elucidation of the function of the NRP synthetase gene, pes1, in A. fumigatus 
by a targeted gene deletion approach, followed by comparative phenotypic 
analysis between wild-type and mutant strains. 
2. Investigation of functional interactions between two apparently unrelated 
NRP synthetase genes, namely sidD and pes1, in A. fumigatus by generation 
of double-gene mutants. 
3. Identification of the metabolite encoded by Pes1 in A. fumigatus by 
comparative metabolite profiling. 
4. Establish a function for the gene, gliK, in the gliotoxin biosynthetic cluster by 
gene deletion in two A. fumigatus strains followed by extensive analysis of 
result mutants. 
5. Develop assay systems for metabolite (TAFC) and anti-GliK IgG detection to 
enable future assessment of these analytes as biomarkers of fungal infection. 
  
 
 
 
 
 
 
 
CHAPTER 2 
 
 
 
Materials and Methods 
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2. Materials and Methods 
2.1 Materials 
All chemicals were purchased from Sigma-Aldrich Chemical Co. Ltd. (U.K.), 
unless otherwise stated. The details of the Materials used in this study can be found 
in Appendix I, at the back of this thesis. 
 
2.2 Methods 
2.2.1 Microbiological Methods – Strain Storage and Growth 
 Fungal and bacterial strains used in this study are listed in Table 2.1 and Table 
2.2, respectively. 
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Table 2.1: Fungal strains used, including antibiotics and supplements used. 
Species Strain Antibiotics/Supplements 
A. fumigatus ATCC46645 N/A 
A. fumigatus ATCC26933 N/A 
A. fumigatus ∆akuB Hygromycin (250 µg/ml) 
A. fumigatus ∆akuB:∆pes1  Pyrithiamine (100 ng/ml) 
A. fumigatus ∆pes146645 Pyrithiamine (100 ng/ml) 
A. fumigatus ∆sidD:∆pes1 Pyrithiamine (100 ng/ml) & 
Hygromycin (250 µg/ml) 
A. fumigatus ∆sidD46645 Hygromycin (250 µg/ml) 
A. fumigatus ∆gliK46645 Pyrithiamine (100 ng/ml) 
A. fumigatus ∆gliK26933 Pyrithiamine (100 ng/ml) 
A. fumigatus ∆sidD:∆pes1:pes1c  Phleomycin (40 ng/ml) & 
Hygromycin (250 µg/ml) & 
Pyrithiamine (100 ng/ml) 
A. fumigatus ∆gliK46645:gliKc  Phleomycin (40 ng/ml) & 
Pyrithiamine (100 ng/ml) 
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Table 2.2: Bacterial strains used, including antibiotics and supplements used. 
Species Strain Antibiotics/Supplements 
E. coli TOP 10 Ampicillin (100 μg/ml) 
E. coli DH5αTM Ampicillin (100 µg/ml) 
E.coli pSK275 Pyrithiamine (100 ng/ml) 
E. coli pProEx™-Htb Ampicillin (100 µg/ml) 
E. coli pAN8-1 Phleomycin (40 µg/ml) 
 
2.2.1.1 A. fumigatus Growth, Maintenance and Storage 
A. fumigatus strains were maintained on ME (Malt extract) agar (Section 9.1.1.3). 
A loop of spores from a stock spore solution was stabbed into the middle of a culture 
plate and plates were incubated at 37 oC for 5-7 days with periodic checking. Once 
full plate growth was observed, plates were sealed with parafilm, and stored inverted 
in a sealed plastic bag at 4 oC. For permanent storage of Aspergillus spores, freshly 
grown spores were harvested from agar plates by adding 10 ml of sterile H2O to the 
conidial culture and rubbing the surface with a sterile disposable spreader to dislodge 
the spores. The spores were transferred to a 50 ml Falcon tube and stored at 4 oC, 
until required. 
 
2.2.1.2 E.coli Growth, Maintenance and Storage 
E. coli strains were grown on Luria-Bertani agar (Section 9.1.8) overnight at 37 
oC or in Luria-Bertani broth (Section 9.1.7) at 37 oC overnight, shaking at 200 rpm. 
Where appropriate, media was supplemented with suitable antibiotics (Table 9.2). 
Bacterial strains were stored at 4 oC for short term storage.  
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2.2.2 Molecular Biological Methods 
2.2.2.1 Isolation of Genomic DNA from A.fumigatus  
A. fumigatus conidia were harvested from five day old plates using PBST (5 ml) 
(Section 9.1.4) and an aliquot of the resulting conidial suspension (100 µl) was used 
to inoculate 200 ml cultures of Sabouraud Dextrose Broth (Section 9.1.1.1).  The 
cultures were incubated at 37 oC for 24 hr with constant agitation. The cultures were 
then filtered through autoclaved miracloth and the mycelia collected. The mycelia 
mass was then flash frozen in liquid Nitrogen and ground to a fine powder using a 
pestle and mortar. The DNA extractions were carried out using the ZR 
Fungal/Bacterial DNA Kit supplied by Zymo Research (California, U.S.A). All 
buffers and reagents were supplied with the kit. For each sample, mycelia (1 g) was 
added to 750 µl DNA buffer in the ZR Bead Bashing tube. The tubes were vortexed 
rigorously for 5 minutes. The bead bashing tubes were centrifuged at 10000 x g for 1 
minute. Supernatant (400 µl) was transferred to Zymo-Spin IV Spin filters in  
collection tubes and centrifuged at 7000 x g for 1 minute. Fungal/Bacterial DNA 
binding Buffer (1200 µl) was added to the filtrates in the collection tubes.  Filtrate 
(800 µl) was transferred to Zymo-Spin IIC Columns in collection tubes and 
centrifuged at 10000 x g for 1 minute. The filtrate was discarded. The remaining 
filtrate (800 µl) was added to the Zymo-Spin IIC columns and centrifuged at 10000 x 
g for 1 minute. DNA Pre-Wash Buffer (200 µl) was added to the Zymo-Spin 
Columns in new collection tubes and centrifuged at 10000 x g for 1 minute. 
Fungal/Bacterial DNA wash buffer (500 µl) was added to the Zymo-Spin IIC 
columns and centrifuged at 10000 x g for 1 minute. The Zymo-Spin IIC columns 
were transferred to clean 1.5 ml microcentrifuge tubes and DNA Elution Buffer (100 
µl) was added to the columns and centrifuged at 10000 x g for 1 minute to elute the 
DNA samples.   
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2.2.2.2 DNA Precipitation 
2.5 X volume 100 % (v/v) ice cold ethanol and 0.1X volume 3M Sodium acetate 
(Section 9.1.15) was added to each DNA sample. The mixture was incubated at -20 
oC for at least 30 minutes and then centrifuged at 17900 x g for 15 minutes. The 
supernatants were discarded and the pellets were resuspended in 100 µl 70 % (v/v) 
Ethanol. The samples were centrifuged at 13000 x g for 10 minutes and the 
supernatants were discarded and the pellets were resuspended in 16 µl sterile water. 
The precipitated DNA samples were stored at -20 oC until required. 
 
2.2.2.3 Polymerase Chain Reaction (PCR) 
Polymerase chain Reaction (PCR) was used to amplify fragments of DNA for 
cloning, transformation constructs, probes, and to test E. coli for recombinant 
plasmid presence. PCR was carried out using either AccuTaq LA polymerase 
(Sigma-Aldrich) or Expand Long Template PCR system (Roche). Annealing 
temperatures were estimated as ca. 4 oC below the melting temperature (Tm) of the 
primers used. Extension times used were ca. 1 min/kb of DNA to be synthesised. 
Reactions were carried out using either the Eppendorf PCR or G-Storm PCR (Roche) 
Systems.  
The general reaction constitutes for both polymerases used was as follows: 
AccuTaq LA polymerase 
10X reaction buffer  2 µl 
dNTP mix (10 µM)  2 µl 
Primer 1 (100 pmol/µl) 1 µl 
Primer 2 (100 pmol/µl) 1 µl 
DMSO    0.8 µl 
DNA template   1-10 ng 
AccuTaq   0.2 µl 
Sterile water   to a total of 20 µl 
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Expand Long Template PCR system 
10X Reaction Buffer  5 µl 
dNTP mix (5 µM)  5 µl 
Primer 1 (100 pmol/µl) 2 µl 
Primer 2 (100 pmol/µl) 2 µl 
DNA template   1-10  ng 
ExpandTaq   1 µl 
Sterile water   to a total of 50 µl 
 
The following reaction cycle was used unless otherwise stated: 
95 oC (denaturing) 1 min 
95 oC (denaturing) 1 min 
56 oC (annealing) 1 min       x 35 cycles 
68 oC (extending) 1 min 
68 oC (extending) 7 min 
 
 
2.2.2.4 Agarose Gel Electrophoresis  
Agarose gel electrophoresis was used to visualise restriction digest reactions, to 
separate DNA for Southern analysis, to separate differently sized DNA fragments 
prior to purification and for estimation of DNA yield. Agarose gels were cast and run 
using Bio-Rad electrophoresis equipment. Agarose gels of between 0.7 – 2 % (w/v) 
in 1X TAE buffer (Section 9.1.12.2) were used, although for the majority of 
applications a 1 % (w/v) content was suitable. Powdered agarose was added to the 
appropriate volume of 1X TAE buffer (Section 9.1.12.2) in a 200 ml flask with loose 
stopper. This was then gently heated in a microwave, with frequent mixing, until the 
agarose had dissolved. While allowing the gel to cool, a mould was prepared by 
inserting the casting unit in a casting holder and sealed. A gel comb was inserted. 
After allowing the gel to cool to 40 - 50 oC, the molten gel was then poured into the 
prepared unit. Ethidium bromide (3 µl) (Section 9.1.12.3) was added to the casting 
unit and the gel was allowed to set on a level surface. Once set, the gel comb was 
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removed gently, and the gel casting unit containing the set gel was placed into the gel 
tank, with the wells nearer the negative (black) electrode. 1 X TAE buffer (Section 
9.1.12.2) was then poured into the gel tank to fully submerge the gel. 
 
2.2.2.5 DNA Gel Electrophoresis 
DNA samples were prepared for loading by adding 5 volumes of DNA sample to 
1 volume of 6 X loading dye (Section 9.1.12.4). DNA fragment size was estimated 
by running molecular weight markers alongside the unknown samples. Three 
different molecular weight markers were used throughout this study: marker VII 
(Roche), 2-log ladder (Roche) and 50 bp ladder (Roche). Gels were electrophoresed 
at 50-100 volts for 30-90 min. 
 
2.2.3 Cloning 
2.2.3.1 Preparation of competent DH5α bacterial cells 
A loopful of the DH5α bacterial cells were inoculated into a 10 ml culture of LB 
broth (Section 9.1.7) and incubated overnight at 37 oC, shaking at 200 rpm. The 
culture was used to inoculate a 1 L culture of LB Broth, which was incubated at 37 
oC, for 2 hr, shaking at 200 rpm. The culture was split into 4 aliquots and incubated 
on ice for 10 min. The cultures were then centrifuged at 2700 x g, for 10 min at 4 oC. 
The supernatant was discarded and the pellets were each resuspended in cold Buffer 
RF1 (10 ml) (Section 9.1.11.3). The suspension was incubated on ice for 30 min. The 
suspension was divided out into 1.5 ml Eppendorf tubes and the cells were 
centrifuged at 2700 x g for 10 min at 4 oC. The supernatant was discarded, and each 
pellet was resuspended in Buffer RF2 (3.2 ml) (Section 9.1.11.4) and kept on ice for 
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15 min. The cells were divided into 100 µl aliquots in Eppendorf tubes and stored at -
70 oC until required. 
 
2.2.3.2 Transformation of DNA into competent DH5α bacterial cells 
Luria- Bertani agar plates (Section 9.1.8) containing Ampicillin (Section 9.1.10) 
were pre-heated at 37 oC for at least one hr. DH5α competent cells (50 µl) (Section 
2.2.3.1) were removed from -70 oC freezer and were defrosted on ice for two 
minutes. DNA (1-10 ng) was added to the DH5α cells. The mixture was incubated on 
ice for five minutes. The mixture was spread onto the agar plates as quickly as 
possible and the plates were incubated at 37 oC overnight. 
 
2.2.3.3 TOPO TA Cloning 
One step cloning of PCR products were carried out using the TOPO TA Cloning 
kit from Invitrogen, according to the manufacturer’s instructions. The principle 
behind one step Cloning is based on the non-template dependant activity of Taq 
polymerase that results in the addition of a single deoxyadenosine (A) to the 3’ ends 
of the PCR products. The linearised cloning vector has single 3’ deoxythymidine (T) 
residues therefore facilitating PCR inserts to ligate efficiently with the vector. The 
TOPO TA Cloning vector map is presented in Figure 2.1.  The TOPO TA Cloning 
kit contains TOP 10 One Shot competent E. coli cells, Super Optimal Catabolite 
repression (SOC) media, TOPO vector and salt solution. Prior to cloning, TOP 10 
cells were thawed on ice and LB agar plates (Section 9.1.8) containing 100 µg/ml 
Ampicillin (Section 9.1.10) pre- warmed in a 37 oC incubator. Genomic DNA PCR 
product (4 µl), Salt solution (1 µl) and TOPO vector (1 µl) were added to a sterile 0.5 
ml tube and left at room temperature for 30 min. A 2 µl aliquot of this reaction 
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mixture was added to a vial of TOP 10 E. coli cells and placed on ice for 30 min. 
Cells were heat shocked at 42 oC for 30 s in a water bath and pre-warmed SOC media 
(200 µl) was added to the vial. The cell suspension was transferred to a 15 ml tube 
and incubated at 37 oC for 1 hr with constant agitation (200 rpm). During this 
incubation period, 32 µl of 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside 
(X-gal) (Promega) (Southampton, UK) (40 mg/ml) was spread over the pre-warmed 
agar plates using a sterile glass spreader and the plates were returned to the 
incubator. This reagent facilitates blue/white colony screening which greatly aids in 
the identification of desired clones. A 50 µl aliquot of the cell suspension was spread 
on the selection plates using a sterile disposable spreader and the plates were 
incubated overnight at 37 oC. White colonies were selected and sub-cultured on to 
LB agar plates (Section 9.1.8) with Ampicillin (100 µg/ml) (Section 9.1.10). Colony 
PCR (Section 2.2.3.4) was carried out to verify the presence of the desired insert in 
the vector of the sample clones. 
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Figure 2.1: Vector map of the TOPO® TA Cloning® vector (Invitrogen, The 
Netherlands). 
 
2.2.3.4 Colony PCR 
Bacterial colonies observed following by transformation could be directly 
screened for presence of the desired plasmid by PCR. Using aseptic techniques, an 
isolated colony was removed using a sterile tip and placed in sterile 0.2 ml 
microcentrifuge tube containing a PCR Mastermix having all components necessary 
for PCR (Section 2.2.2.3) and also streaked onto a reference plate. Genomic DNA 
and DNA negative controls were included and PCR was carried out as described in 
77 
 
Section 2.2.2.3 with the exception that the initial denaturing step was increased to 5 
min at 95 oC to allow the bacterial cells to rupture and release DNA for the PCR 
reaction. 
 
2.2.3.5 Small Scale Plasmid Purification 
Plasmid purification was carried out according to the Qiagen Plasmid purification 
manual using the QIA prep Mini-prep kit. All buffers (P1, P2, N3, PE and EB) and 
columns were supplied with the kit and details of buffer constituents outlined in the 
Qiagen Plasmid Purification Handbook. An isolated colony was picked aseptically 
and used to inoculate LB broth (Section 9.1.7) (3 ml) containing 100 µg/ml 
Ampicillin (Section 9.1.10). The culture was grown overnight at 37 °C and the cells 
harvested by centrifugation at 13,000 x g for 10 min at 4 °C. The supernatant was 
removed and the pellet resuspended in ice cold Buffer P1 (250 µl). Buffer P2 (250 
µl), and Buffer N3 (350 µl) were then added and the tubes inverted 5 times prior to 
centrifugation at 11,000 x g for 1 min at 4 °C. The supernatant was removed, applied 
to the Qiaprep spin column and centrifuged at 11,000 x g for 1 min at 4 °C. The flow 
through was discarded and the column was washed with Buffer PE (750 µl) and 
centrifuged at 11,000 x g for 1 min. Once again the flow through was discarded and 
the DNA was eluted off the column by the addition of Buffer EB (30 µl) followed by 
centrifugation at 14,000 x g for 1 min. The purified plasmid was subsequently 
analysed by DNA gel electrophoresis (Section 2.2.2.5).  
 
2.2.3.6 DNA Sequencing 
DNA sequencing of recombinant clones was performed by Agowa genomics 
(Berlin, Germany) on a commercial basis. 
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2.2.4 RNA Analysis 
2.2.4.1 RNA Isolation 
A. fumigatus liquid cultures which were incubated at the required temperature 
and time were filtered through autoclaved miracloth and the mycelia collected. 
Mycelia were then flash frozen in liquid Nitrogen and ground to a fine powder in a 
mortar by pestle. The RNA was isolated using the RNeasy Kit supplied by Qiagen, 
according to the manufacturer’s instructions. β-mercaptoethanol (10 µl) was added to 
Buffer RLC (1 ml) before RNA extraction. For each sample, Mycelia (100 mg) was 
placed in sterile microcentrifuge tubes.  Buffer RLC (450 µl) was added the each 
sample vortexed vigorously. The lysates were transferred to QIAshredder spin 
columns. The columns were centrifuged at 17,900 x g for 2 min, and the flow 
through was transferred to new microcentrifuge tubes, avoiding the cell debris pellet. 
Ethanol (100 %, 0.5 Volume of the lysate) was added to the lysates and mixed 
immediately. Samples were then transferred to RNeasy spin columns, which were 
placed in 2 ml collection tubes. Columns were centrifuged at 10600 x g for 15 s, and 
the flow through was discarded. Buffer RW1 (700 µl) was added to the columns and 
then centrifuged at 10600 x g for 15 s, discarding the flow through.  Buffer RPE (500 
µl) was added to the columns and centrifuged for 15 s at 10600 x g. The flow 
through was discarded. Buffer RPE (500 µl) was added to the columns and 
centrifuged at 10600 x g for 2 min. The spin columns were removed and placed in 
new collection tubes and were centrifuged for 2 min at 17900 x g, to remove residual 
buffer collected. The columns were removed and placed in 1.5 ml microcentrifuge 
tubes.  RNase-free water (50 µl) was added to the columns and the RNA was eluted 
by centrifuging the column at 10600 x g for 1 min. The RNA samples were stored at 
-70 oC. 
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2.2.4.2 RNA Gel Electrophoresis 
Agarose gels (1 % (w/v)) were prepared by adding agarose (1 g) to 10 X 
Formaldehyde Agarose (FA) gel buffer (10 ml) (Section 9.1.13.3) and the final 
volume was adjusted to 100 ml with DEPC- treated water (Section 9.1.13.2). The 
agarose was melted in a microwave, and was allowed to cool to 65 oC. Formaldehyde 
(37 % (v/v)) (1.8 ml) was added to the agarose solution in a fume hood and the 
solution was poured into the gel tray and allowed to cool. The Formaldehyde/agarose 
gel was placed in an electrophoresis unit using 1X formaldehyde agarose running 
buffer (Section 9.1.13.4). The gel was allowed to equilibrate in the buffer for 30 min 
prior to use. RNA samples were prepared for loading by adding 4 volumes of RNA 
sample to 1 volume of 5X RNA loading buffer (Section 9.1.13.5). The samples were 
incubated at 65 oC for 5 min and allowed to chill on ice. Samples were loaded onto 
the gel and electrophoresed at 90 V for ~2 hr. Formaldehyde agarose gels were 
visualised on the DigiDoc RT system (Alpha Innotech). 
 
2.2.4.3 DNase Teatment of RNA 
DNase treatment of RNA was performed using a DNase kit purchased from 
Sigma-Aldrich. A. fumigatus RNA (0.5 µg) was brought to 8 µl using DEPC water 
(Section 9.1.13.2) in Eppendorf tubes, 1 µl of 10 X reaction buffer and 1 µl of DNase 
1 were added to each of the RNA samples, which were incubated at room 
temperature for 15 min. Stop solution (1 µl) (supplied with kit) was added to the 
solutions, which were heated to 70 oC for 10 min. Samples were stored at –70 oC. 
 
2.2.4.4 cDNA Synthesis  
cDNA synthesis was performed using the SuperScript® III First-Strand Synthesis 
System kit, supplied by Invitrogen (California, U.S.A). All buffers and reagents were 
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supplied with the kit. DNase treated RNA (8 µl), 10 mM dNTP mix (1 µl), Oligo 
(dT) (1 µl), were added to a microfuge tube. Tubes were incubated at 65 oC for 5 
min, and placed on ice for 1 min. A master mix of 10 X Reverse Transcriptase buffer 
(2 µl), 25 mM MgCl2 (4 µl), 0.1 M DTT (2 µl) and RNase OUT recombinant RNase 
Inhibitor (0.9 µl), per sample, was prepared. This master mix (9 µl) was added to 
each RNA sample and mixed gently by pipetting. The samples were then incubated 
at 42 oC for 2 min. Superscript III-Reverse Transcriptase (0.25 µl) was added to each 
sample and mixed, prior to incubation at 42 oC for 50 min. The reaction was 
terminated by heating the samples to 70 oC for 15 min, and chilling the tubes on ice. 
RNase H (1 µl) was added to each sample and incubated at 37 oC for 20 min. The 
samples were stored at -20 oC. 
 
2.2.4.5 Semi-quantitative RT-PCR 
PCR was carried out on the cDNA samples as described in Section 2.2.2.3 with 
the A. fumigatus calmodulin gene serving as a control in RT-PCR experiments 
(Burns et al., 2005). 
 
2.2.4.6 Quantitative Real time PCR 
PCR was carried out on the cDNA samples using the qPCR lightcycler system 
(Roche). A standard curve for each reaction was created by using a serial dilution of 
a cDNA sample. The dilutions were 5-fold dilutions. Once the optimum conditions 
were confirmed by the standard curve, the samples were used at a dilution within the 
serial dilution range, usually 1/25.  
The expression of various genes of interest was measured against the expression 
of the housekeeping gene, Calmodulin (AfuA_4G10050). This quantified the level of 
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expression of the genes of interest relative to the house keeping gene expression, 
which was normalised for all the samples.  
The genes of interest for this project were pes1 (AFUA_1G10380) and gliK 
(AFUA_6G09700). The pes1 gene is large (18.8 kb), and the region of interest is the 
first adenlyation domain, A1 (1.2 kb). The PCR program used for this gene was 
named pes1A1, which amplified a 171 bp region. The gliK gene (822 bp) is 
relatively small compared to pes1 and the PCR program used for this gene was gliK, 
which amplified a 370 bp region.  
 
Reaction Mix 
cDNA 1/25 dilution  5µl 
SYBR Green  10 μl  
Sterile water  2 μl 
Primer 1 (5 μM) 1.8 μl 
Primer 2 (5 μM) 1.8 μl 
 
 
PCR Cycle (Calmodulin) 
95 oC (pre-incubation) 10 min 
95 oC (denaturing)  10 sec 
55 oC (annealing)  30 sec       x 35 cycles 
72 oC (extending)  30 sec 
 
 
 
PCR Cycle (pes1A1, gliK) 
95 oC (pre-incubation) 10 min 
95 oC (denaturing)  10 sec 
60 oC (annealing)  30 sec       x 35 cycles 
72 oC (extending)  30 sec 
 
 
2.2.5 Restriction Enzyme Digests 
Restriction enzymes, 10 X reaction buffers, and bovine serum albumin (BSA) 
were obtained from either Promega (Southampton, UK) or New England Biolabs 
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(Ipswich, UK).  Reactions were carried out according to the manufacturer’s 
instructions, but a typical reaction was performed as follows:  
 
DNA    1 µg  
Enzyme  1 µl  
10 x buffer  1 µl  
BSA (10 μg/μl) 1 µl (if required) 
Sterile water   to final volume of 10 µl.   
 
The total reaction volume was always  > 10 X the volume of enzyme used in 
order to prevent high glycerol concentrations, which could cause non-specific 
digestion (star activity).  Reactions were typically carried out at 37 oC for 3 hr, 
although some enzymes required different incubation temperatures, as per the 
manufacturer’s instructions. Digestion reactions were visualised by agarose gel 
electrophoresis (Section 2.2.2.5)  
 
2.2.6 Ligation of DNA fragments 
Ligation of DNA fragments was required for creating the constructs for pes1 
disruption and gliK deletion transformation and also for the recombinant GliK 
production using the pProEx™-Htb expression vector. DNA was digested (Section 
2.2.5) to create compatible ends and the resultant fragments were subjected to 
agarose gel electrophoresis (Section 2.2.2.5). Ligation reactions were carried out 
using the Fast Ligase (Promega, Southampton, UK) according to the manufacturer’s 
instructions. Ligation reactions were set up using 100 ng vector, using the following 
equation: 
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The ligations were usually carried out with molar ratios of 1:1 and 1:3 and a 
typical reaction was usually made up of the following, and incubated at 22 oC for 2 
hr: 
Vector    100 ng 
Insert    as per equation calculation 
2X Fast ligase Buffer   12.5 µl 
Fast Ligase    1 µl 
Sterile water    to 25 µl 
 
2.2.7 Transformation of selected genes of Aspergillus fumigatus 
The bipartite method of transformation was used for the integration of the 
constructs into the Aspergillus fumigatus genome. Overall, this strategy involved 
three separate overlapping homologous recombination events. The general scheme of 
this method is outlined in Figure 2.2. The method utilises a selection marker that is 
only functioning by the homologous recombination of overlapping ends that unify 
the selection marker. The homologous recombination of the 5’ and 3’ flanking 
regions of the gene of interest are the other two locations of the homologous 
recombination sites. 
 
 
Figure 2.2: General schematic of the bipartite transformation method where the 
homologous recombination of the two separate fragments of the selection marker is 
the initial recombination site. The establishment of the complete selection marker 
enables the use of easy screening on the appropriate selection media. The 
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homologous recombination of the 5’ and 3’ flanking regions of the gene of interest 
direct the targeted replacement of the gene with the selection marker. 
 
In the knock out transformations of pes1 and gliK, the selection marker chosen 
was the pyrithiamine resistance gene, ptrA, excised from the plasmid pSK275 (A 
kind gift from Prof. Sven Krappmann, Göttingen, Germany).  Pyrithiamine is an 
antagonist of thiamine and exposure of Aspergillus fumigatus to pyrithiamine is 
lethal to the fungus. The introduction of the pyrithiamine resistance gene produces 
the required thiamine, and therefore allows the transformed cell to grow in the 
otherwise lethal conditions. 
For the reinsertion of the gene into the mutated strain the previously deleted 
region is PCR amplified from the wild-type strain and integrated into the TOPO 
vector. The plasmid is then linerised by a single restriction enzyme digestion, this is 
the construct used for the transformation. The selection marker is co-transformed, 
with the linerised construct. The transformation occurs by a single homologous 
recombination point. The general schematic of this complementation transformation 
is described in Figure 2.3. 
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Figure 2.3: General schematic of the complementation strategies employed. The 
gene of interest and some of the 5’ and 3’ flanking region is cloned into the TOPO 
vector and subsequently digested with a unique restriction enzyme which cuts the 3’ 
flanking region only. The digested vector is then used as the transformation construct 
where the 3’ flanking region after the restriction cut is used to direct the construct to 
insert into the genome in the 3’ flanking region after the selection marker which was 
already used to remove the gene previously.  
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2.2.7.1 Constructs for Knock out Transformations 
The creation of constructs for the transformation process by the bipartite method 
is based on generating PCR products which contain additional restriction enzyme 
sites anchored onto certain primers. This enables the fragment generated by these 
primers to be digested and ligated to another DNA fragment, generating the final 
PCR products used for the transformation. The primers used for all the 
transformations are listed in Table 2.3.  
For pes1 transformation, the first round PCR generated products of the flanking 
regions used primers that incorporated restriction sites, PvuI and KpnI, used for a 
ligation site with the ptrA cassette (Figure 2.4).  For gliK transformation, the first 
round PCR generated products of the flanking regions used primers that incorporated 
restriction sites, SpeI and HindIII (Figure 2.5). The flanking regions and the plasmid 
pSK275 were digested with the appropriate restriction enzyme and the digested PCR 
products were then ligated to the digested plasmid. The resultant fragments were then 
used as templates for the final PCR, where nested primers for the flanking regions 
and primers incorporated in the ptrA cassette were used to create the constructs used 
for the transformations. The final PCR products were precipitated to reduce the 
volume of the construct required for the transformation.  
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Table 2.3: Oligonucleotide primers used for the creation of constructs for the 
transformation of pes1 and gliK. 
Gene 
Target 
 
Primer 
Name 
Add on 
restriction 
sites 
5’  3’ Sequence 
pes1 5’ forward  GTCGGCATCGGACATCTAC 
pes1 5’ reverse PvuI GACGATCGGTACCATCTGCCACTCAC 
pes1 3’ forward KpnI GCGGTACCCAAGGCATTGGTCTCACTG 
pes1 3’ reverse  CTGTAGCTTCTGGCCGAG 
pes1 5’ nested 
forward 
 CATGCAATCAAGGATATGG 
pes1 3’ nested 
reverse 
 CCTTGCACTACCAATGCTG 
gliK gliK 1 
forward 
 GCATACTGTAGTCGCGGTAGA 
gliK gliK 4 
reverse 
Spe1 GCACTAGTGCTTTCCCCATGTTGCTTG 
gliK gliK 3 
forward 
HindIII CGAAGCTTAGTCTCCATGTCTCCGATG 
gliK gliK 2 
reverse 
 CGAGAGCGTGGCAAACAGAC 
gliK gliK 5’ 
nested 
forward 
 ACGCCTCTAACATGCCATAC 
gliK gliK 3’ 
nested 
reverse 
 GTAGGTCGGCAGGTAGTACA 
ptrA optrA 1 
forward 
 GAGGACCTGGACAAGTAC 
ptrA optrA 2 
reverse 
 CATCGTGACCAGTGGTAC 
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Figure 2.4: Schematic of strategy for generation of transformation constructs used in 
pes1 disruption. Initial PCR products have an add-on restriction site, which is used to 
digest the product to facilitate ligation to the ptrA cassette. This is then used as a 
template for the final PCR products which are the Transformation constructs. The red 
shape depicts the PCR product generated from the 5’ flanking region of pes1. The 
Green shape depicts the PCR product generated from the 3’ region of pes1. The grey 
shape depicts the predicted promoter of pes1. The blue shape depicts the pyrithamine 
resistance cassette excised from the plasmid pSK275. 
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Figure 2.5: Schematic of strategy for generation of transformation constructs used in 
gliK deletion. Initial PCR products have an add-on restriction site, which is used to 
digest the product to facilitate ligation to the ptrA cassette. This is then used as a 
template for the final PCR products which are the transformation constructs. The red 
shape depicts the PCR product generated from the 5’ flanking region of gliK. The 
Green shape depicts the PCR product generated from the 3’ flanking region of gliK. 
The blue shape depicts the pyrithamine resistance cassette excised from the plasmid 
pSK275. 
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2.2.7.2 Constructs for complementation Transformations 
The primers used for the complemented construct are listed in Table 2.4. The 
PCR products were inserted into the TOPO vector, and the orientation of the inserted 
DNA was verified. A single restriction enzyme was located within the 3’ region of 
the inserted DNA, and the entire plasmid was linerised by digesting with this 
restriction enzyme. For pes1, the restriction enzyme was AarI (Figure 2.6), and for 
gliK the restriction enzyme was AleI (Figure 2.7). For the selection marker, the 
phleomycin resistance plasmid, pAN8-1 was used. Due to the necessity of the single 
restriction enzyme in the construct containing vector, it was impossible to add the 
phleomycin resistance cassette to the construct containing vector. Therefore, pAN8-1 
was co-transformed in its circular form along with the linerised construct vector in 
the transformation process. 
 
Table 2.4: Oligonucleotides used for the creation of constructs for the 
complementation transformation of pes1 and gliK. 
Gene 
Target 
 
Primer Name 5’  3’ Sequence 
pes1 5’ nested forward CATGCAATCAAGGATATGG 
pes1 3’ nested reverse CCTTGCACTACCAATGCTG 
gliK gliK 5’ nested 
forward 
ACGCCTCTAACATGCCATAC 
gliK gliK 3’ nested 
reverse 
GTAGGTCGGCAGGTAGTACA 
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Figure 2.6: Schematics of the Complementation strategy employed for the pes1 
reconstitution transformation where (A) Schematic of the generation of the 
constructs for subsequent complementation and (B) Schematic of the transformation 
for compelementation. The red shape depicts the 5’ flanking region of pes1. The 
Green shape depicts the pes1 gene. The grey shape depicts the predicted promoter of 
pes1. The yellow shape depicts the 3’ flanking region. The blue shape depicts the 
pyrithamine resistance cassette excised from the plasmid pSK275. The black shape 
depicts the Topo cloning vector.  
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Figure 2.7: Schematic of the Complementation strategy employed for the gliK 
reconstitution transformation. The red shape depicts the 5’ flanking region of gliK. 
The Green shape depicts the gliK gene. The purple shape depicts the 3’ flanking 
region of gliK. The blue shape depicts the pyrithamine resistance cassette excised 
from the plasmid pSK275. The black shape depicts the Topo cloning vector. 
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2.2.7.3 A. fumigatus Protoplast Preparation 
A. fumigatus conidia were harvested from 5 day old plates grown on Sabouraud 
agar (Section 9.1.1.1) by washing two plates with 5 ml sterile PBST (Section 9.1.4). 
An aliquot of the spore suspension was diluted (1/20 dilution) and counted on a 
haemocytometer. A 500 ml conical flask containing AMM medium (200 ml) 
(Section 9.1.1.6.1) was inoculated with 2 x 108 spores. The culture was incubated 
overnight at 37 oC, whilst shaking at 200 rpm. The mycelia were harvested through 
miracloth and washed through with 600 ml autoclaved distilled water. Excess water 
was removed by gentle blotting. Mycelia (1.5 g) was weighed out in duplicate, and 
each was added to 15 ml Lysis buffer containing lytic enzymes (Section 9.1.16.4.2), 
and then incubated at 30 oC for 3 hr, while shaking at 100 rpm. During the 3 hr, the 
mycelia were removed from the incubator to break up the mycelial mass by pipetting 
gently. After the incubation, the mycelia were placed on ice for 2 min.  The mycelial 
solution was centrifuged at 132 x g for 18 min with the brake off. The supernatant 
was filtered through miracloth and brought up to 40 ml with 0.7 M KCl (Section 
9.1.16.1). The solution was centrifuged at 1769 x g for 12 min with the brake off. 
The supernatant was poured off and discarded. The pellet was resuspended in 20 ml 
0.7 M KCl (Section 9.1.16.1). The solution was centrifuged at 1769 x g for 12 min 
with the brake off. The supernatant was poured off and discarded. The pellet was 
resuspended in 70 µl Buffer L6 (Section 9.1.16.5) and then centrifuged at 58 x g for 
2 min with the brake off. Finally, the protoplasts were viewed on a haemocytometer 
to ensure adequate yield and viability were obtained for the transformation. The 
protoplasts were stored on ice for up to 1 hr before use in transformation 
experiments. 
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2.2.7.4 Transformation of protoplasts 
Between 2 -7 µg of 5’ and 3’ constructs were mixed together and the volume was 
brought up to 50 μl with Buffer L6 (Section 9.1.16.5) in a 50 ml Falcon tube.  
Protoplast (150 μl), of at least 1 x 107/ml were added to the constructs. Buffer L7 (50 
μl) (Section 9.1.16.6) was added to the protoplast/construct mixture and was mixed 
by gentle shaking and placed on ice for 20 min. Buffer L7 (1 ml) (Section 9.1.16.6) 
was added to the mixture and left at room temperature for 5 min, to allow for 
recovery of protoplasts. Buffer L6 (5 ml) (Section 9.1.16.5) was added, and the 
mixture was left on ice until required for plating. 
For the controls, protoplasts (15 μl) were added to Buffer L6 (185 μl) (Section 
9.1.16.5). Buffer L7 (50 μl) (Section 9.1.16.6) was added and the mixture was mixed 
by gentle shaking and placed on ice for 20 min. Buffer L7 (1 ml) (Section 9.1.16.6) 
was added to the mixture and left at room temperature for 5 min, to allow for 
recovery of protoplasts. Buffer L6 (5 ml) (Section 9.1.16.5) was added, and the 
mixture was left on ice until required for plating.  
 
2.2.7.5 Plating of transformation protoplasts 
Regeneration agar (1.8% (w/v), 25 ml) (Section 9.1.1.8.1) containing 
pyrithiamine (25 μl) (Section 9.1.10) was poured into 90 mm petri dishes. The 
protoplasts containing the constructs mixture was brought to a final volume of 30 ml 
using 0.7 % (w/v) regeneration agar (Section 9.1.1.8.2), and 6 ml was poured into 
each of the five regeneration agar petri dishes. 
 For the positive controls, 1.25 ml control protoplasts were added to 0.7 % (w/v) 
regeneration agar (6 ml) (Section 9.1.1.8.2) and poured onto a plate containing 1.8 % 
(w/v) regeneration agar (25 ml) (Section 9.1.1.8.1) only and 125 µl control 
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protoplasts were added to 0.7 % (w/v) regeneration agar (6 ml) (Section 9.1.1.8.2) 
and poured onto a plate containing 1.8 % (w/v) regeneration agar (25 ml) (Section 
9.1.1.8.1) only.  
For the negative controls, 1.25 ml control protoplasts were added to 6 ml 0.7 % 
(w/v) regeneration agar (Section 9.1.1.8.2) and poured onto a plate containing 1.8 % 
(w/v) regeneration agar (25 ml) (Section 9.1.1.8.1) and pyrithiamine (25 μl) (Section 
9.1.10). 
All the plates were left upright at room temperature overnight. 
 
2.2.7.6 Overlaying of transformation plates 
0.7 % (w/v) regeneration agar (50 ml) (Section 9.1.1.8.2) containing pyrithiamine 
(50 μl) (Section 9.1.10) was mixed and 6 ml was poured over the 5 transformation 
plates, and the negative control plate. For the positive control plates, 6 ml of 0.7 % 
(w/v) regeneration agar (Section 9.1.1.8.2) without pyrithiamine was added to each 
of the plates. All the plates were incubated upside down in a 37 oC static incubator 
until colonies were observed through the top of the overlay layer. 
 
2.2.7.7 Isolation of Transformant colonies 
Sabouraud agar (25 ml) (Section 9.1.1.2) containing pyrithiamine (25 μl) 
(Section 9.1.10) was poured into 90 mm petri dishes. The individual colonies were 
numbered on the original plate before they were picked off with a yellow pipette tip 
and transferred to the new Sabouraud agar plate at a marked spot. Roughly nine 
individual colonies were inoculated onto each new plate. The plates were incubated 
at 37 oC in a static incubator until conidiation of colonies were observed. 
 
96 
 
2.2.7.8 Isolating colonies for DNA extraction 
The individual putative transformant colonies were removed from the plates by 
using a blue pipette tip to plug out the colony along with the underneath agar, and 
transferring it to an Eppendorf tube containing PBST (750 µl) (Section 9.1.4). The 
tubes were then vortexed vigorously to release the conidia from the agar and into the 
solution. The conidial suspensions were stored at 4 oC until required. 
 
2.2.7.9 Single spore isolation of transformant colonies 
Putative transformants were diluted by serial dilutions ranging from 10-2 to 10-6 
in filter sterilised PBST (Section 9.1.4). 100 µl of the dilutions were spread onto 
AMM plates (Section 9.1.1.7.1) containing pyrithiamine (100 ng/ml) (Section 9.1.10) 
and incubated at 37 oC in a static incubator until conidiation of colonies were 
observed. The individual colonies were numbered and isolated in PBST (Section 
9.1.4) as described in Section 2.2.7.8 and stored at 4 oC as conidial suspensions. 
 
2.2.7.10 Culturing transformant conidia for DNA extraction  
Putative transformant conidial suspensions (500 µl) (Section 2.2.7.8) were 
inoculated into Sabouraud Dextrose Broth (50 ml) (Section 9.1.1.1) in a 200 ml 
conical flask. The cultures were incubated overnight at 37 oC, whilst shaking at 200 
rpm. 
 
2.2.7.11 Harvesting Mycelia for DNA extraction 
The transformant cultures (Section 2.2.7.10) were filtered individually through 
miracloth to collect the mycelia. The mycelia mass was wrapped in tinfoil, and flash 
frozen in liquid Nitrogen. The mycelia were then crushed with a pestle, and DNA 
was extracted as described in Section 2.2.2.1. 
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2.2.8 Creation of DIG labelled probes 
The probes used in the Southern Blot analysis were created by PCR with the 
incorporation of DIG labelled dNTP’s (Roche). The oligonucleotides used are 
detailed in Table 2.5 and PCR was carried out as described in Section 2.2.2.3. 
 
Table 2.5: Oligonucleotide primer sequences used to generate the probes for 
Southern blot analysis of transformants of pes1 and gliK. 
Probe 
name 
Forward primer Reverse primer Size 
(bp) 
5’ pes1  CATGCAATCAAGGGATATGG GACGATCGGTACCATCTGCCACTCAC 1236 
pes1 
KO 
region  
CGAAACGTCCTCTTTCCTTG TTGTGGGAAGATCTGGAAGG 1149 
5’ gliK  ACGCCTCTAACATGCCATAC GCACTAGTGCTTTCCCCATGTTGCTTG 1096 
gliK 
KO 
region  
TGGGGGAATCTGGTACTTTG ATTTAGACGCTGGCTGCTGT 1029 
3’ gliK  CGAAGCTTAGTCTCCATGTCTCCGATG GTAGGTCGGCAGGTAGTACA 1121 
 
2.2.9 Southern Blot Analysis 
To confirm that the disruption or deletion of the gene occurred, Southern blot 
analysis was employed for screening the putative transformants that successfully 
grew on the plates containing the selection marker. The probes were created by DIG 
labelled PCR amplification of certain regions of the DNA allowing for the 
comparision of wild type and mutant strains, as described in Section 2.2.8.  
For pes1 transformant analysis, the 5’ region before and overlapping with the 
ptrA replacement cassette was probed with a 1236 bp probe homologous to the 
region. For distinction between successful replacement of the target region and wild 
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type strains, the DNA was digested with PvuII which will result in different fragment 
sizes bound to the probe (Error! Reference source not found.). In this case, the 
wild-type strain will result in a 4234 bp fragment size, whereas a successful targeted 
replacement results in a fragment size of 1922 bp, due to PvuII restriction site within 
the ptrA cassette. The complemented strain results in a 3812 bp fragment size as well 
as a 1922 bp fragment size. Also, bands observed at any other size can be deemed as 
untargeted integration of the replacement cassette. The pes1 region was also probed 
with a 1149 bp probe homologous to the region (pes1 KO region probe, Table 2.7). 
The DNA was digested with PvuII resulting in a 4334 bp fragment size for the wild-
type, whereas the ∆pes1 strains would not result in any band as the region bound by 
the probe is not present (Figure 2.9) and the complemented strain results in a 3812 bp 
fragment size. 
For gliK transformant analysis, the 5’ region was probed with a 1096 bp probe 
homologous to the region (Figure 2.10). The DNA was digested with PvuI. The wild-
type strain resulted in a 1926 bp fragment size, whereas ∆gliK resulted in a 2408 bp 
fragment size. The complemented strain resulted in a 2408 bp fragment as well as a 
1625 bp fragment size. The gliK coding region was also probed with a 1029 bp probe 
homologous to the region (Figure 2.13). The DNA was digested with XbaI resulting 
in a 2124 bp fragment size for the wild-type, no fragment for the mutant, and a 2124 
bp fragment size for the complemented strain. 
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Figure 2.8: Schematic of strategy for probing with 5’ pes1 flanking region probe to use in southern blot analysis. Restriction Digestion with PvuII 
results in fragments sizes of 4234 bp for wild-type, 1922 bp for ∆pes1 and two fragments for pes1c (1922 bp and 3812 bp). Restriction Digestion 
with SalI results in fragments sizes of 6118 bp for wild-type, 4608 bp for ∆pes1. pes1c was not screened using this resitiction enzyme. The red 
shape depicts the 5’ flanking region of pes1. The Green shape depicts the pes1 gene. The grey shape depicts the predicted promoter of pes1. The 
yellow shape depicts the 3’ flanking region. The blue shape depicts the pyrithamine resistance cassette excised from the plasmid pSK275. The black 
shape depicts the Topo cloning vector. The pink shape depicts the 5’ pes1 flanking region probe. The symbol P shows where the PvuII restriction 
sites are located and S shows where the SalI restriction sites are located. 
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Figure 2.9: Schematic of strategy for probing with pes1 coding probe to use in southern blot analysis. Digestion with PvuII results in fragments 
sizes of 4234 bp for wild-type, no fragment for ∆pes1 and 3812 bp for pes1c. The red shape depicts the 5’ flanking region of pes1. The Green shape 
depicts the pes1 gene. The grey shape depicts the predicted promoter of pes1. The yellow shape depicts the 3’ flanking region. The blue shape 
depicts the pyrithamine resistance cassette excised from the plasmid pSK275. The black shape depicts the Topo cloning vector. The orange shape 
depicts the pes1KO region probe. 
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Figure 2.10: Schematic of strategy for probing with 5'gliK probe to use in southern blot analysis. Digestion with PvuI results in fragments sizes of 
1926 bp for wild-type, 2408 bp for ∆gliK and two fragments for gliKc of 2408 bp and 1625 bp. The red shape depicts the 5’ flanking region of gliK. 
The Green shape depicts the gliK gene. The purple shape depicts the 3’ flanking region. The blue shape depicts the pyrithamine resistance cassette 
excised from the plasmid pSK275. The black shape depicts the Topo cloning vector. The pink shape depicts the gliK 5’ flanking region probe. 
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Figure 2.11: Schematic of strategy for probing with 5'gliK probe to use in southern blot analysis. Digestion with BamHI and HindIII results in 
fragments sizes of 6245 bp for wild-type, 1715 bp for ∆gliK and two fragments for gliKc of 1715 bp and 5670 bp. The red shape depicts the 5’ 
flanking region of gliK. The Green shape depicts the gliK gene. The purple shape depicts the 3’ flanking region. The blue shape depicts the 
pyrithamine resistance cassette excised from the plasmid pSK275. The black shape depicts the Topo cloning vector. The pink shape depicts the gliK 
5’ flanking region probe. 
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Figure 2.12: Schematic of strategy for probing with 3'gliK probe to use in southern blot analysis. Digestion with SalI results in fragments sizes of 
3213 bp for wild-type, 2032 bp for ∆gliK and two fragments for gliKc of 6038 bp and 3213 bp. The red shape depicts the 5’ flanking region of gliK. 
The Green shape depicts the gliK gene. The purple shape depicts the 3’ flanking region. The blue shape depicts the pyrithamine resistance cassette 
excised from the plasmid pSK275. The black shape depicts the Topo cloning vector. The pink shape depicts the gliK 3’ flanking region probe. 
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Figure 2.13: Schematic of strategy for probing with gliK coding region probe to use in southern blot analysis. Restriction digestion with XbaI 
results in fragments sizes of 2124 bp for wild-type, no fragment for ∆gliK, and 2124 bp for gliKc. The red shape depicts the 5’ flanking region of 
gliK. The Green shape depicts the gliK gene. The purple shape depicts the 3’ flanking region. The blue shape depicts the pyrithamine resistance 
cassette excised from the plasmid pSK275. The black shape depicts the Topo cloning vector. The grey shape depicts the gliK KO region probe. 
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2.2.9.1 Sample Preparation 
The culture was filtered through miracloth to collect the mycelia. The mycelia 
mass was wrapped in tinfoil, and flash frozen in liquid Nitrogen. The Mycelia were 
then crushed with a pestle, and DNA was extracted as described in Section 2.2.2.1, 
followed by DNA precipitation (Section 2.2.2.2). The concentration of the DNA was 
determined by measurement on the Nanodrop (Agilent, CA, USA). 600 ng DNA was 
digested by restriction enzyme (Section 2.2.5) for each of the samples.  
 
2.2.9.2 Southern Blot hybridization 
The digested DNA samples were separated on a 0.7 % (w/v) agarose gels 
(Section 2.2.2.5). Once the gels had run to completion, they were then placed in a 
UV crosslinker (Strategene, La Jolla, CA) and crosslinked at 80000 µjoules for 20 – 
40 s. Photos of the gels was taken with the aid of a UV transilluminator. The 
Southern tower was assembled by filling the reservoir tanks on either side of the 
transfer tray with 500 ml Transfer Buffer (Section 9.1.17.1). Three sheets of 
Whatman paper were cut to fit across the transfer tray and into the reservoir on each 
side and with the exact width of the gels. The gels were then placed on the transfer 
tray over the Whatman paper upside down, and with the wells of the gels closest to 
the reservoirs. The Amersham N+ Hybond membrane (GE Healthcare, Buckingham 
shire, U.K) was then cut to the exact size of the individual gels and placed directly 
on top of the gel, ensuring that no air bubbles are trapped between the gel and the 
membrane. Three pieces of Whatman filter paper was then cut to the size of the 
individual gels and membranes and placed on top. After which, three packets of 
pocket tissues were placed on top of the paper. A glass plate covered all the stacks 
placed on the tray and a 500 g weight, usually in the form of a partially filled duran 
bottle, was placed on top of the stacks. Towers were left for the digested DNA to 
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transfer from the gel to the membrane overnight at room temperature. Generally only 
a maximum of 2 gels were placed in the same tower to ensure complete transfer of 
DNA from the gels to the membranes. 
 
2.2.9.3 Cleaning and Blocking of the membrane 
The Southern Blot stack (Section 2.2.9.2) was taken apart and the membrane and 
gel were removed together and placed on a clean glass plate. The position of the 
wells was marked onto the corresponding place on the membrane, and the gel was 
peeled away from the membrane. The membrane was then soaked in SSC Buffer 
(2X, 40 ml) (Section 9.1.17.3), and rocked gently for 10 min. The membrane was 
removed and placed on a clean glass plate. The membrane was then placed in a uv 
crosslinker (Strategene, La Jolla, CA) and crosslinked at 120000 µjoules for 20 – 50 
sec. The membrane was placed in a hybaid tube with the DNA side facing inwards 
and pre-heated High SDS/Blocking Buffer (15 ml) (Section 9.1.17.8) was added. 
The membrane was rotated in a hybaid oven at 42 oC for approximately 5 hr.  
 
2.2.9.4 Dig Probe preparation and application 
Dig labelled probes were prepared by PCR using Dig labelled dNTPs. The 
concentration of the probe was calculated and 400 ng of the probe was heated for 8 
min at 95 oC to separate the DNA duplex. Probe was added to pre-heated High 
SDS/Blocking Buffer (10 ml) (Section 9.1.17.8). The Buffer was discarded from the 
Hybaid tube containing the membrane and the probe was added. The membrane was 
rotated in the Hybaid oven at 42 oC overnight. 
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2.2.9.5 Dig detection  
The membrane was removed from the Hybaid tube and placed into a container 
with 1X SSC/ 0.1% SDS (w/v) Solution (40 ml) (Section 9.1.17.9) and mixed by 
rocking for 10 min. The Buffer was discarded and replaced again and the wash was 
repeated for another 10 min. The blot was placed in a clean Hybaid tube with 1X 
SSC /0.1% (w/v) SDS Solution (30 ml) (Section 9.1.17.9) and the membrane was 
rotated in the hybaid oven for 15 min at 65 oC. The solution was discarded and 
replaced and the membrane was rotated for 15 min at 65 oC. The solution was poured 
off from the tube and Dig Wash Buffer (10 ml) (Section 9.1.17.10) was poured in 
with the membrane. The membrane was rotated for 5 min in the hybaid oven at 25 
oC. The buffer was poured off from the tube and Dig Buffer 2 (10 ml) (Section 
9.1.17.11) was added and the membrane was rotated in the Hybaid oven for 30 min 
at 25 oC. The Buffer was poured off from the tube and the Anti-Digoxigenin-Fab AP 
conjugate (10 ml) (Section 9.1.17.13) was added. The membrane was rotated for 30 
min at 25 oC. The solution was poured off from the tube and Dig wash buffer (10 ml) 
(Section 9.1.17.10) was added to the tube. The membrane was rotated for 15 min at 
25 oC. The wash step was repeated. The buffer was poured off from the tube and Dig 
Buffer 3 (10 ml) (Section 9.1.17.12) was added and the membrane was rotated at 25 
oC for 5 min. The buffer was poured off from the tube and CSPD Substrate (10 ml) 
(Section 9.1.17.14) was added. The membrane was rotated at 25 oC for 5 min. The 
CSPD Substrate was collected from the tube to be reused. The membrane was 
removed from the hybaid tube and placed on a clean tissue briefly. The membrane 
was then wrapped in a single layer of cling film and incubated at 37 o C for 15 min. 
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2.2.9.6 Development of Southern Blot membrane 
The membrane was placed in a photo developer case and an X-ray film was 
placed over the membrane. The blot was left to transfer to the film for 2 hr. The X-
ray film was removed from the case and placed into Developer Solution (Section 
9.1.18.1) for a couple of seconds or until markings were observed. The film was 
rinsed with water and then placed into Fixer Solution (Section 9.1.18.2). The film 
was then thoroughly rinsed with water and left to dry. 
 
2.2.10 Organic Extraction from supernatants of A. fumigatus cultures 
A. fumigatus culture supernatants (20 ml) were added to chloroform (20 ml) in 50 
ml Falcon tubes which were sealed with parafilm. The mixtures were then placed on 
a rotating wheel overnight. The mixtures were removed and centrifuged for 10 min 
at 650 x g. The top layer from the mixtures were removed and discarded and the 
organic layers containing the supernatant organic extract were stored at -20 oC until 
required. 
 
2.2.11 Rotary evaporation of Organic Extraction Samples 
The supernatant organic extraction samples (~20 ml) (Section 2.2.10) were 
placed in an evaporation bulb and the bulb was connected to the rotary evaporation 
equipment whilst sitting in a water bath set to 37 oC. The chloroform evaporated 
leaving the dried organic extract in the bulb. The extracts were resuspended in HPLC 
grade Methanol (200 µl), and transferred to clean micro-centrifuge tubes and stored 
at -20 oC. 
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2.2.12 Organic extraction from plugs of A. fumigatus on agar plates  
Organic extraction from agar plugs was carried out as described by Smedsgaard 
(1997) where A. fumigatus conidia were point inoculated onto the centre of an AMM 
agar plate and allowed to dry before incubating at 37 oC for 5 days. Plug extracts 
were removed from the agar along the radius of the plate using a cork drill, which 
usually yielded about six agar plugs per plate radius. The individual plugs from a 
plate were combined in the organic extraction buffer (Section 9.1.19) and sonicated 
in a sonication water bath for 60 min. The extract contained in the organic extraction 
buffer was removed to a clean micro-centrifuge tube and evaporated to dryness in a 
fume hood. The extract was resuspended in HPLC grade Methanol (400 µl), and 
stored at -20 oC. 
 
2.2.13 Reverse Phase - High Performance Liquid Chromatography (HPLC) 
analysis 
2.2.13.1 In house RP-HPLC analysis 
Organic extracts from supernatant (Section 2.2.10) were analysed by reverse 
phase HPLC with UV detection (Agilent 1200 system), using a C18 RP-HPLC 
column at a flow rate of 1 ml/min. The general gradient used was as follows, unless 
otherwise stated: Acetonitrile content beginning at 5 % Acetonitrile up to 99 % 
Acetonitrile content over 30 min. Samples (ranging from 20 to 100 µl) were injected 
onto the column and the separation of the compounds was observed at 220 nm, 260 
nm and 280 nm, unless otherwise stated. 
 
2.2.13.2 External RP-HPLC analysis 
HPLC separation of agar plug extractions (Section 2.2.12) was carried out by 
Prof. Thomas Larsen (Denmark technical university, Denmark) using a didode array 
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and high resolution mass spectrometry. The organic extracts were analysed using an 
RP-HPLC Agilent 1100 system with a Luna C18 II column equipped with a photo 
diode array detector and coupled to a LCT orthogonal time-of-flight MS with Z-
spray ESI source and a LockSpray probe.  
 
2.2.14 Gliotoxin uptake assay 
The strains were cultured in MM media (20 ml) (Section 2.1.1.6.3) at 37 oC, for 
24 hr. At the 24 hr time point gliotoxin (5 µg/ml) was added to the cultures and 2 ml 
aliquot of the supernatant was removed. The cultures were returned to the incubator 
and after 15 min, 2 ml supernatant was removed from the cultures. This was repeated 
at the 30 and 45 min timepoints. The extracted supernatants were organically 
extracted with 1:1 ratio of chloroform, and the extract was allowed to dry overnight 
in a fume hood. The dried extract was resuspended in 55 μl Methanol. The extracts 
were then analysed by RP-HPLC (Section 2.2.13.1) to measure the amount of 
gliotoxin still remaining in the supernatant. The mycelia from the cultures were 
lyophilized and weighted. 
 
2.2.15 E.coli Expression using the pPRoEx™HTb expression vector 
The PCR product of the gliK gene was integrated into the pPRoEx™-HTb 
expression vector (Figure 2.14) by linerising the vector within the multiple cloning 
site and ligation of the free ends of the linerised vector and the PCR product 
together. The orientation of the ligation was restricted to only the correct one by 
ensuring that that linerising digestion was conducted with two incompatible 
enzymes. The PCR that created the gliK product had add-on nucleotides that ensured 
that the ligation did not shift any of the subsequential amino acid expression. 
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Figure 2.14: Vector map of the pPRoEx-HTb expression vector (Invitrogen). 
 
2.2.16 Small scale induction of the recombinant pProEx:GliK Clones 
Once it was verified that the pProEx:GliK vector had transformed correctly into 
E. coli, small-scale inductions were carried out to confirm GliK production. A 10 ml 
LB broth (Section 9.1.7) culture was set up containing 100 μg/ml ampicillin (Section 
9.1.10) which was then inoculated with the pProEx:GliK plasmid and incubated 
overnight at 37 oC whilst shaking at 200 rpm. This culture was then used to inoculate 
a 50 ml LB broth culture (Section 9.1.7) containing 100 μg/ml ampicillin (Section 
9.1.10). The culture was incubated at 37 oC whilst shaking at 200 rpm until an OD600 
value of 0.5 – 0.7 was reached. Once the culture had reached the target growth level, 
a 1 ml aliquot was removed and kept as an un-induced aliquot used for reference. 
The expression was induced by adding IPTG (Section 9.1.22.1), to a final 
112 
 
concentration of 1 mM and the culture was incubated further, and at the time points, 
1, 2 and 3 hr, 1 ml aliquots were removed, and kept as post induced time-point 
samples. The remaining culture was centrifuged at 3200 g at 4 oC, for 20 min and the 
sample aliquots were centrifuged at 17900 x g for 1 min. The supernatants were 
discarded and the pellets were kept at -20 oC until required.   
  
2.2.17 Protein extraction from recombinant pProEx:GliK cultures 
Lysis Buffer (9 ml) (Section 9.1.22.2) was added to every 1 g of pelleted cells. 
The samples were sonicated whilst sitting on ice. Lysozyme (80 μl) (Section 
9.1.22.3) was added per 1 g of pellet, and the sample was incubated at 20 oC for 1 hr 
45 min constantly shaking. Sodium Deoxycholate (80 μl, 120 mM) (Section 
9.1.22.4) was added to the samples and incubated at 20 oC for 15 min whilst shaking. 
The samples were sonicated on ice. The samples were centrifuged at 12000 x g for 
10 min at 4 oC. An aliquot (1 ml) was removed from the supernatant, and the rest of 
the supernatant was discarded. The pellets were resuspended in wash buffer (9 ml) 
(Section 9.1.22.5) per original 1 g. The samples were centrifuged at 12000 x g for 10 
min at 4 oC. An aliquot (1 ml) of the supernatants were taken and the rest of the 
supernatant was discarded. The samples were resuspended in 2 M urea Buffer (2.5 
ml) (Section 9.1.22.6) per original 1 g. The samples were centrifuged at 12000 x g 
for 10 min at 4 oC. An aliquot (1 ml) of the supernatants were taken and the rest of 
the supernatant was discarded. The samples were resuspended in 8 M Urea Buffer 
(400 μl) (Section 9.1.22.7) per original 1 g. The samples and aliquots were stored at -
20 oC until required. 
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2.2.18 Sodium Dodecyl Suphate Polyacrylamide Gel Electrophoresis (SDS-
PAGE) 
SDS PAGE gels were prepared according to Table 2.6.  The gels were cast using 
the Mini-Protean II gel casting apparatus (Biorad, CA, USA) according to the 
manufacturer’s instructions. Lysis buffer (100 µl) (Section 9.1.23.6) was added to 
each of the protein extract samples (Section 2.2.17) and vortexed thoroughly. 
Aliquots (20 μl) of the samples were removed and Solubilisation Buffer (5X, 5 µl) 
(Section 9.1.23.7) was added to the aliquots. Samples were boiled for 10 min and 
then centrifuged briefly to collect the samples. The samples were loaded onto the gel 
using a Hamilton syringe. Electrophoresis begun at a setting of 80 V for about 30 
min, followed by an increase to 120 V for approximately 1 hr, using 1 X running 
Buffer (Section 9.1.23.8.1).  
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Table 2.6: Components of the SDS-PAGE 12% Gels 
  Stacking Gel   Resolving Gel 
Reagent 12%   12% 
    
Water 9.3 ml  6.1 ml 
1.5M Tris HCl 7 ml   
0.5M Tris HCl   2.5ml 
30% (w/v) acylamide 11.3 ml  1.3 ml 
10% SDS 280 µl  100 µl 
TEMED 23 µl  20 µl 
10% APS 100 µl   200 µl 
 
 
2.2.19 Coomasie Blue Staining 
The gels were removed and transferred to Coomassie Blue Stain Solution (20 ml) 
(Section 9.1.23.9) where it was left mixing overnight. After which, the staining 
solution was discarded and Destain solution (20 ml) (Section 9.1.23.10) was added 
to the gel, and was left mixing until all the staining had been removed, which was 
usually 1 hr. The Destain solution was removed and the gel was left in water until 
required. 
 
2.2.20 Western Blot Analysis 
Nitrocellulose paper (NCP) and 6 sheets of Whatmann filter paper were cut to 
the size of the gel and soaked in Towbin Transfer Buffer (Section 9.1.24.1) for 15 
min. The SDS-PAGE gels were removed gently from the electrophoresis unit and 
assembled on the transfer unit in a NCP “sandwich” containing 3 sheets of saturated 
filter paper, soaked NCP, SDS-PAGE gel, and another set of 3 sheets of filter paper. 
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Transfer occurred at 18 V for 30 min, and then the NCP was removed and placed in 
a container with Blocking Buffer (Section 9.1.24.2), and left gently agitating 
overnight. The blocking buffer was poured off and the primary antibody (anti-His6 
monoclonal IgG) diluted in Blocking Buffer was added to the blot and was left 
gently rocking for 1 hr at room temperature. The blot was then washed with 2 X 10 
min washes of PBST (Section 9.1.4). The secondary HRP-conjugated antibody was 
diluted in Blocking buffer and added to the blot and left gently rocking for 1 hr at 
room temperature. The antibody was poured off and the blot was washed twice with 
PBST for 10 min. DAB blot developer (Section 9.1.24.5) or AEC Substrate Solution 
(Section 9.1.24.4.5) was added to the blot and left to rock for 10 min. The blot was 
removed and rinsed with distilled water and allowed to dry on filter paper. 
 
2.2.21 Optimisation of Coating Concentration for recombinant GliK Antigen. 
Microtitre plates were coated with a range of concentrations of GliK, beginning 
at 8 µg/ml, and double diluted down to 0.5 μg/ml. The antigen was diluted in 
Carbonate buffer (Section 9.1.25.1), and 100 μl was added to each well. Plates were 
sealed and incubated at 37 oC for 2 hr. Plates were washed PBST (Section 9.1.4) and 
Blocking buffer (100 μl) (Section 9.1.25.2) was added to each well and incubated at 
37 oC for 2 hr. The blocking buffer was removed from the wells. Anti-His 
monoclonal antibody was diluted in Antibody Buffer (Section 9.1.25.3) at various 
dilutions (1/1000, 1/2500, 1/5000). The plate was incubated with 100 μl of the anti-
His dilutions in the appropriate wells at 37 oC for 1 hr. Plates were washed three 
times and TMB Substrate (Section 9.1.25.5) (100 μl) was added to each well, and 
incubated at room temperature for 10 min. The reaction was terminated by adding 
Sulphuric acid (1 N) (Section 9.1.25.6). The absorbance was measured at 
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wavelengths of 450 and 630 nm. The optimum coating concentration was determined 
for recombinant GliK antigen. 
 
2.2.22 ELISA for Sera screening for GliK reactivity 
Microtitre plates were coated with recombinant GliK (2 µg/ml) at 37 oC for 2 hr. 
The plates were washed twice with PBST (Section 9.1.4). Blocking buffer (100 µl) 
(Section 9.1.25.2) were added to each well and incubated at 37 oC for 2 hr, or at 4 oC 
overnight. The blocking buffer was removed from the wells and diluted serum (100 
µl, 1/100 dilution) was added to the appropriate wells. PBST (100 µl) (Section 9.1.4) 
was added as control to the appropriate wells. The plate was incubated at 37 oC for 1 
hr. The plates were washed out with PBST (Section 9.1.4) four times and the 
residual PBST was tapped out of the wells. The HRP-conjugated anti-human IgG 
(100 µl) (Section 9.1.25.4) was added to each of the wells and the plates were 
incubated at 37 oC for 1 hr. The plates were washed with PBST (Section 9.1.4) four 
times and the residual PBST was tapped out. Tetramethylbenzidine (TMB) (100 µl) 
(Section 9.1.25.5) was added to each well and the plates were incubated for 10 min 
at room temperature covered in tinfoil. The reaction was stopped by adding Stop 
solution (100 µl, 1 N H2SO4) (Section 9.1.25.6) to each well. The absorbance 
readings were calculated using a plate reader set at 450 nm and then at 630 nm, for 
background subtraction. The delta OD was calculated by subtracting the readings at 
630 nm from 450 nm.  
 
2.2.23 Galleria mellonella Infections 
The larvae of the Greater wax moth (Galleria mellonella) can be used as an in 
vivo method for testing the pathogenicity of microbial pathogens (Kavanagh and 
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Reeves, 2004). The larvae contain haemolymph which contains cells and anti-
microbial peptides which respond to the invading pathogen (Morton et al., 1987). In 
particular, haemolymph contains haemocytes, which function in a similar manner to 
phagocytes of mammals (Kavanagh and Reeves, 2004). Melanisation is key part of 
the insects defence against a wide range of pathogens. Melanin is formed in the 
haemocytes and is released by rupture and is activily transported to the cuticle or 
depositied on the invading microbe within the haemolymph (Soderhall and Cerenius, 
1998). Therefore, this build up of melanin is an indication of the presence of a 
pathogen and can be used as a method of measuring the difference in infection by a 
pathogen such as A. fumigatus (Reeves et al., 2004a) and furthermore differenciating 
between the wild-type and mutant strains. 
The conidia were prepared by harvesting 5 day old A. fumigatus Sabouraud 
culture plates (Section 9.1.1.2) in PBST-80 (5 ml) (Section 9.1.5). The conidial 
suspension was centrifuged at 650 x g for 5 minutes to pellet the conidia. The 
supernatant was discarded and the pellet was resuspended in PBS (10 ml) (Section 
9.1.3). The conidia were washed twice more with PBS and the conidia were finally 
resuspended in PBS (5 ml) (Section 9.1.3). The conidia were counted on a 
haemocytometer and the concentration was adjusted to the required amount for the 
inoculation. G. mellonella larvae were divided into groups of ten and placed in 90 
mm petri dishes that contained a single sheet of filter paper. All were weighed and 
size matched. The larvae were inoculated through the last proleg on the left with a 
conidial solution (20 µl). The larvae were incubated at 30 oC and the surviving larvae 
were counted at predetermined time points, usually 24, 48 and 72 hr.   
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2.2.24 Statistical Analysis 
All data was analysed using built-in GraphPad prism version 5.01 functions, as 
specified. The level of significance was set at p < 0.05 (*), P < 0.001 (**), and p< 
0.0001 (***), unless otherwise stated. Post hoc comparisons between groups were 
performed using the Bonferroni multiple comparisons test, unless otherwise stated. 
 
2.2.25 Software Graphing 
All graphs were compiled using Graphpad Prism version 5.01, unless otherwise 
stated. 
  
 
 
 
 
 
 
CHAPTER 3 
 
 
 
Disruption of the Non Ribosomal Peptide Synthetase 
gene, pes1, in Aspergillus fumigatus 
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3. Disruption of the Non Ribosomal Peptide Synthetase gene, pes1, in Aspergillus 
fumigatus 
3.1 Introduction 
Pes1, a non-linear non-ribosomal peptide synthetase deviates from the standard 
(CAT)n architecture of bacterial NRPS. Previously, the pes1 gene has been shown to 
be involved in the response to oxidative stress, and to have involvement in resistance 
to neutrophil killing (Reeves et al., 2006). It is also one of 943 genes which is 
regulated by the global transcription factor LaeA (Perrin et al., 2007), of which, 102 
are deemed to be involved in secondary metabolism. Furthermore, pes1 was found to 
be also regulated by StuA, a developmental regulator in A. fumigatus (Sheppard et 
al., 2005) that controls the regulation of at least 94 genes.  
As of yet, the product of the pes1 gene is unknown. However, molecular 
techniques such as gene disruption or deletion have led to the conclusive 
identification of many genes in the A. fumigatus genome and their respective 
functions, such as the siderophore biosynthesis genes, sidA, sidC, sidD, sidF and 
sidG (Schrettl et al., 2007) and the gliotoxin biosynthesis genes, gliP and gliZ (Bok 
et al., 2006a; Cramer et al., 2006a). Therefore, the gene disruption technique was 
selected to assist in identifying the pes1 gene product.  
As described in Chapter 1, there are many strategies now available for use in 
fungal gene deletion such as homologous recombination with a single construct and 
homologous recombination with two overlapping constructs utilising a split marker 
(Nielsen et al., 2006). Site-directed modifications can be achieved by homologous 
recombination (HR) where the selection marker replaces the site of interest by 
integration with the aid of homologous recombination sequences (HRS) that flank 
the selection marker. The constructs which contain the HRSs are required to have at 
least 1 kb flanking both sides of the target site, hindering efficient construct 
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generation (Frandsen et al., 2008). Therefore, the utilisation of the bipartite method 
has greatly increased the efficient generation of the constructs and increased the 
potential of targeted integration, while eliminating the survival of cells containing 
only partial integration.  
As the success rate of the bipartite method is higher than other methods (Nielsen 
et al., 2006), this strategy was employed for the disruption of pes1. The pes1 gene is 
large, 18.8 kb, therefore the strategy chosen was to disrupt the gene, rather than a full 
deletion in order to prevent the expression of the gene. The predicted combined 
promoter and first adenylation domain were the target for deletion (3 kb).  The 
generation of the constructs in the bipartite method involves a series of PCR, 
digestion and ligation steps using target DNA and a selection marker obtained from a 
vector (Figure 3.1).   
 
 
Figure 3.1: Flow diagram depicting the generation of constructs for the bipartite 
transformation method. 
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The selection marker chosen for this project was the pyrithiamine resistance gene 
(ptrA)(Kubodera et al., 2000) which can be readily extracted by digestion from the 
pSK275 plasmid (Figure 3.2). Pyrithiamine inhibits the production of thiamine 
pyrophosphokinase (TPK), which is an essential co-factor in the synthesis of 
thiamine pyrophosphate (TPP) from thiamine. TPP is essential for enzymes involved 
in carbohydrate metabolism (Baker et al., 2001). The product of the pyrithiamine 
resistance gene is able to hinder the pyrithiamine inhibition of the TPP production 
pathway and therefore facilitate normal growth of the fungus. The pyrithiamine 
resistance gene was originally isolated from A. oryzae and was cloned into pSK275. 
It is not usually expressed in other fungal species, making it a useful selection marker 
in many fungal transformations. The ptrA cassette removed from the plasmid 
contains the T7/lac promoter and the pyrithiamine resistance gene. Consequently, for 
this project where the gene disruption strategy is reliant on the selection marker, the 
ptrA gene should be highly beneficial because of its strict selection and relative ease 
of use. Selection of A. fumigatus transformants could be chosen based on resistance 
to pyrithiamine (100 ng/ml) (Kubodera et al., 2002). 
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Figure 3.2: Vector map of the pyrithamine resistance pSK275 plasmid. The ptrA 
cassette is located from 497 bp – 2768 bp.  
 
Three different A. fumigatus strains were chosen in which to disrupt pes1 gene 
expression, namely ∆akuB, ∆sidD, and ATCC46645. The A. fumigatus ∆akuB strain 
is a strain that is deficient in non-homologous end joining (NHEJ) DNA repair 
(Krappmann et al., 2006; da Silva Ferreira et al., 2006a). This deficiency increases 
the occurrence of targeted transformations, as the strain will only integrate DNA that 
has a homologous target. The A. fumigatus ∆akuB strain has been successfully used 
for a number of gene deletion experiments in Aspergillus species (e.g. gliP, the 
NRPS involved in gliotoxin biosynthesis (Kupfahl et al., 2006), calA, the calcineurin 
A catalytic subunit (da Silva Ferreira et al., 2007), and mpkA, a mitogen-activated 
protein kinase involved in cell wall signalling (Valiante et al., 2008). 
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The sidD gene has been shown to be directly involved in the biosynthesis of the 
siderophore, Triacetylfusarinine C (TAFC) (Figure 1.14) (Schrettl et al., 2004). SidD 
catalyses an intermediate step in the biosynthesis of TAFC by converting N5-cis-
anhydromevalanyl-N5-hydroxy-L-ornithine to Fusarinine C (FSC) before conversion 
into TAFC. Fungi have two separate methods for the uptake of iron; the Reductive 
Iron Assimilation (RIA) method, where readily available iron is obtained from the 
surrounding environment and utilised by the fungus and the siderophore recruitment 
method where TAFC is released by the fungus in low iron conditions to scavenge for 
residual iron in the surrounding environment and so facilitate iron uptake by the 
fungus (Haas, 2003). An A. fumigatus ∆sidD mutant was created which is unable to 
synthesise TAFC (a gift from Prof. Hubertus Haas) (Schrettl et al., 2007). It has also 
been shown that the sidD gene is indirectly involved in response to oxidative stress 
and directly involved with the virulence of A. fumigatus (Schrettl et al., 2007). 
Previous studies have shown that siderophore related NRP synthetases may play a 
role in protecting A. fumigatus against oxidative stress as part of the host defence 
response (Eisendle et al., 2003). NPS6, a siderophore found in the maize pathogen 
Cochliobolus heterostrophus, an ortholog of A. fumigatus sidD, was found to be 
responsible for oxidative stress resistance and virulence (Lee et al., 2005). To 
enhance the likelihood of obtaining mutants (∆pes1) with a clear phenotype, it was 
decided to use these strains, ∆akuB and ∆sidD, which contain additional deficiencies 
to ensure the best opportunity of characterising the pes1 gene product. 
Previously, it was reported that pes1 has a similar homology to AbrePsy1 of 
Alternaria brassicae and PES of Metarhizium anisopliae which are responsible for 
the production of siderophores or destruxin (Bailey et al., 1996; Guillemette et al., 
2004; Neville et al., 2005). The initial similarity seen between these NRPS genes 
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lead to speculation that the pes1 gene in A. fumigatus may be involved in siderophore 
biosynthesis in this species. However, further investigation demonstrated that pes1 
expression was unaffected by iron levels (Reeves et al., 2006) and also that destruxin 
is not detected in A. fumigatus (Neville et al., 2005).  Thus, although pes1 has been 
shown not to be involved in siderophore biosynthesis, there is no indication of a 
definitive function to date.  
There is a possibility that fungal NRPS genes may be signalling or interacting 
with each other, as this type of cross-talk between NRPS clusters has been well 
established in bacteria (Revill et al., 1995; Summers et al., 1995; Madduri et al., 
2001). The disruption of pes1 in A. fumigatus ∆sidD background may highlight how 
fungal NRPS products may interact with or signal each other, especially in relation to 
the oxidative stress response, i.e., the absence of both NRPS genes may enhance the 
effect of the pes1 gene deficiency. As pes1 has been shown to play a role in oxidative 
stress response (Reeves et al., 2006), the gene product may be more likely to be 
identified while the fungus experiences such a stress. As mentioned in Chapter 1, 
there are few reports on the generation of double knock out mutants in Aspergillus 
species, the majority of which are carried out in A. nidulans (Stringer and 
Timberlake, 1995; Paris et al., 2003a; Belaish et al., 2008; El-Ganiny et al., 2008). 
There are no reported double NRPS related mutants in A. fumigatus. Therefore, the 
production of a double mutant in A. fumigatus lacking sidD and pes1 is of great 
interest as it may provide evidence that NRPS genes cross-talk and can compensate 
for loss of function or that certain NRPS genes may be involved in signalling to other 
NRPS genes not clustered together. Ultimately, the double mutation may result in 
severe stress for A. fumigatus such that the function of pes1 may become 
increasingly apparent. 
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If the two strains, ∆akuB and ∆sidD, have significant phenotype differences, then 
the effect of pes1 disruption may be undetectable, especially if the background 
mutation has the same phenotypical response that the pes1 mutation may confer. The 
ATCC46645 strain is a clinical isolate of A. fumigatus and the use of this strain can 
give an understanding of the direct effect of losing the pes1 product, in the absence 
of other deficiencies. Also, the use of a wild-type strain may show that the lack of 
pes1 on its own has no obvious phenotypic disadvantage to A. fumigatus tentatively 
indicating that pes1 acts with other NRPS products, or is compensated by another 
product formation. 
A final step in the verification of a gene product is to reintroduce the gene into 
the mutant strain. If a product can be identified during phenotypic analysis, the 
complementation of gene should be capable of producing that product again 
(Steinbach et al., 2006; Bok et al., 2006a; Schrettl et al., 2007; Ejzykowicz et al., 
2009). The reappearance of the relevant metabolite or phenotypic behaviour in the 
complemented strain is conclusive proof of the gene function.  
The overall objectives of this chapter are to (i) create constructs that enable the 
disruption of pes1, (ii) utilise the bipartite transformation technique in conjunction 
with the pyrithiamine resistance cassette (ptrA) to transform A. fumigatus, (iii) 
disrupt the pes1 gene in three different strains of A. fumigatus, namely, ∆akuB, 
∆sidD, and ATCC46645 and (iv) reintroduce the deleted region of the pes1 gene 
back into the ∆sidD:∆pes1 strain.  The establishment of pes1 disrupted strains will 
allow for comparative analysis to identify the phenotypic and metabolic components 
that pes1 may play a role in, which will be investigated in Chapter 4. 
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3.2 Results 
3.2.1 Generation of constructs by PCR 
The constructs used in the creation of A. fumigatus pes1 were generated from the 
flanking regions of the target DNA as described earlier in Figure 2.4. The primers 
used in the generation of the constructs are detailed in Table 2.3. The initial PCR 
steps amplified the 5’ and 3’ regions, respectively, of the pes1 target region. The 
primers used for this amplification incorporated additional restriction sites to 
facilitate specific digestion and subsequent ligation of the PCR products to the 
pyrithiamine resistance (ptrA) gene. Primer 5’ reverse, contained a PvuI restriction 
site, and Primer 3’ forward contained a KpnI restriction site. The 5’ PCR generated a 
fragment of 1345 bp, named P1 and the 3’ PCR generated a fragment of 1430 bp, 
named P2 (Figure 3.3).  The PCR products, P1 and P2, were gel purified to remove 
any non-specific products.  
The plasmid pSK275 and the gel purified PCR products, P1 and P2, were 
digested with specific restriction enzymes (Figure 3.4). To obtain the ptrA gene from 
the plasmid pSK275, the plasmid was digested with PvuI and KpnI, separately. P1 
was digested with PvuI and P2 was digested with KpnI. The digested products were 
gel purified for use in ligation.  
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Figure 3.3: PCR products from the amplification of the 5’ and 3’ flanking region of 
the pes1 deletion target. Lane L: Molecular weight marker ladder (Roche VII), Lanes 
1-3: 5’ flanking region PCR product, P1 (1345 bp), lanes 4 – 6: 3’ flanking region 
PCR product, P2 (1430 bp). 
 
 
 
Figure 3.4: Preparation of fragments by digestion for generation of deletion 
constructs. Lane L: Molecular weight marker ladder (Roche VII), Lane 1: PCR 
product, P1, digested with PvuI (1341 bp), Lane 2: PCR product, P2, digested with 
KpnI (1423 bp), Lane 3: pSK27 digested with PvuI (3935 and 974 bp), Lane 4: 
pSK275 digested with KpnI (4909 bp). 
 
The digested P1 product (1341 bp) was ligated with the PvuI digested pSK275 
(3935 bp), named ligation 1 and the digested P2 product (1423 bp) was ligated with 
the KpnI digested pSK275 (4909 bp), named ligation 2. These ligations were used as 
the template for the final PCR amplification, where ligation 1 was used to create the 
5’ deletion construct (2942 bp) and ligation 2 was used to create the 3’ deletion 
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construct (2435 bp) (Figure 3.5). The 5’ and 3’ deletion constructs were gel purified 
and concentrated for subsequent protoplast transformation (Figure 3.6).  
 
 
Figure 3.5: Purification of the 5’ and 3’ deletion constructs used in the 
transformation process to disrupt pes1. (A) Lane L: Molecular weight marker ladder 
(Roche VII), Lanes 1 – 4:  5’ construct PCR product (2942 bp). (B) Lane L: 
Molecular weight marker ladder (Roche VII), Lanes 1 – 4: 3’ construct PCR product 
(2435 bp). 
 
 
Figure 3.6: Schematic of the transformation for the disruption of pes1 in the A. 
fumigatus genome. The overlapping region of the ptrA gene from each construct 
(2379 bp) is the homologous recombination site which results in the completion of 
the ptrA gene in the mutant strain. The 5’ and 3’ regions of the gene of interest 
ligated to the incomplete ptrA gene are the other two recombination sites which 
results in the targeted integration of ptrA into the genome. 
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3.2.2 Generation of DIG labelled probes by PCR for transformant 
identification. 
The regions chosen for Southern blot analysis were the 5’ region upstream of the 
deletion target and also a region within the deleted region (Figure 3.7). Probes were 
generated by PCR amplification using primers detailed in Table 2.5 containing DIG- 
labelled nucleotides, which allowed the probe DNA to be detectable during Southern 
blot analysis, as described in Section 2.2.8. The PCR products were gel extracted and 
purified (Figure 3.8). 
 
 
Figure 3.7: Schematic of the annealing sites of the 5’ and pes1 probes designed for 
pes1 that will result in different fragment binding between the wild-type and ∆pes1 
strains. The red shape depicts the 5’ flanking region of pes1. The Green shape 
depicts the pes1 gene. The grey shape depicts the predicted promoter of pes1. The 
blue shape depicts the pes1KO region probe. The pink shape depicts the 5’pes1 
probe. 
 
 
130 
 
 
Figure 3.8: Generation of DIG labelled probes by PCR (A) PCR amplified 5' probe 
region of pes1. Lane L: Molecular weight marker ladder (Roche VIII). Lanes 1 – 3: 
5’ pes1 probe PCR product (1236 bp), (B) PCR amplified region of pes1 used in the 
DIG labelled probe. Lane L: Molecular weight marker ladder (Roche VII). Lanes 1 – 
3:  pes1 region PCR amplified product (1149 bp). 
 
3.2.3 Protoplast transformation facilitating the disruption of A. fumigatus pes1 
by replacement of the promoter and first adenylation domain 
The constructs from Section 3.2.1 were used for transformation in three different 
strains of A. fumigatus, namely ∆akuB, ∆sidD, and ATCC46645. At least 3 μg of 
each of the constructs were used for the individual transformation processes. 
Specifically, 3 μg of each construct was used for the A. fumigatus ∆akuB 
transformation, 6 μg of each construct was used for A. fumigatus ∆sidD 
transformation, and 5 μg of each construct was used for the A. fumigatus 
ATCC46645 transformation. The transformation processes were carried out as 
described in Section 2.2.7. The resultant transformants were initially screened on 
agar plates containing pyrithiamine (100 ng/ml), and are detailed in Table 3.1. The 
colonies that were able to grow on the media containing pyrithiamine indicated that 
the ptrA gene had integrated as a whole and conferred resistance to pyrithiamine and 
therefore had successfully integrated the construct fragments by recombination. The 
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resultant transformants were screened by Southern blot analysis for the disruption of 
pes1.  
 
Table 3.1: Summary of the screening process required for the identification of ∆pes1 
in A. fumigatus ∆akuB, ∆sidD and ATCC46645, respectively. 
Strain Number of 
putative 
Transformant 
colonies 
No. of colonies 
Screened 
Successful 
Transformants 
∆akuB 36 9 8 
∆sidD(46645) 48 10 1 
ATCC46645 27 7 1 
 
3.2.3.1 Disruption of the pes1 gene in A. fumigatus ∆akuB 
The analysis of the transformation of A. fumigatus ∆akuB was carried out on nine 
possible transformants (Figure 3.9). The expected band size of 4608 bp, as calculated 
by the pes1 Southern strategy detailed in Section 2.2.9 (Figure 2.8), was observed in 
all nine transformants. One transformant contained an additional non-specific signal. 
A band was not detected at 6118 bp, indicating that wild-type A. fumigatus was not 
present in any of the transformants.  
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Figure 3.9: Identification of A. fumigatus ∆akuB:∆pes1 strain (A) DNA digested 
with SalI for probing by Southern blot with the 5’ pes1 probe and (B) corresponding 
Southern blot. Lane L: Molecular weight marker ladder (Roche VIII), Lane 1: ∆akuB 
(6118 bp), Lanes 2-10: Possible transformants (4608 bp), labelled PA 1 – 9. 
Transformant PA2 is marked with * below the lane. 
  
To confirm the disruption of pes1, transformant PA2 was single spored as 
described in Section 2.2.7.8, and the first resultant individual colony was subjected to 
restriction digestion using PvuII (Figure 3.10). The wild-type band was observed at 
4234 bp and the mutant signal at 1922 bp. This confirmed that that transformant 
PA2.1 contained a targeted disruption of pes1 in the A. fumigatus strain ∆akuB. 
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Figure 3.10: Identification of A. fumigatus ∆akuB:∆pes1 strain (A) DNA digested 
with PvuII for probing by Southern blot with the 5’ pes1 probe and (B) 
corresponding Southern blot. Lane L: Molecular weight marker ladder (Roche VIII), 
Lane 1: ∆akuB (4234 bp), Lane 2: single spored transformant PA2.1 (1922 bp). 
 
3.2.3.2 Disruption of the pes1 gene in the ∆sidD strain 
The successful disruption of pes1 in A. fumigatus ∆akuB confirmed the deletion 
constructs were functioning in A. fumigatus. Thus, the same strategy was used to 
disrupt pes1 in the A. fumigatus ∆sidD (Schrettl et al., 2007). The analysis of the 
transformation of the ∆sidD strain was carried out on ten putative transformants 
(Figure 3.11). Of the transformants, six still displayed the band at 6118 bp which 
indicated the presence of the A. fumigatus wild-type strain (PD1, 2, 3, 4, 5, and 6), 
and of these, one also contained the mutant band (4608 bp) (PD6), the other five 
contained additional non-specific bands. Two putative transformants did not contain 
either the wild-type or the mutant bands (PD9 and PD10), and were representative of 
non-targeted integrations.  Transformant PD8 contained the single mutant signal 
(4608 bp), suggesting that the transformant may be an A. fumigatus ∆sidD:∆pes1 
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mutant. The restriction digestion of the ∆sidD strain resulted overactivity of the 
digestion and therefore was not visible on this blot, but was repeated and can be seen 
in Figure 3.12, Figure 3.13 and Figure 3.15. 
 
 
Figure 3.11: Identification of A. fumigatus ∆sidD:∆pes1 strain (A) DNA digested 
with SalI for probing with 5’pes1 probe and (B) corresponding Southern blot. Lane 
L: Molecular weight marker ladder (Roche VII), Lane 1: ATCC46645 (6118 bp), 
Lane 2: ∆sidD, Lanes 3 – 12: possible transformants, named PD 1 – 10. 
Transformant PD8 is marked with * below the lane. 
 
To confirm that the transformant PD8 was a pure mutant, the transformant was 
single spored as described in Section 2.2.7.8. Three of the resultant individual 
colonies were screened (Figure 3.12). Two of the samples still contained faint wild-
type signal (6118 bp), as well as other non-specific integrations (PD8.2 and PD8.3). 
Sample PD8.1 exhibited no non-specific bands, but still contained the remnants of 
the wild-type signal. All of the transformants contained the expected ∆pes1 mutant 
band (4608 bp). 
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Figure 3.12: Identification of A. fumigatus ∆sidD:∆pes1 strain (A) DNA digested 
with SalI for probing with 5’pes1 probe and (B) corresponding Southern blot. Lane 
L: Molecular weight marker ladder (Roche VII), WT: ATCC46645, Lanes 4 – 6:  
single spored transformants in ∆sidD strain, named PD8.1, PD8.2, and PD8.3, 
respectively. Transformant PD8.1 is marked with * below the lane. 
 
Transformant PD8.1 was single spored to remove the wild-type spore 
contamination of the mutant spores. Six single spored colonies were analysed (Figure 
3.13). The re-analysis was conducted using an alternative restriction enzyme, namely 
PvuII. This alternative analysis resulted in a clear blot for interpretation, as the size 
difference between the wild-type and mutant signals is greater. All of the 
transformants contained the mutant signal (1922 bp). Three of the samples (PD8.1.1, 
PD8.1.2, and PD8.1.4) contained a non-specific signal. Transformants PD8.1.3, 
PD8.1.5 and PD8.1.6 were representative of single targeted integrations and 
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transformant PD8.1.5 was chosen as the transformant to be used as the A. fumigatus 
∆sidD:∆pes1 strain. 
 
 
Figure 3.13: Identification of A. fumigatus ∆sidD:∆pes1 strain (A) DNA digested 
with PvuII for probing with 5' pes1 probe and (B) corresponding Southern blot. Lane 
L: Molecular weight marker ladder (Roche VII), Lane WT: ATCC46645, Lanes 1 – 
6: Single spored PD8.1 transformants, named PD8.1.1 – PD8.1.6, ∆pes1(∆akuB) was 
used as a positive control for the ∆pes1 signal on the blot. Transformant PD8.1.5 is 
marked with * below the lane. 
 
3.2.3.3 Disruption of the pes1 gene in A. fumigatus ATCC46645 
The previous disruptions described in Sections 3.2.3.1 and 3.2.3.2 were both in 
backgrounds where additional genes, akuB and sidD, respectively, had already been 
disrupted or deleted. Thus, it was important for classification of pes1 function to 
have a strain that was representative of only pes1 gene disruption.  
Consequently, the same transformation process was used to disrupt pes1 in the A. 
fumigatus ATCC46645 strain as was used in the generation of A. fumigatus ∆akuB 
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and ∆sidD. The analysis of the pes1 disruption in the ATCC46645 strain was 
performed on seven transformants (Figure 3.14), where the five of the transformants 
had the expected band size of the mutant (1922 bp). Only one, PW6, had no other 
ectopic integrations, nor did it have a band corresponding to the wild-type signal 
(4234 bp).  
 
 
Figure 3.14: Identification of A. fumigatus ∆pes146645 strain (A) DNA digested with 
PvuII for probing with 5' pes1 probe and (B) corresponding Southern blot. Lane L: 
Molecular weight marker dig labelled ladder (Roche VII), WT: ATCC46645, Lanes 
3 – 9: possible transformants, named PW 1 – 7.  PW6 is marked with * below the 
lane. 
 
As transformant PW6 contained no ectopic integrations, it was re-analysed to 
confirm ∆pes1 genotype (Figure 3.15). A single band corresponding to 1922 bp was 
evident in transformant PW6 which confirmed that it contained a targeted disruption 
of pes1 in A. fumigatus ATCC46645. 
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Figure 3.15: Identification of A. fumigatus ∆pes146645 strain (A) DNA digested with 
PvuII for probing with 5' pes1 probe, and (B) corresponding Southern blot. Lane L: 
Molecular weight marker dig labelled ladder (Roche VII), Lane 1: ATCC46645, 
Lane 2: ∆sidD, Lane 3: putative transformant, PW6, Lane 4: ∆pes1:∆sidD (PD8.1.5).  
 
3.2.3.4 Complementation of pes1 into A. fumigatus ∆sidD:∆pes1  
Once it had been established that pes1 was successfully deleted from the A. 
fumigatus ∆akuB, ∆sidD, and ATCC46645 strains, the gene was reintroduced into 
the genome of the ∆sidD:∆pes1 strain, to establish if any pes1 related phenotype 
alterations would be restored. This would help clarify that any phenotypical 
differences observed between A. fumigatus ∆sidD and ∆sidD:∆pes1 that restore with 
the return of the gene can be attributed to the product of the pes1.  
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The reintroduction of pes1 into the genome of A. fumigatus ∆sidD:∆pes1 was 
carried out as described in Section 2.2.7.2, where the DNA encoding the deleted 
section of the pes1 gene was cloned into TOPO and linearized with a unique 
restriction enzyme, creating a linear fragment homologous to the 3’ flanking region 
of the ptrA gene (Figure 2.6), which, if targeted homologous recombination occurs, 
will reintroduce the relative region of pes1 into the genome after the ptrA gene. This, 
in effect, would re-establish the pes1 promoter and A1 region with the remainder of 
the disrupted pes1 gene, thereby reconstituting the entire pes1 gene. 
 
The region encoding the promoter and A1 domain of pes1 was PCR amplified 
using primers, P5 and P6 (Table 2.3), resulting in a 5881 bp fragment (Figure 3.16 
(A)). The PCR product was gel extracted and purified. The PCR product was cloned 
into TOPO vector as described in Section 2.2.3.3. To verify the cloning, the modified 
vector was digested with the restriction enzymes NotI and SalI which upon 
successful cloning would result in distinct fragments of 8393 bp and 1411 bp (Figure 
3.16 (B)). After confirmation of successful cloning, the TOPO vector containing the 
pes1 fragment was linearised by digestion with the restriction enzyme AarI (Figure 
3.16 (C)). 
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Figure 3.16: Constructs for complementation of pes1 into the genome of 
∆sidD:∆pes1. (A) PCR amplification of the pes1 region (5331 bp), (B) Digestion of 
the TOPO vector incorporating the pes1 region with NotI and SalI to confirm the 
cloning of pes1 into TOPO (8393 bp and 1411 bp), (C) linearization of the TOPO 
vector incorporating pes1 by digestion with AarI (9804 bp). 
 
The selection marker utilised in this transformation was phleomycin resistance, 
which was available in the plasmid, pAN8-1 (Punt and van den Hondel, 1992). As 
this method is dependent on the presence of unique restriction site (AarI) within the 
pes1 region cloned into the TOPO vector, it was impossible to also incorporate a 
selection marker into the TOPO vector, without introducing additional AarI sites 
which are located in selection marker plasmid. Therefore, the phleomycin resistance 
plasmid, in its circular form, was co-transformed into A. fumigatus ∆sidD:∆pes1 
with the linear TOPO vector incorporating the promoter and A1 domain of pes1 
(Figure 2.6).  
 
The regions chosen for Southern blot analysis were the 5’ region upstream of 
the deletion target and also a region within the deleted region, which were already 
used in the Southern blot strategies to identify the ∆pes1 strains. As the reconstituted 
strain still retained ptrA and also now incorporated part of the TOPO vector, the 
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binding of the 5’ pes1 probe would result in two binding fragments, 3812 and 1922 
bp, and the coding region probe would result in a single fragment of 3812 bp (Figure 
2.8 and Figure 2.9). These sizes are distinctly different from the binding pattern 
observed in the wild-type (4234 bp) and pes1 mutant (1922 bp) strains, and so can be 
readily identified as the complemented strain, ∆sidD:pes1c. 
 
The screening for the complemented pes1 was carried out by Southern blot 
analysis as described previously, and the results are depicted in Figure 3.17. 
Transformants PDC5 and PDC6, illustrate perfect examples of the pes1c gene 
integrated in a targeted fashion into the ∆sidD:∆pes1 strain (3812 bp and 1922 bp). 
The blot showed that transformants PDC 1, 2, 3, 4, 7, 8, and 9 showed no integration 
of the pes1c and returned the ∆pes1 signal (1922 bp). None of the transformants 
showed contamination by a wild-type strain (4234 bp). 
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Figure 3.17: Identification of A. fumigatus pes1c strain (A) DNA digested with PvuII 
for probing with 5' pes1 probe and (B) corresponding Southern blot. Lane L: 
Molecular weight marker ladder (Roche VII), WT: ATCC46645, Lanes 3 - 11: 
putative complemented transformants, PDC1 – 9. Transformants PDC5 and PDC6 
are marked with * below the respective lanes. 
 
The complemented transformants PDC5 and PDC6 were re-analysed by 
Southern analysis, whereby increased resolution of PvuII-digested DNA was 
undertaken by increasing electrophoresis time to distinguish between the reintegrated 
pes1 gene (3812 bp) and the wild-type fragment (4234 bp) (Figure 2.8), as they are 
similar in size (Figure 3.18). Transformant PDC5 showed that the band that was 
previously interpreted as the integrated pes1 gene was in fact a non-targeted 
integration, as it was larger than the expected signal size of 3812 bp. Transformant 
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PDC6 contains the predicted banding pattern (3812 and 1922 bp, respectively) and so 
is confirmed as the complemented strain, A. fumigatus ∆sidD:pes1c. 
 
 
Figure 3.18: Identification of A. fumigatus pes1c strain (A) DNA digested with PvuII 
for probing with 5' pes1 probe, and (B) corresponding Southern blot. Lane L: 
Molecular weight marker dig labelled ladder (Roche VII), Lane 1: ATCC46645 
(4234 bp), Lane 2: ∆sidD (4234 bp), Lane 3: ∆pes146645 (1922 bp), Lane 4: 
∆sidD:∆pes1 (1922 bp), Lane 5: putative transformant PDC5, lane 6: putative 
transformant PDC6. 
 
To further verify the complementation of the pes1 gene, A. fumigatus 
ATCC46645, ∆sidD, ∆pes146645, ∆sidD:∆pes1 and ∆sidD:pes1c strains were probed 
for the pes1 region that was deleted in the mutants and reintroduced in the 
complemented strain. For the wild-type strains, this would result in a detection of a 
fragment of 4234 bp, ∆pes1 strains would yield no signal, and the complemented 
strain would result in a restriction fragment of 3812 bp. This blot is depicted in 
Figure 3.19, where the expected patterns were observed.  
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Figure 3.19: Verification of the A. fumigatus mutant and complemented strains. (A) 
DNA digested with PvuII for probing with pes1 coding region probe and (B) 
corresponding Southern blot. Lane L: Molecular weight marker dig labelled ladder 
(Roche VII), Lane 1: ATCC46645, Lane 2: ∆sidD, Lane 3: ∆pes146645, Lane 4: 
∆sidD:∆pes1, Lane 5: ∆sidD:pes1c. 
 
Overall, these results confirm disruption of pes1 in A. fumigatus ATCC46645 
and ∆sidD, respectively, as well as reconstitution of the gene in ∆sidD: ∆pes1 to 
yield A. fumigatus ∆sidD:pes1c. 
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3.3 Discussion 
The intention of the work described here was to establish a transformation 
strategy that would target a disruption of the pes1 gene in A. fumigatus. The 
constructs generated to carry out such transformation are specific for each gene 
target and therefore the creation of the DNA fragments required is a tedious but 
essential step in a successful transformation. The constructs need to be between 0.5 
and 1 kb in length, with the partial selection marker ligated via a specific restriction 
enzyme site. The correct ligation is essential as this is the template for the final PCR 
that creates the constructs, as an inefficient ligation will result in partial amplification 
of the template, where the target flanking region or the partial selection marker 
amplifies separately. The bipartite method (Nielsen et al., 2006) reduces the number 
of PCR steps used as there are only two rounds of PCR in comparison to the three 
rounds used in the double joint method (Yu et al., 2004). This reduction of the PCR 
steps reduces the possibility of incorporating unwanted mutations that may occur 
from amplification with DNA polymerase (Nielsen et al., 2006). This bipartite 
method was used to create the three different A. fumigatus ∆pes1 mutant strains, 
∆akuB:∆pes1, ∆sidD:∆pes1 and ∆pes146645 which were disrupted by removing the 
first adenylation domain of the gene. The pes1 gene was restored using a linearised 
vector containing the missing adenylation domain, resulting in the complemented 
strain, ∆sidD:pes1c.  
Advances in the transformation of Aspergillus spp. have improved the 
transformation rate where construct generation has increased the likelihood of 
targeted integration, rather than ectopic integrations (Kuwayama et al., 2002; Yu et 
al., 2004; Nayak et al., 2006; Nielsen et al., 2006). As the bi-partite method relies on 
three homologous recombination events, namely the recombination of ptrA and then 
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the 5’ and 3’ flanking regions of the target DNA, respectively, the success rate of 
such a task is quite low. Furthermore, the number of transformants able to grow on 
the selective media is low, due to the inability of transformants containing only 
partial integrations to survive on the selection media. Any colonies that do grow on 
the selective media are expected to be the result of the recombination of the selection 
marker and very likely the result of successful integration of both constructs (Nielsen 
et al., 2006). The transformation method generally used in fungal genetic 
manipulations is the PEG-mediated transformation of protoplasts. This method has 
been unchanged for the last 20 years and although the exact mechanisms of the PEG 
system are unknown, this method of DNA uptake into the genome gives an 
advantage over other fungal transformation methods such as Agrobacterium 
tumefaciens and electroporation as mentioned in Chapter 1. 
Fungal transformation was carried out in A. fumigatus ∆akuB initially, to 
verify if it was possible to disrupt such a large gene, in a targeted fashion. Using A. 
fumigatus ∆akuB background for the disruption of pes1 confirmed that the constructs 
and transformation method chosen were capable of this targeted disruption. The pes1 
disruption in A. fumigatus ∆akuB resulted in all nine transformants screened 
containing the targeted disruption, with only one of the nine also containing an 
additional integration. The drawback with using A. fumigatus ∆akuB in 
transformations is that the akuB mutation itself may have an impact on fungal growth 
and development. Previously, it was demonstrated that the phenotype of the NHEJ 
deficient strains had no altered morphology and extremely mild sensitivities to 
genotoxins including methyl methanesulphonate (MMS) and UV (Ninomiya et al., 
2004; Nayak et al., 2006) but these investigations were not in-depth analysis and the 
alterations that the strain may be harbouring could impinge upon the phenotypical 
147 
 
analysis of a further gene deletions. Indeed, Nielsen et al. (2008) have pointed out 
that gene targeting carried out in NHEJ deficient strains should ideally be followed 
by a restoration of the NHEJ activity before characterisation of the mutant strain. 
Once it was established that this transformation method and construct choice 
was effective in the disruption of pes1 in a targeted manner, the transformation was 
carried out using A. fumigatus ∆sidD, which yielded more transformant colonies than 
the A. fumigatus ∆akuB transformation. However, the screening of the first ten 
colonies identified only one as being a single targeted integration. Thus, the other 
colonies growing on the selective pyrithiamine were most probably due to ectopic 
integrations of the constructs, with reconstitution of ptrA. An important factor to 
consider in double deletion strategies is the presence of the selection marker already 
utilised for the first gene deletion. In this case, sidD had been replaced with the 
hygromycin resistance gene, hyg, and therefore, the use of this selection marker is 
ruled out for any subsequent mutation in this strain (Schrettl et al., 2007). As there 
are a limited number of selection markers to choose from for fungal transformations, 
the number of different transformations that can be carried out on the same strain is 
restricted to the number of selection markers available. 
It was also important to have a wild-type disrupted version of the ∆pes1 for 
comparative purposes, and therefore, the pes1 gene was disrupted in the A. fumigatus 
ATCC46645 clinical isolate strain. This transformation resulted in the lowest number 
of colonies and also had a low rate of targeted integration, where only one out of 
seven colonies screened was representative of the correct integration. 
The pes1 gene was previously disrupted (Reeves et al., 2006), by replacing 
the second adenylation domain with a zeocin-pyrG cassette using the double joint 
PCR (DJ-PCR) method (Yu et al., 2004). The DJ-PCR method integrates a single 
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construct into the target genome, which has greater potential, than bi-partite 
constructs, to integrate randomly into the genome, as well as by targeted integration. 
The screening method, in that study, for transformation was carried out by Southern 
blot and RT-PCR of the deleted region of pes1, verifying the mutant inability to 
transcribe the pes1 gene, but did not verify that the transformation event was solely 
targeted to the pes1 gene region. As there is potential for ectopic integrations, it is 
essential to verify that only a single targeted transformation event has occurred 
before phenotypic analysis. For this reason, the method of screening transformations 
by Southern blot analysis of the 5’ or 3’ flanking regions, as adopted herein,  
immediately highlights any non-specific integration and such transformants can be 
ruled out of further analysis. The work presented in this chapter confirms the 
specificity of the bipartite method. 
NRP synthetase genes are restricted to bacterial and fungal species, which 
allows for the prediction of gene function in one species by comparing to the 
orthologs observed in other species, as in the case of identifying the gliotoxin 
biosynthetic cluster in A. fumigatus which was found by its similar homology to the 
sirodesmin biosynthesis cluster in Leptosphaeria maculans (Gardiner and Howlett, 
2005a). But this type of investigation can only be carried out if the orthologs have a 
defined function. The majority of NRPS-related genes identified in A. fumigatus have 
either undefined orthologs or no orthologs available, making analysis difficult as 
there is no indication of the function of the NRP synthetase under investigation. 
Therefore, gene deletion by transformation can facilitate the identification of a gene 
function by comparing the phenotypic and metabolic difference observed between 
the wild-type and mutant strains. 
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Microarray studies have shown that the pes1 gene is one of the genes 
upregulated in stressful environments such as hypoxia (Gardiner and Howlett, 2005a; 
Willger et al., 2008). Here, the SrbA transcription factor was investigated for 
regulation of genes during hypoxic condition, by creating a srbA deficient strain. In 
the analysis, pes1 expression had the highest increase in fold change expression 
(23.36) of all the genes investigated in the wild-type during hypoxia compared to the 
∆sbrA strain. This would indicate that Pes1 is involved in the stress response and 
perhaps defence in such conditions. Interestingly, Pes1 is also regulated by the 
transcription factor LaeA, where pes1 expression is downregulated in a ∆laeA strain 
(Perrin et al., 2007). LaeA is a global regulator of secondary metabolites in many 
Aspergillus spp. and is also involved in controlling the expression of certain 
virulence factors (Bok et al., 2005). laeA encodes a nuclear protein that is required 
for the expression of genes involved in sterigomycystin, penicillin, lovastatin and 
gliotoxin biosynthesis (Bok and Keller, 2004). Also, pes1 expression is severly 
downregulated in ∆stuA strain. StuA is one of the proteins that regulate the 
morphogenesis and virulence in A. fumigatus and the ∆stuA strain is susceptible to 
the application of hydrogen peroxide (Sheppard et al., 2005).  
The downregulation of pes1 in A. fumigatus ∆laeA and absence of expression 
in A. fumigatus ∆stuA suggests that pes1 is responding to changes in transcription 
factor presence and external factors, indicating that pes1 expression may only be 
activated when the surrounding environment deviates from optimal conditions. If this 
is valid, then the function of pes1 may not be observed unless the fungus is 
experiencing a stress, either an internal change in transcription factor signalling or an 
external stress environment. Therefore, the generation of the double mutant A. 
fumigatus ∆sidD:∆pes1 where the pes1 deficiency is in addition to the extracellular 
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siderophore deficiency, may result in a distinctive phenotype of the double 
deficiency, and may potentially reveal the pes1 function by comparison to the wild-
type strain and also the single ∆sidD strain. As the product of the sidD gene is 
already defined as being involved in the biosynthesis of fusarinine C (FC), one of the 
intermediates of the biosynthesis of the extracellular siderophore, TAFC, the 
different phenotypes between A. fumigatus ∆sidD and ∆sidD:∆pes1 can be 
accredited to the pes1 deficiency. Chapter 4 further characterises the A. fumigatus 
∆pes1 mutants and presents phenotypical and metabolite analysis of the pes1 
disrupted mutants with the overall goal of identifying the nature and function of the 
Pes1 peptide. 
  
 
 
 
 
 
 
CHAPTER 4 
 
 
 
Phenotypic analysis of A. fumigatus ∆pes1 mutant 
strains 
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4. Phenotypic analysis of A. fumigatus ∆pes1 mutant strains 
4.1 Introduction 
Certain fungal metabolites display antimicrobial activity, hence it has been 
hypothesized that they serve as a defence mechanism against other micro-organisms in 
the environment (Waring and Beaver, 1996). Cramer et al. (2006b) have used 
phylogenomics and functional genomics to identify NRP synthetase genes in five 
Aspergillus species, focusing on Aspergillus fumigatus. In the phylogenetic 
investigation, 14 NRP synthetase genes were identified, including pes1 (named NRPS1 
in the study) (AFUA_1G10380). The adenylation domains of pes1 were shown to 
cluster repeatedly with the same uncharacterised NRP synthetase genes from other 
Aspergillus species; including A. nidulans, A. terreus, A. oryzae, and A. flavus. Real 
time PCR analysis by Cramer et al. (2006b) showed that pes1 expression was only 
detected in liquid cultures of Sabouraud broth, using A. fumigatus Af293.  
Concurrently, Reeves et al. (2006) confirmed pes1 expression, using RT-PCR analysis, 
in cultures of Minimal Essential Media (MEM) containing Foetal Calf Serum (FCS) (5 
% v/v) using A. fumigatus ATCC26933, ATCC16424 and ATCC13073, where pes1 
expression varied between the strains analysed. These two studies have highlighted that 
the expression of pes1 is not constitutive and therefore, that there is regulated 
production of the metabolite encoded by pes1.  
The regulation of secondary metabolite production has been identified in A. 
nidulans where production of sterigmatocystin and aflatoxin are controlled by G 
protein-cyclic AMP-protein kinase A regulation (Hicks et al., 1997). As decribed in 
Chapter 1 (Section 1.4.4), LaeA is a global regulator in A. fumigatus and other fungi, 
and is required for secondary metabolite production (Bok and Keller, 2004). 
Importantly, it was established that LaeA is responsible for the regulation of gene 
152 
 
expression during vegetative growth and sporulation in A. fumigatus (Bok et al., 2005). 
The loss of LaeA resulted in impaired virulence in A. fumigatus which correlated with 
the loss of secreted factors from the fungus, including cell wall structural components 
such as hydrophobins, and pigments which confer resistance to phagocytic killing. 
Here, it was also hypothesised that molecules secreted from conidia may impart 
resistance to phagocytosis and that characterisation of conidial metabolites missing 
from A. fumigatus ∆laeA may provide more insight into this phenomenon.  
Perrin et al. (2007) have established a genome-wide comparison of the genes 
regulated by the LaeA transcription factor by comparing A. fumigatus ∆laeA with its 
cognate wild-type, which established the genes regulated by the global regulator. In this 
study, expression of pes1 was down-regulated in the A. fumigatus ∆laeA strain. Also, 
expression of the genes found in the gliotoxin, fumitremorgin B and ergot alkaloid 
biosynthetic clusters was down-regulated. Thus, it has been suggested that reduction in 
virulence of the ∆laeA strain is most likely attributed to the combined loss of the array 
of metabolites that are not produced in the absence of LaeA induction.  
Sheppard et al. (2005) generated an A. fumigatus ∆stuA strain which resulted in the 
production of abnormal conidiophores. StuA is a member of the APSES (Asm1p, 
Phd1p, Sok2p, Efg1p and StuAp) group of transcription factors that are key regulators 
of fungal development (Dutton et al., 1997). Transcriptional profiling of the ∆stuA 
strain indicated that 104 genes were differentially expressed in the mutant strain 
compared to the wild-type and complemented strains. pes1 was one of the genes 
identified as differently expressed in the ∆stuA strain, whereby pes1 expression was 
downregulated, but not absent, indicating that while StuA may influence the expression 
of pes1, it does not completely control pes1 expression. Interestingly, the biosynthetic 
cluster encoding genes involved in the production of the tremorgenic mycotoxin, 
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fumitremorgin B, was found to be StuA dependant. Furthermore, A. fumigatus ∆stuA 
was susceptible to oxidative stress following exposure to hydrogen peroxide, but only 
showed a trend towards reduced virulence.  
Taken together, pes1 expression was down-regulated in both ∆laeA and ∆stuA 
strains, where each of these transcription factors are associated with the regulation of 
secondary metabolite production. As mentioned in Chapter 3, pes1 was previously 
disrupted which resulted in a mutant that has reduced virulence in the Galleria 
mellonella insect model system, increased sensitivity to oxidative stress and neutrophil-
mediated phagocytosis (Reeves et al., 2006). This pattern of reduced virulence is 
similar to the ∆stuA strain, indicating that pes1 may play a role in downstream activity 
consequent to stuA expression. Also, A. fumigatus ∆pes1 displayed altered conidial 
morphology and hydrophobicity, similar to that of the A. fumigatus ∆laeA strain, 
indicating that the altered conidial morphology observed in ∆laeA may be in-part due to 
the down-regulation of pes1 expression (Figure 4.1) (Bok et al., 2005; Reeves et al., 
2006).  The indication that pes1 may function downstream of these transcription factors 
gives an insight into the potential function of this NRP synthetase gene.  
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Figure 4.1: Scanning electron micrographs of conidia (approx 3 µm in diameter) of (A) 
wild-type Af293 and ∆laeA (Bok et al., 2005) and (B) wild-type Af293.1 and ∆pes1 
(Reeves et al., 2006) showing the similar conidial surface alterations in the ∆laeA and 
∆pes1 strains. 
 
Furthermore, another NRPS deficient strain, ∆sidD results in a similar phenotype to 
∆pes1, which also exhibits sensitivity to oxidative stress with reduced virulence 
(Schrettl et al., 2007). As described in Chapter 1, sidD is the NRP synthetase involved 
in the production of the extracellular siderophore TAFC. Cramer et al. (2006b) reported 
that sidD was the most expressed NRP synthetase during incubation with macrophages, 
indicating that the production of TAFC plays a role in protecting the organism during 
the infection process of the fungus from the immune response of the human host. Using 
the ∆sidD strain as a background to disrupt pes1 may highlight possible NRP synthetase 
peptide interaction or signalling, especially in relation to the similar observed response 
to oxidative stress in the separate single mutants (Reeves et al., 2006; Schrettl et al., 
2007). As mentioned in Chapter 3, identification of the Pes1–encoded NRP peptide may 
be possible due to the potential accumulative effect of the double mutant. 
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Consequently, pes1 disruption was carried out in three different strains, A. 
fumigatus ∆akuB, ∆sidD and ATCC46645, as detailed in Chapter 3. The resultant 
phenotypical observations were used to further characterise the function of pes1. To 
investigate the elusive function of pes1, the strains lacking a functional pes1 gene, were 
subjected to extensive phenotypical analysis, which included exposure to oxidative 
stress agents such as hydrogen peroxide, as well as anti-fungals and gliotoxin, a toxin 
produced by A. fumigatus which has been indicated as a cause of oxidative stress 
(Schrettl et al., 2010).  
The objective of the work presented in this chapter is to compare phenotypic and 
metabolite differences between the wild-type and respective mutant strains. This 
involved (i) identifying pes1 expression by real time PCR, (ii) establishing growth 
differences after exposure to anti-fungals, oxidative stress and other agents, (iii) use of 
Galleria mellonella as a model of infection and (iv) identifying metabolites produced 
by RP-HPLC and LC-MS-DAD. 
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4.2 Results 
4.2.1 Real time PCR determination of pes1 expression 
The expression of pes1 has previously been demonstrated at the 24, 48, and 72 hr 
time-points in various isolates of A. fumigatus by RT-PCR (Reeves et al., 2006). As the 
pes1 transcript is large, sections of the gene were selected in order to investigate the 
relationship between fungal growth and pes1 expression. As the A. fumigatus ∆pes1 
strains disrupted herein lacked the predicted promoter and first adenylation domain, a 
region of the first adenylation domain (pes1A1, hereafter pes1) (Figure 2.4) was chosen 
to be the region amplified in the PCR analysis. Relative quantification of pes1 gene 
expression was calculated by comparison to the constitutively expressed Calmodulin 
gene (calm) (AFUA_4G10050). This gene is expressed at the same level regardless of 
time-point, media, or additive (Burns et al., 2005). Therefore, the expression of the 
gene of interest can be compared to the expression of calmodulin and the difference is 
expressed as a ratio, where the expression of calmodulin is adjusted to 1 and the 
expression of the gene of interest is expressed as a ratio compared to calmodulin 
expression. 
Firstly, the expression of pes1 was measured in the A. fumigatus strain ATCC46645 
in different liquid media types, namely, Sabouraud media (SAB), Minimal media 
(MM), and Aspergillus Minimal media (AMM). The cultures were grown for 24, 48 
and 72 hr (Figure 4.2). There is only low expression of pes1 in Sabouraud media at 24 
and 48 hr, and no expression detectable at 72 hr. The expression of pes1 in MM media 
is approximately the same at 24 and 48 hr, whereas the expression level drops at 72 hr. 
The highest expression of pes1 was seen in AMM media, where the highest expression 
was seen at 48 hr. The expression decreased to zero at 72 hr. 
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Figure 4.2: qRT-PCR analysis of pes1 expression at 24, 48 and 72 hr in A. fumigatus 
ATCC46645 cultured in various media types at 37 oC. 
 
Secondly, if successful, the disruption of pes1 in the genome A. fumigatus 
ATCC46645 and ∆sidD46645 should result in the absence of expression of the pes1 gene. 
As AMM gave the greatest expression of pes1, this medium was chosen to establish an 
absence of pes1 expression in the mutant strains. Since pes1 expression was evident at 
24 hr in AMM, this time-point was selected for subsequent analysis. A. fumigatus 
ATCC46645 and ∆sidD46645 expressed pes1, whereas ∆pes146645 and ∆sidD:∆pes1 did 
not, confirming the disruption of pes1 from the genome of these mutant strains. The 
complemented strain, ∆sidD:pes1c, exhibited the highest expression of pes1 (Figure 
4.3). 
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Figure 4.3: qRT-PCR analysis of pes1 expression in A. fumigatus ATCC46645, 
∆sidD46645, ∆pes146645, ∆sidD:∆pes1 and ∆sidD:pes1c  in AMM in 37 oC at 24 hr. The 
relative expression of pes1 in ∆sidD had a 2.69 fold change higher than the expression 
of pes1 in A. fumigatus ATCC46645. The expression of pes1 had a 3.38 fold change 
higher in ∆sidD:pes1c than the expression of pes1 in A. fumigatus ATCC46645. The 
analysis confirmed the disruption of pes1 in ATCC46645 and ∆sidD as the ∆pes1 
expression in the ∆pes1 and ∆pes1:∆sidD strains was complely absent (n = 3). 
 
AMM liquid cultures of A. fumigatus ATCC46645, ∆sidD46645, and ∆sidD:pes1c 
were treated with hydrogen peroxide (1 mM final conc.) at 21 hr and the culture was 
harvested 3 hr later. The expression of pes1 was evident (Figure 4.4), however exposure 
of A. fumigatus to hydrogen peroxide caused a decrease in pes1 expression for all 
strains. The final concentration of hydrogen peroxide (1 mM) was chosen to ensure that 
the fungus was capable of maintaining growth and production of mycelia for the 
extraction of RNA. 
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Figure 4.4: qRT-PCR analysis of pes1 expression in A. fumigatus ATCC46645, 
∆sidD46645 and ∆sidD:pes1c, with and without hydrogen peroxide (1 mM) spiked into 
the media. 
 
4.2.2 Assessment of A. fumigatus ∆pes1 susceptibility to oxidative stress and anti-
fungal exposure 
Reeves et al. (2006) showed that pes1 plays an important role in oxidative stress 
response and virulence of A. fumigatus. Here, to further clarify these findings, A. 
fumigatus ∆akuB and ∆akuB:∆pes1 were exposed to hydrogen peroxide and various 
anti-fungal drugs, namely voriconazole and amphotericin B. The strains were also 
subjected to gliotoxin exposure to investigate if the toxin had any deleterious effect on 
the pes1 deficient strains in this background.  
 
4.2.2.1 Plate assays of A. fumigatus ∆akuB:∆pes1 
Initially, it was observed that A. fumigatus ∆pes1 was only capable of maintaining 
83 % growth compared to its wild-type, ∆akuB, but this growth difference was not 
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deemed significant (Figure 4.5). After 72 hr growth on AMM plates, there was a 
significant difference in the radial growth of A. fumigatus ∆akuB:∆pes1 strain 
compared to ∆akuB, when hydrogen peroxide (2 mM) was present (P < 0.01) (Figure 
4.5). The presence of this concentration of hydrogen peroxide reduced A. fumigatus 
∆pes1 growth by 80 %, compared to the wild-type which, itself, was reduced by 40 %. 
A. fumigatus ∆pes1 was unable to grow at 3 mM hydrogen peroxide, however, as the 
wild-type strain was only capable of 20 - 40 % growth at this concentration, this was 
not deemed significant. Neither strain was capable of growth at 4 mM hydrogen 
peroxide. At the lower hydrogen peroxide concentration (1 mM), both strains were 
capable of equivalent radial growth. 
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Figure 4.5: Effect of hydrogen peroxide on the growth of A. fumigatus ∆akuB and 
∆akuB:∆pes1, respectively. Significant growth inhibition of ∆akuB:∆pes1 was evident 
at 2 mM hydrogen peroxide compared to the wild-type, akuB (* = P < 0.01)(n = 4). 
 
After 72 hr growth on AMM plates, there was a significant decrease in the radial 
growth of A. fumigatus ∆akuB:∆pes1 compared ∆akuB when voriconazole was present 
in the medium (Figure 4.6). The difference in radial growth was significant even at the 
lowest concentration of voriconazole (0.05 µg/ml) (P < 0.01). The difference is highly 
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significant when the voriconazole concentration was increased to 0.15 and 0.25 μg/ml, 
respectively (P < 0.001). The akuB background strain also exhibits a decrease in radial 
growth (~ 50 %) at the highest voriconazole concentration used (0.25 μg/ml), indicating 
that A. fumigatus is sensitive to high concentrations of voriconazole, under the 
experimental conditions used, as would be expected. 
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Figure 4.6: Effect of voriconazole (0 – 0.25 µg/ml) on the growth of A. fumigatus 
∆akuB and ∆akuB:∆pes1, respectively. Significant growth inhibition of ∆akuB:∆pes1, 
compared to ∆akuB, is evident (** = P < 0.01, *** = P < 0.001)(n = 6).  
 
After 72 hr growth on AMM plates, there was a significant decrease in the radial 
growth of A. fumigatus ∆akuB:∆pes1 compared to ∆akuB when amphotericin B was 
present in the media (Figure 4.7). A. fumigatus ∆akuB increased in radial growth at the 
lower concentrations of amphotericin B, 0.15 and 0.25 μg/ml, respectively, whereas A. 
fumigatus ∆akuB:∆pes1 decreased in radial growth significantly (P < 0.001) at these 
concentrations of amphotericin B. At the higher concentrations of amphotericin B, 
growth of A. fumigatus ∆akuB decreased but not to the same extent as ∆akuB:∆pes1 (P 
< 0.01). 
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Figure 4.7: Effect of amphotericin B on the growth of A. fumigatus ∆akuB and 
∆akuB:∆pes1, respectively. Significant growth inhibition of ∆akuB:∆pes1, compared to 
∆akuB, is evident at 0.15 – 075 µg/ml amphotericin B (** = P < 0.01, *** = P < 
0.001)(n = 2). 
 
After 72 hr on AMM plates in the presence of gliotoxin (0 – 20 μg/ml), there was no 
significant growth difference between A. fumigatus ∆akuB and ∆akuB:∆pes1 strains 
(Figure 4.8).  
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Figure 4.8: Effect of gliotoxin on the growth of A. fumigatus ∆akuB and ∆akuB:∆pes1, 
respectively. No significant growth inhibition of ∆akuB:∆pes1 is evident (n = 4). 
 
Both strains were still maintaining over 50 % growth at the highest concentration of 
gliotoxin (20 µg/ml), and the reduction in growth is significantly different from the 
growth observed without gliotoxin added, where ∆akuB was capable of 61 % growth (P 
< 0.001) and ∆akuB:∆pes1 was capable of 63 % growth (P < 0.05) (Figure 4.9). 
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Figure 4.9: Effect of gliotoxin on the growth of A. fumigatus ∆akuB and ∆akuB:∆pes1, 
respectively. Significant growth inhibition was evident at 20 µg/ml gliotoxin application 
for both strains (*** = P < 0.001, * = P < 0.05). Redrawn from Figure 4.8 for clarity. 
 
4.2.2.2 Phenotypic analysis of A. fumigatus ∆pes146645 
After 72 hr growth on AMM plates in the presence of hydrogen peroxide (0 – 4 
mM), there was no significant growth difference between the A. fumigatus ATCC46645 
and ∆pes146645 strains (Figure 4.10). 
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Figure 4.10: Effect of hydrogen peroxide on the growth of A. fumigatus ATCC46645 
and ∆pes146645, respectively. No significant growth inhibition of ∆pes146645 was evident 
(n = 4). 
 
After 72 hr on AMM plates in the presence of voriconazole, there was a significant 
decrease in the radial growth of A. fumigatus ∆pes146645 compared to ATCC46645 when 
voriconazole was present in the media (Figure 4.11). The difference is significant when 
the voriconazole concentration is 0.15 µg/ml (P < 0.05). Both strains were incapable of 
growth at 0.25 µg/ml concentration of voriconazole.  
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Figure 4.11: Effect of voriconazole on the growth of A. fumigatus ATCC46645 and 
∆pes146645, respectively. Significant growth inhibition of ∆pes146645 was evident in the 
preence of voriconazole (0.15 µg/ml), compared to A. fumigatus ATCC46645 (* = P  < 
0.05) (n = 4). 
 
After 72 hr growth on AMM plates in the presence of amphotericin B (0 – 0.75 
μg/ml), there was no significant growth difference between the A. fumigatus 
ATCC46645 and ∆pes146645 strains (Figure 4.12). 
 
167 
 
0 0.15 0.25 0.5 0.75
0
50
100 ATCC46645
∆pes146645
Amphotericin B concentration (µg/ml)
%
 
Ra
di
al
 
G
ro
w
th
 
Figure 4.12: Effect of amphotericin B on the growth of A. fumigatus ATCC46645 and 
∆pes146645, respectively. No significant growth inhibition of ∆pes146645 was evident (n  
= 4). 
 
4.2.2.3 Phenotypic analysis of A. fumigatus double mutant, ∆sidD:∆pes1 
After 72 hr growth on MM plates in the presence of hydrogen peroxide, significant 
growth difference was observed between ATCC46645 and ∆sidD46645 and also between 
ATCC46645 and ∆sidD:∆pes1 at a concentration of 2 mM hydrogen peroxide (P < 
0.001) (Figure 4.13), however there was no significant difference in radial growth 
between A. fumigatus ∆sidD46645 and ∆sidD:∆pes1. 
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Figure 4.13: Effect of hydrogen peroxide on the growth of A. fumigatus ATCC46645, 
∆pes146645, ∆sidD46645, and ∆sidD:∆pes1, respectively. Significant growth inhibition of 
∆sidD46645and ∆sidD:∆pes1 was evident at the highest concentration of hydrogen 
peroxide (2 mM), compared to wild-type (*** = P < 0.001) (n = 3). 
 
After 72 hr growth on MM plate in the presence of voriconazole (0 – 0.5 μg/ml), 
significant growth differences were observed between ATCC46645 and ∆sidD46645 and 
also between ATCC46645 and ∆sidD:∆pes1 at a concentration of 0.05 µg/ml 
voriconazole (P < 0.001) (Figure 4.14). At the higher concentration of 0.15 µg/ml 
voriconazole, there was a significant growth difference between ATCC46645 and 
∆sidD46645 (P < 0.01). There was also lower significant growth difference between 
ATCC46645 and ∆pes146645 and also between ATCC46645 and ∆sidD:∆pes1 at this 
concentration of voriconazole, but to a lesser extent (P < 0.05). No significant growth 
differences were observed between ∆pes146645, ∆sidD46645 and ∆sidD:∆pes1 indicating 
that there is no additive effect of voriconazole sensitivity in ∆sidD:∆pes1. 
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Figure 4.14: Effect of voriconazole on the growth of A. fumigatus ATCC46645, 
∆pes146645, ∆sidD46645, and ∆sidD:∆pes1, respectively. Significant growth inhibition of 
∆sidD46645and ∆sidD:∆pes1 was evident (*** = P < 0.001, ** = P < 0.01, * = P < 0.05) 
(n = 3). 
 
After 72 hr growth on MM plates in the presence of amphotericin B (0 – 0.75 
µg/ml), significant growth differences were observed between A. fumigatus 
ATCC46645 and ∆sidD:∆pes1 at 0.15 µg/ml concentration (P < 0.05) (Figure 4.15). No 
other significant growth differences were observed. 
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Figure 4.15: Effect of amphotericin B on the growth of A. fumigatus ATCC46645, 
∆pes146645, ∆sidD46645, and ∆sidD:∆pes1, respectively. Significant growth inhibition of 
∆sidD:∆pes1 was evident at the lowest concentration of amphotericin B (0.15 μg/ml) (* 
= P < 0.05) (n = 3). 
 
4.2.3 Evaluation of culture media type and iron on fungal growth 
Conidia (~100 spores/ 10 µl) were inoculated onto agar plates of AMM or MM, 
which differed in their respective nitrogen sources. AMM media contained ammonium 
tartrate as the nitrogen source, whereas MM media contained L-glutamine. L-glutamine 
is involved in the production of L-ornithine (Jones, 1985), which is used in the first 
committed step in siderophore biosynthesis (Eisendle et al., 2003). Consequently, A. 
fumigatus ∆sidD and ∆sidD:∆pes1 were unable to grow on AMM (Figure 4.16), unless 
a high concentration of iron was present in the media(1.5 mM). The high concentration 
of iron (1.5 mM) is 150 times the concentration of iron used in standard Aspergillus 
growth medium (Eisendle et al., 2003).  
On media containing L-glutamine, the ∆sidD46645 and ∆sidD:∆pes1 strains were 
capable of significant growth in the presence of low levels of iron (10 μM) (Figure 
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4.16). The iron supply limitation coupled with the potential absence of the pes1 peptide 
product caused a trend towards an accumulative detrimental effect in this low iron 
condition. Therefore, Minimal media containing L-glutamine was used for all further 
plate assay experiments using A. fumigatus ∆sidD and ∆sidD:∆pes1, to ensure all 
strains were capable of measureable growth in the basic media. 
As expected, in the presence of bathophenanthroline disulfonic acid disodium salt 
(BPS), both A. fumigatus ∆sidD and ∆sidD:∆pes1 were unable to grow as BPS chelates 
all available iron (Figure 4.16). Therefore due to the absence of sidD, the mutant strains 
are unable to produce TAFC to remove the iron bound to BPS and are incapable of 
surviving in the absence of iron. The same result was observed, as expected, in the iron 
deficient (-Fe) media (Figure 4.16). 
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Figure 4.16: Effect of media type in conjunction with increasing levels of iron 
available, on A. fumigatus growth containing ∆sidD. (A) radial growth on media 
containing ammonium tartrate. (B) radial growth on media containing L-glutamine in 
conjunction with increasing levels of iron available. Iron availability is noted as BPS: 
iron chelator; -Fe: No iron added to media; +Fe: 10 µM FeSO4; and +hFe: 1.5 mM 
FeSO4 Significant difference in radial growth is observed in ∆sidD and ∆sidD:∆pes1 
strains, compared to wild-type, between the two media types (P < 0.001) (n = 2). 
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Furthermore, the source of iron plays an important role in the radial growth 
capabilities of A. fumigatus ∆sidD46645 and ∆sidD:∆pes1 (Figure 4.17). Conidia (100 
spores/ 10µl) were inoculated onto plates containing a low concentration of iron (10 
µM), ∆sidD46645 and ∆sidD:∆pes1 were unable to grow when the iron source was FeCl3, 
whereas, when FeSO4 was the iron source, these strains were capable of maintaining 
some growth, although this growth was still significantly different from A. fumigatus 
ATCC46645. Notably, ∆sidD:∆pes1 showed a trend towards a lower capability of 
growth in the iron limited condition, compared to ∆sidD, when both growth rates were 
compared to the wild-type (P < 0.001 and P < 0.01, respectively). Both iron sources at 
the higher concentration (1.5 mM) resulted in restoration of full growth for both sidD 
deficient strains. This iron-dependant growth capability has been noted previously in 
Aspergillus spp. (Eisendle et al., 2003). 
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Figure 4.17: Effect of the source of iron in minimal media on A. fumigatus 
ATCC46645, ∆sidD46645 and ∆sidD:∆pes1 (*** = P < 0.001, ** = P < 0.01) (n = 2). 
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After 72 hr growth on minimal media with L-glutamine as the nitrogen source, an 
interaction between growth and hydrogen peroxide and available iron was observed. A. 
fumigatus ∆sidD46645 and ∆sidD:∆pes1 were unable to grow in the absence of iron in 
conjunction with the presence of hydrogen peroxide at different concentrations (0 – 4 
mM) (P < 0.001), due to the absence of sidD (Figure 4.18).   
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Figure 4.18: Effect of hydrogen peroxide on the growth of A. fumigatus ATCC46645, 
∆sidD46645, ∆sidD:∆pes1 without iron present in the media (*** = P < 0.001) (n = 2). 
 
Supplementing with FeCl3 (10 µM) did not restore the growth of either ∆sidD46645 
or ∆sidD:∆pes1 (P < 0.001) (Figure 4.19 (A)). The addition of a higher concentration of 
FeCl3 (1.5 mM) resulted in 100 % growth capabilities of all strains in all concentrations 
of hydrogen peroxide used (0 – 4 mM) (Figure 4.19 (B)). Using FeSO4 (10 µM) as the 
iron source, growth of A. fumigatus ∆sidD46645 and ∆sidD:∆pes1 was observed at lower 
concentrations of hydrogen peroxide (0 – 2 mM) (P < 0.01), although the double mutant 
appeared to grow slightly better under these conditions (Figure 4.19 (C)). The addition 
of a higher concentration of FeSO4 (1.5 mM) resulted in 100 % growth of all strains in 
all concentrations of hydrogen peroxide tested (0 – 4 mM) (Figure 4.19 (D)).  
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Figure 4.19: Effect of hydrogen peroxide on the growth of A. fumigatus ATCC46645, 
∆sidD46645, ∆sidD:∆pes1 in conjunction with different iron sources (A) radial growth on 
increasing hydrogen peroxide with 10 µM FeCl3 as the iron source, (B) radial growth on 
increasing hydrogen peroxide with 1.5 mM FeCl3 as the iron source, (C) radial growth 
on increasing hydrogen peroxide with 10 µM FeSO4 as the iron source, (D) radial 
growth on increasing hydrogen peroxide with 1.5 mM FeSO4 as the iron source (*** = 
P < 0.001, ** = P < 0.01, * = P < 0.05) (n = 2). 
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 Interestingly, growth of A. fumigatus ATCC46645 in hydrogen peroxide (3 mM) is 
the same regardless of the iron source used (Figure 4.20). Without iron present, 
ATCC46645 is capable of a maximum radial growth of ~16 mm, whereas the addition 
of iron (10 µM), the radial growth reached ~25 mm and the addition of the higher 
concentration of iron (1.5 mM) resulted in a radial growth of ~35 mm, on either iron 
source.  
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Figure 4.20: Effect of the source of iron in conjunction with the exposure to hydrogen 
peroxide (3 mM) on the growth of A. fumigatus ATCC46645. 
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4.2.4 Galleria infection model 
Galleria mellonella larvae are used as a model system for the innate immune 
response of mammals to infection with A. fumigatus and to assess the relative virulence 
of fungal mutants (Kavanagh and Reeves, 2004). The larvae were injected with conidia 
(1 x 106) and incubated for up to 72 hr at 30 oC, as described in Section 2.2.25 and were 
inspected at 24, 48 and 72 hr for survival. The melanisation of the larvae was easily 
observed indicating the presence of A. fumigatus is causing an immune response within 
the larvae. The difference between A. fumigatus ATCC46645 and ∆sidD46645, 
∆pes146645 and ∆sidD:∆pes1 was clear at the 48 hr time point (Figure 4.21 and Figure 
4.22).  
 
 
Figure 4.21: Galleria mellonella larvae displaying different levels of melanisation due 
to injection of A. fumigatus conidia (48 hr) (A) PBS control; (B) ATCC46645; (C) 
∆sidD46645; (D) ∆pes146645; and  (E) ∆sidD:∆pes1. 
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Survival curves, representative of three independent experiments, are shown in 
Figure 4.22. All the larvae showed similar survival rates at 24 hr. At 48 hr the 
difference between the strains became more evident. The A. fumigatus strains clustered 
into two groups at the 48 hr time point with a low survival rate group consisting of 
ATCC46645 (25 % survival), ∆pes146645 (30 %), and ∆sidD:pes1c (33 %). The second 
group had a higher survival rate consisting of ∆sidD46645 (48 %), and ∆sidD:∆pes1 (53 
%). Indicating that sidD plays a more important role in the pathogenicity of A. 
fumigatus than pes1. Mortality (100 %) was observed for all larvae after 72 hr 
incubation, except for the PBS controls. 
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Figure 4.22: Survival of Galleria mellonella larvae infected with A. fumigatus 
ATCC46645, ∆sidD46645, ∆pes146645, ∆sidD:∆pes1 and ∆sidD:pes1c and relevant 
significance table (* = P < 0.01, ** = P < 0.01, *** = P < 0.001) (n = 90).  
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4.2.5 Identification of non-ribosomal peptide encoded by A. fumigatus pes1 
Pes1, as an NRP synthetase, is highly likely to be involved in the biosynthesis of a 
low molecular mass metabolite. Thus, culture supernatants were examined for the 
presence of such a metabolite, by comparing the metabolite profile from culture 
supernatants of the A. fumigatus wild-type strain to the pes1 mutant strains. 
Supernatants were collected from liquid cultures and subjected to organic extraction as 
described in Section 2.2.10. Organic extracts were fractionated by Reversed Phase – 
High Performance Liquid Chromatography (RP – HPLC), as described in Section 
2.2.13.1. Initial results revealed a similar metabolite profile from wild-type and mutant 
strains (Figure 4.23). 
For a more detailed analysis, the strains were grown on AMM agar plates and point 
inoculated into the centre of the plate and incubated for five days at 37 oC. Organic 
extraction of agar plugs were taken and organic material was extracted as described in 
Section 2.2.12 (Smedsgaard, 1997). The extracts were analysed in triplicate in 
collaboration with the Denmark Technical Institute, by LC-MS-DAD, as described in 
Section 2.2.13.2. Figure 4.24 details the RP-HPLC chromatograms for A. fumigatus 
wild-type and ∆pes1 strains.  
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Figure 4.23: HPLC chromatograms detailing the fractionation of metabolites from 
supernatant organic extractions of A. fumigatus liquid cultures for the identification of 
the pes1 product, at 220nm. (A) ATCC46645 and (B) ∆pes146645, which show 
extremely similar metabolite profiles. 
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Fumigaclavine C was present in both A. fumigatus ∆akuB and ATCC46645 but 
absent in both ∆akuB:∆pes1 and ∆pes146645 (Figure 4.24 and Figure 4.25). The RP-
HPLC chromatograms clearly demonstrate that the wild-type strains produce a high 
amount of fumigaclavine C, whereas in the mutant strains, fumigaclavine C is 
completely absent. This significant observation represents the first confirmation of A. 
fumigatus pes1 involvement in the biosynthesis of a specific metabolite. 
Fumigaclavine C is the final product of a complex biosynthetic pathway (Unsold 
and Li, 2005) and it was suspected that loss of fumigaclavine C production might result 
in increased levels of putative biosynthetic intermediates or related fumigaclavines. 
Thus, the presence of additional metabolites was assessed during these fractionations. 
Fumigaclavine A was present in all strains, and production appeared to be increased in 
A. fumigatus ∆akuB:∆pes1 compared to ∆akuB, however ∆pes146645 produced the same 
level of fumigaclavine A as ATCC46645 (Figure 4.24 and Figure 4.25). An 
unidentified metabolite with a mass of 309 (retention time 5.17 min) is only observed in 
∆akuB and is absent in all the other strains (Figure 4.24 and Figure 4.25). TR-2 and 
fumitremorgin C are absent in ∆akuB, but present in ∆akuB:∆pes1  (Figure 4.24) 
whereas both metabolites are present in ATCC46645 and ∆pes146645, with a slight 
increase in production in ∆pes146645 (Figure 4.25). Fumitremorgin B and A are absent in 
all strains. Verruculogen is present in all strains, but the production is increased in both 
∆pes1 strains (Figure 4.24 and Figure 4.25). 
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Figure 4.24: Total ion chromatograms (0 – 15 min) representative of metabolites detected from A. fumigatus (A) ∆akuB and (B) 
∆akuB:∆pes1. Major differences between the chromatograms are annotated as follows; A; Fumigaclavine A (1.44 min), B; 
Fumigaclavine C (5.02 min), C; unknown peak (m/z 309) (5.17 min), D; TR-2 (7.88 min) E; Fumitremorgin C (8.22 min) and F; 
Verruculogen (shouldering peak 10.96 min). Red arrow highlights the absence of fumigaclavine C in ∆akuB:∆pes1. 
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Figure 4.25: Total ion chromatograms (0 – 15 min) representative of metabolites detected from A. fumigatus (A) ATCC46645 and (B) 
∆pes146645. Major differences between the chromatograms are annotated as follows; A; Fumigaclavine A (1.44 min), B; Fumigaclavine 
C (5.03 min), D; TR-2 (7.88 min) E; Fumitremorgin C (8.22 min) and F; Verruculogen (shouldering peak 10.96 min). Red arrow 
highlights the absence of fumigaclavine C in ∆pes146645. 
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Identification of each of the metabolites was confirmed by searching for the 
specific mass of each metabolite. Fumigaclavine C was identified by searching for a 
mass of 367 [M+H]+, where the fumigaclavine C peak was observed at a retention 
time of 5.03 min. This peak was absent in the ∆pes1 strains (Figure 4.26). 
Fumigaclavine A was identified by searching for a mass of 299 [M+H]+, and was 
identified in all strains at a retention time of 1.44 min (Figure 4.27). Fumitremorgin 
C was identified at m/z 390 [M+H]+ and also by UV spectrophotometry (Figure 
4.28). TR-2 was identified at m/z 394 [M-2xH2O+H]+ and also be UV 
spectrophotometry (Figure 4.28). Verruculogen was identified by ion trace mass 
spectrometry, where it was identified at m/z 512 [M+H]+ with a retention time of 
10.97 min and also at m/z 494 [M-H2O+H]+ with a retention time of 10.96 min 
(Figure 4.29). Verruculogen elutes slightly later than, and appears as a shoulder of, 
the pseurotin A or D peaks (m/z 432 for [M+H]+) at 10.79 and 10.81 min. A 
summary of all metabolites identified is detailed in Table 4.1. 
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Figure 4.26: Fumigaclavine C identification by mass spectrometry. (A) Fumigaclavine C in A. fumigatus ∆akuB identifying at m/z 367 [M+H]+ 
(retention time 5.03 min) and (B) absence of relevant peak in ∆akuB:∆pes1 strain. 
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Figure 4.27: Identification of fumigaclavine A by mass spectrometry. (A) fumigaclavine A in A. fumigatus ∆akuB at m/z 299 [M+H]+ (retention 
time 1.44 min) and (B) Fumigaclavine A in A. fumigatus ∆akuB:∆pes1 at  m/z 299 [M+H]+ (retention time 1.44 min). 
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Figure 4.28: Mass spectrometry and UV spectrophotometry identifying TR-2 and fumitremorgin C in ∆akuB:∆pes1. (A) Mass spectrometry 
identification of fumitremorgin C, iontrace m/z 380 [M+H]+, (B) Mass spectrometry identification of TR-2, iontrace m/z 394 [M-2xH2O+H]+, 
(C) UV spectrophotometry confirming the identity of fumitremorgin C and (D) UV spectrophotometry confirming the identity of TR-2. 
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Figure 4.29: Verruculogen identification by mass spectrometry. (A) iontrace identification m/z 512 [M+H]+ where verruculogen is identified at 
10.97 min, (B) iontrace identification m/z 585 [M+CH3CN+Na]+, and (C) iontrace identification m/z 494 [M-H2O+H]+ where verrucululogen is 
identified  at 10.96 min. 
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Table 4.1: Metabolites produced by wild-type (∆akuB and ATCC46645) and ∆pes1 
(∆akuB and ATCC46645). 
Metabolite Retention time  Structure 
Fumigaclavine A 1.44 min 
 
Fumigaclavine C 5.02 min 
 
Peak (m/z 309) 5.17 min Unknown 
TR-2 7.88 min 
 
Fumitremorgin C 8.22 min 
 
Verruculogen 10.96 min 
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The relative production of each metabolite identified was compared between 
wild-type and respective ∆pes1 strains and is detailed in Table 4.2. 
 
Table 4.2: Ion count of metabolites identified by mass spectrometry in A. fumigatus 
wild-type and ∆pes1 strains. 
 A. fumigatus 
Metabolite ∆akuB ∆akuB:∆pes1 ATCC46645 ∆pes146645 
 Ion Count 
Fumigaclavine C 2.42e4 Absent 1.18e3 Absent 
Fumigaclavine A 1.64e3 2.02e4 1.94e4 1.90e4 
Fumitremorgin C 114 1.73e3 750 1200 
TR-2 - - 865 1100 
Verruculogen 90.1 162 450 548 
 
 
Table 4.1 and 4.2 summarise the findings of the LC-mass spectrometry 
metabolite profiling of A. fumigatus wild-type and ∆pes1 strains. Table 4.1 shows the 
nomenclature, LC retention time and structure of all relevant metabolites. The 
similarity between fumigaclavine A and C is notable. Table 4.2 clearly shows that 
fumigaclavine C is absent in both ∆pes1 mutants and allows us to conclude that pes1, 
in part, mediates fumigaclavine biosynthesis and the absence of fumigaclavine C 
contributes to phenotypic differences between A. fumigatus wild-type and ∆pes1. 
191 
 
4.3 Discussion 
The disruption of pes1 in A. fumigatus has provided an opportunity to investigate 
the possible functions of the gene. The disruption of this gene was not lethal to the 
fungus in any of the strains used, and therefore demonstrates that pes1 production is 
not essential for primary growth and development of the fungus. The disruption of A. 
fumigatus pes1 was confirmed by real-time PCR expression analysis. Plate assay 
analysis showed that the disruption of pes1 in A. fumigatus ∆akuB, ATCC46645 and 
∆sidD46645 resulted in strains which had different sensitivities to hydrogen peroxide 
(H2O2), voriconazole (VCR) and amphotericin B (AmpB) where ∆akuB:∆pes1 has 
the greatest sensitivity in the presence of all three (P < 0.01 at 2 mM H2O2, P < 0.001 
at 0.15 µg/ml VCR, and P < 0.001 at 0.15 µg/ml AmpB). A. fumigatus ∆pes146645 
does not display the same sensitivities to hydrogen peroxide or amphotericin B, only 
displaying sensitivity toward voriconazole (P < 0.01 at 0.15 µg/ml). Whereas, 
∆sidD:∆pes1 is more sensitive in the presence of hydrogen peroxide (P < 0.001 at 2 
mM) than the other disrupted strains, but is less sensitive to voriconazole (P < 0.01 at 
0.15 µg/ml) and amphotericin B (P < 0.01 at 0.15 µg/ml). Interestingly, at the lower 
concentration of voriconazole (0.005 µg/ml), ∆sidD:∆pes1 is more sensitive than 
∆pes146645 (P < 0.001), where ∆pes146645 displays the same growth capabilities as the 
wild-type, ATCC46645. It was observed that the ∆sidD46645 and ∆sidD:∆pes1 strains 
required supplementation with L-glutamine rather than ammonium tartrate in iron 
limited (10 µM) conditions and that the iron source was also significantly important 
for the growth capabilities of these strains. Iron sulphate was able to maintain 
approximately 50 % growth for A. fumigatus ∆sidD46645 (P < 0.001) and 
∆sidD:∆pes1 (P < 0.0001), whilst iron chloride was still ineffective in restoring 
growth, unless the iron concentration was increased to 1.5 mM. Furthermore, iron 
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sulphate combined with a low hydrogen peroxide concentration (1 mM or 2 mM) 
resulted in growth reduction of ∆sidD46645 and ∆sidD:∆pes1 (P < 0.001) compared to 
the wild-type, ATCC46645. Infection studies using the insect host G. mellonella 
showed that the virulence of A. fumigatus is reduced due to the absence of the sidD 
gene (P = 0.001), and a further reduction in virulence was observed in the double 
mutant ∆sidD:∆pes1 (P = 0.0002). Finally and most significantly, HPLC analysis 
determined that the strains ∆akuB:∆pes1 and ∆pes146645 were deficient in 
fumigaclavine C which for the first time implicates a role for pes1 in fumigaclavine 
C biosynthesis.  
The expression pattern of pes1 was investigated to establish the optimal media 
and time point for pes1 expression, which would therefore potentially produce the 
Pes1-encoded NRP product. The relationship between the level of pes1 expression 
and the amount of the Pes1-encoded NRP product is not known. The expression of 
pes1 was analysed by real-time PCR in the strain A. fumigatus ATCC46645 grown in 
Aspergillus minimal media (AMM), Minimal media (MM) and Sabouraud media 
(SAB). The expression pattern of pes1 had been previously examined by Cramer et 
al. (2006b) and Reeves et al. (2006) where a range of media types and strains were 
used in their respective expression analysis. There was no expression of pes1 in A. 
fumigatus AF293 cultured in Czapek’s broth or RPMI, and minimal expression using 
Sabouraud media (Cramer et al., 2006b). Whereas using MEM + FCS culture media 
for culturing A. fumigatus ATCC26933, ATCC16424, and ATCC13073 resulted in 
expression of pes1, with different levels between the strains (Reeves et al., 2006).  
As the previous expression analysis conducted did not include the strains used in the 
disruption of pes1 for this project, the expression of pes1 in A. fumigatus 
ATCC46645 was profiled using a variety of media types and range of time-points. 
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The expression of pes1 in A. fumigatus ATCC46645 was highest in cultures of all 
media types at either 24 or 48 hr, with a decrease at 72 hr. The lowest overall 
expression was observed in Sabouraud media, whereas in MM, there was a slight 
increase in expression of pes1. The highest expression was seen in AMM media, in 
24 and 48 hr, with 48 hr having the highest expression. The real-time PCR analysis 
of pes1 confirmed that pes1 expression was not detected in the mutant strains, A. 
fumigatus ∆pes146645 and ∆sidD:∆pes1, and also the restoration of expression of pes1 
in the complemented strain, ∆sidD:pes1c. This analysis confirms the Southern blot 
analysis of the mutants detailed in Chapter 3. 
 
pes1 has previously been shown to confer protection against oxidative stress 
(Reeves et al., 2006). In plate assays, there was a significant decrease in radial 
growth of A. fumigatus ∆akuB:∆pes1 compared to ∆akuB at 2 mM hydrogen 
peroxide (P < 0.01). This is in contrast to the application of hydrogen peroxide to A. 
fumigatus ATCC46645 and ∆pes146645, where there was no difference observed 
between the wild-type and respective mutant strain. Additionally, A. fumigatus 
∆sidD46645 and ∆sidD:∆pes1 exhibited a significant decrease in radial growth 
compared to ATCC46645 (2 mM hydrogen peroxide) (P < 0.001). Clearly, there is 
strain variability between ∆akuB and ATCC46645, in so far as, ATCC46645 is less 
sensitive to exogenous hydrogen peroxide.  
In voriconazole plate assays, A. fumigatus ∆akuB:∆pes1 was sensitive to the 
presence of this anti-fungal, compared to the wild-type, ∆akuB. Even at the lowest 
voriconazole concentration (0.05 μg/ml), there was a significant decrease in growth 
(P < 0.01) of ∆akuB:∆pes1. The higher concentrations of voriconazole (0.015 & 0.25 
μg/ml) resulted in a further decrease in radial growth in ∆akuB:∆pes1 (P < 0.001). 
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For ∆pes146645, there was also a significant decrease in radial growth compared to A. 
fumigatus ATCC46645 at 0.15 μg/ml (P < 0.05). Interestingly, both A. fumigatus 
ATCC46645 and ∆pes146645 were incapable of growth at 0.25 µg/ml voriconazole, 
whereas A. fumigatus ∆akuB was capable of approximately 50 % growth and 
∆akuB:∆pes1 was capable of about 10 % growth. A. fumigatus ∆sidD46645 and 
∆sidD:∆pes1 were capable of between 40 – 50 % growth in 0.05 and 0.15 μg/ml 
voriconazole, respectively. This indicates that the sensitivity towards voriconazole is 
more pronounced in ∆sidD, compared to ∆pes146645, as there is a greater decrease in 
radial growth in ∆sidD46645 than ∆pes146645. This sensitivity of ∆sidD towards 
voriconazole has not been observed previously. The ∆sidD:∆pes1 strain has the same 
radial growth as ∆sidD46645, indicating that the sensitivity towards voriconazole is not 
an accumulative effect in the double mutant. Furthermore, in transcriptome analysis 
of A. fumigatus gene expression during exposure to voriconazole, the expression of 
pes1 was found not to be significantly changed (da Silva Ferreira et al., 2006b). This 
highlights the importance of focused studies which can vary the conditions to analyse 
selected specific genes at the same time, whereas global studies are capable of 
screening many genes in one condition at the same time. 
 
In the amphotericin B plate assays, A. fumigatus ∆akuB:∆pes1 was sensitive to 
even the lowest level (0.15 μg/ml) (P <0.001), compared to the background strain, 
∆akuB and this sensitivity was observed at all concentrations used (P < 0.01). This 
was in contrast to A. fumigatus ATCC46645 and ∆pes146645 where there was no 
difference in radial growth between the wild-type and mutant strain. A. fumigatus 
∆sidD46645 and ∆sidD:∆pes1 were also capable of maintaining similar growth, as 
were ATCC46645 and ∆pes146645. However, at 0.15 µg/ml, ∆sidD:∆pes1 exhibited a 
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decrease in radial growth compared to ATCC46645 (P < 0.05). Reeves et al. (2004) 
showed that the presence of amphotericin B was in part responsible for an increase in 
the production of gliotoxin, and suggested that this may be due to pores created in 
the membrane by amphotericin B binding to the membrane sterols. This pore 
creation may be an advantage to the fungus in the presence of low concentrations of 
amphotericin B, as the wild-type strain was capable of over 100 % radial growth 
compared to growth on media-only plates, indicating that there is an advantage for 
the fungus to grow in the presence of low concentrations of amphotericin B. 
Potentially, growing the strains in liquid media containing amphotericin B, and 
measuring the gliotoxin secretion may provide more insight to the possibility of 
amphotericin B enhancing gliotoxin production.  
 
The addition of gliotoxin did not have any impact on the radial growth of A. 
fumigatus ∆akuB:∆pes1, indicating that pes1 peptide production or function is not 
inhibited by the presence of gliotoxin. This also shows that the phenotypic results 
observed are specifically due to the absence of Pes1 production in A. fumigatus and 
not as a result of the transformation process itself, which should not interfere with the 
expression and function of other genes.  
 
On media plates without additives, A. fumigatus ∆akuB:∆pes1 was only capable 
of maintaining  81 %  radial growth compared to ∆akuB, indicating that mutations in 
this strain may result in higher sensitivities to hydrogen peroxide, voriconazole and 
ampothericin B, especially if the gene deleted or disrupted is involved in conferring 
protection against these agents. As mentioned in the previous Chapter, the 
characterisation of mutations conducted in the ∆akuB background should be carried 
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out after akuB has been restored (Nielsen et al., 2008). The radial growth phenotypes 
observed in the A. fumigatus ATCC46645 and ∆sidD46645 and respective ∆pes1 
mutations, were less sensitive to hydrogen peroxide and anti-fungals, than the strains 
containing the akuB mutation, indicating that akuB strain may already exhibit 
sensitivities to these agents, and that the disruption of pes1 could be adding to the 
sensitivities observed. This “unmasking” of the effect of the presence of hydrogen 
peroxide or anti-fungals in a sensitive strain, enhances the effect due to the absence 
of pes1, whereas in the other wild-type strain, ATCC46645, the mutation did not 
display any phenotypical difference when grown in the same conditions. Indeed, the 
∆akuB strain had a slower growth rate than ATCC46645 and after 72 hr resulted in a 
smaller radial diameter on minimal media, 31.8 (±0.125) mm and 38.25 (±1.898) 
mm, respectively.  Therefore, the use of the ∆akuB strain may be beneficial in the 
preliminary screening of phenotypic results, as this strain may potentiate the 
sensitivities of the mutated strain and indicate a possible line of enquiry in further 
phenotypic analysis.  
 
A. fumigatus ATCC46645 and ∆pes146645 exposed to hydrogen peroxide have the 
same growth capabilities, whereas the hydrogen peroxide inhibition assay conducted 
by Reeves et al. (2006) showed that the diameter of the inhibition zones increased as 
the dose of hydrogen peroxide increased, but that the effect was more pronounced in 
the A. fumigatus ∆pes1 strain, compared to the wild-type AF293.1. As the hydrogen 
peroxide is placed in “pockets” in the agar and subsequently, A. fumigatus conidia 
are applied to the plate, the conidia of the mutant strain isolated onto the plate would 
be capable of growing on the agar away from the hydrogen peroxide pockets. In the 
hydrogen peroxide plate assays described here, the conidia were inoculated together 
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onto one spot on the plate, and the hydrogen peroxide was distributed throughout the 
agar at a specific concentration. Theoretically, activation of protective mechanisms 
against the presence of hydrogen peroxide may occur earlier than in inhibition zone 
assays, as well as conidia protecting other conidia due to clumping in one location 
resulting in similar sensitivities seen between A. fumigatus ATCC46645 and 
∆pes146645. Also, once mycelia begin to form the difference between wild-type and 
mutant becomes negligible, especially if pes1 is a conidial-related gene, as the 
mycelial will activate alternative oxidative stress resistance genes, such as the 
catalases (Paris et al., 2003b).  
 
The media type plays an important role in the growth capabilities of A. fumigatus. 
This was especially highlighted in the different growth patterns observed for A. 
fumigatus ∆sidD46645 and ∆sidD:∆pes1 in AMM compared to MM media types. A. 
fumigatus ∆sidD46645 and ∆sidD:∆pes1 were not able to grow on AMM in the lower 
iron concentration (10 µM), but were able to maintain some growth on MM at this 
iron concentration (P < 0.001). Both strains were capable of maintaining similar 
growth capabilities as the wild-type, ATCC46645 when the iron concentration was 
increased (1.5 mM) on either media types. The difference between the two media 
types is the source of nitrogen. In AMM, the nitrogen source is ammonium tartrate 
and in MM, the nitrogen source is L-glutamine. L-glutamine can be used to synthesis 
L-ornithine, which is converted to N5-hydroxy-L-ornithine during the first step of 
siderophore biosynthesis (Jones, 1985). As L-glutamine plays a role in the 
siderophore biosynthesis process, iron utilisation by the sidD deficient strains was 
investigated. The iron source also plays an important role in the growth capabilities 
of siderophore utilising organisms. It has been established that A. nidulans can 
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acquire iron from iron sulphate and not iron chloride (Eisendle et al., 2003). Similar 
results were observed during this project, where A. fumigatus ∆sidD and 
∆sidD:∆pes1 were capable of growth in the low iron concentration (10 µM) when the 
iron source was iron sulphate but not capable of any growth when the iron source 
was iron chloride (P < 0.001). Maximum growth was observed with both iron 
sources when the iron concentration was increased (1.5 mM). As the ∆sidD strains 
cannot utilise the siderophore system of recruiting iron (Schrettl et al., 2007), the 
reductive iron assimilation (RIA) system (Howard, 1999) is solely relied upon for the 
iron recruitment. The source of iron is obviously important at the lower 
concentrations available, whereas at the higher concentrations, ample iron is 
available to utilise and does not restrict the growth of A. fumigatus ∆sidD, as the 
siderophore system is not required in this iron replete condition.  
Previously, Schrettl et al (2007) demonstrated that the siderophore deficient 
strains were sensitive to oxidative stress. In particular, it was shown that ∆sidD was 
sensitive to hydrogen peroxide in plate assays with various iron concentrations. As 
the pes1 gene is putatively thought to also be involved protection against oxidative 
stress (Reeves et al., 2006), A. fumigatus ATCC46645, ∆sidD46645 and ∆sidD:∆pes1 
strains were exposed to increasing amounts of hydrogen peroxide with and without 
the presence of iron from different sources and at different concentrations. The wild-
type strain is able to compensate for the lack of iron by utilising the siderophore 
system (Haas et al., 1999), and resist the oxidative stress response. Evidently, the 
lack of the extracellular siderophore system is too much of a stress for the ∆sidD46645 
strain to grow, and consequently, the ∆sidD:∆pes1 strain also unable to maintain 
growth. It was therefore investigated if the supplementation with different iron 
sources and concentration would restore growth in the mutant strains. 
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Interestingly, A. fumigatus ∆sidD46645 and ∆sidD:∆pes1 strains grown on media 
containing hydrogen peroxide (1 – 2 mM) in conjunction with 10 µM iron sulphate 
resulted in both strains capable of 20 % radial growth compared to ATCC46645 (P < 
0.01), whereas growth on media containing hydrogen peroxide in conjunction with 
10 µM iron chloride did not result in any growth (P < 0.001). In the presence of the 
higher iron concentration (1.5 mM) from either sources, both ∆sidD46645 and 
∆sidD:∆pes1 strains were capable of maintaining the same radial growth as 
ATCC46645 in the presence of any of the hydrogen peroxide concentrations used (1 
– 4 mM). Upon the addition of a high concentration of iron, all strains no longer 
required the siderophore system, and therefore experienced only a single stress 
(hydrogen peroxide) instead of multiple stress factors. Therefore, ∆sidD46645 acts 
exactly like the wild-type during the iron replete conditions, regardless of the type of 
iron supplied, which enables ∆sidD:∆pes1 to maintain full growth capabilities. The 
lower concentration of FeSO4 (10 µM) is not enough iron supplementation to 
maintain the iron acquisition through the reductive iron assimilation (RIA) system, 
and requires the activation of the siderophore system when the available iron is used 
up. However, the initial iron acquisition by RIA enables the fungus to maintain some 
growth in the presence of hydrogen peroxide. This demonstrates the essential nature 
of iron recruitment by the fungus during oxidative stress, which counteracts the 
accumulative detrimental effect of the absence of a second gene, pes1, known to 
facilitate resistance to oxidative stress. 
 
The G. mellonella insect host model has been used to study the virulence of 
bacteria (Jander et al., 2000) and fungi (Cotter et al., 2000; Reeves et al., 2004a), as 
an alternative to using murine models. There is a good correlation between the G. 
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mellonella and murine response to fungal infection (Brennan et al., 2002). As 
described in Chapter 1, the larvae of G. mellonella exhibit a similar innate immune 
response to that of a human in response to a pathogen (Kavanagh & Reeves, 2004). 
Reeves et al. (2004a) used the G. mellonella host model as a method of determining 
the virulence of A. fumigatus. The G. mellonella host system was also used to 
compare A. fumigatus AF293.1 and ∆pes1. Here, the virulence of ∆pes1 was shown 
to be reduced compared to the wild-type, 48 hr post injection (Reeves et al., 2006). 
As part of this project, the A. fumigatus ATCC46645, ∆sidD46645, ∆pes146645 and 
∆sidD:∆pes1 strains were used to infect G. mellonella larvae to determine the 
virulence of each strain. After 48 hr, there was significantly different survival rates 
between the strains, where G. mellonella infected with A. fumigatus ∆sidD46645 (49 
%) and ∆sidD:∆pes1 (53 %) displayed the highest survival rates. A. fumigatus 
∆pes146645 (30 %) and ∆sidD:pes1c (33 %) infected larvae had similar survival rates. 
A. fumigatus ATCC46645 infected larvae displayed the lowest survival rate (25 %), 
which was expected.  
A reduced virulence was observed in all mutants compared to the wild-type 
strain, with ∆sidD46645 (P = 0.001) and ∆sidD:∆pes1 (P = 0.0002) being the most 
significant. These results show that pes1 and sidD play an important role in the 
virulence of A. fumigatus and the combined loss of these genes contribute to the 
greatest virulence diminution in A. fumigatus. As the larvae injected with either 
∆sidD46645 or ∆sidD:∆pes1 conidia showed the greatest survival rate, it is a 
possibility that sidD plays a greater role than pes1 in the pathogenicity of A. 
fumigatus, with pes1 playing a contributing role.  This virulence difference between 
the mutant strains is observed in the higher survival rate of A. fumigatus ∆sidD46645 
infected larvae compared to the ∆pes1 infected larvae (P = 0.028). All the larvae, 
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irrespective of the strains, reached 100 % mortality after 72 hr incubation, indicating 
that attenuated virulence was not achieved by the absence of these genes individually 
or combined, and that the invasion capacity of these A. fumigatus mutant strains 
remained intact. 
 
The creation of mutant strains gave rise to the opportunity of analysing the 
metabolites produced by wild-type and mutant strains by RP-HPLC and mass 
spectrometry. Initially, the culture filtrates were analysed by RP-HPLC with the aim 
to identify and compare secreted metabolites in the wild-type and ∆pes1 mutant 
strains, as this method has previously identified metabolites such as brevianamide F 
(Maiya et al., 2006) and Pseurotin A (Maiya et al., 2007) in A. fumigatus. However, 
this analysis showed no difference between the strains. Subsequently, agar plate plug 
extractions of A. fumigatus ∆akuB and ATCC46645 and their respective pes1 
mutation strains, ∆akuB:∆pes1 and ∆pes146645, were taken following the protocol of 
Smedsgaard (1997). This extraction method ensures the inclusion of conidial and 
mycelial related metabolites, which would have been excluded in the culture filtrate 
analysis, as well as profiling the metabolites secreted into the agar (Smedsgaard and 
Nielsen, 2005). The agar plug extractions of all strains were subjected to RP-HPLC 
and mass spectrometry analysis. Both A. fumigatus ∆akuB:∆pes1 and ∆pes146645 
were deficient in fumigaclavine C production, compared to the corresponding wild-
type strains. As mentioned in Chapter 1, fumigaclavine C is one of seven ergot 
alkaloids produced by A. fumigatus. Therefore, the presence of the proposed 
fumigaclavine C precursor, fumigaclavine A, was searched for and observed in all 
strains, wild-type and mutant. Interestingly, the production of fumigaclavine A was 
increased in ∆akuB:∆pes1, whereas ∆pes146645 produced the same amount of this 
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metabolite as ATCC46645. As the mutant strains are both capable of producing 
fumigaclavine A but not fumigaclavine C, the biosynthesis of this metabolite is 
reliant on the presence of the NRP synthetase, Pes1, and therefore for the first time, 
establishes a role for this NRP synthetase in the biosynthesis of fumigaclavine C. 
 
Considering the involvement of the NRP synthetase, Pes1, in the biosynthesis of 
fumigaclavine C, the biosynthetic cluster of the ergot alkaloid identified in A. 
fumigatus was reviewed to clarify a role for Pes1 in Fumigaclavine C biosynthesis. 
Previously, the A. fumigatus fumigaclavine biosynthetic cluster was identified by the 
cloning and overexpression of the dimethylallyltryptophan synthase encoded by 
fgaPT2 (AFUA_2G18040) (Unsold and Li, 2005). This gene showed significant 
identity (54 %) to cpd1, the dimethylallyltryptophan synthase, of Claviceps 
purpurea. Genes surrounding fgaPT2 also had significant similarity to other genes 
involved in the ergot alkaloid synthase (EAS) cluster of C. purpurea, including 
fgaOX3 (53 % identity to cpox3), fgaOX1 (41 % identity to cpox1), fgCAT (57 % 
identity to cpcat2) and fgaOX2 (66 % identity to cpox2) (Unsold & Li, 2005). fgaDH 
has an identity of 78 % to cpox2 of C. purpurea (Wallwey et al., 2010). The genes 
spanning from AFUA_2G17960 to AFUA_2G18060 in the genome were therefore 
identified as members of the A. fumigatus ergot alkaloid biosynthetic cluster (Figure 
4.30).  
C. purpurea produces the ergot alkaloid, lysergic acid and derivatives of this are 
ergopeptides such as ergoamine (Riederer et al., 1996). Most of the chemistry of 
ergot alkaloids has been studied using C. purpurea, as the biosynthetic gene cluster 
for ergot alkaloids was discovered in this fungus (Tudzynski et al., 1999). The 
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cluster was identified by genomic walking with a starting point at cpd1 (previously 
known as dmaW) (Tudzynski et al., 1999). 
Another member of the ascomycota, Neotyphodium lolii, produces similar ergot 
alkaloids, named ergovaline and its derivatives such as ergine (Wang et al., 2004). 
Interestingly, the C. purpurea and N. lolii ergot alkaloid biosynthetic clusters both 
contain at least one NRP synthetase. The biosynthetic cluster of C. purpurea contains 
three NRP synthetases, lpsA, lpsB and lpsC. lpsA is a trimodular NRP synthetase and 
lpsB is a monomodular NRP synthetase, whereas lpsC is also a trimodular NRP 
synthetase but has not been assigned a function in the biosynthesis of ergot alkaloids 
in C. purpurea. In N. lolii, only the lpsB gene is present in the cluster, but Southern 
blot analysis has identified the presence of the lpsA gene in the genome (Fleetwood 
et al., 2007).  
 
The A. fumigatus ergot alkaloid cluster does not contain any NRP synthetase 
genes and there is extensive gene rearrangement between the ergot alkaloid gene 
clusters in all three species, as depicted in Figure 4.30, which details the ergot 
alkaloid gene clusters identified in A. fumigatus, C. purpurea and N. lolii, with the 
general gene function of each strain indicated by the same colour across the three 
individual clusters. As there has been frequent gene renaming within all three 
clusters, this is the first time that the separate clusters are displayed together which 
shows the most recent gene names associated with putative functions. The 
information was compiled from publications that either displayed one or two of the 
clusters (Haarmann et al., 2005; Lorenz et al., 2007), or had all three clusters but no 
gene function alignment (Fleetwood et al., 2007).   A. fumigatus contains three genes 
in the centre of the cluster which are not present in the other clusters, namely an O-
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acetyltransferase, fgaAT, involved in the conversion of fumigaclavine B to 
fumigaclavine A (Liu et al., 2009) and two cytochrome P450 monooxygenases, 
which have not been assigned a function. Also different in the A. fumigatus cluster is 
the presence of a second reverse prenyltransferase, fgaPT1 (Unsold and Li, 2006). 
The dioxygenase, easH, was determined to be a pseudogene in A. fumigatus 
(Fleetwood et al., 2007), and therefore is not included in the proposed biosynthetic 
gene cluster schematic (Figure 4.30).  
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Figure 4.30: Proposed biosynthetic gene clusters of ergot alkaloid synthase genes in A. fumigatus, C. purpurea and N. lolii (Coyle and Panaccione, 
2005; Haarmann et al., 2005; Unsold and Li, 2005; Fleetwood et al., 2007; Lorenz et al., 2007). 
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The ergot alkaloid pathway is complex and not fully understood, differing 
between alkaloid producers (Figure 4.31 and Figure 4.32). The ergot alkaloid 
biosynthetic pathways of A. fumigatus and N. lolii have a common origin with 
Clavicipitaceous fungi, where there is a homolog in the initial determinant step of 
converting L-tryptophan to 4-L-DMAT (Coyle and Panaccione, 2005). In C. 
purpurea the biosynthetic production of the ergot alkaloid ergoamine begins with the 
prenylation of L-tryptophan with Dimethylallyl pyrophosphate (DMAPP) by the 
dimethylallyltryptophan (DMAT) synthetase, Cpd1, to result in 4-L-DMAT. This is 
then converted to 4-DMA-L-abrine by the N-methyltransferase, EasF. This is then 
converted to chanoclavine-1 by undetermined steps, but which include the 
oxidoreductase, Cpox1. The chanoclavine-1 is converted to chanoclavine-1-aldehyde 
by the dehydrogenase, Cpox2. This then undergoes steps which include the 
oxidoreductase, Cpox3 and an unknown reaction carried out by EasG which result in 
the production of agroclavine. This is then converted to elymoclavine by unknown 
reactions. Elymoclavine is the converted to paspalic acid by the cytochrome P450 
monoxygenase, CloA. The orientation of the COOH acid is changed by an unknown 
spontaneous reaction and results in the production of lysergic acid. The conversion of 
lysergic acid to ergotamine is catalyzed by the monomodular NPR synthetase, LpsB, 
and the multimodular NRP synthetase, LpsA, where the lysergic acid is combined 
with three amino acids, usually alanine, phenylalanine and proline. It was established 
that derivatives of ergotamine could be synthesised by replacing the first two amino 
acids, alanine and phenylalaine with alternative amino acids, but that proline was 
essential for LspA activation (Walzel et al., 1997). The proposed biosynthetic 
pathway of ergtoamine is detailed in Figure 4.31. 
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Figure 4.31: Proposed biosynthetic pathway of ergotamine, an ergot alkaloid in C. purpurea. (Riederer et al., 1996; Walzel et al., 1997; Correia 
et al., 2003; Coyle et al., 2010). 
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In A. fumigatus the biosynthetic production of fumigaclavine C also begins with 
the prenylation of L-tryptophan with DMAPP by the DMAT synthase, fgaPT2 to 
result in 4-L-DMAT. This is converted to 4-DMA-L-abrine by the N-
methyltransferase, FgaMT. This is converted to chanoclavine-1 by undetermined 
steps, but which include the oxidoreductase, FgaOx1. The chanoclavine-1 is 
converted to chanoclavine-1-aldehyde by the dehydrogenase, FgaDH. This then 
undergoes steps which include the oxidoreductase, FgaOX3 and an unknown 
reaction carried out by FgaFS which results in the production of festuclavine (also 
known as agroclavine). It is from this point that the ergot alkaloid biosynthesis 
deviates from that of C. purpurea. Festuclavine is converted to fumigaclavine B by 
unknown reactions. Fumigaclavine B is converted to fumigaclavine A by the O-
acetyltransferase, FgaAT. Fumigaclavine A is converted to fumigaclavine C by a 
reverse prenyltransferase, FgaPT1. The proposed biosynthetic pathway of 
fumigaclavine C in A. fumigatus is detailed in Figure 4.32. 
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Figure 4.32: Proposed biosynthesis pathway of the ergot alkaloid, fumigaclavine C, in A. fumigatus (Unsold and Li, 2006; Rigbers and Li, 2008; 
Coyle et al., 2010; Wallwey et al., 2010). 
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The ergot alkaloids were confirmed to be associated with the conidia, as an A. 
fumigatus ∆brlA strain, unable to produce conidiophores, did not produce any ergot 
alkaloids (Coyle et al., 2007). pes1 was previously identified as a gene involved in 
conidial morphology and hydrophobicity (Reeves et al., 2006). As the absence of 
pes1 expression, a known conidial related gene, is causing the lack of production of 
the conidial related metabolite, fumigaclavine C, the biosynthesis of this metabolite 
must require the involvement of the NRP synthetase, pes1, at some unknown stage 
during the biosynthetic process.  
An A. fumigatus ∆laeA strain, deficient in the global transcription factor is unable 
to produce any of the fumigaclavine products (Perrin et al., 2007). Interestingly, pes1 
expression is down-regulated in ∆laeA, which enables us to conclude that down-
regulation of pes1 in ∆laeA leads to the decrease in the production of these 
metabolites, specifically fumigaclavine C. The similarities between the ∆laeA and 
∆pes1 strains have been noted recently in relation to the involvement of metabolites 
in the pathogenicity of A. fumigatus, in a study concentrating on the association of 
LaeA mediated phagocytosis with the hydrophobin layer of conidia in A. fumigatus 
(Dagenais et al., 2010). Also, as pes1 expression is down-regulated in an A. 
fumigatus ∆stuA strain, which also exhibits conidial morphology differences, which 
may be a result of the down-regulation of pes1 (Sheppard et al., 2005). 
 
The A. fumigatus fumigaclavine biosynthetic cluster has been extensively studied 
(Willingale et al., 1983; Unsold and Li, 2006; Kato et al., 2009; Maiya et al., 2009; 
Steffan et al., 2009) but there are still a number of undefined reaction steps, and 
genes in the cluster with unknown functions. As pes1 is a multimodular non-linear 
NRP synthetase, and the biosynthesis of ergotamine in C. purpurea involves a 
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trimodular NRP synthetase (lpsA), it is possible that pes1 shares a common ancestor 
with the NRP synthetase, lpsA. The NRP synthetases involved in ergotamine 
biosynthesis use lysergic acid as a specific substrate, activated through the NRP 
synthetase, lpsB, which sequentially adds three amino acids to the activated lysergic 
acid, suggesting that there are four peptide synthetase domains on the LPS 
multienzyme complex (Walzel et al., 1997). Pes1 contains four adenylation domains 
for binding individual amino acids and has a non-linear type organisation, indicating 
that it may bind a complex peptide amongst its substrates, and may use domains 
more than once in the peptide production process (Section 1.4.1, Figure 1.6). A. 
fumigatus also has two monomodular NRP synthetases, pesG and pesL. Interestingly, 
in an A. fumigatus ∆pesL mutant strain, the production of fumigaclavine C is absent 
(Karen O’Hanlon – personal communication), indicating that this monomodular NRP 
synthetase may have a common origin with the monomodular NRP synthetase also 
found in C. purpurea (lpsB).  
 
In A. fumigatus ∆pes1, the production of the precursor fumigaclavine A is 
unhindered, which strongly indicates that pes1 absence is most likely preventing the 
conversion of fumigaclavine A to fumigaclavine C by the reverse prenyltransferase, 
FgaPT1. FgaPT1 has strict specific substrate specificity (Unsold and Li, 2006). In 
vitro experimentation directly reacted the substrate, fumigaclavine A with the reverse 
prenyltransferase, resulting in the production of fumigaclavine C (Unsold and Li, 
2006). Possibly, in vivo, the direct interaction of substrate and transferase may not 
occur as easily, and may require the tethering of the substrate to an NRP synthetase, 
such as Pes1 for the reaction to occur. As the production of the precursor of 
fumigaclavine C, fumigaclavine A is not inhibited, pes1 absence may interfere with 
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the prenylation step. Furthermore, analysis of A. fumigatus ∆fgaPT2 mutant which 
could not convert L-tryptophan to 4-L-DMAT revealed a small quantity of 
chanaclavine still being produced, even though this is thought to be one of the 
intermediates further along the biosynthetic pathway, indicating that there may be an 
alternative pathway to fumigaclavine C type products (Unsold and Li, 2005).  
Conversely, in vitro experimentation found that methylation of L-tryptophan 
could be induced resulting in the production of L-abrine. This in turn was accepted 
by FgaPT2 as a substrate for prenylation. But the methyltransferase FgaMT, would 
not accept L-tryptophan as a substrate unless it was previously prenylated, indicating 
the substrate specificity required in ergot alkaloid production (Rigbers and Li, 2008). 
As these reactions were carried out in vitro, the full biosynthetic reaction cannot be 
easily defined, especially if an NRP synthetase is involved.  
Alternatively, fumigaclavine A may be produced by an alternative Pes1-
independent pathway. 
 
The A. fumigatus fumigaclavine biosynthetic cluster most likely has a common 
origin with the ergotamine biosynthetic cluster from C. purpurea, which contains 
NRP synthetases. The extensive gene rearrangement seen in the A. fumigatus 
fumigaclavine cluster may have resulted in the translocation of the NRP synthetase 
genes to other parts of the genome which remain intimately involved in the 
biosynthesis of the ergot alkaloid, fumigaclavine C. Evidence for this type of cluster 
cross-talk is beginning to emerge in the literature (Lazos et al., 2010). 
 
In summary, phenotypic analysis of disrupted A. fumigatus pes1 in three strains 
namely, ∆akuB, ∆sidD and ATCC46645 resulted in (i) sensitivity to hydrogen 
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peroxide, voriconazole and amphotericin B to varying degrees between the different 
strains, (ii) an inability of the ∆sidD:∆pes1 strain to maintain similar growth 
capabilities as ∆sidD during iron limiting conditions, (iii) an additive sensitivity of 
the pes1 disruption in the ∆sidD background towards amphotericin B, (iv) a decrease 
in virulence in all mutant strains compared to the wild-type, and (v) the absence of 
fumigaclavine C production in ∆pes1 strains.  
The ergot alkaloid production in A. fumigatus was not thought to involve NRP 
synthetases, even though the C. purpurea ergot alkaloid biosynthetic cluster, which 
was used to identify the A. fumigatus ergot alkaloid cluster, contains two functional 
NRP synthetases. We propose that gene rearrangement within the A. fumigatus 
cluster masked the potential NRPS involvement. The exact mechanism by which 
Pes1 is involved in the production of fumigaclavine C is still unknown, but this 
“cluster cross-talk” between pes1 and the fumigaclavine C cluster has implications 
for all the undefined NRP synthetase genes in A. fumigatus. 
  
 
 
 
 
 
 
CHAPTER 5 
 
 
 
Functional characteristaion of gliK – a component of 
the gliotoxin biosynthetic cluster of Aspergillus 
fumigatus 
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5. Functional characterisation of gliK – a component of the gliotoxin 
biosynthetic cluster of Aspergillus fumigatus 
5.1 Introduction 
There is significant identity between the A. fumigatus gliotoxin biosynthetic 
cluster and the L. maculans sirodesmin biosynthetic cluster, including, gliZ, the zinc 
finger transcriptional regulator (Bok et al., 2006a); gliP, the nonribosomal peptide 
synthetase; gliG, the glutathione S-transferase; gliN, the methyl transferase; gliM, the 
O-methyl transferase; gliC, the cytochrome P450 monooxygenase; gliI, the 
aminocyclopropane carboxylic acid synthase; gliJ, the dipeptidase; and gliT, the 
thioredoxin reductase which are all thought to be genes required for ETP 
biosynthesis. Three other genes in the gliotoxin cluster have no orthologs in the 
sirodesmin cluster, and these are: gliF, a cytochrome P450 monooxygenase; gliA, the 
multi facilitator superfamily (MFS) transporter; and gliK, a protein of unknown 
function.  
gliF, encoding an extra P450 monooxygenase, may be involved in the addition of 
the hydroxyl group to the phenylalanine residue in an indirect manner, where the 
hydroxyl group is derived from one of the intermediates, as this is the function of 
sirE found in the sirodesmin cluster, which also encodes for an additional P450 
monoxygenase (Gardiner and Howlett, 2005a).  
The A. fumigatus gliotoxin cluster contains a MFS transporter (gliA), whereas, 
the L. maculans sirodesmin cluster contains an ABC (ATP-Binding Cassette) (sirA) 
transporter (Gardiner and Howlett, 2005a). This is interesting as it suggests that the 
same type of toxin is produced in a similar manner and yet has a different class of 
transporter. MFS transporters are more common than ABC transporters in fungal 
genomes, and this is especially true of A. fumigatus where there are 45 ABC 
transporters compared to 275 MFS transporters (Chang et al., 2004). The MFS-type 
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transporters have been associated with the production of aflatoxins (Aspergillus spp., 
aflT), HC-toxin (Cochliobolus carbonum, TOXA), trichothercenes (Fusarium 
sporotrichioides, TRI12), cercosporins (Cercospora kikuchii, CFP) and poxilline 
(Penicillium poxilli, paxT) (Pitkin et al., 1996; Alexander et al., 1999; Callahan et 
al., 1999; Young et al., 2001; Chang et al., 2004).  Previously it has been shown 
that, in sirodesmin production by L. maculans, the ABC transporter (sirA) is not 
essential for sirodesmin production but facilitates self protection (Gardiner et al., 
2005b). Here, it was shown that the expression of sirA is controlled by the 
mechanism that regulates the other genes in the cluster and also by sirodesmin itself. 
Conversely, aflT, a gene encoding the MFS transporter for aflatoxin in A. 
parasiticus, was not involved in the toxin production, nor was it essential for 
aflatoxin secretion, indicating that there may be other components involved in the 
transportation of toxins in association with the MFS type transporter. This study also 
indicated that the expression of the transporter was not controlled by the cluster 
transcription factor, but by the FadA-dependent G-protein signalling pathway 
(Chang et al., 2004).  
Previous studies have involved disruption of individual genes from the A. 
fumigatus gliotoxin cluster, and have identified that gliotoxin production was 
completely absent when the transcription factor, gliZ, was deleted (Bok et al., 2006a) 
and also when gliP, the NRP synthetase was deleted (Kupfahl et al., 2006; Cramer et 
al., 2006a; Sugui et al., 2007; Spikes et al., 2008). Gliotoxin production was restored 
with the reconstitution of the respective deleted gene. These studies definitively 
confirmed that the cluster discovered in A. fumigatus was responsible for the 
production of gliotoxin. The expression of all cluster components except gliP was 
restored when exogenous gliotoxin was applied to the ∆gliP mutant (Cramer et al., 
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2006a); indicating that gliotoxin itself can potentially regulate the cluster expression, 
in conjunction with the transcription factor.  
The hypothetical protein, encoded by gliK, in the gliotoxin biosynthetic cluster 
found in A. fumigatus has not been characterised to date. Organisms which contain 
the MFS transporter rather than an ABC transporter associated with gliotoxin 
production, also have a gliK-type gene adjacent, or nearby (Patron et al., 2007), 
whereas organisms that contain the ABC transporter do not contain a gliK gene 
within the cluster (Table 5.1). Therefore, it is possible that the protein encoded by 
gliK may be involved in the efflux of ETP toxins by the MFS transporter and its 
presence adjacent to the MFS transporter (gliA) makes it an interesting choice of 
study. 
 
Table 5.1: Transporter types involved in gliotoxin production and their association 
with gliK (Patron et al., 2007). 
ABC & MFS ABC  MFS + gliK MFS only 
A. flavus L. maculans A. fumigatus A. clavatus 
A. oryzae T. reesei P. lilacinoechinulatum C. globusum 
 A. zeae A. clavatus  
  T. virens  
  A. terreus  
 
Consequently, it was of interest to investigate the role of gliK in A. fumigatus. 
This investigate was initiated by the deletion of the entire gliK gene (872 bp) and 
replacement with the pyrithiamine resistance selection marker, ptrA (2051 bp) 
(Figure 2.5). Thus, the gliK gene was deleted in two different A. fumigatus strains, 
ATCC46645 and ATCC26933, both of which are human clinical isolates. Clinical 
isolates of A. fumigatus have been shown to vary in their ability to produce gliotoxin 
(Kupfahl et al., 2008). ATCC46645 is generally regarded as a non- to low-gliotoxin 
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producing strain, even though it possesses the genes for normal production, and 
ATCC26933 has been shown to produce significant amounts of gliotoxin (Reeves et 
al., 2004a). Therefore, to generate gliK deficient mutants which originate from 
strains with different gliotoxin producing capabilities could elucidate the role of this 
functionally uncharacterised component of the gliotoxin biosynthetic cluster.  
 
5.2 Results 
5.2.1 Generation of constructs for the transformation of gliK 
The constructs used for the creation of the gliK deficient mutants were generated 
from the flanking regions of the gliK gene (Figure 2.5). The flanking regions were 
amplified by PCR to generate the 5’ flanking region, PCR1 (1250 bp), and the 3’ 
flanking region, PCR2 (1211 bp). The primer sets for the flanking region PCR 
amplification contained unique restriction sites to facilitate specific digestion for 
subsequent ligation of the PCR products to the pyrithiamine resistance selection 
marker gene, ptrA; the reverse primer in the 5’ flanking region contained a SpeI 
restriction site, and the forward primer in the 3’ flanking region contained a HindIII 
restriction site. The ptrA gene was digested from the pSK275 plasmid by digestion 
with SpeI and HindIII.  
The PCR reactions were optimised by using the three different reaction buffers 
provided with the Expand Long template PCR system (Roche). The PCR products, 
PCR1 and 2 were gel purified to remove any non-specific products  
(Figure 5.1). 
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Figure 5.1: PCR products of the flanking region of the gliK deletion target, 
amplified using the three different reaction buffers provided. Lane L: Molecular 
weight marker ladder (Roche VII), Lanes 1 – 3: 5’ flanking region PCR1 products 
(1250 bp), Lanes 4 – 6: 3’ flanking region PCR2 products (1211 bp). 
 
The PCR products were digested with the appropriate restriction enzyme, 
specifically, PCR1 was digested with SpeI (1243 bp) and PCR2 was digested with 
HindIII (1208 bp) (Figure 5.2) and the plasmid pSK275 was digested with both SpeI 
and HindIII simultaneously, to yield the ptrA gene which was contained within the 
smaller fragment (2049 bp) (Figure 5.3). The double digestion of the pSK275 
plasmid increased the probability of the subsequent ligations to occur in the preferred 
orientation, as the digested fragment has a different restriction site at each alternative 
end, thereby reducing the number of unintentional ligations. 
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Figure 5.2: Digested PCR products. Lane L: Molecular weight marker ladder, Lane 
1: PCR1 product digested with SpeI (1243 bp), Lane 2: PCR2 product digested with 
HindIII (1208 bp) 
 
 
Figure 5.3: Plasmid pSK275 digested with SpeI and HindIII to release the ptrA 
gene. Lane L: Molecular weight marker ladder (Roche VII), Lane 1: digested 
pSK275; ptrA gene (2049 bp), plasmid backbone (2860 bp), undigested plasmid 
(4909 bp) 
 
The digested PCR products (Figure 5.2) were ligated to ptrA (2049 bp). The SpeI 
digested PCR1 product was ligated to the SpeI digested side of ptrA, named ligation 
1, and the HindIII digested PCR2 product was ligated to the HindIII digested side of 
ptrA, named ligation 2. These ligations were used as the templates for the final PCR 
amplifications where ligation 1 was used to create the 5’ construct (2616 bp) and 
ligation 2 was used to create the 3’ construct (2199 bp) (Figure 5.4) for subsequent 
protoplast transformation. The 5’ and 3’ constructs were gel purified and 
precipitated.  
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Figure 5.4: Final PCR products used for the deletion of gliK (A) Lane L: Molecular 
weight marker ladder (Roche VII), Lanes 1 – 3: Final PCR product of the 5’ 
construct (2616 bp), (B) Lanes 4 – 6: Final PCR product of the 3’ construct (2199 
bp). 
 
5.2.2 Generation of DIG-labelled probes by PCR for transformant 
identification. 
The regions chosen for Southern blot analysis were the 5’ region upstream of 
gliK, the 3’ region downstream of gliK and also a selected region within the gliK 
deletion target itself. The probes were generated by PCR and contained DIG-labelled 
nucleotide bases, as described in Section 2.2.8. The PCR products were gel extracted 
and purified (Figure 5.5). 
 
 
Figure 5.5: DIG labelled probes for use in transformant screening. (A) 5' gliK probe: 
Lane L: Molecular weight marker ladder (Roche VII), Lane 1: 5’ gliK probe PCR 
product (1097 bp), (B) gliK coding region probe: Lane L: Molecular weight marker 
ladder (Roche VII), Lane 1: gliK coding region probe PCR product (1029 bp), (C) 3’ 
gliK probe PCR product (1121 bp). 
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5.2.3 Protoplast transformation of A. fumigatus facilitating the deletion of the 
gliK gene.  
The constructs were transformed into two different strains of A. fumigatus, with 
differing gliotoxin-producing capabilities, namely ATCC46645 and ATCC26933. At 
least 2.5 µg of each of the constructs were used for the individual transformation 
processes. Specifically, 3.4 µg of each construct was used for the ATCC46645 
transformation and 2.5 μg of each construct was used for ATCC26933 
transformation. The transformation process was carried out as described in Section 
2.2.7. For both strains, the transformations were carried out twice. The resulting 
potential transformants are detailed in Table 5.2. The resultant transformants were 
screened on pyrithiamine plates (100 ng/ml) and colonies were screened by Southern 
blot analysis for the absence of gliK.  
 
 
Table 5.2: Colony numbers screened in the deletion of gliK from two different 
strains of Aspergillus fumigatus. 
Strain No of 
Transformation 
Experiments 
Number of 
putative 
Transformant 
colonies 
No. of 
colonies 
screened 
Successful 
Transformants 
ATCC46645 2 65 65 0 
64 48 1 
ATCC26933 2 27 27 0 
31 31 1 
 
 
5.2.3.1 gliK deletion in the ATCC46645 strain 
The results depicted in Figure 5.6 show the analysis of 14 possible transformants. 
The expected signals are detailed in Figure 2.12. Of the putative transformants, six 
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retained the wild type signal (3217 bp), eight exhibited non-specific banding, five 
contained the expected mutant signal (2032 bp) along with other non-specific 
banding and two contained the mutant signal only.   
 
 
Figure 5.6: Identification of A. fumigatus ∆gliK46645 by Southern blot analysis. (A) 
DNA digested with SalI for probing by Southern blot with the 3’gliK probe and (B) 
corresponding Southern blot. Lane L: Molecular weight marker ladder (Roche VIII), 
Lane 1: ATCC46645 (3217 bp), Lanes 2-15: Possible transformants (2032 bp), 
named K1 - 14. Transformants K7 and K8 are marked by * below the respective 
lanes. 
 
The potential deletion mutants, K7 and K8, were single-spored and re-analysed 
using different restriction enzymes, to confirm the single targeted integration (Figure 
2.12). The single-spored colonies of K7 did not result in any definitive bands upon 
the Southern analysis. The single-spored colonies of K8, resulted in three of the 
clones containing only the wild-type signal (6245 bp), and one containing the 
expected band for the targeted integration, and was named K8.1 (1715 bp) (Figure 
5.7). There was also some non-specific binding which occurred using this analysis, 
223 
 
which resulted in bands appearing around 6245 bp, which can be seen in the ladder 
lane. 
 
 
Figure 5.7: Identification of A. fumigatus ∆gliK46645 by Southern blot analysis. (A) 
DNA double digested with BamHI and HindIII for probing by Southern blot with the 
3’gliK probe and (B) corresponding Southern blot. Lane L: Molecular weight marker 
ladder (Roche VIII), Lane 1: ATCC46645, Lanes 2 & 3: single spored sample K7, 
named K7.2 & K7.4, Lanes 4 – 7: single-spored sample K8, named K8.1, K8.3, K8.4 
and K8.5. Transformant K8.1 is marked with * below the respective lane. 
 
To further clarify this result, transformant K8.1 was re-analysed by an alternative 
restriction digestion using PvuII (Figure 2.10). This alternative analysis resulted in a 
clear blot for interpretation. Figure 5.8 depicts the Southern blot where the wild-type 
signal (1926 bp) and the mutant signal (2408 bp) can be easily distinguished. This 
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confirmed that that transformant K8.1 contains a targeted deletion of gliK in the A. 
fumigatus strain ATCC46645. 
 
 
Figure 5.8: Identification of A. fumigatus ∆gliK46645 by Southern blot analysis. (A) 
DNA digested with PvuII for probing with the 5'gliK probe and (B) corresponding 
Southern blot. Lane L: Molecular weight marker dig labelled ladder (Roche VII), 
Lane 1:  ATCC46645 (1926 bp), Lane 2: ∆gliK46645 (2408 bp). 
 
5.2.3.2 gliK deletion in the ATCC26933 strain 
The ATCC26933 transformation was conducted by the same method and with 
the same constructs as for the ATCC46645 transformation. Screening for the mutant 
was conducted by Southern blot analysis, and the ∆gliK46645 strain (K8.1) was used 
as a positive control on the blot (Figure 5.9). Of the eight transformants screened, 
three transformants, K2.1, K2.2 and K2.8, retained the wild-type signal (1926 bp), 
and two (K2.4 and K2.6) retained the wild-type signal, as well as other ectopic 
integration bands. Three transformants gave the correct size band (2408 bp) which 
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indicated a successful targeted transformation, namely K2.3, K2.5 and K2.7.  These 
three transformants also had no other ectopic integration bands, nor the wild-type 
signal. This confirmed that the transformants were targeted deletions of gliK in the 
A. fumigatus strain ATCC26933. 
 
 
Figure 5.9: Identification of A. fumigatus ∆gliK26933 by Southern blot analysis. (A) 
DNA digested with PvuII for probing with 5'gliK for Southern blot analysis and (B) 
corresponding Southern blot. Lane L: Molecular weight marker dig labelled ladder 
(Roche VII), Lane 1: ATCC26933 (1926 bp), Lane 2: ∆gliK46645 (2408 bp), Lanes 3 
– 10: possible transformants of ATCC26933, named K2.1 – K2.8.  Transformants 
K2.3, K2.5 and K2.7 are marked by * below the respective lanes. 
 
To further confirm the positive transformants, the transformants, K2.3, K2.5, and 
K2.7 were probed with the gliK coding region probe (Figure 2.13) and analysed by 
Southern blot to confirm the absence of gliK in the transformant strains (Figure 
5.10).  The wild-type signal is faint but can been seen at 2120 bp in lane 1. The 
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transformant of ∆gliK46645 is located in lane 2 and as expected does not result in any 
signal. Only one of the three possible transformants resulted in the expected signal 
absence, indicative of the deletion of gliK. This is transformant K2.3, located in lane 
3. The other two possible transformants, K2.5 and K2.7 yielded non-specific 
binding. This result confirms that the transformant K2.3 contains targeted deletion of 
gliK.  
 
 
Figure 5.10: Identification of A. fumigatus ∆gliK26933 by Southern blot analysis. (A) 
DNA digested with XbaI for probing with the gliK coding region probe and (B) 
corresponding Southern blot. Lane L: Molecular weight marker dig labelled ladder 
(Roche VII), Lane 1: ATCC26933 (2120 bp), lane 2: ∆gliK46645, Lane 3 – 5: possible 
transformants of ATCC26933, named K2.3, K2.5 and K2.7.  Transformant K2.3 is 
marked by * below the respective lane. 
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5.2.3.3 Complementation of gliK into the ∆gliK46645 strain 
Once it had been established that gliK was successfully deleted from the 
ATCC46645 strain, it was important to reintroduce the gene back into the mutant 
strain, to establish if any of the phenotype deficiencies may be restored. This ensures 
that any differences observed between the wild-type and the mutant can be attributed 
to the product of the gene. The reintroduction of gliK to the ∆gliK46645 strain, was 
carried out as described in Section 2.2.7.2, where the DNA encoding the gliK gene 
was cloned into TOPO and linearized with a unique restriction enzyme (AleI) (Figure 
2.7), creating a linear fragment homologous to the 3’ flanking region of the ptrA 
gene, which if targeted homologous recombination occurs will reintroduce the gliK 
gene into the genome of A. fumigatus ∆gliK46645 after the ptrA gene.  
 
The region encoding gliK was PCR amplified using primers detailed in Table 
2.4, resulting in a 3528 bp fragment (Figure 5.11 (A)). The PCR product ws gel 
extracted and purified. The PCR product was cloned into TOPO vector as described 
in Section 2.2.7.2. To verify the cloning, the modified vector was digested with the 
restriction enzymes XmaI and XhoI which upon successful cloning would result in 
distinct fragments of 4201 bp and 3257 bp (Figure 5.11 (B)). After confirmation of 
successful cloning, the TOPO vector containing the gliK fragment was linearised by 
digestion with the restriction enzyme AleI (Figure 5.11 (C)). 
 
228 
 
 
Figure 5.11: Constructs for complementation of gliK into the genome of ∆gliK46645. 
(A) PCR amplification of the gliK region (3528 bp), (B) Digestion of the TOPO 
vector incorporating the gliK region with XmaI and XhoI to confirm the cloning of 
gliK into TOPO (4201 bp and 3257 bp), (C) linearization of the TOPO vector 
incorporating gliK by digestion with AleI (7458 bp). 
 
The selection marker employed in this transformation was phleomycin 
resistance, available in the plasmid pAN8-1. As this method is dependent on a 
unique restriction site in the TOPO vector containing the gliK gene, it was 
impossible to also incorporate the selection marker into the TOPO vector, along with 
the gliK gene (Figure 5.12). Therefore, the pAN8-1 plasmid was co-transformed in 
circular form with the linear TOPO vector containing gliK.  
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Figure 5.12: Schematic of the transformation for the complementation of gliK into 
the A. fumigatus ∆gliK46645 genome. The red shape depicts the 5’ flanking region of 
gliK. The Green shape depicts the gliK gene. The purple shape depicts the 3’ 
flanking region. The blue shape depicts the pyrithamine resistance cassette excised 
from the plasmid pSK275. The black shape depicts the Topo cloning vector. 
 
Screening for the complemented gliK was carried out by Southern blot analysis 
following selection on phleomycin as described previously, and the results shown in 
Figure 5.13. Transformants KC5 and KC8, showed no integration of the gliK, 
remaining as gliK mutant strains (2408 bp). Whereas transformants KC3, KC4 and 
KC6, showed a targeted integration of the gliK gene (1625 bp) but also had an 
ectopic band, close to the size of the wild-type strain (1926 bp), KC2 had the same 
pattern as these transformants, with an additional lower band. Transformants KC1, 
KC7 and KC9, illustrate perfect examples of the gliKc gene integration in a targeted 
fashion into the A. fumigatus ∆gliK46645 strain (2408 bp and 1625 bp). 
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Figure 5.13: Identification of A. fumigatus gliKc by Southern blot analysis. (A) DNA 
digested with PvuII for probing with 5' gliK for Southern blot analysis and (B) 
corresponding Southern blot. Lane L: Molecular weight marker ladder (Roche VII), 
Lane 1: ATCC26933 (1926 bp), Lane 2: ∆gliK46645(2408 bp), Lanes 3 – 11: possible 
transformants encoding the complemented gliKc (1625 bp and 2408 bp), named KC1 
– KC9. Transformants KC1, KC7 and KC9 are marked by * below their respective 
lanes. 
 
The Southern blot was repeated with the KC1, KC7 and KC9 transformants to 
clarify the result observed in Figure 5.13. The repeat Southern analysis confirmed 
that the three transformants each had the expected banding pattern (fragment sizes) 
that indicates the reintroduction of the gliK gene into the ∆gliK strain (Figure 5.14), 
to yield A. fumigatus gliKc. 
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Figure 5.14: Identification of A. fumigatus gliKc by Southern blot analysis. (A) DNA 
digested with PvuII for probing with 5' gliK for Southern blot analysis and (B) 
corresponding Southern blot. Lane L: Molecular weight marker dig labelled ladder 
(Roche VII), Lane 1: ATCC26933 (1926 bp), Lane 2: ∆gliK46645 (2408 bp), Lanes 3 
– 5: transformants encoding the complemented gliKc (1625 bp & 2408 bp), named 
KC1, KC7 and KC9. 
 
 To verify the complemented strains, the transformants were screened with 
another probe, namely the 3’ gliK probe (Figure 2.12). This analyses integrations 
which were positive for complementation when probed with the 5’ gliK probe, as 
those not confirmed by the 3’ gliK probe could be a false positive, as the full 
construct would not be integrated in a targeted manner. The transformants were 
probed with the 3’gliK probe and analysed by Southern blot (Figure 5.15), where the 
wild-type band had an expected fragment size of 3212 bp, ∆gliK had a fragement sze 
of 2032 bp and the complemented strain had a two fragment sizes of 2032 bp and 
6038 bp. The transformants that were previously determined by the 5’ gliK Southern 
analysis to be positive for the gliKc integration, KC1, KC7 and KC9, all had different 
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banding patterns in the 3’ gliK Southern blot analysis. Transformants KC7 and KC9, 
had strong additional bands visible with the 3’ gliK probe, whereas KC1 did not. 
This transformant, KC1, was taken to be the best representation of the 
complementation transformation, as it had a perfect representation of the 
complementation in the 5’ analysis and no additional bands in the 3’ analysis. 
 
 
Figure 5.15: Identification of A. fumigatus gliKc by Southern blot analysis. (A) DNA 
digested with SalI for probing with 3' gliK for Southern blot analysis and (B) 
corresponding Southern blot. Lane L: Molecular weight marker ladder (Roche VII), 
Lane 1: ATCC46645 (3212 bp), Lane 2: ∆gliK46645 (2032 bp), Lanes 3 – 11: possible 
transformants encoding the complemented gliKc (2032 bp & 6038 bp), named KC1 – 
KC9. Transformants KC1, KC7 and KC9 are marked by * below the respective 
lanes. 
 
To further verify the reintroduction of the gliK gene into the mutant, the wild-
type, ∆gliK46645 and gliKc, were probed for a region of the gliK gene that was deleted 
(Figure 5.16). All the strains had a background signal at a high molecular size, of 
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unknown origin. The wild-type and the gliKc strains contained the expected gliK 
signal at 2120 bp, whereas the mutant contained no evidence of gliK presence, 
thereby confirming the reintroduction of the gliK gene into the genome of A. 
fumigatus ∆gliK46645 and also the absence of the gliK gene in the mutant strain.  
 
 
Figure 5.16: Identification of A. fumigatus gliKc by Southern blot analysis. (A) DNA 
digested with XbaI for probing with gliK coding probe for Southern blot analysis & 
(B) corresponding Southern blot. Lane L: Molecular weight marker dig labelled 
ladder (Roche VII), Lane 1: ATCC46645 (2120 bp), Lane 2: ∆gliK46645, Lane 3: 
gliKc (2120 bp). 
 
5.2.4 Real time PCR expression levels of gliK 
Gene expression can be quantified relative to a constitutively expressed gene, 
usually a housekeeping gene. In this project, the gene expression quantification is a 
relative quantification compared to the constitutively expressed Calmodulin gene 
(calm) (AFUA_4G10050) (Burns et al., 2005). This gene is expressed at the same 
level regardless of time-point, media, or additives. The expression of calmodulin is 
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adjusted to 1 and the expression of the gene of interest is expressed as a ratio 
compared to calmodulin expression. 
Firstly, the expression of gliK was measured in A. fumigatus ATCC46645 in 
different liquid media types, namely, Sabouraud media, Minimal media (MM) and 
Aspergillus Minimal media (AMM). The cultures were grown for 24, 48 and 72 hr, 
respectively (Figure 5.17). 
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Figure 5.17: qRT-PCR analysis of gliK expression at 24, 48 and 72 hr in A. 
fumigatus ATCC46645 cultured in various media at 37 oC.  
 
Expression of gliK never reached over a ratio of 1 indicating that it is expressed 
at a much lower level than calmodulin. The results show that gliK expression is 
highest in AMM media at 24 hr. Interestingly, gliK expression is absent in the 
Sabouraud media at all time points. The expression of gliK in MM media is 
approximately the same at 24 and 48 hr, whereas, the expression level drops 
dramatically at 72 hr (P < 0.1). In AMM cultures, the highest expression of gliK was 
at 24 hr which reduced considerably at 48 hr (P < 0.01) and is barely detectable at 72 
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hr (P < 0.001). This indicates that gliK expression is highest in minimal media and at 
early time-points during culture.   
Secondly, the deletion of gliK from the genome in the ∆gliK46645 strain should 
result in absence of gliK expression. As culturing in AMM gave the greatest 
expression of gliK, this media was chosen to confirm the absence of gliK expression 
in A. fumigatus ∆gliK46645 (Figure 5.18). 
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Figure 5.18: qRT-PCR analysis of gliK expression in A. fumigatus ATCC46645 and 
∆gliK46645, respectively, in AMM at selected time points at 37 oC.  
 
gliK was expressed in A. fumigatus ATCC46645 at 24 and 48 hr time points, 
whereas the ∆gliK46645 strain did not express gliK, thereby confirming the deletion of 
gliK from the genome. 
 
As gliK is located adjacent to the transporter gene, gliA, the integrity and 
expression of gliA (AFUA_6G09710) was verified by RT-PCR in A. fumigatus 
ATCC46645, ∆gliK and gliKc to determine if the deletion of gliK and subsequent 
reinsertion of gliK disrupted the expression of this adjacent gene. RT-PCR was 
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conducted using the house-keeping gene Calmodulin (calm) (Burns et al., 2005) as a 
control to verify that the samples used were gDNA free as gliK has a predicted intron 
of 50 bp, and such a small size difference is difficult to visualise by DNA 
electrophoresis. Also, gliA has no predicted introns, resulting in the same 
amplification size of cDNA or gDNA. Therefore, a gDNA control for gliK and gliA 
would not serve any purpose in this study. The genomic DNA amplification of calm 
results in a band of 617 bp, whereas the cDNA amplification of calm results in a 
band of 348 bp, due to the removal of the intron during cDNA synthesis. The 
amplification of gliK cDNA results in a band of 370 bp, and the amplification of gliA 
results in a band of 155 bp (Figure 5.19). 
 
 
Figure 5.19: RT-PCR analysis of gliK and gliA expression in A. fumigatus 
ATCC46645, ∆gliK46645and gliKc respectively.  
 
The expected bands were observed for all samples. gliK expression was observed 
in the wild-type and complimented strain, with a lack of expression in the mutant 
strain. gliA expression was observed in all strains, verifying that the deletion and 
reinsertion of gliK did not disrupt the expression of gliA. 
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As gliK is a component of the gliotoxin biosynthetic cluster, located adjacent to 
the transporter gene, gliA, the application of exogenous gliotoxin may have an 
impact on the expression of gliK. Liquid cultures of A. fumigatus ATCC46645 in 
AMM were spiked with gliotoxin (5 μg/ml final) at 21 hr and the cultures harvested 
at 24 hr (Schrettl et al., 2010). The expression of gliK was determined in A. 
fumigatus ATCC46645 with and without gliotoxin presence (Figure 5.20). 
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Figure 5.20: qRT-PCR analysis of gliK expression in A. fumigatus ATCC46645 in 
AMM at 24 hr at 37 oC, with and without exogenous gliotoxin spiked into the media. 
Column 1: gliK expression in A. fumigatus ATCC46645 strain; Column 2: gliK 
expression in A. fumigatus ATCC46645 strain spiked with 5 μg/ml gliotoxin. 
 
The expression of gliK in A. fumigatus ATCC46645 did not significantly 
increase in the presence of gliotoxin. This may indicate that gliK expression is not 
dramatically controlled by the presence of gliotoxin. As gliotoxin is produced by the 
fungus itself, the concentration used may not have been sufficient to induce gliK 
expression.  
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AMM liquid cultures of A. fumigatus ATCC46645 were spiked with hydrogen 
peroxide (1 mM) at 21 hr and the culture was harvested at 24 hr. The expression of 
gliK was detected (Figure 5.21), whereby exposure of A. fumigatus to hydrogen 
peroxide caused an increase in gliK expression from a relative ratio of 0.1665 to 
3.193 (P = 0.0101). 
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Figure 5.21: qRT-PCR analysis of gliK expression in A. fumigatus ATCC46645 in 
AMM at 24 hr at 37 oC, with and without hydrogen peroxide spiked into the media. 
Column 1: gliK expression in A. fumigatus ATCC46645 strain; Column 2: gliK 
expression in A. fumigatus ATCC46645 strain spiked with 1 mM hydrogen peroxide 
(final concentration). 
 
5.2.5 Plate assays  
5.2.5.1 Gliotoxin Plate assays 
Schrettl et al. (2010) have recently shown that A. fumigatus is capable of self-
protection against gliotoxin, and that deletion of gliT from the gliotoxin biosynthetic 
cluster can render the mutant strain sensitive to exogenous gliotoxin. In plate assays 
where A. fumigatus wild-type and ∆gliK strains were grown on agar containing 
gliotoxin (0 – 20 μg/ml), both ∆gliK mutants were significantly more sensitive to 
gliotoxin (p < 0.001), and the reduced growth rate was seen at every time point of 
the assay, where the greatest difference in growth was seen at 72 hr (Figure 5.22 and 
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Figure 5.23). After 72 hr growth on AMM plates, there is a significant decrease in 
the radial growth of A. fumigatus ∆gliK46645 strain compared to the wild-type strain 
when gliotoxin was present in the media (Figure 5.22). The difference is highly 
significant when the gliotoxin concentration is increased to 10 and 20 µg/ml, 
respectively (p < 0.001). A. fumigatus ATCC46645 also exhibited a decrease in 
radial growth (~20 %) at the highest gliotoxin concentration used (20 μg/ml), 
compared to the media without gliotoxin, indicating that A. fumigatus wild-type is 
sensitive to high concentrations of gliotoxin, under the experimental conditions used. 
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Figure 5.22: Effect of gliotoxin on the growth of A. fumigatus ATCC46645 and 
∆gliK46645, respectively.  Significant growth inhibition of A. fumigatus ∆gliK46645 
is evident at 72 hr (n = 3). 
 
The decrease in radial growth due to the presence of exogenous gliotoxin was 
also observed in A. fumigatus ∆gliK26933 mutant strain at all gliotoxin concentrations 
tested (Figure 5.23). This decreased radial growth was highly significant at 10 and 
20 μg/ml gliotoxin, respectively (p < 0.001). Similar to A. fumigatus ATCC46645, 
ATCC26933 showed a decrease in growth ability in gliotoxin (20 μg/ml), where 
240 
 
there was a reduction in radial growth of 21 % compared to the media without 
gliotoxin. 
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Figure 5.23: Effect of gliotoxin on the growth of A. fumigatus ATCC26933 and 
∆gliK26933, respectively.  Significant growth inhibition of A. fumigatus ∆gliK26933 is 
evident at 72 hr (n = 4). 
  
5.2.5.2 Hydrogen peroxide susceptibility assays 
After 72 hr growth on AMM plates, there was a significant difference in the 
radial growth of the A. fumigatus ∆gliK46645 strain compared to the wild-type strain 
when hydrogen peroxide (2 mM) was present (p < 0.01) (Figure 5.24). This 
concentration of hydrogen peroxide rendered the mutant strain incapable of any 
growth. Neither strain was capable of growth at 5 mM hydrogen peroxide. At the 
lower hydrogen peroxide concentration (1 mM), both strains were capable of 
equivalent radial growth. 
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Figure 5.24: Effect of hydrogen peroxide on the growth of A. fumigatus 
ATCC46645 and ∆gliK46645, respectively.  Significant growth inhibition of A. 
fumigatus ∆gliK46645 is evident at 72 hr (n = 3). 
 
A. fumigatus ∆gliK26933 showed the same pattern of growth on hydrogen peroxide 
plate assays, as the ∆gliK46645 strain (Figure 5.25). There was significantly different 
radial growth at 2 mM hydrogen peroxide between the  A. fumigatus ATCC26933 
and ∆gliK26933 strains (p < 0.01), as the mutant strain was incapable of any growth at 
this concentration. This inability of the mutant strain to grow was also observed at 3 
mM hydrogen peroxide, but this was not found to be significant as the wild-type 
growth was also severely diminished.  
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Figure 5.25: Effect of hydrogen peroxide on the growth of A. fumigatus 
ATCC26933 and ∆gliK26933, respectively.  Significant growth inhibition of A. 
fumigatus ∆gliK26933 is evident at 72 hr (n = 4). 
 
5.2.5.3 Voriconazole Plate assays 
After 72 hr on AMM plates in the presence of voriconazole (0 – 0.25 μg/ml), 
there was no significant growth difference between the A. fumigatus ATCC46645 
and ∆gliK46645 strains (Figure 5.26). Neither strain was capable of growth on the 0.25 
µg/ml concentration of voriconazole. 
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Figure 5.26: Effect of voriconazole on the growth rate of A. fumigatus ATCC46645 
and ∆gliK46645, respectively.  No significant growth inhibition of A. fumigatus 
∆gliK46645 is evident (n = 3). 
 
After 72 hr growth on AMM plates, there was a marginal decrease in radial 
growth of the ∆gliK26933 strain compared to that of the ATCC26933 observed on the 
higher concentrations of voriconazole (0.15 μg/ml and 0.25 μg/ml), but this 
difference in radial growth was not found to be significant (Figure 5.27). 
Interestingly, at the lower concentration (0.05 μg/ml), the radial growth of the 
mutant strain was greater than that of the wild-type strain. Again, this difference was 
not significant. 
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Figure 5.27: Effect of voriconazole on the growth of A. fumigatus ATCC26933 and 
∆gliK26933, respectively.  No significant growth inhibition of A. fumigatus ∆gliK26933 
is evident (n = 4). 
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5.2.6 RP-HPLC analysis of gliotoxin production 
As gliotoxin is a secreted from A. fumigatus, supernatants were collected from A. 
fumigatus wild-type and ∆gliK liquid cultures and subjected to organic extraction as 
described in Section 2.2.10. Organic extracts were fractionated by Reverse Phase - 
High Performance Liquid Chromatography (RP-HPLC) to determine whether the A. 
fumigatus ∆gliK strains could produce gliotoxin. Initial results revealed that A. 
fumigatus ATCC46645 did not produce significant amounts of gliotoxin and 
therefore it was difficult to determine if the removal of gliK had an impact on 
gliotoxin production (Figure 5.28).  The gliotoxin standard was detected at a 
retention time of 14.41 min (A254nm). A. fumigatus ATCC46645 produced a small 
peak at a retention time 14.37 min, which can be identified as gliotoxin. The analysis 
of the A. fumigatus ∆gliK46645 showed that this strain did not produce a metabolite 
that corresponded to gliotoxin. 
As the A. fumigatus ATCC46645 strain produces gliotoxin in such small 
quantities, the A. fumigatus ATCC26933 strain was employed, as this was a known 
producer of gliotoxin. RP-HPLC analysis of the A. fumigatus ATCC26933 strain 
showed clear gliotoxin production, resulting in a peak observed at a retention time of 
15.216 min, comparable to the standard gliotoxin peak (15.243 min) (Figure 5.29). 
The RP-HPLC gradient conditions were altered, which resulted in the elevated 
retention time of gliotoxin, compared to the previous analysis (15.25 min compared 
to 14.4 min). The mutant, ∆gliK26933 produced a metabolite corresponding to 
gliotoxin at the expected retention time, 15.267 min but at a very low level. A new 
metabolite with a retention time of 12.975 min was evident in cultures from A. 
fumigatus ∆gliK26933.  
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Figure 5.28: HPLC chromatograms detailing the fractionation of metabolites from 
A. fumigatus liquid cultures for the identification of gliotoxin production. Detection 
at 254nm. (A) standard gliotoxin with a retention time of 14.4 min, (B) ATCC46645 
with a gliotoxin peak at the retention time of 14.376 min, and (C) ∆gliK46645 lacking 
in a corresponding gliotoxin peak. Note the increased sensitivity of detection for C, 
compared to B. 
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Figure 5.29: HPLC chromatograms detailing the fractionation of metabolites from 
A. fumigatus liquid cultures for the identification of gliotoxin production. Detection 
at 254nm. (A) standard gliotoxin with a retention time of 15.2 min, (B) ATCC26933 
with a 15.2 min retention time peak, and (C) ∆gliK26933, illustrating virtual absence 
of gliotoxin secretion at 15.2 min. 
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To confirm the results observed for altered gliotoxin production, organic extracts 
were treated with sodium borohydride to generate the dithiol form of gliotoxin 
(reduced gliotoxin; Figure 5.1). Sodium borohydride reduces the disulphide bridge to 
yield the dithiol form. Davis et al. (2010) showed that this reduction decreases the 
retention time of gliotoxin by approximately 1 min.  
For the ATCC46645 analysis, the standard gliotoxin produced a peak at a 
retention time of 14.4 min. Once reduced, this peak shifted to a retention time of 
13.38 min. It was unclear in A. fumigatus ATCC46645 if the peak barely detectable 
at 14.4 min retention time was gliotoxin (Figure 5.30). As the peak was so small, the 
reduction effect is unclear with very little changing in the reduced sample. The 
mutant strain, A. fumigatus ∆gliK46645, did not produce a peak at 14.4 min, and 
therefore chemical reduction did not lead to any conclusive results to determine the 
effect of the gliK deletion. 
For the analysis of A. fumigatus ATCC26933, the standard gliotoxin was 
detected at the retention time of 15.2 min. Once reduced, gliotoxin had a shorter 
retention time of 14.1 min. A. fumigatus ATCC26933 showed a corresponding peak 
to the gliotoxin standard at the expected retention time of 15.2 min. After reduction, 
the dithiol form of gliotoxin was detectable at the shorter retention time of 14.1 min. 
Thereby, confirming the production of gliotoxin in the ATCC26933 strain. 
Additionally, the peak observed at 15.0 min was also reduced. The mutant strain, 
∆gliK26933, exhibited a minor peak at the 15.2 min retention time which when 
reduced, was unclear if the reduction had any effect on this metabolite. The peak 
observed at 15.0 min was clearly reduced. In addition, the ∆gliK26933 strain produces 
a larger peak, with a retention time of 12.9 min, than that observed in the wild-type 
strain (Figure 5.31). 
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Figure 5.30: HPLC chromatograms of the fractionation of metabolites from A. fumigatus liquid cultures for the identification of gliotoxin 
production by reduction with sodium borohydride. (A & B) Unreduced and reduced Standard gliotoxin, with retention time peaks at 14.4 min 
and 13.38 min, respectively. (C & D) Unreduced and reduced ATCC46645, where the peak at the retention time 14.4 min did not alter by 
reduction, (E & F) Unreduced and reduced ∆gliK46645, where the peak at retention time 14.4 min did not alter by reduction. 
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Figure 5.31: HPLC chromatographs of the fractionation of metabolites from A. fumigatus liquid cultures for the identification of gliotoxin 
production by reduction with sodium borohydride. (A & B) Unreduced and reduced Standard gliotoxin, with retention time peaks at 15.2 min 
and 14.1 min, respectively. (C & D) Unreduced and reduced ATCC26933, where the corresponding gliotoxin peak at the retention time 15.2 min 
was reduced to a lower retention time of 14.1 min, (E & F) Unreduced and reduced ∆gliK26933 where the peak at retention time 15.02 min was 
reduced. 
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5.2.7 Complementation analysis 
The reinsertion of the gliK gene back into the A. fumigatus ∆gliK46645 can 
potentially recover the strain from the deficiencies of the mutation. qRT-PCR 
analysis confirmed that the expression of gliK had been restored in the 
complemented strain (Figure 5.32). The expression of gliK in the complemented 
strain was higher than the original wild type which may indicate that gliK may have 
reinserted into sites other than the targeted region. Although previous plate assays 
involving gliK had shown that the mutant strains are sensitive to gliotoxin (Section 
5.2.5.1), the complemented strain did not return to full growth capabilities in the 
presence of gliotoxin (Figure 5.33). The complemented and mutant strains retained 
the same sensitivity to gliotoxin compared to the wild-type, and there was no 
significant difference in growth between the mutant and the complemented strains at 
any of the gliotoxin concentrations. Therefore, the reinsertion of the gliK gene has 
not recovered the wild-type phenotype, indicating that the inserted gliK is not 
functioning as in the original. 
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Figure 5.32: qRT-PCR analysis of gliK expression in A. fumigatus ATCC46645, 
∆gliK46645, and gliKc in AMM at 24 hr at 37 oC. 
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Figure 5.33: Effect of gliotoxin on the growth of A. fumigatus ATCC46645, 
∆gliK46645, and gliKc respectively (n = 2). 
 
gliKc was also cultured in liquid media and the supernatant was examined for 
gliotoxin production by RP-HPLC. As the background strain is ATCC46645, a small 
producer of gliotoxin, it was not expected that the gliKc would produce a vast amount 
of gliotoxin. Nevertheless, the organic extract was subjected to reduction by sodium 
borohydride, as previously described. The RP-HPLC analysis of the gliKc cultures 
showed that that the peak at retention time of 14.4 min, was the same as the wild-
type potential gliotoxin (Figure 5.34). The gliKc analysis showed that the 
complemented strain produces a peak at a retention time of 13.9 min, which was not 
observed in the A. fumigatus ATCC46645 or ∆gliK46645 strains.  
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Figure 5.34: HPLC chromatograms of the fractionation of metabolites from A. fumigatus liquid cultures for the identification of gliotoxin 
production by reduction with sodium borohydride. (A & B) Unreduced and reduced ATCC46645, where the corresponding peak to the gliotoxin 
standard at the retention time 14.4 min was not reduced, (C & D) unreduced and reduced gliKc where there was no corresponding gliotoxin peak 
at retention time 14.4 min. The peak at 13.9 min was partially reduced.The peak which corresponded to the gliotoxin peak is highlighted by a red 
arrow. 
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5.2.8 Gliotoxin uptake assay 
Gliotoxin has been shown to have an impact on the expression of genes within 
the gliotoxin biosynthetic cluster, whereby the addition of gliotoxin to A. fumigatus 
∆gliP strain restored the expression of all the other genes within the gliotoxin 
biosynthetic cluster (Cramer et al., 2006a). Also, the transporter genes contained in 
the sirodesmin biosynthetic cluster of L. maculans can impart self-protection against 
the toxin (Gardiner et al., 2005b), indicating that the presence of the toxin can induce 
expression of certain genes within the cluster. Schrettl et al. (2010) have described 
that A. fumigatus ∆gliT is unable to sustain growth in the presence of gliotoxin 
confirming that gliT protects against exogenous gliotoxin and therefore represents a 
mechanism within the fungus to self-protect against gliotoxin presence. Similarly, 
the plate assays previously described in this chapter show that the ∆gliK strains, 
regardless of background, are significantly more sensitive to the presence of 
gliotoxin, than wild-type, and therefore gliK may be involved in protection against 
gliotoxin toxicity in A. fumigatus. As gliotoxin clearly affects A. fumigatus, it was 
important to establish the baseline production of gliotoxin and also to investigate if 
gliK might have a role in gliotoxin uptake or release (efflux).  
The RP-HPLC analysis showed that A. fumigatus ATCC46645 is capable of 
producing gliotoxin in very small quantities (Section 5.2.6). To further investigate 
the production of gliotoxin by this strain, the gliotoxin production was examined by 
analysing the gliotoxin production by RP-HPLC and taking into account the quantity 
of the mycelia mass produced, as detailed in Section 2.2.14. It was confirmed that the 
ATCC46645 strain produced a residual amount of gliotoxin, (mean ± SEM) 0.3 ± 
0.13 ng/mg mycelia (Figure 5.35). A. fumigatus ∆gliK46645 did not produce gliotoxin 
to the same extent as the wild-type strain, but it did produce a residual amount of 
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gliotoxin, 0.032 ± 0.02 ng/mg mycelia (Figure 5.35) (P = 0.001). This indicates that 
gliK may not be involved directly in the biosynthesis in gliotoxin, but that its 
deficiency is detrimental to the export, secretion or uptake of gliotoxin.  
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Figure 5.35: Gliotoxin production in AMM liquid cultures from strains 
ATCC46645 and ∆gliK46645.  
 
Given the low extent of secretion of significant amounts of gliotoxin by A. 
fumigatus ATCC46645 and ∆gliK46645, it was decided to evaluate the uptake of 
relatively high concentrations of exogenously added gliotoxin to both wild-type and 
∆gliK46645strains in liquid culture (5 µg/ml for 0 – 45 min). The extracts were then 
analysed by RP-HPLC to determine the amount of gliotoxin still remaining in the 
supernatant and gliotoxin uptake was related to mycelial mass. It was observed that 
significantly less gliotoxin was present in culture supernatants of A. fumigatus 
∆gliK46645 compared to ATCC46645 after gliotoxin exposure, at 15 min (P = 0.0102), 
and 30 min (P = 0.0045) suggesting that gliotoxin is either (i) removed more rapidly 
from the supernatant or (ii) is effluxing more slowly from the mycelia of A. 
fumigatus ∆gliK46645 (Figure 5.36). After 45 min post-spiking of gliotoxin into the 
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cultures, the level of gliotoxin increases in the ∆gliK cultures, possibly because 
alternative efflux mechanisms had been activated.  
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Figure 5.36: The amount of gliotoxin remaining in culture supernatants at time point 
intervals after exposure of A. fumigatus ATCC46645 and ∆gliK46645 to gliotoxin (5 
µg/ml) over a 0 – 45 min duration. 
 
The uptake rate of gliotoxin from the supernatant by the mycelia of the wild-type 
and mutant strain was calculated at 15 min intervals (Figure 5.37) where the first 15 
min after gliotoxin application, A. fumigatus ∆gliK46645 exhibited a gliotoxin uptake 
rate of 31.443 pg/mg mycelia/min, over three times that of A. fumigatus ATCC46645 
(9.337 pg/mg mycelia/min) (P = 0.0039). The wild-type strain had a relatively 
constant level of gliotoxin over 45 min in the supernatant, indicating that the wild-
type strain displayed a balance between uptake and efflux of gliotoxin. In A. 
fumigatus ∆gliK46645, gliotoxin levels began to stabilise in the supernatant after the 
initial uptake in the first 15 min of exposure. Thus, it appears that deletion of gliK 
has disrupted a gliotoxin efflux mechanism in A. fumigatus and points to a role for 
gliK in gliotoxin secretion. If gliK was a component of a gliotoxin uptake 
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mechanism, then one would have expected constant, or elevated, gliotoxin levels in 
A. fumigatus ∆gliK46645 spiked culture supernatants. 
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Figure 5.37: Gliotoxin uptake rate by A. fumigatus ATCC46645 and ∆gliK46645 in 
liquid cultures at selected time points. 
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5.3 Discussion 
Many fungi produce metabolites which are toxic to the producer, which leads to 
the question of how the fungus protects itself from the deleterious effects of its own 
metabolites. These species, including A. fumigatus, have incorporated efficient 
resistance mechanisms for protection against the specific metabolite. Efflux 
pathways exhibit such functions; transporting the toxin in/out of the cell, inhibiting 
the toxic effect of the metabolite or sensing of internal toxin levels (Andrade et al., 
2000; Del Sorbo et al., 2000; Gardiner et al., 2005b). The gliotoxin biosynthetic 
cluster contains 13 genes and only certain genes have been characterised, mainly 
those involved in the formation of, or self-protection against, gliotoxin (Kupfahl et 
al., 2006; Bok et al., 2006a; Cramer et al., 2006a; Scharf et al., 2010) or those that 
were identified by homology to genes in other ETP producing species (Gardiner and 
Howlett, 2005a; Gardiner et al., 2005b). Although orthologs to gliK exist in other 
fungi, bioinformatic analysis of gliK in terms of comparative function prediction or 
conserved domain analysis has provided no clue as to its function (Patron et al., 
2007). Recently, certain genes in the gliotoxin biosynthetic cluster have been 
associated with protection against gliotoxin, such as gliT, the thioredoxin reductase, 
which has been shown to play a self-protecting role against gliotoxin as disruption of 
this gene renders the fungus completely sensitive to exogenous gliotoxin in plate 
assays (5 µg/ml)(Schrettl et al., 2010) and in inhibition assays (3 mM) (Scharf et al., 
2010). The gliotoxin transporter, gliA, was shown to confer resistance to gliotoxin in 
the L. maculans ∆sirA (Gardiner et al., 2005b). Interestingly, GliA was unable to 
extend this resistance to sirodesmin, indicating that the transport mechanisms of the 
gliotoxin MFS transporter, GliA, and the sirodesmin ABC transporter, SirA, are 
specific for the molecules that they recognise. Here, the deletion of gliK in A. 
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fumigatus ATCC46645 and ATCC26933 resulted in strains that became highly 
sensitive to exogenous gliotoxin and hydrogen peroxide, but were unaffected by 
exposure to the anti-fungal voriconazole. Hence, gliK, which appears to facilitate 
gliotoxin efflux, may, directly or indirectly, play a role in self-protection against the 
toxicity of gliotoxin. Furthermore, gliotoxin production was severely diminished in 
A. fumigatus ∆gliK46645 and in ∆gliK26933, in particular. Finally, it was demonstrated 
that exogenous gliotoxin entered the mycelia at a significantly faster rate in A. 
fumigatus ∆gliK46645 (31.443 pg/mg mycelia/ min) than ATCC46645 (9.337 pg/mg 
mycelia/min) (P = 0.0039). Combined, these observations strongly suggest that gliK 
is a component of a gliotoxin efflux mechanism in A. fumigatus, since involvement 
in uptake would have results in exogenous gliotoxin levels in ∆gliK greater than 
those of wild-type. 
 
As described in Chapter 3, gene deletion carried out by the bi-partite 
transformation process increases the rate of targeted integration whilst reducing the 
number of ectopic and partial integrations (Nielsen et al., 2006). Complementation of 
the gene deletion is carried out by using a linearised plasmid containing the gene of 
interest for homologous recombination, with a separate selection marker which is co-
transformed. To investigate if the restoration of the gliK gene into the ∆gliK46645 
strain would return the wild–type phenotype of self-protection against gliotoxin, a 
complemented strain was generated. Although the Southern blot analysis confirmed 
the reinsertion of the gliK, qRT-PCR and RT-PCR showed that the gene was 
expressed and RT-PCR of the adjacent gene, gliA, verified that the deletion and 
reinsertion of gliK did not disrupt the expression of the transporter gene, subsequent 
phenotypic analysis (gliotoxin sensitivity) revealed that the gliK complementation 
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did not resolve the mutant phenotype. Although this indicates that the gliK 
complementation process did not fully restore the function of the gene, the reason 
remains unclear. However a number of possibilities arise: (i) The selection marker 
for complementation (phleomycin) was co-transformed with intact gliK into A. 
fumigatus ∆gliK46645, possibly resulting in insertion into the genome at random 
locations. This could have had detrimental effects on A. fumigatus in the presence of 
gliotoxin, as the location(s) of the insertion cannot be determined and this additional 
disruption may have caused pleiotropic effects that went undetected; (ii) As the 
reintroduction of gliK was confirmed to occur after the ptrA selection marker used in 
the original mutation, this shift in location may have hindered either gene integrity, 
transcription or control by the cluster transcription factor, gliZ (Bok et al., 2006). In 
the expression analysis by real time PCR, the expression of gliK in the gliKc strain 
was higher than the wild-type which may indicate that gliK reinserted more than 
once into the genome during transformation. Maiya et al (2006) have also concluded 
that the increased transcription observed in their complementation of ftmA, a gene 
involved in the biosynthesis of fumitremorgin, resulted from the high copy number 
due to ectopic integration and/or high transcription activity at the site of integration. 
 
The maximum yield of metabolite is highly influenced by the growth conditions, 
especially the culture media (Kosalec et al., 2005b). Consequently, assessment of 
gliK expression, under different culture conditions, was undertaken to establish the 
best conditions for assessment of the relationship between gliK expression and 
gliotoxin production. gliK expression was found to be highest at 24 hr in AMM and 
this time point and media was used in all subsequent gliK expression analysis, RP-
HPLC and gliotoxin secretion studies. gliK expression was also evident in MM at 24 
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and 48 hr, though it had decreased by 72 hr, indicating that gliK is normally 
expressed early on in cultures and may not be required in the latter stages of fungal 
culture. gliK expression was undetectable in Sabouraud media at any time point, and 
in A. fumigatus ∆gliK46645, thereby confirming absence of gene presence in the latter. 
 
It now appears that three systems may operate in A. fumigatus to either protect 
against gliotoxin or mediate efflux from the cell. Although a statistically significant 
difference in growth rates was observed between A. fumigatus wild-type(s) and 
respective ∆gliK strains, addition of gliotoxin did not completely suppress growth of 
∆gliK46645 and ∆gliK26933, even at high concentrations of gliotoxin (20 µg/ml). This 
indicates that the protective role of GliT (Schrettl et al., 2010) is capable of 
detoxifying gliotoxin, possibly in conjunction with GliA functionality as efflux pump 
(Gardiner et al., 2005b) under these conditions which, in turn, may part-compensate 
for the loss of GliK, provided that the amount of gliotoxin does not exceed the levels 
with which the cell can cope.  
 
Although exogenous gliotoxin (5 µg/ml) had no effect on gliK expression in A. 
fumigatus ATCC46645, we found that 3 hr exposure to hydrogen peroxide induced a 
nineteen fold increase in gliK expression (P = 0.0101). Moreover, exposure of A. 
fumigatus wild-type and ∆gliK26933/∆gliK46645 to hydrogen peroxide also resulted in a 
differential growth response. Here, increased mutant sensitivity to hydrogen peroxide 
(2 mM) was observed whereby the mutant strains were incapable of any growth, 
unlike both wild-type strains which exhibited approximately 50 % growth. If 
gliotoxin efflux was impaired in A. fumigatus ∆gliK, then these observations suggest 
that elevated levels of intracellular gliotoxin may potentiate hydrogen peroxide-
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mediated oxidative stress. Moreover, although not demonstrated herein, they imply 
that gliotoxin efflux may result from hydrogen peroxide exposure, possibly as a 
mechanism to control the intracellular redox balance. Indeed Schrettl et al. (2010) 
have noted the gliotoxin may play a role in regulating the redox status of A. 
fumigatus.  
 
Conversely, no significant difference between the growth rate of wild-type and 
their respective mutant strains in the presence of the anti-fungal, voriconazole, was 
observed indicating that gliK does not play a role in antifungal resistance. Indeed, in 
the transcriptional profiling of certain genes during voriconazole exposure, gliT 
expression was not altered by the presence of voriconazole (da Silva Ferreira et al., 
2006b). Although this was the only gene from the gliotoxin biosynthetic cluster 
tested, it is likely that the gene expression of all the genes involved in gliotoxin 
biosynthesis were not differently expressed during exposure to voriconazole. 
 
Gliotoxin identification by RP-HPLC is enabled by comparison of the retention 
times (Rt) of A. fumigatus-derived metabolites, generally in organic extracts, to that 
of a standard gliotoxin preparation (Belkacemi et al., 1999; Kupfahl et al., 2006). 
Davis et al. (2010) developed a new method for gliotoxin detection which worked by 
labelling the reduced form of gliotoxin with 5’-iodoacetamidofluorescein (5’-IAF) 
following prior sodium borohydride reduction. They avoided use of reductants such 
as GSH or DTT which resulted in diminished sensitivity of detection of labelled 
gliotoxin due to depletion of the alkylation agent (5’-IAF). Sodium borohydride has 
previously been used to reduce other metabolites of Aspergillus spp., including 
sterigmatocystin and versicolorin A hemiacetals (Chen et al., 1977) and aflatoxin 
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(Johnson et al., 2008). Thus, Davis et al. (2010) have utilised reduction of the 
disulfide bridge of gliotoxin, via sodium borohydride, to improve the specificity of 
gliotoxin detection as formation of the reduced (dithiol) form of gliotoxin results in a 
decreased Rt of gliotoxin, by approximately 1 min, under identical RP-HPLC 
conditions. Therefore, sodium borohydride was used in our study to investigate the 
presence of, and provide extra confirmatory data for, gliotoxin production by A. 
fumigatus wild-type and ∆gliK strains, respectively. 
 
Gliotoxin production by A. fumigatus ATCC46645 was at too low a level to 
reliably assess by RP-HPLC (+/- sodium borohydride reduction) if ∆gliK, had any 
effect on gliotoxin production. This was not the case for A. fumigatus ATCC26933, 
where the amount of gliotoxin produced was easily observed prior to reduction, and 
subsequent reduction confirmed gliotoxin presence by the appearance of the dithiol 
form at a reduced retention time (Bernardo et al., 2003) in organic extracts of the 
wild-type culture supernatants. Gliotoxin secretion by the corresponding mutant, 
∆gliK26933, was effectively abolished, which was confirmed by absence of the 
reduced form of gliotoxin at the expected Rt of 14.1 min. However, both A. 
fumigatus ∆gliK strains were able to produce gliotoxin, albeit minimally (Figure 
5.35), and so it can be deduced that gliK is not essential for gliotoxin biosynthesis. 
Based on these data, we hypothesise that gliK may be involved in gliotoxin efflux 
from, or less likely, uptake into, A. fumigatus. 
The analysis of RP-HPLC fractionation of ∆gliK26933 showed an increase in an 
unknown peak at a retention time of 12.9 min, which was reduced in both wild-type 
and mutant strain. Other peaks observed in ATCC26933 fractionation identified 
metabolites which were reduced by sodium borohydride (13.9 and 15 min). It is 
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highly possible that these metabolites are unrelated to gliotoxin, as they are present 
in ∆gliK26933.  
 
Based on our observations that (i) both A. fumigatus ∆gliK mutants acquired 
increased sensitivity to exogenous gliotoxin (5 µg/ml); (ii) exposure to hydrogen 
peroxide significantly induced gliK expression, while also impairing ∆gliK growth 
with respect to wild-type(s), and finally (iii) disruption of gliK resulted in a tenfold 
decrease in gliotoxin efflux in A. fumigatus- it is hypothesised that gliK may play a 
role in gliotoxin efflux from A. fumigatus. Consequently, it was decided to assess the 
relative uptake rates of exogenous gliotoxin by A. fumigatus ATCC46645 and 
∆gliK46645 to indirectly investigate the role of gliK in gliotoxin efflux. Here, we 
reasoned that if ∆gliK46645 could uptake gliotoxin normally, but exhibit impaired 
efflux compared to wild-type, then the exogenous levels of gliotoxin should reduce 
more rapidly- and to a greater extent- in ∆gliK46645 cultures. These strains were 
selected because the low levels of endogenous gliotoxin produced (Schrettl et al., 
2010) would not interfere with measurement of exogenously added gliotoxin. 
Previous work (unpublished; Dr Stephen Carberry personal communication) had 
suggested that a 45 min experimental period would be optimal for assessment of 
gliotoxin uptake by A. fumigatus. 
Data analysis indicated that 15 min after gliotoxin addition (5 µg/ml final), there 
was a significantly lower level of gliotoxin present in A. fumigatus ∆gliK46645 
supernatants, compared to wild-type (P = 0.0102). This difference was also evident at 
30 min after addition (P= 0.0045), but at 45 min the level of exogenous gliotoxin in 
supernatants of A. fumigatus ∆gliK46645 began to increase and no statistically 
significant difference in exogenous gliotoxin levels between mutant and wild-type 
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was apparent (wild-type vs ∆gliK46645: 0.831 ± 0.356 ng/mg mycelia and 0.668 ± 
0.171 ng/mg mycelia, respectively). This is possibly due to activation of the auto-
protective gliT response which has also been proposed to facilitate gliotoxin efflux 
from A. fumigatus (Schrettl et al., 2010). Assessment of gliotoxin efflux in an A. 
fumigatus ∆gliK:∆gliT double mutant would confirm this speculation. Overall, we 
propose that exogenous gliotoxin levels drop rapidly (0 - 30 min) in A. fumigatus 
∆gliK46645 due to an impaired efflux pathway, consequent to gliK deletion, and thus 
conclude that gliK is involved in gliotoxin efflux from A. fumigatus. We predict that 
gliK acts in association with with gliA, the MFS transporter (Gardiner and Howlett, 
2005a), to maintain gliotoxin homeostasis in A. fumigatus, and to facilitate gliotoxin 
efflux under normal conditions but that gliT–mediated efflux (Schrettl et al., 2010) 
occurs when A. fumigatus encounters elevated gliotoxin levels. If gliK was involved 
in gliotoxin uptake, then one would have observed either no change, or an elevation 
of exogenous gliotoxin levels in A. fumigatus ∆gliK46645. This was not observed. 
 
Sirodesmin, another ETP toxin, is produced by L. maculans and biosynthesis is 
encoded by a multigene cluster analogous to that which encodes gliotoxin production 
in A. fumigatus (Gardiner et al., 2005b). Deletion of sirA, the sirodesmin transporter 
gene also led to increased sensitivity to exogenous sirodesmin and gliotoxin. 
Interestingly, introduction of A. fumigatus gliA recovered resistance to exogenous 
gliotoxin (10 µM), but not sirodesmin, in L. maculans ∆sirA:gliA. Gardiner et al. 
(2005a) noted that production and secretion of sirodesmin actually increased by 39 % 
in L. maculans ∆sirA compared to wild-type and speculated about the presence of 
alternative toxin efflux mechanisms. Subsequently, Schrettl et al. (2010) proposed 
that, in addition to the role of gliA in gliotoxin efflux by A. fumigatus, gliT plays an 
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essential role as a component of the auto-protective strategy against the cytotoxic 
effects of the ETP toxin. Furthermore, we now predict that gliK is essential for the 
effective functionality of gliA-mediated gliotoxin efflux from A. fumigatus. 
 
Genes, other than encoding MFS or ABC transporters, involved in the 
transportation of biosynthesised molecules have been well documented in bacteria 
where several genes that encode membrane pumps of MFS transporter types are 
tightly linked to one or more genes involved in the biosynthesis of the molecule 
which is being pumped (Neal and Chater, 1987; Guilfoile and Hutchinson, 1992; 
Pitkin et al., 1996). Overlapping transporters have also been well documented such 
as in C. nicotianae where the ABC transporter ATR1 involved in cercosporin 
production worked along with a MFS transported CnCFP which was involved in the 
auto-resistance to cercosporin (Amnuaykanjanasin and Daub, 2009).  Also, 
Bradshaw et al (2009) suggested that the MFS transporter encoded by dotC was not 
the major efflux pump for dothistromin and concluded that there are other factors 
besides DotC facilitating the efflux of the toxin.  
 
Figure 5.38 details a proposed model for the role of GliK in gliotoxin efflux by A. 
fumigatus. Here, endogenous, or exogenous gliotoxin which enters the cell, cycles 
between the oxidised and reduced forms, in part controlled by GliT 
activity/availability and chemical reduction by intracellular GSH (Schrettl et al., 
2010). Gliotoxin secretion occurs when the oxidised form is transported out of the 
cell by the GliK/GliA-mediated efflux system. In the absence of GliK, the elevated 
amount of gliotoxin accumulating in the cell exceeds the capacity of the GliA efflux 
system and activates the GliT self-protection system. Concomitant alteration of the 
267 
 
redox state within the cell occurs (due to GSH oxidation to GSSG) and a significant 
diminution in cell growth occurs, as we have observed (Figures 5.26 and 5.27). 
Absence of GliT leads to a complete inability to growth in the presence of elevated 
gliotoxin levels (Schrettl et al., 2010). 
 
 
 
Figure 5.38: A proposed model for GliK functionality in gliotoxin efflux by A. 
fumigatus, based on experimental observations detailed herein (Schrettl et al., 2010). 
In this model, GliK acts with GliA, and indirectly GliT, to mediate gliotoxin efflux. 
Absence of GliK would lead to increased gliotoxin levels in the cell, significantly 
hampering, but not overcoming the inducible GliT control the gliotoxin redox state. 
This would account for the impaired, but not absence of, growth observed for A. 
fumigatus ∆gliK mutants in the presence of gliotoxin. Note: Exogenous gliotoxin 
enters A. fumigatus via the cell membrane/wall by an, as yet, unidentified 
mechanism. Endogenous gliotoxin results from activity of the gliotoxin biosynthetic 
cluster (Gardiner and Howlett, 2005a). 
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In summary, targeted deletion of A. fumigatus gliK, a component of the gliotoxin 
biosynthetic cluster, in two fungal strains which produce low and high levels of 
gliotoxin, respectively, resulted in acquisition of (i) sensitivity to exogenous 
gliotoxin, (ii) increased sensitivity to hydrogen peroxide and (iii) impaired secretion 
of gliotoxin. We identify gliK as a component of the gliotoxin efflux system in A. 
fumigatus and predict that (i) hydrogen peroxide exposure may induce gliotoxin 
efflux, (ii) a ∆gliK:∆gliT double mutant would be completely unable to efflux 
gliotoxin and (iii) increased intracellular gliotoxin levels due to ∆gliK cause an 
alteration in the redox status of A. fumigatus resulting in growth diminution. Future 
work will investigate these hypotheses. 
 
  
 
 
 
 
 
 
CHAPTER 6 
 
 
 
New Diagnostic Strategies for Detection of A. 
fumigatus Exposure in Humans 
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6. New Diagnostic Strategies for Detection of A. fumigatus Exposure in Humans 
6.1 Introduction 
A. fumigatus produces many metabolites that are secreted into the surrounding 
environment (Frisvad et al., 2009). These secreted metabolites are recognisable by 
the immune system of the host and can alter the response of the immune system 
components in eliminating the infection. Pathogenic fungi avoid detection by the 
host immune response which aids the fungus in establishing growth and facilitating 
development (Toyotome et al., 2009). As A. fumigatus infections occur for the most 
part in immunocompromised individuals, the immune response is unable to 
recognise the pathogen, resulting in a fatal infection (Latge, 1999). Hence, in parallel 
to understanding the fungus and the mechanisms it deploys to colonise the host, 
there is a drive to develop rapid and specific diagnostic tools to identify A. fumigatus 
infection at an early stage, so that a better outcome for the infected individual may 
result.  
As described in Chapter 1, there are only a few diagnostic tests for the detection 
of the presence of A. fumigatus, (i) Biopsy, (ii) Galactomannan assay (de Repentigny 
et al., 1987; Maertens et al., 2007), (iii) PCR of A. fumigatus genes (Bretagne et al., 
1995; Yamakami et al., 1996; Schabereiter-Gurtner et al., 2007) and (iv) (1-3)β-
glucan test (Mitsutake et al., 1995; Krishnan-Natesan and Chandrasekar, 2008). 
Besides direct confirmation of biopsy examination, non-invasive diagnostic tests 
have shown limited success, with the galactomannan assay being the most reliable 
test (Scotter and Chambers, 2005). Therefore, test systems have been used in 
combination to try to increase the sensitivity and specificity of the available assays 
(Costa et al., 2002), but there is still a need to improve the detection and diagnosis of 
Aspergillus related infections. 
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A. fumigatus is responsible for certain hypersensitivity respiratory disorders 
(Cockrill and Hales, 1999). In fact, some asthma related allergies are due to A. 
fumigatus allergic reactions (Agarwal, 2009). The human host response specific to A. 
fumigatus antigens includes increased levels of total IgE, A. fumigatus  specific IgG 
and IgE, as well as a high eosinophil count (Gautam et al., 2007). Of the predicted 
10,000 proteins of A. fumigatus, only eight have been identified as positive allergens, 
namely, Aspf1, Aspf2, aspf3, Aspf4, Aspf6, glycoprotein (gp) 55, Aspf23 and an 
immune-dominant peptide of Aspf1 (Gautam et al., 2008).  
In immunocompromised patients, diagnosis of A. fumigatus infection is usually 
carried out by screening for the detection of circulating antigens, such as 
galactomannan and (1-3)β-glucans, as described in Chapter 1. Due to the lack of a 
full immune response in these patients, the usefulness of an antibody detection 
screening system seemed redundant, due to the defective antigen presentation 
function (Saugier-Veber et al., 1993). However, the detection of anti-Aspergillus 
antibodies may be useful as a prognosis marker (Hope et al., 2005). As native 
antigens cannot be always identified and isolated for use in creating specific 
antibodies, recombinant antigens can be produced using bacterial expression 
systems, usually E. coli – as noted for detection of anti-GliT IgG (Schrettl et al., 
2010). Such expression systems can be used to create recombinant antigens for use 
in serological investigations.  
Here, recombinant GliK (encoded by AFUA_6G09700; Chapter 5) was 
generated, and produced using the PproEx™-Htb expression system. The 
recombinant protein can be isolated and used as the antigen in ELISA assays to 
determine if anti-GliK antibodies are present in human serum.  
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The aims of this chapter are to (i) clone and confirm expression of recombinant 
GliK in E. coli, and (ii) use an enzyme linked immunosorbant assay (ELISA) to 
evaluate the prevalence of GliK antibodies in human serum in a healthy cohort. 
 
6.2 Results 
6.2.1 Recombinant expression of GliK in E. coli 
Separate from investigating the potential of TAFC as a diagnostic marker, a 
component of the gliotoxin biosynthetic cluster, GliK, was also examined. This was 
conducted by generating recombinant GliK, expressed in E. coli. 
Primers were designed to amplify the gliK region and also to incorporate two 
restriction sites, EcoRI and HindIII into the forward and reverse primers, 
respectively, to allow for directional cloning into the pProEx™-Htb expression vector 
(Table 6.1). A. fumigatus cDNA was used as the template for the PCR amplification 
of the gliK gene. 
 
Table 6.1: Primers used to amplify gliK gene. 
Primer (F/R) Restriction 
site 
Sequence (5’ – 3’) 
gliK – F  Forward EcoRI AAGGAATTCAAATGGGGAAAGCAG 
gliK – R Reverse HindIII GAAAGCTTCTAAGCCGCCCTTCTAGA 
 
cDNA synthesised from A. fumigatus was PCR amplified using gliK and 
calmodulin (calm) (Burns et al., 2005) primers, separately and the gliK RT-PCR 
product was verified by gel electrophoresis (Figure 6.1). The gliK RT-PCR 
amplification only amplified the cDNA of the first PCR reaction, and very faintly, 
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the fourth PCR reaction. The gliK gene has a predicted intron of 50 bp 
(http://www.cadre-genomes.org.uk), and such a small size difference is difficult to 
determine by DNA electrophoresis, therefore the calm RT-PCR has confirmed that 
all four replicate PCR reactions are gDNA free as the cDNA template resulted in an 
amplification of a 348 bp product, rather than the gDNA amplification of 617 bp.  
 
 
Figure 6.1: Reverse transcriptase PCR amplification of A. fumigatus ATCC46645 
cDNA (A) using gliK primers Lane L: Molecular weight marker ladder (Roche VII), 
Lanes 1 - 4: cDNA amplification PCR product (1328 bp), Lane 5: Blank control, 
Lane 6: gDNA positive control (1328 bp) and (B) using calmodulin primers Lane L: 
Molecular weight marker ladder (Roche VII), Lanes 1 - 4: cDNA amplification PCR 
product (348 bp), Lane 5: Blank control, Lane 6: gDNA positive control (617 bp). 
 
The gliK product was cloned into the pCR®II-TOPO® vector and transformed 
into E. coli. The resulting colonies were tested for integration of the DNA by 
restriction digest, using XbaI (Figure 6.2). The correct digestion pattern for the 
insertion of gliK cDNA into the TOPO vector was observed (5132 bp and 77 bp), 
and in the forward orientation. Digestion of the TOPO vector results in a 
linearization of the vector (3931 bp).  
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Figure 6.2: Restriction digest of gliK cloned into TOPO with XbaI. Lane L: 
Molecular weight marker ladder (Roche VII), Lane 1: Digested colony resulting in 
the expected band size of 5132 bp (the second band at 77 bp is not usually visible), 
Lane 2: TOPO vector linearised without gliK insertion (3931 bp). 
 
After confirmation that gliK cDNA cloned correctly into TOPO, the pProEx™-
Htb plasmid and the TOPO vector containing gliK were each digested with both 
EcoRI and HindIII, to result in the release of gliK from TOPO and also to open the 
pProEx™-Htb plasmid for subsequent ligation with the excised gliK (Figure 6.3). 
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Figure 6.3: Restriction digests with EcoRI and HindIII to release gliK cDNA from 
TOPO and the opening of the pProEx™-Htb vector for ligation. (A) Digestion of 
gliK:TOPO. Lane L: Molecular weight marker ladder (Roche VII), Lane 1 - 4: gliK 
released from the TOPO vector (1267 bp) and the remaining vector (3864 bp), Lane 
5: gliK:TOPO undigested (3864 bp) and (B) Digestion of pProEx™-Htb. Lane L: 
Molecular weight marker ladder (Roche VII), Lanes 1 – 2: digested pProEx™-Htb 
(4696 bp). 
 
The appropriate gliK cDNA digested product was gel extracted and ligated to the 
digested pProEx™-Htb vector. The resultant ligation was used to transform E. coli 
DH5α. The colonies were screened by PCR for the gliK insertion (Figure 6.4) and 
the positive colonies resulted in an amplification product of 1328 bp. Not all 
colonies contained the plasmid and insert.  
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Figure 6.4: Colony PCR of transformed DH5α E. coli containing gliK cDNA within 
the pProEx-HtB vector. Lane L: Molecular weight marker ladder (Roche VII). Lanes 
1 – 10: colonies screened by PCR for gliK (1328 bp), where colonies, with the 
exception of colonies 2 and 5, resulted in positive PCR amplification. 
 
One of the positive clones was digested by the restriction enzymes, BamHI and 
PvuI together, to confirm the insertion of the gliK cDNA sequence into the 
pProEx™-Htb plasmid (Figure 6.5). The pProEx™-Htb:gliK vector resulted in the 
expected banding pattern of 3749 bp and 2264 bp, whereas the pProEx™-Htb vector 
without the cDNA results in a banding pattern of 3749 bp and 1030 bp. 
 
 
Figure 6.5: Restriction digests to confirm gliK integration into the pProEx™-Htb 
plasmid. Lane L: Molecular weight marker ladder (Roche VII), Lane 1: pProEx™-
Htb:gliK digestion (3749 bp and 2264 bp), Lane 2: pProEx™-Htb only  digestion 
(3749 bp and 1030 bp). 
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The restriction digestions and colony PCR confirmed the presence of the gliK 
gene in the pProEx™-Htb plasmid. The plasmid was sequenced to confirm that gliK 
remained in frame to enable protein expression. Sequence analysis was performed on 
a commercial basis (AGOWA, Germany), and was compared to the predicted 
sequences according to CADRE (http://www.cadre-genomes.org.uk), with ID 
AFUA_6G09700. The cDNA was sequenced from the M13 primer site which is 
incorporated in both the TOPO vector and the pProEx™-Htb plasmid. The 
sequencing of the gliK cDNA in the TOPO vector confirmed the correct sequence of 
gliK and also revealed that the intron predicted in the CADRE sequence was not a 
true intron (Figure 6.6). The sequencing of the gliK cDNA in the pProEx™-Htb 
plasmid confirmed that the gliK cDNA ligated and cloned correctly into the plasmid 
(Figure 6.7).  There are five discrete residue changes, three of which result in an 
alteration of amino acid sequence (Table 6.2). The translated GliK protein sequence 
was aligned with the predicted protein sequence in CADRE and this alignment 
confirmed that the gene remained in-frame for protein expression (Figure 6.8).  
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Sequence_1: gliK in TOPO Sequenced 
Sequence_2: gliK gDNA predicted from CADRE (AfuA_6g09700  
 
Similarity : 631/631 (100.00 %) 
 
Seq_1  1     ACGACTCACTATAGGGCGAATTGGGCCCTCTAGATGCATGCTCGAGCGGCCGCCAGTGTG  60 
                                                                          
Seq_2  1     ------------------------------------------------------------  0 
 
 
Seq_1  61    ATGGATATCTGCAGAATTCGCCCTTACAGAACGCAAAGAGCAAGCAACATGGGGAAAGCA  120 
                                                            |||||||||||| 
Seq_2  1     ------------------------------------------------ATGGGGAAAGCA  12 
 
 
Seq_1  121   GCGTTGCAAGACCCTCATGGGGGAATCTGGTACTTTGCCTACGGCTCCAACTTACGCCTC  180 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  13    GCGTTGCAAGACCCTCATGGGGGAATCTGGTACTTTGCCTACGGCTCCAACTTACGCCTC  72 
 
 
Seq_1  181   TCGGTACTGGAGAATCGAGGCATCAAAGCACTGGATATCAAGGCCGTCATTGTCCCCTCA  240 
        |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Seq_2  73    TCGGTACTGGAGAATCGAGGCATCAAAGCACTGGATATCAAGGCCGTCATTGTCCCCTCG  132 
 
 
Seq_1  241   CACTACCTGACCTTCGACATCTTTGGCATCCCGTACGCGGAACCTTCCTTTGCCAGCGTC  300 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  133   CACTACCTGACCTTCGACATCTTTGGCATCCCGTACGCGGAACCTTCCTTTGCCAGCGTC  192 
 
 
Seq_1  301   GCCCCCTTTGCCCGCGAGAAGAAAACCACCCTGCGACTGGGCGATTCACCCGCTTCTCGC  360 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  193   GCCCCCTTTGCCCGCGAGAAGAAAACCACCCTGCGACTGGGCGATTCACCCGCTTCTCGC  252 
 
 
Seq_1  361   GACGTTCCGCCGGTTCAGGGACTCGCCTATCTTTTAAATCCCAGGGATTACCGGCAGCTG  420 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  253   GACGTTCCGCCGGTTCAGGGACTCGCCTATCTTTTAAATCCCAGGGATTACCGGCAGCTG  312 
 
 
Seq_1  421   GTCATCAGCGAAGGCGGCGGCGTGGCTTACGATGAGGTCGAGGTCCATGCCTCGATCCTC  480 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  313   GTCATCAGCGAAGGCGGCGGCGTGGCTTACGATGAGGTCGAGGTCCATGCCTCGATCCTC  372 
 
 
Seq_1  481   GACAAGGACGGCAAACCCGACCCCGGCGCGACCCTGATTGCTCGGACCTTGCAAGCCAAG  540 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  373   GACAAGGACGGCAAACCCGACCCCGGCGCGACCCTGATTGCTCGGACCTTGCAAGCCAAG  432 
 
 
Seq_1  541   TACCCCTGGCGACCTAACGGTGCGCCCAGTGCGCGCTACCTGGTGAGCGGCCCCGGAACA  600 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  433   TACCCCTGGCGACCTAACGGTGCGCCCAGTGCGCGCTACCTGgtgagcggccccggaaca  492 
 
 
Seq_1  601   GAATCATGCTCTGCGATACTGATCGGAAACAGGGCCTCATCTCGACGGGGTGCAAACAGA  660 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  493   gaatcatgctctgcgatactgatcggaaacagGGCCTCATCTCGACGGGGTGCAAACAGA  552 
 
 
Seq_1  661   ATGAGCCGCTCACGGCATACAGCGACTATATTGATTCCTTACCGGCCTATGAGCCGCCGA  720 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  553   ATGAGCCGCTCACGGCATACAGCGACTATATTGATTCCTTACCGGCCTATGAGCCGCCGA  612 
 
 
Seq_1  721   CATCCCTCCATGCCAAGG--------------------------------------      738 
             ||||||||||||||||||                                           
Seq_2 613    CATCCCTCCATGCCAAGGTGGGAGGTCTTCTTTTCCTGATGTTCTGGCGTCC          672 
Figure 6.6: Alignment of sequence of gliK cDNA within the TOPO vector with the 
sequence predicted from CADRE. The sequenced cDNA contained the sequence of 
the predicted intron (highlighted in yellow), which indicates that this is not an intron, 
as predicted. 
278 
 
Sequence_1: gliK in pProEx Sequenced,  
Sequence_2: gliK gDNA predicted  
Similarity : 860/861 (99.88 %) 
 
Seq_1  1     CCATCACCATCACGATTACGATATCCCAACGACCGAAAACCTGTATTTTCAGGGCGCCAT  60 
                                                                          
Seq_2  1     ------------------------------------------------------------  0 
 
 
Seq_1  61    GGGATCCGGAATTCAAATGGGGAAAGCAGCGTTGCAAGACCCTCATGGGGGAATCTGGTA  120 
                             |||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  1     ----------------ATGGGGAAAGCAGCGTTGCAAGACCCTCATGGGGGAATCTGGTA  44 
 
 
Seq_1  121   CCTTGCCTACGGCTCCAACTTACGCCTCTCGGTCCTGGAGAATCGAGGCATCAAAGCACT  180 
             | ||||||||||||||||||||||||||||||| |||||||||||||||||||||||||| 
Seq_2  45    CTTTGCCTACGGCTCCAACTTACGCCTCTCGGTACTGGAGAATCGAGGCATCAAAGCACT  104 
 
 
Seq_1  181   GGATATCAAGGCCGTCATTGTCCCCTCGCACTACCTGACCTTCGACATCTTTGGCATCCC  240 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  105   GGATATCAAGGCCGTCATTGTCCCCTCGCACTACCTGACCTTCGACATCTTTGGCATCCC  164 
 
 
Seq_1  241   GTACGCGGAACCTTCCTTTGCCAGCGTCGCCCCCTTTGCCCGCGAGAAGAAAACCACCCT  300 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  165   GTACGCGGAACCTTCCTTTGCCAGCGTCGCCCCCTTTGCCCGCGAGAAGAAAACCACCCT  224 
 
 
Seq_1  301   GCGACTGGGCGATTCATCCGCTTCTCGCGACGTTCCGCCGGTTCAGGGACTCGCCTATCT  360 
             |||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  225   GCGACTGGGCGATTCACCCGCTTCTCGCGACGTTCCGCCGGTTCAGGGACTCGCCTATCT  284 
 
 
Seq_1  361   TTTAAATCCCAGGGATTACCGGCAGCTGGTCATCAGCGAAGGCGGCGGCGTGGCTTACGA  420 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  285   TTTAAATCCCAGGGATTACCGGCAGCTGGTCATCAGCGAAGGCGGCGGCGTGGCTTACGA  344 
 
 
Seq_1  421   TGAGGTCGGGGTCCATGCCTCGATCCTCGACAAGGACGGCAAACCCGACCCCGGCGCGAC  480 
             |||||||| ||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  345   TGAGGTCGAGGTCCATGCCTCGATCCTCGACAAGGACGGCAAACCCGACCCCGGCGCGAC  404 
 
 
Seq_1  481   CCTGATTGCTCGGACCTTGCAAGCCAAGTACCCCTGGCGACCTAACGGTGCGCCCAGTGC  540 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  405   CCTGATTGCTCGGACCTTGCAAGCCAAGTACCCCTGGCGACCTAACGGTGCGCCCAGTGC  464 
 
 
Seq_1  541   GCGCTACCTGGTGAGCGGCCCCGGAACAGAATCATGCTCTGCGATACTGATCGGGAACAG  600 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||| ||||| 
Seq_2  465   GCGCTACCTGgtgagcggccccggaacagaatcatgctctgcgatactgatcggaaacag  524 
 
 
Seq_1  601   GGCCTCATCTCGACGGGGTGCAAACAGAATGAGCCGCTCACGGCATACAGCGACTATATT  660 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  525   GGCCTCATCTCGACGGGGTGCAAACAGAATGAGCCGCTCACGGCATACAGCGACTATATT  584 
 
 
Seq_1  661   GATTCCTTACCGGCCTATGAGCCGCCGACATCCCTCCATGCCAAGGTGGGAGG       713 
             ||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  585   GATTCCTTACCGGCCTATGAGCCGCCGACATCCCTCCATGCCAAGGTGGGAGG         638 
 
 
Figure 6.7: Alignment of the sequence of gliK within the pProEx™-Htb plasmid 
with the sequence predicted from CADRE. Alterations of residues are highlighted in 
grey.  
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predicted      -------------------------MGKAALQDPHGGIWYFAYGSNLRLSVLENRGIKAL 35 
sequenced      HHHHDYDIPTTENLYFQGAMGSGIQMGKAALQDPHGGIWYLAYGSNLRLSVLENRGIKAL 60 
**************:******************* 
 
predicted      DIKAVIVPSHYLTFDIFGIPYAEPSFASVAPFAREKKTTLRLGDSPASRDVPPVQGLAYL 95 
sequenced      DIKAVIVPSHYLTFDIFGIPYAEPSFASVAPFAREKKTTLRLGDSSASRDVPPVQGLAYL 120 
        *********************************************.************** 
 
predicted      LNPRDYRQLVISEGGGVAYDEVEVHASILDKDGKPDPGATLIARTLQAKYPWRPNGAPSA 155 
sequenced      LNPRDYRQLVISEGGGVAYDEVGVHASILDKDGKPDPGATLIARTLQAKYPWRPNGAPSA 180 
               ********************** ************************************* 
 
    predicted       RYLV 159 
    sequenced       RYLV 184 
        ****  
 
Figure 6.8: Protein sequence of GliK translated from cloned cDNA. The cloned 
DNA is in frame with the N-terminal histidine affinity tag (part of which is 
underlined in green). The pProEx-Htb vector is underlined in Blue and the translated 
cDNA is underlined in red. 
 
Three of the observed amino acids were not as predicted (Table 6.2). These 
discrete differences may be a result of the strain difference between the sequenced A. 
fumigatus strain AF293 and the strain used in this experiment, ATCC46645. 
 
Table 6.2: Sequence of residues that result in a different protein sequence between 
the predicted protein sequence from CADRE (AF293) and the actual sequenced 
strain (ATCC46645) 
Residue 
location 
Sequenced 
(ATCC46645) 
Predicated 
(AF293) 
 Residues Amino acid Residues Amino acid 
122 CTT Leucine (L) TTT Phenylalanine (F) 
317 TCC Serine (S) CCC Proline (P) 
429 GGG Glycine (G) GAG Glutamic acid (E) 
 
 
These changes may also indicate non-conserved aspects of the gene or they may 
be due to errors introduced during the amplification of the cDNA by PCR, even 
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though proof-reading Taq was used to reduce the possibility of such alterations 
occurring. 
Detection of the protein expression of GliK in recombinant E. coli was carried 
out by induction using IPTG followed by SDS-PAGE and Western Blot analysis. 
Small scale cultures were induced and grown for 3 hr, with samples taken pre-
induction and also at hourly time points. Both the SDS-PAGE and Western Blot 
analysis resulted in an approximate molecular mass of 30.5 kDa, which was expected 
of the recombinant GliK (rGliK) (Figure 6.9).  
In order to check rGliK solubility, the cultures were induced as before with 
IPTG, cultured for 3 hr and then subjected to a series of purifications to determine 
the solubility of the protein, as described in Section 2.2.14. The extracts from the 
different stages of solubility were subjected to SDS-PAGE and Western blot 
analysis. Both the SDS-PAGE and the Western blot analysis showed the presence of 
rGliK at the correct molecular mass, 30.5 kDa. The recombinant protein was deemed 
to be insoluble in solubilisation buffers Triton X-100, and 2 M urea and was finally 
resuspended in 8 M Urea Buffer (Figure 6.10). The soluble protein was quantified by 
the Bradford protein assay, and was determined to be 5.69 mg/ml. 
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Figure 6.9: (A) SDS-PAGE and (B) Western blot analysis of recombinant GliK 
(rGliK) expression. Lane L contains the molecular mass marker; Lane 1 contains the 
non-induced cell extract; Lane 2 – 4 contains the cell extracts taken 1 – 3 hr post-
induction (30.5 kDa); Lane 5 is empty; Lane 6 contains rGliG (26 kDa), a positive 
control (Davis et al., submitted). 
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Figure 6.10: (A) SDS-PAGE and (B) Western blot analysis of rGliK solubility. Lane 
L contains the Molecular mass marker; Lanes 1 – 3 contain the Triton X-100 soluble 
protein; Lane 4 contains the 2 M Urea extract; Lanes 5 & 6 contain the 8 M Urea 
extract (30.5 kDa); Lane 7 contains rGliG (26 kDa), a positive control (Davis et al., 
submitted). 
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6.2.2 Immunoreactivity of GliK 
Previous immunoassays determined that there was a prevalence of anti-GliT and 
GliG IgG in human serum (Davis et al., 2010; Schrettl et al., 2010). Therefore, an 
assay was developed to determine if anti-GliK IgG were present in human serum. 
Microtitre plates were coated with the rGliK at a range of coating concentrations (0.5 
- 8 µg/ml) to determine the optimum coating concentration (Figure 6.11). The 
dilutions were also carried out with and without 0.01 % (w/v) SDS. The purpose of 
the SDS is to facilitate homogenous coating of the antigen. The antigen was detected 
on the plate using an anti-His6 monoclonal antibody (1/10000) and a goat anti-mouse 
IgG horseradish peroxidase (HRP) conjugate (1/5000). The substrate used was 
tetramethylbenzidine (TMB) and the reaction was stopped by the addition of 1 N 
Sulphuric acid solution. The optimum coating concentration for the rGliK antigen 
was determined to be 4 µg/ml in coating buffer containing 0.01 % (w/v) SDS, as no 
increased absorbance was observed as a result of increasing rGliK coating 
concentration. 
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Figure 6.11: Optimisation of the coating concentration for the GliK ELISA. The 
microtitre plate was coated with the purified rGliK (0.5 – 8 µg/ml) diluted in 
carbonate buffer. The anti-His6 monoclonal antibody was diluted in a range of 
carbonate buffer (1/1000, 1/2500 and 1/5000) either with or without 0.01 % (w/v) 
SDS. 
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The optimum concentration of rGliK (4 µg/ml) was coated onto 96 well plates, 
and human sera (n = 71) were screened by ELISA. Sera were assayed in duplicate on 
the microtitre plate, and repeated, resulting in two sets of results for each sample 
analysed (Figure 6.12).  
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Figure 6.12: Detection of anti-GliK IgG in human serum. Samples 1 – 71 were 
screened, including an anti-His6 positive control and a negative control. 
 
ELISA results were expressed as index values (I.V.) representing specimen 
absorbance divided by the cut-off absorbance. The cut-off value for the GliK ELISA 
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was established by determining the absorbance values of the lowest ten values of the 
71 samples. The cut-off value of the assay was defined by adding twice the standard 
deviation to the mean absorbance of the ten samples (Table 6.3). The established cut-
off value was determined to be 0.339. 
 
Table 6.3: Establishing the cut off valve of the rGliK ELISA 
Assay Mean of 
lowest ten 
samples 
Standard 
deviation 
(STDEV) 
2 X STDEV Cut-off value 
GliK ELISA 0.262 0.039 0.077 0.339 
  
The results of the serum reactivity were calculated as Index Values (I.V.) as 
follows: the mean absorbance reading for each serum sample was divided by the cut-
off value (0.339). An I.V. of greater than 1 was deemed to be seropositive, between 1 
– 2 was deemed to be weakly seropositive, between 2 – 4 was deemed to be medium 
seropositive and greater than 4 was deemed to be highly seropositive. Of the serum 
samples screened (n = 71), 82 % (58/71) were seropositive; indicating that there is a 
prevalence of exposure to GliK in healthy individuals. None of the serum samples 
were highly seropositive, whereas the majority either displayed medium 
seropositivity (21 %) or weak seropositivity (61 %) reaction. Seronegative samples 
accounted for 18 % of the cohort tested (Figure 6.13). 
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Figure 6.13: The Human IgG reactivity towards rGliK antigen. The total number of 
serum samples (n = 71). The seroreactivity toward the GliK antigen were further 
grouped into categories: Seronegative,  an I.V. of less than 1, Weak seropositive, an 
I.V. of between 1 – 2, Medium seropositive, an I.V. of between 2 – 4 and High 
seropositive, an I.V. of higher than 4. Each category was scored as a percentage of 
the total number of serum samples screened. 
 
6.3 Discussion 
Secreted metabolites from A. fumigatus can potentially be used as a method of 
specific and sensitive detection of infection. Current detection of Aspergillus 
infection relies upon invasive procedures such as lung biopsy or broncoscopy 
procedures. Non-invasive methods have been limited to the detection of cell wall 
components of the fungus such as the β-galactomannan or (1-3)β-glucan. Alternative 
diagnosis tools are needed in the detection and diagnosis of Aspergillus infections. 
Here, a component of the gliotoxin biosynthetic cluster, GliK, was examined as 
potential diagnostic markers for the detection of Aspergillus infection.  
 
Production of recombinant proteins has previously been used to characterise A. 
fumigatus protein function (Burns et al., 2005; Davis et al., 2010; Schrettl et al., 
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2010), but this approach can also been used to characterise the prevalence of 
antibodies against such proteins in the human sera (Davis et al., 2010). Here, gliK, a 
gene encoding an unknown protein in the gliotoxin biosynthetic cluster, was cloned 
into a bacterial expression system to induce production of this protein. It was verified 
that GliK expression was successful using the pProEx-Htb expression system to 
yield recombinant GliK (rGliK). The rGliK protein was insoluble in Triton X-100 
and 2 M urea solubilisation buffers, but was successfully solubilised in 8 M urea 
buffer. The purified recombinant protein was used in an ELISA assay to investigate 
the seroprevalence of GliK antibodies. A random cohort of healthy sera samples (n = 
71) was screened in duplicate by ELISA, where rGliK was used as the antigen. It 
was discovered that there was a weak to medium seropositive reaction to the rGliK 
as 82 % (58/71) of the sera screened had anti-GliK antibodies present. This indicates 
that GliK interaction with healthy individuals is a common occurrence, and that the 
presence of GliK is capable of stimulating an immune response.  
 
There is a need to extend the available diagnostic repertoire for the detection and 
diagnosis of Aspergillus infections, as there is an increase in the number of reported 
anti-fungal resistant strains (Denning and Hope, 2010; Schrettl et al., 2010), as well 
as a delay in diagnosis of this potentially fatal infection (Maschmeyer et al., 2007). 
A. fumigatus infection is the leading cause of fungal related fatalities, and early 
detection is the key to fighting this pathogen (Agarwal, 2009). Metabolites secreted 
from the fungus during infection may provide an opportunity to detect an infection if 
diagnostic assays were used to specifically screen for such metabolites (Hope et al., 
2005). Most of the metabolites produced by A. fumigatus are not recognised or 
detectable by the human immune system (Latge, 1999), which makes them suitable 
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as new diagnostic markers. Generation of recombinant antigens can be used in an 
ELISA which can screen human sera samples for the circulating anti-fungal 
antibodies. The ELISA procedure has been shown to be useful in the detection of 
antibodies associated with A. fumigatus, as the rGliK protein demonstrated that there 
is a prevalence of anti-GliK antibodies in healthy human sera.  
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7. Discussion 
7.1 Establishment of a role for Pes1 in fumigaclavine C production in A. 
fumigatus 
The sequencing of the genome of A. fumigatus has identified that genes involved 
in the biosynthesis of particular secondary metabolites are mainly found in clusters 
(Nierman et al., 2005). In A. fumigatus, at least 26 secondary metabolite biosynthetic 
clusters have been identified, comprised of NRPS, PKS or DMAPP type genes 
(Keller et al., 2005). However, the identification of the metabolites produced by 
many of these gene clusters is still unclear. Identification of NRP peptides is difficult 
as the substrate for the NRP synthetase may include fatty acids and α-hydroxy acids, 
as well as other non-proteogenic and proteogenic amino acids (Schwarzer et al., 
2003).  NRP peptides can also undergo post-biosynthetic modifications, which can 
also make the link between NRP synthetase gene and corresponding peptide product 
harder to establish (Stack et al., 2007). In previous functional genomic analysis of A. 
fumigatus, genes of interest have either been part of a defined cluster, such as gliP of 
the gliotoxin biosynthetic cluster (Kupfahl et al., 2006) or else a gene with a defined 
role, following identification of orthologs in other fungal species. For example, the 
role of fgaPT2 in the biosynthesis of fumigaclavines in A. fumigatus was established 
by comparison to an ortholog in C. purpurea, cpd1, which had already been defined 
as the first step in the biosynthesis of the ergot alkaloid in this pathogen(Unsold and 
Li, 2005). 
In previous work, expression of pes1 has been altered by the deletion of other 
genes, such as laeA, encoding a global regulator (Perrin et al., 2007). Such 
investigations have determined that pes1 is under the same regulation as many of the 
secondary metabolite clusters but have not specifically examined the role of pes1 in 
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A. fumigatus. Hence, the identification that pes1 plays a role in the biosynthesis of 
the ergot alkaloid, fumigaclavine C, is the first time that a specific role for pes1 in 
secondary metabolite biosynthesis has been elucidated.  
Fumigaclavine C is produced in the conidia and therefore, most of the production 
of fumigaclavine C will be early in culture (Panaccione and Coyle, 2005), as the 
latter stages of culturing would contain more mycelia than conidia and therefore the 
amount of fumigaclavine C would diminish. Coyle et al. (2007) have noted that 
cultures grown on solid-based media produce more ergot alkaloids than cultures 
grown in liquid media, due to the higher level of conidia. In this thesis, analysis of 
pes1 expression in A. fumigatus ATCC46645 showed that pes1 was expressed at a 
higher level at 24 and 48 hr than 72 hr, regardless of media type, which is consistent 
with the predicted production time-frame of fumigaclavine C in liquid media 
cultures.  
pes1 has been previously shown to be expressed during oxidative stress 
conditions (Reeves et al., 2006). However in the present work, pes1 expression was 
shown to be down-regulated in the presence of hydrogen peroxide (1 mM) in the 
strains A. fumigatus ATCC46645, ∆sidD and ∆sidD:pes1c after 24 hr incubation in 
AMM media. The down-regulation of pes1 may be compensated for by the mycelial 
oxidative stress response components, such as the catalases (Paris et al., 2003b).  
Fumigaclavine C production is completely abolished in A. fumigatus ∆pes1 
strains. The fumigaclavine C biosynthetic cluster does not include pes1 in A. 
fumigatus and we therefore propose that there has been extensive gene reorganisation 
in the cluster, which resulted in the migration of pes1 onto chromosome 1, distant 
from the ergot alkaloid gene cluster located on chromosome 2. Gene rearrangement 
has also occurred within the cluster compared to the C. purpurea ergot alkaloid 
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biosynthetic cluster (Coyle and Panaccione, 2005), with which A. fumigatus shares 
similarity (Unsold and Li, 2005; Wallwey et al., 2010). Therefore, A. fumigatus ergot 
alkaloid production is likely to be a result of cluster cross-talk between the genes 
within the ergot alkaloid biosynthetic cluster and the distantly located pes1. There 
has been extensive investigation into the fumigaclavine C biosynthetic pathway, but 
there are still a number of undefined reaction steps, and genes in the cluster with 
unknown functions (Unsold and Li, 2006; Rigbers and Li, 2008; Liu et al., 2009; 
Coyle et al., 2010; Wallwey et al., 2010).  
The cross-talk between pes1 and the remainder of the fumigaclavine C encoding 
genes is an unusual arrangement in A. fumigatus, as generally the genes involved in 
the biosynthesis of a specific metabolite are all located adjacent to each other (Maiya 
et al., 2006; Maiya et al., 2007; Perrin et al., 2007; Fedorova et al., 2008; Fox et al., 
2008). Indeed, the majority of secondary metabolites are produced by defined 
clusters located near the telomeres (Keller et al., 2005). However, there is an 
emergence of translocated or “orphan” genes identified distant from the cluster with 
which they co-operate to encode the biosynthesis of a specific metabolite. This is the 
case for the siderophore, erythrochelin, in Saccharopolyspora erythraea, which 
utilises two seemingly orphan NRP synthetase genes to synthesise the siderophore, in 
conjunction with genes found in a separate cluster  (Lazos et al., 2010). Also, in A. 
fumigatus, sidA, essential for the biosynthesis of both intracellular and extracellular 
siderophores, TAFC and FC, is located away from the siderophore biosynthetic 
cluster (Schrettl et al., 2004). The genes involved in siderophore biosynthesis can be 
identified due to the availability of orthologs of the siderophore biosynthetic genes, 
and confirmed experimentally due to controlled expression regulated by iron 
availability (Reiber et al., 2005). However, for NRP synthetase genes such as pes1, 
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no specific expression control has been identified, apart from the regulation by the 
global regulator of secondary metabolite production, LaeA, which controls a 
multitude of gene clusters (Bok and Keller, 2004) and the down-regulation of some 
NRP synthetase genes in the absence of the StuA transcription factor (Sheppard et 
al., 2005). Therefore, the involvement of pes1 in fumigaclavine C biosynthesis 
implies that there may be other orphan or cluster independent genes in the A. 
fumigatus genome which may be associated with the many previously identified 
metabolic biosynthetic processes, for which the full biosynthetic pathway is not 
completely understood. 
Further to the findings presented herein with respect to NRP peptide interactions 
contributing to voriconazole resistance and the identification of a definite role for 
pes1 in fumigaclavine C biosynthesis, a number of questions remain outstanding: 
1.  What is the molecular basis of the role played by fumigaclavine C in 
protecting against oxidative stress in A. fumigatus ∆sidD under iron-limiting 
conditions? 
2. What is the precise role of Pes1 in fumigaclavine C production? 
3.  What is the amino acid substrate specificity of Pes1 modules (n = 4)? 
4. To what extent is secondary metabolite/natural product cluster cross-talk 
occurring, and why? 
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7.2 Establishment of GliK involvement in gliotoxin efflux from A. fumigatus 
Gliotoxin is a member of the ETP family and is one of the many secreted 
metabolites from A. fumigatus. Bioinformatic analysis identified a cluster of 13 genes 
which mediate gliotoxin biosynthesis (Gardiner and Howlett, 2005a; Schrettl et al., 
2010). gliK, encoding a protein of unknown function, is part of this cluster. Although 
orthologs of gliK exist in other fungi, the precise function in gliotoxin biosynthesis 
has remained elusive (Patron et al., 2007). Recently, it has been identified that there 
are certain genes, for example gliT, within the cluster which confer protection against 
gliotoxin (Scharf et al., 2010; Schrettl et al., 2010). Also, the MFS transporter 
encoded by gliA, plays a role in protection against gliotoxin, as was demonstrated in 
a L. maculans ∆sirA:gliA strain (Gardiner et al., 2005b). 
Prior to the work carried out as part of this thesis, the exact role of gliK in 
gliotoxin biosynthesis or efflux was unclear. However, the efflux mechanism is 
proposed to be facilitated by the gliotoxin transporter, gliA (Gardiner et al., 2005b), 
and also the gliotoxin oxidoreductase, gliT (Scharf et al., 2010; Schrettl et al., 2010). 
Herein, it is proposed that co-operation between these three genes facilitates the 
gliotoxin homeostasis in A. fumigatus, as well as gliotoxin efflux under basal 
conditions. In elevated exogenous gliotoxin conditions, gliT-mediated efflux occurs 
(Schrettl et al., 2010). In the absence of GliK, there is a short-term accumulation of 
gliotoxin within mycelia, exceeding the capacity of the GliA efflux system. This 
internal level of gliotoxin is harmful to the organism, and activates the GliT self-
protection activities (Schrettl et al., 2010). This ability to react to an increase in 
intracellular gliotoxin is part of the self-protection system operated by the fungus. In 
the model proposed in this thesis (Figure 5.42), which is based on experimental 
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observation, GliK functions with GliA, and indirectly with GliT, to mediate the 
efflux of gliotoxin.  
Identification of a role for a protein of unknown function, such as gliK, with no 
functionally annotated ortholog or identifiable domains was challenging. As gliK is 
located within the gliotoxin biosynthetic cluster, there was a likelihood that the 
protein played some role in gliotoxin production (Gardiner and Howlett, 2005a). 
Comparison of the gliotoxin biosynthetic genes to the sirodesmin biosynthetic genes 
of L. maculans showed that there was no ortholog of gliK, indicating that the protein 
was not likely to be necessary for gliotoxin biosynthesis (Gardiner and Howlett, 
2005a). It has been noted that orthologs of gliK are only present in gliotoxin-
producing organisms where there is a MFS type transporter, such as GliA (A. 
fumigatus), rather than an ABC type transporter, such as SirA (L. maculans) (Table 
5.1)(Patron et al., 2007). 
The co-operation between GliA, an MFS transporter and GliK for the efflux of 
gliotoxin from A. fumigatus has ramifications for the production of other fungal 
toxins similar to gliotoxin. In particular, production of sirodesmin of L. maculans 
(Gardiner et al., 2005b), dothstromin of D. pini (Bradshaw et al., 2009), and 
aflatoxin of A. parasiticus (Chang et al., 2004) do not rely solely on the transporter 
for each of their respective toxins, however other contributing factors have not yet 
been determined.  
In the case of sirodesmin production in L. maculans, SirA, the ABC transporter is 
regulated by the transcription factor, SirZ, as well as the presence of sirodesmin 
itself. In ∆sirA, there was an elevated production of sirodesmin, which strongly 
suggests that there are other efflux mechanisms of sirodesmin (Gardiner et al., 
2005b). Dothstromin production in D. pini was unaffected by the absence of the MFS 
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transporter, DotC and this mutant was not sensitive to the presence of exogenous 
dothstromin (Bradshaw et al., 2009). The authors note that there may be complex 
feedback regulation in the efflux and biosynthesis of the toxin, which has not yet 
been identified and elude to the possibility that compartmentalisation of the toxin 
may occur within the cell. 
Intracellular vesicles, termed aflatoxisomes, have recently been shown to be 
involved in late-stage aflatoxin biosynthesis and export from Aspergillus parasiticus 
(Chanda et al., 2009). These authors also demonstrated that aflatoxin biosynthesis 
was, in part, coordinated by Velvet (VeA) (Bayram et al., 2008), a global regulator 
of Aspergillus secondary metabolism. Since VeA is primarily expressed under dark 
conditions, Chanda et al. (2009) have proposed that aflatoxin production may occur 
deep in soil to protect the fungal colony against predation by worms and insects, 
thereby ensuring survival of A. parasiticus in the environment. Given the auto-toxic 
(Schrettl et al., 2010) and fungistatic effects of gliotoxin (Doyle et al., 2010), it is 
conceivable that gliotoxin export also involves intracellular vesicular trafficking. 
However, although a role for intracellular vesicles involved in the intracellular 
transport of gliotoxin in A. fumigatus has been proposed (Schrettl et al., 2010), no 
experimental evidence has been provided to support this hypothesis. Now that a role 
of GliK in gliotoxin efflux has been identified, future GliK studies may resolve the 
gliotoxin storage/release mechanism in A. fumigatus. It is tempting to speculate that 
GliK may act as a targeting protein which directs gliotoxin-containing vesicles to the 
cell membrane prior to secretion. 
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9. Appendix I 
9.1 Materials 
9.1.1 Aspergillus Media and Agar 
9.1.1.1 Sabouraud Dextrose Broth 
Sabouraud-dextrose broth (30 g) (Oxoid, Cambridge, UK) was added to 1 L 
distilled water, and dissolved. The solution was autoclaved and stored at 4 
o
C. 
 
9.1.1.2 Sabouraud Agar 
Sabouraud agar (65 g) (Oxoid, Cambridge, UK) was added to 1 L distilled water 
and dissolved. The solution was autoclaved, and allowed to cool to ~50 
o
C. Agar (25 
ml) was subsequently poured into 90 mm petri dishes, under sterile conditions. The 
plates were allowed to set and stored at 4 
o
C. 
 
9.1.1.3  Malt Extract Agar 
Malt extract agar (50 g) (Difco, Maryland, USA) was added to 1 L distilled 
water, and dissolved. The solution was autoclaved, and allowed to cool to ~50 
o
C. 
Agar (25 ml) was then poured into 90 mm petri dishes, under sterile conditions. The 
plates were allowed to set and stored at 4 
o
C. 
 
9.1.1.4 Aspergillus Minimal Media 
9.1.1.4.1 50 X Salt Solution 
KCl (26 g), MgSO4.7H2O (26 g), and KH2PO4 (76 g) was dissolved in 1 L 
distilled water and autoclaved. The solution was stored at 4 
o
C. 
 
9.1.1.4.2 100 X Ammonium Tartrate 
Ammonium Tartrate (92 g) was dissolved in 1 L distilled water. The solution was 
autoclaved and stored at room temperature. 
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9.1.1.4.3 0.3 M L-Glutamine 
L-glutamine (43.8 g) was dissolved in 800 ml distilled water. 1-2 drops of conc. 
HCl was added to aid dissolving. The pH was adjusted to pH 6.5 and the final 
volume was brought up to 1 L. The solution was filter sterilised and stored at room 
temperature. 
 
9.1.1.5 Trace Elements 
9.1.1.5.1 Trace Elements containing Iron 
Na2B4O7.7H2O (40 mg), CuSO4.5H2O (400 mg), FeSO4.7H2O (800 mg), 
Na2MoO.2H2O (800 mg), and ZnSO4.7H2O (8 g) were dissolved in order, in 800 ml 
distilled water allowing each to dissolve completely before addition of the next 
component. A few drops of conc. HCl was added to maintain the solution. The 
solution was then brought up to 1 L with distilled water, and filter sterilised.   
 
9.1.1.5.2 Trace Elements without Iron 
Na2B4O7.10H2O (40 mg), CuSO4.5H2O (400 mg), MnSO4.10H2O (800 mg), 
Na2MoO.2H2O (800 mg) and ZnSO4.7H2O (8 g) were dissolved in order, in 800 ml 
distilled water allowing each to dissolve completely before addition of the next 
component. A few drops of conc. HCl was added to maintain the solution. The 
solution was then brought up to 1 L with distilled water, and filter sterilised.   
 
9.1.1.6 Aspergillus Minimal Media Liquid 
9.1.1.6.1 AMM Containing Iron 
Salt solution (50 X, 20 ml), Ammonium Tartrate (100 X, 10 ml), and Glucose (10 
g) were added to 800 ml distilled water. Trace elements containing Iron (1 ml) 
(Section 9.1.1.5.1) was added and the solution was adjusted to pH 6.8. The solution 
was brought to 1 L distilled water, mixed, autoclaved at 105 
o
C for 30 min and stored 
at room temperature. 
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9.1.1.6.2 AMM without Iron 
Salt solution (50 X, 20 ml), Ammonium Tartrate (100 X, 10 ml), and Glucose (10 
g) were added to 800 ml distilled water. Trace elements without Iron (1 ml) (Section 
9.1.1.5.2) was added and the solution was adjusted to pH 6.8. The solution was 
brought to 1 L distilled water, mixed, autoclaved at 105 
o
C for 30 min and stored at 
room temperature. 
 
9.1.1.6.3 MM containing Iron 
Salt solution (50 X, 20 ml), glucose (10 g) and trace elements containing iron (1 
ml) (Section 9.1.1.5.1) were added to 800 ml distilled water and dissolved. The pH of 
the solution was adjusted to pH 6.5 and made up to 1 L distilled water. The solution 
was autoclaved at 105 
o
C for 30 min. Filter sterilised L-glutamine (0.3 M, 66.3 ml) 
(Section 9.1.1.4.3) was added to the solution. The solution was stored at room 
temperature.  
 
9.1.1.6.4 MM without Iron 
Salt solution (50 X, 20 ml), glucose (10 g) and trace elements without iron (1 ml) 
(Section 9.1.1.5.2) were added to 800 ml distilled water and dissolved. The pH of the 
solution was adjusted to pH 6.5 and made up to 1 L distilled water. The solution was 
autoclaved at 105 
o
C for 30 minutes. Filter sterilised L-glutamine (0.3 M, 66.3 ml) 
(Section 9.1.1.4.3) was added to the solution. The solution was stored at room 
temperature.  
 
9.1.1.7 Aspergillus Minimal Media Agar 
9.1.1.7.1 AMM Agar 
Agar (20 g) was added to 1 L of AMM Liquid media (Section 9.1.1.6.1 or 
9.1.1.6.2). The solution was autoclaved and allowed to cool to about 50 
o
C and the 
agar mixture (25 ml) was poured into 90 mm petri dishes under sterile conditions and 
stored at 4 
o
C. 
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9.1.1.7.2 MM Agar 
Agar (20 g) was added to 1 L of MM Liquid Media without added L-glutamine 
(Section 9.1.1.6.3 or 9.1.1.6.4). The solution was autoclaved and allowed to cool to 
about 50 
o
C. L-glutamine (0.3 M; 66.3 ml) was mixed into the cooling agar solution 
and the agar mixture (25 ml) was poured into 90 mm petri dishes under sterile 
conditions and stored at 4 
o
C. 
 
9.1.1.8 Regeneration Agar 
9.1.1.8.1 1.8 % (w/v) Regeneration Agar 
Aspergillus salt solution (50 X; 20 ml), Ammonium Tartrate (100 X; 10 ml), and 
Trace elements (1 ml) (Section 9.1.1.5.1) were added to 800 ml distilled water and 
dissolved. The solution was adjusted to pH 6.8. Sucrose (342 g) was added and the 
solution was made up to 1 L distilled water. Agar (18 g) was added to the solution. 
The solution was autoclaved and kept at 65 
o
C until required. 
 
9.1.1.8.2 0.7% (w/v) Regeneration Agar 
Aspergillus salt solution (50 X; 20 ml), Ammonium Tartrate (100 X; 10 ml), and 
Trace elements (1 ml) (Section 9.1.1.5.1) were added to 800 ml distilled water and 
dissolved. The pH of the solution was adjusted to pH 6.8. Sucrose (342 g) was added 
and the solution was made up to 1 L distilled water. Agar (7 g) was added to the 
solution. The solution was autoclaved and kept at 65 
o
C until required. 
 
9.1.2 Solutions for pH Adjustment 
9.1.2.1 5 M Hydrochloric Acid (HCl) 
Deionised water (40 ml) and hydrochloric acid (43.64 ml) were added slowly to a 
glass graduated cylinder. The final volume was adjusted to 100 ml. The solution was 
stored at room temperature. 
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9.1.2.2 5 M Sodium Hydroxide (NaOH) 
NaOH pellets (20 g) were added to deionised water (80 ml) and dissolved using a 
magnetic stirrer. The final volume was adjusted to 100 ml. The solution was stored at 
room temperature. 
 
9.1.3 Phosphate Buffer Saline 
One PBS tablet (20 X) (Oxoid, Cambridge, UK) was added to 200 ml of distilled 
water, and dissolved by stirring. The solution was autoclaved and stored at room 
temperature. 
 
9.1.4 Phosphate Buffer Saline-Tween 20 (PBST) 
Tween-20 (0.5 ml) was added to 1 L PBS (Section 9.1.3). The solution was 
stored at room temperature. 
 
9.1.5 Phosphate Buffer Saline-Tween 80 (PBST-80) 
Tween-80 (0.5 ml) was added to 1 L PBS (Section 9.1.3). The solution was 
stored at room temperature. 
 
9.1.6 Plate assays 
Plate assay additives were prepared as stock solutions in either water or 
methanol. Iron solutions were stored at room temperature, 
bathophenanthrolinedisulfonic acid disodium salt (BPS), voriconazole, hydrogen 
peroxide, and menadione solutions were stored at 4 
o
C. Gliotoxin and amphothericin 
B solutions were stored at -20 
o
C.  Further details are provided in Table 9.1. 
 
 
 
 
  
Table 9.1: Plate assay additives. 
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Plate Additive   Stock Diluents 
Conc. in 
plate 
Vol/50 ml 
Agar  
Iron FeCl3 1 mM Water 10 μM 500 μl 
75 mM Water 1.5 mM 1 ml 
FeSO4 1 mM Water 10 μM 500 μl 
75 mM Water 1.5 mM 1 ml 
      
Batho-phenanthroline-
disulfonic acid disodium 
salt 
BPS 10 mM Water 200 μM 1 ml 
      
Hydrogen peroxide H2O2 1 M Water 1 mM 50 μl 
Water 2 mM 100 μl 
Water 3 mM 150 μl 
Water 4 mM 200 μl 
      
Voriconazole Vrc 100 μg/ml Water 0.15 μg/ml 15 μl 
Water 0.25 μg/ml 25 μl 
      
Menadione 
 
20mM Methanol 10mM 25μl 
   
 20mM 50μl 
   
 30mM 75μl 
      
Gliotoxin GT 1 mg/ml Methanol 5 μg/ml 250 μl 
Methanol 10 μg/ml 500 μl 
Methanol 20 μg/ml 1 ml 
   
   
Ampothericin B Amp B 
 
Water 0.15μg/ml 30μl 
   
 0.25μg/ml 50μl 
   
 0.5μg/ml 100μl 
  
9.1.7 Luria-Bertani Broth 
LB Broth (25 g) (Difco, Maryland, USA) was dissolved in 1 L distilled water and 
dissolved. The solution was autoclaved and stored at 4 
o
C. 
 
9.1.8 Luria-Bertani Agar 
LB Agar (40 g) (Difco, Maryland, USA) was dissolved in 1 L distilled water.  
The solution was autoclaved, and allowed to cool to ~50 
o
C. Agar (25 ml) was then 
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poured into 90 mm petri dishes, under sterile conditions and allowed to set. They 
were stored at 4 
o
C. 
 
9.1.9 80 % (v/v) Glycerol 
Glycerol (80 ml) was added to 20 ml deionised water. The solution was 
autoclaved and stored at 4 
o
C. 
 
9.1.10 Antibiotics and Supplements 
All antibiotics were supplied by Sigma-Aldrich, with the exception of 
hygromycin B (Melford Laboratories Ltd, Suffolk, U.K). Antibiotics were prepared 
in water and stored at -20 
o
C, with the exception of hygromycin B, which was stored 
at 4 
o
C. Further details are provided in Table 9.2. 
 
Table 9.2: Common antibiotics and supplements with working concentrations 
Antibiotic Diluent Stock 
concentration 
Typical working conc. 
Ampicillin water 100 mg/ml 100 μg/ml 
Hygromycin B water 420 mg/ml 250 μg/ml 
Pyrithiamine water 100 μg/ml 100 ng/ml 
Phleomycin water 25 mg/ml 40 μg/ml 
 
9.1.11 E. coli transformation buffers 
9.1.11.1 5 M Potassium Acetate 
Potassium acetate (4.907 g) was dissolved in distilled water (10 ml). 
 
9.1.11.2 0.2 M Acetic Acid 
Acetic acid (1 ml, 17.48 M) was added to distilled water (86.4 ml). 
 
329 
 
9.1.11.3 RF1 
Potassium acetate (3 ml, 5 M) (Section 9.1.11.1), Calcium chloride dihydrate 
(0.75 g), and glycerol (75 g) were added to 450 ml distilled water. The pH was 
adjusted to pH 5.92 with 0.2 M acetic acid (Section 9.1.11.2). Rubidium chloride (6 
g) and MnCl2.4H2O (4.95 g) were added to the solution and the final volume was 
brought to 500 ml with distilled water. The solution was filter-sterilised and stored at 
4 
o
C. 
 
9.1.11.4 RF2 
Rubidium chloride (0.6 g), calcium chloride dihydrate (5.5 g), MOPS (1.05 g) 
and glycerol (75 g) were added to 400 ml distilled water. The pH was adjusted to 6.8 
with 5 M NaOH (Section 9.1.2.2).  The final volume brought up to 500 ml. The 
solution was filtered sterilised and stored at 4 
o
C. 
 
9.1.12 DNA Electrophoresis Reagents 
9.1.12.1 50 X Tris-Acetate Buffer (TAE) 
Trizma base (242 g) was added to 57.1 ml glacial acetic acid and 100 ml of 0.5 M 
EDTA, pH 8.0. The volume was adjusted to 1 L with distilled water. The solution 
was stored at room temperature. 
 
9.1.12.2 1 X Tris-Acetate Buffer (TAE) 
50 X TAE (20 ml) (Section 9.1.12.1) was added to distilled water (980 ml). The 
solution was stored at room temperature. 
 
9.1.12.3 Ethidium  Bromide 
Ethidium bromide was supplied at 10 mg/ml of which 3 μl was used per 100 ml 
agarose gel. 
 
9.1.12.4 6 X DNA Loading Dye 
Loading dye (Promega, Southampton, UK) was used at the concentration 
supplied. 
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9.1.13 RNA  Electrophoresis Reagents 
9.1.13.1 RNA Glassware 
All glassware required for RNA reagent preparation was soaked in 5% (v/v) HCl 
overnight and rinsed with DEPC water (Section 9.1.13.2). 
 
9.1.13.2 Diethylpyrocarbonate H2O (DEPC) 
DEPC (1 ml) was added to 1 L distilled water in a pre-treated 1L Duran bottle 
(Section 9.1.13.1). The bottle was placed on a magnetic stirrer, and allowed to stir 
overnight. The solution was autoclaved and stored at room temperature. 
 
9.1.13.3 10 X Formaldehyde Agarose (FA) Buffer 
MOPS (41.9 g), sodium acetate (6.8 g) and 0.5 M EDTA pH 8 (20 ml) were 
dissolved in 800 ml DEPC water (Section 9.1.13.2). The pH of the solution was 
adjusted to pH 7.0 and the final volume brought up to 1 L with DEPC water. The 
solution was autoclaved and stored at room temperature. 
 
9.1.13.4 1 X Formaldehyde Agarose (FA) Running Buffer 
FA gel buffer (10 X, 100 ml), 37 % (v/v) (12.3 M) formaldehyde (20 ml) and 
DEPC water (Section 9.1.13.2) (880 ml) were added to a pre-treated 1 L Duran bottle 
(Section 9.1.13.1). The solution was stored at room temperature. 
 
9.1.13.5 5 X RNA Loading Buffer 
Bromophenol Blue (25 mg), 0.5 M EDTA pH 8.0 (80 μl), 37 % (v/v) (12.3 M) 
formaldehyde (750 μl), glycerol (2 ml), formamide (3.084 ml) and 10X FA Buffer (4 
ml) (Section 9.1.13.3), were added together. The buffer was stored at 4 
o
C for three 
months. 
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9.1.14 10 % (w/v) Sodium Dodecyl Sulphate (SDS) 
SDS (10 g) was added to 100 ml deionised water, and dissolved. The solution 
was stored at room temperature. If SDS precipitated, the solution was incubated at 37 
o
C until the SDS went back into solution. 
 
9.1.15 0.3 M Sodium Acetate 
Sodium acetate (2.46 g) was dissolved in 100 ml distilled water. The solution was 
mixed and stored at room temperature. 
 
9.1.16 Transformation Reagents 
9.1.16.1 0.7 M Potassium Chloride 
KCl (26.1 g) was dissolved in 500 ml distilled water. The solution was 
autoclaved and stored at room temperature. 
 
9.1.16.2 25 mM Potassium Phosphate Monobasic 
KH2PO4 (1.7 g) was dissolved in 500 ml distilled water. 
 
9.1.16.3 25 mM Potassium Phosphate dibasic 
K2HPO4 (0.87 g) was dissolved in 200 ml distilled water. 
 
9.1.16.4 Lysis Buffer and Lytic Enyzmes 
9.1.16.4.1 Lysis Buffer 
KCl (26.1 g) was dissolved in 25 mM KH2PO4 (350 ml) (Section 9.1.16.2). The 
pH was adjusted to pH 5.8 with 25 mM K2HPO4 (Section 9.1.16.3). The solution was 
brought to 500 ml with distilled water. 
 
9.1.16.4.2 Lysis Buffer containing Lytic Enzymes 
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Lytic enzymes from Trichoderma harzianum (0.45 g) were added to 15 ml lysis 
buffer (Section 9.1.16.4.1) and filter sterilised with a 0.45 μm filter, changing the 
filter after every 10 ml. 
 
9.1.16.5 Buffer L6 
Sorbitol (72.88 g), Tris-HCl (0.484 g), and CaCl2.2H2O (0.588 g) were dissolved 
in 400 ml distilled water. The pH was adjusted to pH 7.5. The solution was 
autoclaved and stored at room temperature. 
 
9.1.16.6 Buffer L7 
PEG 6000 (60 g) was added to distilled water (40 ml). Tris-HCl (0.157 g) and 
CaCl2.6H2O (0.219 g) was added. Conc. HCl was added to aid dissolution. The pH 
was adjusted to pH 7.5, the solution was autoclaved and stored at room temperature. 
 
9.1.17 Southern Blot reagents 
9.1.17.1 Transfer buffer 
Sodium hydroxide (0.6 M; 16 g) and Sodium chloride (0.4 M; 35.07 g) were 
dissolved in 800 ml distilled water. The volume was adjusted to 1 L with distilled 
water.  
 
9.1.17.2 20 X SSC 
Sodium chloride (175.3 g) and Sodium citrate (88.2 g) were added to distilled 
water (800 ml). The pH was adjusted to pH 7 and the volume brought up to 1 L 
distilled water. The solution was autoclaved and stored at room temperature. 
 
9.1.17.3 2 X SSC 
SSC (100 ml, 20 X) (Section 9.1.17.2) was added to 900 ml distilled water and 
stored at room temperature. 
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9.1.17.4 Dig Buffer 1 (10 X) 
Malic Acid (23.22 g) and NaCl (17.5 g) were added to 180 ml distilled water. 
The pH was adjusted to pH 7.5.  Pellets of NaOH were added to aid dissolving. The 
volume was brought to 200 ml with distilled water. The solution was stored at room 
temperature. 
 
9.1.17.5 Dig Buffer (1 X) 
Malic Acid (2.322 g) and NaCl (1.75 g) were added to 180 ml distilled water. 
The pH was adjusted to pH 7.5.  Pellets of NaOH were added to aid dissolving. The 
volume was brought to 200 ml with distilled water. The solution was stored at room 
temperature. 
 
9.1.17.6 Blocking Reagent 
Blocking Reagent was obtained from Roche Applied Science (Mannheim, 
Germany). 
 
9.1.17.6.1 10 % (w/v) Blocking Reagent 
Blocking reagent (50 g) (Section 9.1.17.6) was dissolved in 500 ml Dig Buffer 1 
(10X) (Section 9.1.17.4). The solution was mixed by stirring and slight heating. The 
solution was then autoclaved and stored at 4
o
C. 
 
9.1.17.7 10 % (w/v) Laurosarcosine 
Lauroylsarcosine (1 g) was dissolved in 10 ml distilled water. 
 
9.1.17.8 High SDS/Blocking Buffer 
Sodium Dodecyl Sulphate (SDS) (35 g), formamide (250 ml), SSC (20 X, 125 
ml) (Section 9.1.17.2), Blocking reagent (10 % (w/v), 100 ml) (Section 9.1.17.6.1), 
and Lauroylsarcosine (10 % (w/v), 5 ml) (Section 9.1.17.7) were added to 1 L 
distilled water. The solution was mixed and stored at 4 
o
C. Before use the solution 
was pre-heated at 65 
o
C for 15 minutes. 
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9.1.17.9 1 X SSC/0.1 % (w/v) SDS 
SSC (20 X, 50 ml) (Section 9.1.17.2) and 4 ml of 10 % (w/v) SDS (Section 
9.1.14) was added to distilled water (946 ml). The solution was mixed and stored at 
room temperature. 
 
9.1.17.10 Dig Wash Buffer (0.3 % (v/v) Tween-20 in Dig Buffer 1) 
Tween 20 (0.15 g) was added to Dig Buffer 1 (1 X, 50 ml) (Section 9.1.17.5). 
The solution was mixed and filter sterilised.  
 
9.1.17.11 Dig Buffer 2 
Dig Buffer 1 (1 X) (Section 9.1.17.5) (20 ml) and Blocking reagent (Section 
9.1.17.6) (2 g) was mixed and filter sterilised and used immediately. 
 
9.1.17.12 Dig Buffer 3 
Tris-HCl (1.575 g), NaCl (0.584 g) and MgCl2 (1.02 g) was dissolved in distilled 
water (90 ml). The pH was adjusted to pH 9.5 and the final volume brought up to 100 
ml. The solution was filtered sterilised and then stored at room temperature. 
  
9.1.17.13 Anti-Digoxigenin-Alkaline Phosphatase (AP), Fab fragment conjugate 
Anti-Digoxigenin- AP, Fab fragments (Roche, Mannheim, Germany) (2 μl) was 
added to 20 ml Dig Buffer 2 (Section 9.1.17.11). 
 
9.1.17.14 Chemiluminescent substrate phosphatase detection (CSPD) Substrate 
CSPD (50 μl) (Roche, Mannheim, Germany) was added to Dig Buffer 3 (5 ml) 
(Section 9.1.17.12). 
 
9.1.18 Chemicals for Photography 
9.1.18.1 Developer Solution 
The Developer (Kodak) was diluted 1/4 in distilled water and stored in a tinfoil 
covered Duran in a dark room. 
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9.1.18.2 Fixer Solution 
The fixer solution (Kodak) was diluted 1/5 in distilled water and stored in a 
tinfoil covered Duran in a dark room. 
 
9.1.19 Organic Extraction Buffer 
Ethyl Acetate (300 ml), dichloromethane (200 ml) and Methanol (100 ml) were 
mixed together and stored in a Duran covered in tinfoil and stored at 4 
o
C. 
 
9.1.20 HPLC Reagents 
9.1.20.1 Solvent A: 0.1 % (v/v) Trifluroacetic acid (TFA) in HPLC grade water 
TFA (1 ml) was added to HPLC Grade Water (1 L) in a darkened Duran. 
 
9.1.20.2 Solvent B: 0.1 % (v/v) Trifluroacetic acid (TFA) in HPLC grade 
Acetonitrile 
TFA (1 ml) was added to HPLC Grade Acetonitrile (1 L) in a darkened Duran. 
 
9.1.21 Triacetylfusarinine C (TAFC) Conjugation Reagents 
9.1.21.1 BSA (6 mg/ml) 
BSA (62 mg) was dissolved in PBS (103 ml) (Section 9.1.3). 
 
9.1.21.2 Sulfo N-hydroxysulfosuccinimidyl-4-azidobenzoate (HSAB) 
preparation 
HSAB (6 mg) was dissolved in DMSO (150 μl), in a 15 ml Falcon tube covered 
in tinfoil. PBS (Section 9.1.3) was added to bring the solution up to 3 ml. 
 
9.1.22 Protein Induction and Purification Reagents 
9.1.22.1 1 M Isopropyl β-D-Thiogalactopyranoside (IPTG) Solution.  
IPTG (0.238 g) was dissolved in 1 ml distilled water. The solution was filter 
sterilised and stored at -20 
o
C. 
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9.1.22.2 Lysis Buffer 
Trizma base (3.02 g), EDTA (0.186 g), Sodium chloride (2.92 g) and Glycerol 
(50 ml) were dissolved in 400 ml distilled water. The pH was adjusted to pH 8.0. The 
final volume was made up to 500 ml with deionised water, and stored at 4 
o
C. 
 
9.1.22.3 Lysozyme Stock 
Lysozyme (10 mg) was dissolved in 1 ml distilled water. 
 
9.1.22.4 Sodium Deoxycholate (120mM) 
Sodium deoxycholate (50 mg) was added to 1 ml distilled water. 
 
9.1.22.5 Wash Buffer 
Trizma base (3.02 g), EDTA (0.186 g), Sodium Chloride (2.92 g) and Triton-X-
100 (20 ml) were dissolved in 400 ml distilled water. The pH was adjusted to pH 8.0, 
and the final volume was made up to 500 ml with deionised water, and stored at 4 
o
C. 
 
9.1.22.6 2 M Urea Buffer 
Trizma base (3.02 g), Urea (60 g), and EDTA (0.186 g) were dissolved in 300 ml 
deionised water and the pH was adjusted to pH 8.0. The final volume was made up to 
500 ml with deionised water, and stored at 4 
o
C. 
 
9.1.22.7 8 M Urea Buffer 
Trizma base (3.02 g), Urea (240 g), and EDTA (0.186 g) were dissolved in 300 
ml deionised water. The pH was adjusted to pH 8.0. The final volume was made up 
to 500 ml with deionised water, and stored at 4 
o
C. 
 
9.1.23 SDS-PAGE Reagents 
9.1.23.1 1.5 M Tris-HCl, pH 8.8 
Trizma base (18.15 g) was dissolved in 75 ml deionised water. The pH was 
adjusted to pH 8.8 and the volume brought up to 100 ml with deionised water. The 
solution was stored at 4 
o
C. 
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9.1.23.2 0.5 M Tris-HCl, pH 6.8 
Trizma base (6.05 g) was dissolved in 75 ml deionised water. The pH was 
adjusted to pH 6.8 and the solution was brought to a final volume of 100 ml with 
deionised water. The solution as stored at 4 
o
C. 
 
9.1.23.3 10 % (w/v) Ammonium Persulphate 
Ammonium persulphate (0.1 g) was added to 1 ml deionised water. The solution 
was stored at 4 
o
C, and used immediately. 
 
9.1.23.4 30 % (w/v) Acrylamide/Bis 
Protogel (National Diagnostics, Hessle Hull, England) was obtained which 
contained 30 % (w/v) acrylamide: 0.8% (w/v) Bis-acrylamide. 
 
9.1.23.5 0.5 % (w/v) Bromophenol Blue 
Bromophenol blue (0.1 g) was added to deionised water (20 ml). The solution 
was stored at 4 
o
C. 
 
9.1.23.6 Lysis Buffer 
NaH2PO4.2H2O (1.5 g) and Sodium Chloride (4.3 g) were dissolved in 250 ml 
distilled water. The solution was stored at room temperature. 
 
9.1.23.7 5 X Solubilisation Buffer 
Glycerol (10 ml) was added to deionised water (4 ml), containing 1.6 ml of 10 % 
(w/v) SDS and 1 ml of 0.5 M Tris-HCl, (pH 6.8). The solution was mixed and then 
2-mercapthoethanol (0.4 ml) was added along with 0.2 ml of 0.5% (w/v) 
bromophenol blue solution (Section 9.1.23.5). The solution was stored at room 
temperature. 
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9.1.23.8 5 X Electrode Running Buffer 
Trizma base (15 g), glycine (72 g) and SDS (5 g) were dissolved in deionised 
water (800 ml). The final volume was adjusted to 1 L. The solution was stored at 
room temperature. 
 
9.1.23.8.1 1 X Electrode Running Buffer 
5 X Electrode Running Buffer (200 ml) (Section 9.1.23.8.1) was added to 800 ml 
distilled water. The solution was stored at room temperature.  
 
9.1.23.9 Coomassie Blue Stain Solution 
Coomassie® Brilliant Blue R (2.5 g), glacial acetic acid (100 ml), methanol (450 
ml) and deionised water (50 ml) were added to a glass bottle and mixed. The solution 
was brought to a final volume of 1 L and the solution was stored at room 
temperature. 
 
9.1.23.10 Destain Solution 
Glacial acetic acid (100 ml) and methanol (150 ml) was added to 750 ml 
deionised water. The solution was stored at room temperature. 
 
9.1.24 Western Blot Reagents 
9.1.24.1 Towbin Electrotransfer Buffer 
Trizma base (30.3 g) and glycine (144 g) were added to 3 L deionised water and 
1 L methanol. The pH was adjusted to between 8 – 8.5 and the final volume brought 
to 5 L with deionised water. The solution was stored at room temperature. 
 
9.1.24.2 Blocking Solution 
Marvel® (Powdered Milk) (5 g) was added to 100 ml PBST (Section 9.1.4). 
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9.1.24.3 Substrate Buffer (0.1 M Tris-HCl, pH 7.6) 
Trizma base (12.1 g) was added to 800 ml deionised water. The pH was adjusted 
to pH 7.6 and the final volume was brought up to 1 L with deionised water. The 
solution was stored at room temperature. 
 
9.1.24.4 AEC Substrate Buffer Components 
9.1.24.4.1 0.2 M Acetic acid Solution 
Acetic acid (11.45 ml, 17.48 M) was added to 1 L distilled water. The solution 
was kept at room temperature. 
 
9.1.24.4.2 0.2 M Sodium acetate Solution 
Sodium acetate (27.2 g) was added to 1 L distilled water. The solution was kept 
at room temperature. 
 
9.1.24.4.3 AEC Substrate Buffer 
Acetic acid (148 ml, 0.2 M) (Section 9.1.24.4.1) was mixed with Sodium acetate 
(352 ml, 0.2 M) (Section 9.1.24.4.2). The pH was adjusted to 5, if required and the 
final volume was brought to 1 L with distilled water.  The solution was stored at 
room temperature. 
 
9.1.24.4.4 AEC Substrate 
3-Amino-9-Ethylcarbazole (AEC) (1 tablet) was dissolved in N,N-
Dimethylformamide (1 ml) and vortexed until dissolved. 
 
9.1.24.4.5 AEC Substrate Solution 
AEC Substrate (1 ml, Section 9.1.24.4.4) was added to 25 ml AEC Substrate 
Buffer (Section 9.1.24.4). Once mixed, Hydrogen peroxide (10 μl) was added to the 
solution. The solution was used immediately.  
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9.1.24.5 DAB Solution 
3, 3’ –diaminobenzidine (DAB) (1 tablet) was dissolved in Substrate Buffer (15 
ml) (Section 9.1.24.3). Hydrogen Peroxide (7 μl) was added and the solution was 
used immediately. 
 
9.1.25 ELISA Buffers and Reagents 
9.1.25.1 1X Carbonate Buffer 
Na2CO3 (5.3 g) was dissolved into 900 ml distilled water. NaHCO3 (4.2 g) was 
added and the pH was adjusted to pH 9.6 with 5 M HCl (Section 9.1.2.1). The final 
volume was brought up to 1 L with distilled water. 
 
9.1.25.2 ELISA Blocking Buffer 
Sucrose (10 g) and BSA (1 g) was added to 100 ml Carbonate Buffer (Section 
9.1.25.1). 
 
9.1.25.3 ELISA Antibody Buffer 
BSA (1 g) was added to PBST (100 ml) (Section 9.1.4)  
 
9.1.25.4 HRP-conjugated human IgG 
HRP-conjugated human IgG (2 μl) was added to ELISA Antibody Buffer (20 ml) 
(Section 9.1.25.3) and kept on ice until required. 
 
9.1.25.5 Tetramethylbenzidine (TMB) Substrate 
Tetramethylbenzidine (TMB) Substrate was used according to manufacturer’s 
instructions. TMB was used at room temperature and kept out of light, as it is light 
sensitive. 
 
9.1.25.6 ELISA Stop solution (1N H2SO4) 
Sulphuric acid (6.9 ml) was added to distilled water (250 ml) in a fume hood, 
using a glass graduated cylinder. The solution was stored in a glass Duran at room 
temperature.  
